{"meta":{"query_hash":"b7d1b77a1ab4","filters":{"venue":"Drugs"},"cohort_total":213,"direct_labels_cover":0,"predictions_cover":213,"exported":213,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/b7d1b77a1ab4","api":"https://metacan.xera.ac/api/v1/cohort?venue=Drugs"},"results":[{"id":"W1027163360","doi":"10.1007/s40265-015-0422-x","title":"Controversies Around Epidemiology, Diagnosis and Treatment of Clostridium difficile Infection","year":2015,"lang":"en","type":"review","venue":"Drugs","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of British Columbia Hospital","funders":"","keywords":"Clostridium difficile; Fidaxomicin; Medicine; Vancomycin; Metronidazole; Epidemiology; Intensive care medicine; Incidence (geometry); Pharmacotherapy; Infection control; Disease; Internal medicine; Antibiotics; Pediatrics; Microbiology","score_opus":0.1530025530572249,"score_gpt":0.4150057551255378,"score_spread":0.26200320206831285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1027163360","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000029776484,0.99932075,0.00001372254,0.0004363209,0.00007819841,0.0000013608214,0.000008362979,6.792434e-7,0.00011091205],"genre_scores_gemma":[0.00037699818,0.99899405,0.000059125694,0.00039676492,0.00013422409,0.0000028572465,0.000009136975,3.5926612e-7,0.000026500482],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9975961,0.0007182509,0.0006528125,0.00023053352,0.0006964764,0.00010583522],"domain_scores_gemma":[0.9909384,0.006776935,0.0012421762,0.000095433745,0.0007955448,0.00015144367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004651735,0.0008039568,0.003406978,0.0049070283,0.00048231037,0.0026670713,0.0015105085,0.002370219,0.0026112502],"category_scores_gemma":[0.011264088,0.0004989566,0.0015745455,0.005982856,0.0014808471,0.0027492272,0.0012915523,0.0024507572,0.00044717113],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018874774,0.000060267368,0.0009002363,0.18170005,0.0008404231,0.00019926972,0.00022823978,0.00028268268,0.00032363753,0.006761116,0.031040639,0.77747464],"study_design_scores_gemma":[0.000108108,0.0001387724,0.0033643811,0.17485037,0.0031065452,0.0014256716,0.00048333174,0.00011800586,0.0002523771,0.0059254263,0.8101621,0.000064888285],"about_ca_topic_score_codex":0.004563459,"about_ca_topic_score_gemma":0.008915305,"teacher_disagreement_score":0.0049070283,"about_ca_system_score_codex":0.0019721237,"about_ca_system_score_gemma":0.006596596,"threshold_uncertainty_score":0.024601042},"labels":[],"label_agreement":null},{"id":"W114418843","doi":"10.2165/00003495-200464120-00001","title":"Biological Agents for Rheumatoid Arthritis","year":2004,"lang":"en","type":"review","venue":"Drugs","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arthritis Research Centre of Canada; Vancouver Hospital and Health Sciences Centre; University of British Columbia","funders":"","keywords":"Medicine; Rheumatoid arthritis; Pharmacotherapy; Arthritis; Intensive care medicine; Internal medicine","score_opus":0.07007589361737611,"score_gpt":0.3673728519366236,"score_spread":0.2972969583192475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W114418843","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001065392,0.9965669,0.00017312077,0.00022887427,0.0005029206,0.000026178164,0.000040122493,0.000016417223,0.0023389142],"genre_scores_gemma":[0.00081888225,0.99484295,0.0003480249,0.00043104944,0.00040043518,0.000028589184,0.000058533056,0.0000024679791,0.0030691603],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99967885,0.000057784946,0.00006630506,0.00003735861,0.00012468366,0.00003516928],"domain_scores_gemma":[0.9995784,0.00013648342,0.00013366295,0.000018517265,0.0000877612,0.000045056968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007093577,0.0019052195,0.0028074607,0.005087185,0.00040438856,0.0010818131,0.0010859558,0.001497973,0.009471804],"category_scores_gemma":[0.00088398746,0.0004940583,0.0007010634,0.0035440812,0.00067958503,0.0015475531,0.00093224546,0.0022354086,0.0058483887],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022185734,0.00014346429,0.000091817936,0.02374567,0.00013240128,0.00027212384,0.000051323033,0.00023907374,0.0028247787,0.0015545755,0.06053978,0.91018313],"study_design_scores_gemma":[0.00011555716,0.0002138654,0.00053508615,0.0031713813,0.00030699087,0.0010726956,0.000031899857,0.000050506347,0.00047724304,0.0006153549,0.993396,0.000013559624],"about_ca_topic_score_codex":0.0014139566,"about_ca_topic_score_gemma":0.004757507,"teacher_disagreement_score":0.009471804,"about_ca_system_score_codex":0.00066301203,"about_ca_system_score_gemma":0.0014203842,"threshold_uncertainty_score":0.031686366},"labels":[],"label_agreement":null},{"id":"W1161070254","doi":"10.1007/s40265-015-0443-5","title":"A Practical Approach to the Management of Radiation-Induced Hemorrhagic Cystitis","year":2015,"lang":"en","type":"review","venue":"Drugs","topic":"Polyomavirus and related diseases","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Hemorrhagic cystitis; Radiation therapy; Cystoscopy; Urology; Surgery; Urinary system; Complication; Internal medicine; Chemotherapy; Cyclophosphamide","score_opus":0.07932815640015588,"score_gpt":0.38248011252988123,"score_spread":0.30315195612972534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1161070254","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011676165,0.9977806,0.00032620502,0.0005273627,0.00021028404,0.0000067963815,0.000013423011,0.000009936643,0.0010087206],"genre_scores_gemma":[0.001340114,0.9964803,0.00067041663,0.000572967,0.0003832628,0.000008152551,0.000030741245,0.0000016298341,0.00051243865],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99978286,0.000048959017,0.000045067944,0.000031000483,0.000075650656,0.000016492144],"domain_scores_gemma":[0.999652,0.00018999823,0.000060514103,0.00000972938,0.000064596075,0.000023072713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043221246,0.00069292623,0.001201073,0.0024117334,0.0003636492,0.0009453957,0.0007555834,0.0012372336,0.003559467],"category_scores_gemma":[0.0008872104,0.00021427334,0.0007710052,0.0010666151,0.00046878902,0.0011982676,0.0006709619,0.002259774,0.000969165],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059547037,0.00010055296,0.00030551807,0.014949393,0.00012165529,0.0006376948,0.00004668029,0.0002507679,0.0010464528,0.0022679104,0.023225375,0.9569885],"study_design_scores_gemma":[0.00007639782,0.00022558926,0.0027381235,0.014662669,0.00046794207,0.010551364,0.00015159119,0.00030877124,0.0009040453,0.0040810495,0.96577483,0.000057596593],"about_ca_topic_score_codex":0.0012105677,"about_ca_topic_score_gemma":0.0025644568,"teacher_disagreement_score":0.003559467,"about_ca_system_score_codex":0.0004661559,"about_ca_system_score_gemma":0.0010374459,"threshold_uncertainty_score":0.011907637},"labels":[],"label_agreement":null},{"id":"W1248577202","doi":"10.2165/11641160-000000000-00000","title":"Management of Bleeding in Patients Receiving Conventional or New Anticoagulants","year":2012,"lang":"en","type":"review","venue":"Drugs","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Anticoagulant; Intensive care medicine; Clotting factor; Resuscitation; Major bleeding; Anesthesia; Surgery; Atrial fibrillation; Internal medicine","score_opus":0.06856875756673375,"score_gpt":0.34879708797077874,"score_spread":0.280228330404045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1248577202","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001418164,0.9992899,0.0000741996,0.00013043277,0.000068498135,0.0000031922602,0.000009356723,0.0000033375538,0.0002792157],"genre_scores_gemma":[0.0010688548,0.9981912,0.0002707321,0.00015999432,0.00016591542,0.0000038270155,0.000024089093,8.012853e-7,0.00011466526],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99964905,0.00005952752,0.000096825366,0.00005556868,0.00011854109,0.000020407726],"domain_scores_gemma":[0.99923956,0.00042682624,0.00018566388,0.000010519599,0.00010310186,0.000034223816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006208512,0.00082386524,0.001841544,0.002666333,0.00020617973,0.0010129923,0.0009435769,0.0009769552,0.002044204],"category_scores_gemma":[0.0016474342,0.0002844466,0.0008684902,0.0019910499,0.0003733761,0.0009411886,0.00043620297,0.001529505,0.0005376829],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013936657,0.000089748195,0.00079744303,0.030168718,0.00035797112,0.0003100957,0.000047079553,0.00022344218,0.00046866745,0.0006225781,0.012556416,0.95421845],"study_design_scores_gemma":[0.0005011358,0.00069760776,0.01580908,0.06556954,0.004718155,0.014283561,0.00036171678,0.0007858161,0.0010129004,0.003334655,0.8927746,0.00015131409],"about_ca_topic_score_codex":0.0016943008,"about_ca_topic_score_gemma":0.003677925,"teacher_disagreement_score":0.002666333,"about_ca_system_score_codex":0.0004397411,"about_ca_system_score_gemma":0.000863414,"threshold_uncertainty_score":0.00683856},"labels":[],"label_agreement":null},{"id":"W132865001","doi":"10.2165/00003495-200666002-00004","title":"Resolution of Severe Diarrhoea and Return to Work in a Patient Converted from Mycophenolate Mofetil to Enteric-coated Mycophenolate Sodium (myfortic??)","year":2006,"lang":"en","type":"article","venue":"Drugs","topic":"Mycobacterium research and diagnosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Mycophenolate; Medicine; Enteric coated; Mycophenolic acid; Pharmacotherapy; Internal medicine; Transplantation","score_opus":0.0074920783094953,"score_gpt":0.23229367395914763,"score_spread":0.22480159564965232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W132865001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97224784,0.0031691594,0.0013028606,0.012274291,0.0013198386,0.00017234495,0.00026702118,0.00014659851,0.009100022],"genre_scores_gemma":[0.9931625,0.0011937951,0.0006282338,0.0027815222,0.00060570927,0.000014881012,0.00012806764,0.000020647496,0.0014646203],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9994868,0.00008696536,0.00006262458,0.00008579429,0.000060718492,0.00021701887],"domain_scores_gemma":[0.9986601,0.00037581142,0.00015051026,0.000086185806,0.00007524483,0.00065221614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029746883,0.0010218346,0.0011282003,0.001085004,0.0020798985,0.0012647688,0.0013239079,0.0068252897,0.0016829843],"category_scores_gemma":[0.00328332,0.000778518,0.002093148,0.00073931576,0.0009845537,0.0010660589,0.0009510869,0.005121775,0.00068153965],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067836203,0.00042208214,0.011899449,0.00005577372,0.000039914874,0.98076195,0.00025782525,0.00013763273,0.0011945013,0.00015412988,0.0006149141,0.0037835145],"study_design_scores_gemma":[0.00028333595,0.0027947633,0.03787572,0.00005024985,0.000056157554,0.95470315,0.0005632729,0.0005511669,0.0011768149,0.00020380557,0.0016866791,0.000054881784],"about_ca_topic_score_codex":0.0027134612,"about_ca_topic_score_gemma":0.0042088334,"teacher_disagreement_score":0.0068252897,"about_ca_system_score_codex":0.0012239726,"about_ca_system_score_gemma":0.00084322307,"threshold_uncertainty_score":0.008880556},"labels":[],"label_agreement":null},{"id":"W1424849964","doi":"10.2165/11593730-000000000-00000","title":"Biosimilars of Biological Drug Therapies","year":2011,"lang":"en","type":"review","venue":"Drugs","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":122,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Biosimilar; Risk analysis (engineering); Medicine; Immunogenicity; Drug; Pharmacology; Intensive care medicine; Immune system; Immunology","score_opus":0.10087913348773116,"score_gpt":0.349562527575078,"score_spread":0.24868339408734685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1424849964","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010910407,0.9975109,0.00030792758,0.00019730645,0.00035974447,0.0000059620656,0.000013435006,0.0000060357625,0.0014895716],"genre_scores_gemma":[0.00090663537,0.99633324,0.00051556673,0.00030226278,0.00045584294,0.00000807084,0.000040441348,0.0000028613817,0.00143507],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994491,0.00010588538,0.000078325036,0.00007646652,0.00025144313,0.00003893125],"domain_scores_gemma":[0.998862,0.0005896245,0.00019059223,0.000038195005,0.0002573092,0.000062241874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014541189,0.0012906448,0.0015701229,0.0034640785,0.00029266631,0.0015188906,0.0010863309,0.001722591,0.0041575544],"category_scores_gemma":[0.0018970257,0.00036484055,0.0004834226,0.0032048526,0.00089273637,0.0019861932,0.00093877595,0.0021165411,0.0027156414],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008460922,0.000082969804,0.00008927937,0.00824026,0.000043492248,0.00018931163,0.000036033307,0.00034063423,0.0023807331,0.0052745785,0.028079884,0.95515805],"study_design_scores_gemma":[0.000021578262,0.000074859316,0.0003226872,0.0016391019,0.000046427424,0.0009231298,0.00002660482,0.0000989515,0.000668017,0.0017024875,0.99446493,0.000011245588],"about_ca_topic_score_codex":0.00073659315,"about_ca_topic_score_gemma":0.0013732649,"teacher_disagreement_score":0.0041575544,"about_ca_system_score_codex":0.0008690738,"about_ca_system_score_gemma":0.00122256,"threshold_uncertainty_score":0.013908386},"labels":[],"label_agreement":null},{"id":"W1480461509","doi":"10.2165/11636220-000000000-00000","title":"Sedation for Critically Ill or Injured Adults in the Intensive Care Unit","year":2012,"lang":"en","type":"review","venue":"Drugs","topic":"Anesthesia and Sedative Agents","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University; Foothills Medical Centre; University of Calgary","funders":"Alberta Innovates; Alberta Innovates - Health Solutions; University of Calgary; Canadian Anesthesiologists' Society; Heart and Stroke Foundation of Canada","keywords":"Sedation; Medicine; Sedative; Delirium; Intensive care medicine; Intensive care unit; Dexmedetomidine; Critically ill; Mechanical ventilation; Randomized controlled trial; Intensive care; MEDLINE; Anesthesia; Surgery","score_opus":0.09949290808970769,"score_gpt":0.3955438668134486,"score_spread":0.29605095872374093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1480461509","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000114285285,0.9993537,0.000060716084,0.000076695615,0.000066756234,0.0000045854576,0.000009574749,0.0000028080347,0.00031098363],"genre_scores_gemma":[0.00064134813,0.9988489,0.0001541104,0.00011403936,0.000065231296,0.000004710622,0.000014313271,7.990743e-7,0.00015657058],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997223,0.000055162112,0.00007993331,0.000041967924,0.00008253062,0.000017997341],"domain_scores_gemma":[0.99936074,0.0003324892,0.00016556987,0.000010937494,0.00009750167,0.000032819044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006302855,0.0008914031,0.0018071411,0.0018319042,0.00024307244,0.0007128195,0.0007937613,0.0008696363,0.0022235687],"category_scores_gemma":[0.0012003136,0.00025933076,0.00066540163,0.001900295,0.0004370758,0.0010212015,0.00061022287,0.0013443475,0.0006367107],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011694068,0.0000653843,0.00024075975,0.046259444,0.00020885517,0.0001447124,0.000040028855,0.00018837099,0.0007535415,0.00061968085,0.011591851,0.9397705],"study_design_scores_gemma":[0.00021566433,0.00050962553,0.0063797883,0.052885033,0.0018727274,0.004317569,0.00026611722,0.00035285813,0.0012253281,0.0017072953,0.93019456,0.000073330135],"about_ca_topic_score_codex":0.002259488,"about_ca_topic_score_gemma":0.0061314693,"teacher_disagreement_score":0.002259488,"about_ca_system_score_codex":0.00051251723,"about_ca_system_score_gemma":0.001308068,"threshold_uncertainty_score":0.0074386},"labels":[],"label_agreement":null},{"id":"W14899582","doi":"10.2165/11635740-000000000-00000","title":"Thrombolytic Therapy for Acute Ischaemic Stroke","year":2012,"lang":"en","type":"article","venue":"Drugs","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Ontario Brain Institute; University of Calgary","funders":"Alberta Innovates","keywords":"Medicine; Thrombolysis; Stroke (engine); Intensive care medicine; Fibrinolytic agent; Acute stroke; Tissue plasminogen activator; Ischaemic stroke; SAFER; Internal medicine; Myocardial infarction; Ischemia","score_opus":0.01915028886389957,"score_gpt":0.3109649841788531,"score_spread":0.2918146953149535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W14899582","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.047761645,0.6884844,0.00097098685,0.030637838,0.004082828,0.00028432184,0.0010407065,0.0001317469,0.22660555],"genre_scores_gemma":[0.37454063,0.55523247,0.0032907866,0.013915967,0.010958974,0.00034179955,0.0019683486,0.000038379432,0.039712574],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996482,0.00009744632,0.00006641029,0.000019432102,0.00011863972,0.000049835588],"domain_scores_gemma":[0.9996426,0.00010203983,0.00011043264,0.000013263124,0.000051168656,0.00008046091],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042676972,0.0002709985,0.00062703,0.0011576611,0.0004265806,0.0008119166,0.0002407475,0.0005156123,0.0069814296],"category_scores_gemma":[0.0022590389,0.0000711503,0.00035298098,0.0011117015,0.00014055113,0.00037916854,0.00024340082,0.0007769735,0.0021881224],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023007863,0.0009467647,0.012244488,0.002514014,0.0003304032,0.0013405985,0.00013658137,0.00019695533,0.001262982,0.0073998733,0.11656975,0.8547567],"study_design_scores_gemma":[0.0042899675,0.00344204,0.16629748,0.005319582,0.0017137448,0.010203491,0.00028532193,0.00070573855,0.0017659349,0.011266974,0.7946511,0.00005861143],"about_ca_topic_score_codex":0.0012434283,"about_ca_topic_score_gemma":0.0038141985,"teacher_disagreement_score":0.0069814296,"about_ca_system_score_codex":0.0006726996,"about_ca_system_score_gemma":0.0012204424,"threshold_uncertainty_score":0.023355246},"labels":[],"label_agreement":null},{"id":"W1527756626","doi":"10.2165/11585440-000000000-00000","title":"Drug-Resistant Tuberculosis","year":2011,"lang":"en","type":"article","venue":"Drugs","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Regimen; Tuberculosis; Adverse effect; Pharmacotherapy; Drug resistance; Intensive care medicine; Drug; Bedaquiline; Disease; Mycobacterium tuberculosis; Pharmacology; Surgery; Internal medicine; Pathology","score_opus":0.037385107576415146,"score_gpt":0.30448286132137475,"score_spread":0.2670977537449596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1527756626","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4414896,0.17921636,0.005547964,0.024318617,0.0030519017,0.00068494206,0.016632888,0.00048119243,0.3285765],"genre_scores_gemma":[0.91836876,0.04047389,0.0020313363,0.008331546,0.0017714076,0.00012447646,0.0047306893,0.00005488941,0.024113081],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985667,0.0006080813,0.00017948108,0.00014246191,0.000332627,0.00017073956],"domain_scores_gemma":[0.99699616,0.00067582435,0.0011751634,0.0003452922,0.0003842866,0.00042324813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009017676,0.00024378288,0.00042931875,0.0012814428,0.0004106853,0.00093486503,0.00035527736,0.0005123651,0.010182913],"category_scores_gemma":[0.004247258,0.000114482726,0.00029133313,0.0015373622,0.00039102955,0.00047956847,0.00044444666,0.0009387696,0.0022334664],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090498774,0.0007103303,0.48168257,0.002201019,0.00034196835,0.0051995,0.0006153423,0.00019126131,0.006584435,0.012674242,0.06528694,0.42360744],"study_design_scores_gemma":[0.00014308376,0.0009613713,0.4875596,0.0014660596,0.00038886035,0.026177032,0.0007117636,0.00048166513,0.0036710154,0.0035095296,0.47489575,0.0000343362],"about_ca_topic_score_codex":0.0017336321,"about_ca_topic_score_gemma":0.0021427313,"teacher_disagreement_score":0.010182913,"about_ca_system_score_codex":0.0005016754,"about_ca_system_score_gemma":0.0005225425,"threshold_uncertainty_score":0.034065247},"labels":[],"label_agreement":null},{"id":"W1598581251","doi":"10.2165/11599470-000000000-00000","title":"The Cost Effectiveness of Human Papillomavirus Vaccines","year":2012,"lang":"en","type":"review","venue":"Drugs","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; Providence Health Care Research Institute; Providence Health Care; BC Centre for Disease Control; University of British Columbia","funders":"","keywords":"Medicine; Human papillomavirus; Human papillomavirus vaccine; Virology; Pharmacotherapy; Immunology; Gardasil; Internal medicine; Cancer; Cervical cancer","score_opus":0.12372828497937456,"score_gpt":0.4621449820442727,"score_spread":0.33841669706489813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1598581251","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006151317,0.9995522,0.000018164488,0.00011945309,0.000042834843,0.0000022273525,0.000015050634,8.4948414e-7,0.00018762273],"genre_scores_gemma":[0.0011313679,0.9985354,0.00006164476,0.000118472955,0.00006781674,0.000004097415,0.000014854135,5.477687e-7,0.00006584958],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991744,0.00026026776,0.00013674737,0.000080650105,0.000297462,0.00005049319],"domain_scores_gemma":[0.9977864,0.0016905334,0.0002936684,0.000023123712,0.00017350032,0.00003275141],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001453777,0.0009952651,0.003069329,0.00286506,0.00016274881,0.0012301338,0.0010371044,0.0015128893,0.004630127],"category_scores_gemma":[0.0040967646,0.00035167774,0.001906072,0.0034319074,0.00044638917,0.0010661859,0.00052534445,0.0014076977,0.00043165375],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005202512,0.000050667164,0.00028979662,0.11919751,0.0019188386,0.00011961283,0.000027522678,0.00074601773,0.0003658844,0.0031411664,0.017408526,0.8562142],"study_design_scores_gemma":[0.0008915689,0.0007695097,0.0074711014,0.15292996,0.017598098,0.0025520502,0.00023565293,0.0007400825,0.001032608,0.008482948,0.8072069,0.00008952774],"about_ca_topic_score_codex":0.003778661,"about_ca_topic_score_gemma":0.0054305964,"teacher_disagreement_score":0.004630127,"about_ca_system_score_codex":0.0018239885,"about_ca_system_score_gemma":0.0017747249,"threshold_uncertainty_score":0.01548928},"labels":[],"label_agreement":null},{"id":"W169459663","doi":"10.2165/00003495-200161040-00003","title":"Review of Macrolides and Ketolides","year":2001,"lang":"en","type":"review","venue":"Drugs","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":301,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Manitoba","funders":"","keywords":"Roxithromycin; Ketolide; Telithromycin; Microbiology; Clarithromycin; Erythromycin; Streptococcus pneumoniae; Macrolide Antibiotics; Azithromycin; Haemophilus influenzae; Antibiotics; Medicine; Chemistry; Biology","score_opus":0.043274835764260965,"score_gpt":0.3807761641455251,"score_spread":0.3375013283812642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W169459663","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000709506,0.9987488,0.00007330508,0.00011386123,0.00028502458,0.000008347765,0.00003494521,0.000008313984,0.0006564683],"genre_scores_gemma":[0.00024941188,0.9985257,0.00020475793,0.0001900243,0.00027884045,0.0000074377513,0.00004239065,0.0000011852096,0.00050035235],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999619,0.00005252251,0.000097777374,0.000051321975,0.00015101569,0.00002833004],"domain_scores_gemma":[0.99948263,0.00018738027,0.00013622586,0.000013181415,0.0001319479,0.000048671973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005981301,0.0015595284,0.0029865522,0.00474565,0.0003169762,0.001360803,0.0012741515,0.0013238676,0.0056774435],"category_scores_gemma":[0.0011495036,0.00047784363,0.0008101947,0.0066731307,0.00042590103,0.0017157985,0.0008531172,0.0013670034,0.0027249386],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021675273,0.00009487223,0.00021043407,0.051487137,0.00026760515,0.00038792382,0.000053741263,0.0003588111,0.0018023971,0.00078723655,0.071095526,0.8732376],"study_design_scores_gemma":[0.00007400328,0.00014758068,0.0011984089,0.0069492967,0.0004781892,0.0016913352,0.000049278333,0.000077357756,0.0002592877,0.00042799613,0.9886221,0.000025029005],"about_ca_topic_score_codex":0.0022852414,"about_ca_topic_score_gemma":0.0049809366,"teacher_disagreement_score":0.0056774435,"about_ca_system_score_codex":0.0007080484,"about_ca_system_score_gemma":0.0019626038,"threshold_uncertainty_score":0.0189929},"labels":[],"label_agreement":null},{"id":"W186149320","doi":"10.2165/11595870-000000000-00000","title":"Current and Emerging Drug Treatment Options for Alzheimerʼs Disease","year":2011,"lang":"en","type":"review","venue":"Drugs","topic":"Alzheimer's disease research and treatments","field":"Medicine","cited_by":233,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Pharmacotherapy; Drug; Disease; Current (fluid); Alzheimer's disease; Intensive care medicine; Pharmacology; Internal medicine","score_opus":0.10408147618995826,"score_gpt":0.41435526508169573,"score_spread":0.31027378889173746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W186149320","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000102036305,0.9984143,0.00010515708,0.00022586269,0.0001254222,0.0000070347996,0.000022122758,0.000008524147,0.0009896307],"genre_scores_gemma":[0.00078729563,0.9978896,0.0002550833,0.0002360663,0.00014908549,0.000010854773,0.00003062204,0.0000013298942,0.00064002565],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99980146,0.000033665136,0.000048013553,0.00003010675,0.00006518936,0.000021621436],"domain_scores_gemma":[0.99956757,0.00021717389,0.00009852236,0.000011041745,0.00007268741,0.00003301187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006769016,0.0012126479,0.0023950692,0.0031313805,0.00031706505,0.0010144337,0.00091641414,0.0012180512,0.006334217],"category_scores_gemma":[0.0008575097,0.0003422401,0.0007024207,0.0025753325,0.00047543854,0.0017586137,0.0006149485,0.0018257161,0.0021604656],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015086945,0.00009699585,0.00009876357,0.01625221,0.000119487064,0.0001595494,0.000033197928,0.0001914118,0.0007572022,0.001478704,0.022749925,0.9579117],"study_design_scores_gemma":[0.00014231305,0.00026641897,0.00097482995,0.007419348,0.00073200086,0.0015489033,0.000072198294,0.00017466032,0.0005398798,0.0019851525,0.9861189,0.000025386318],"about_ca_topic_score_codex":0.0013697025,"about_ca_topic_score_gemma":0.0048960736,"teacher_disagreement_score":0.006334217,"about_ca_system_score_codex":0.000657303,"about_ca_system_score_gemma":0.0012761743,"threshold_uncertainty_score":0.021190047},"labels":[],"label_agreement":null},{"id":"W1964772192","doi":"10.2165/00003495-200464060-00004","title":"Current Issues in the Management of Urinary Tract Infections","year":2004,"lang":"en","type":"review","venue":"Drugs","topic":"Urinary Tract Infections Management","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Royal University Hospital","funders":"","keywords":"Medicine; Intensive care medicine; Pharmacotherapy; Urinary system; Current (fluid); Internal medicine","score_opus":0.04426529444297341,"score_gpt":0.3864096607318575,"score_spread":0.3421443662888841,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964772192","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004311172,0.9988336,0.00006714835,0.00031172804,0.00023118188,0.000003020784,0.0000053514477,0.0000043239997,0.0005006659],"genre_scores_gemma":[0.00027497433,0.99862456,0.00022044906,0.00026947894,0.00031517813,0.0000041789694,0.00001105496,9.289225e-7,0.0002792955],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993513,0.00014661868,0.00013108941,0.000079675825,0.0002450514,0.00004622414],"domain_scores_gemma":[0.99828845,0.0009619017,0.00026387794,0.00002944334,0.00035134386,0.000105032086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015044257,0.0011976401,0.0029095144,0.003476268,0.00048030683,0.002030102,0.0014365995,0.0019335331,0.0039116303],"category_scores_gemma":[0.0022147556,0.0004264838,0.00081240415,0.0046442547,0.0008534384,0.0025134413,0.0007702304,0.0027339177,0.0019482976],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008656384,0.000097956756,0.00029955988,0.021342197,0.00009638493,0.00034003664,0.000055664917,0.00027224174,0.0004388359,0.0014292368,0.03016485,0.94537646],"study_design_scores_gemma":[0.000051334468,0.00016892726,0.0016128903,0.015284859,0.0003195533,0.002851094,0.00014778019,0.00016397338,0.00021881962,0.001528908,0.97762215,0.000029725274],"about_ca_topic_score_codex":0.002331808,"about_ca_topic_score_gemma":0.0058270106,"teacher_disagreement_score":0.0039116303,"about_ca_system_score_codex":0.001060003,"about_ca_system_score_gemma":0.0021228571,"threshold_uncertainty_score":0.0130857825},"labels":[],"label_agreement":null},{"id":"W1965009420","doi":"10.2165/00003495-200767140-00007","title":"Fluoroquinolones for the Treatment of Pulmonary Tuberculosis","year":2007,"lang":"en","type":"review","venue":"Drugs","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; University of British Columbia; BC Centre for Disease Control","funders":"","keywords":"Medicine; Moxifloxacin; Ethambutol; Pyrazinamide; Gatifloxacin; Levofloxacin; Tolerability; Rifampicin; Tuberculosis; Internal medicine; Culture conversion; Regimen; Bedaquiline; Adverse effect; Mycobacterium tuberculosis; Surgery; Antibiotics; Sputum; Pathology","score_opus":0.12201034200474559,"score_gpt":0.43324468431030594,"score_spread":0.31123434230556035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965009420","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004016468,0.99958795,0.000031842676,0.00007178862,0.00006818768,0.000002873479,0.000008045639,0.0000022191336,0.00018701438],"genre_scores_gemma":[0.00033004698,0.99924314,0.00010336579,0.00009010979,0.00007275869,0.0000025672703,0.000013434087,4.72929e-7,0.00014406811],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9996984,0.0000647198,0.00006585866,0.000044273598,0.000102785576,0.000023956633],"domain_scores_gemma":[0.9992073,0.00043397347,0.00016816551,0.0000148989,0.00013399564,0.000041620347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076781603,0.0010705042,0.0024267384,0.003834499,0.00029074764,0.0008403403,0.0011694513,0.0011287804,0.0037832286],"category_scores_gemma":[0.0012875857,0.00032497046,0.00081968715,0.003791987,0.00049323885,0.0010213684,0.00056498294,0.0015546489,0.0011465374],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013348873,0.000070698254,0.00018778683,0.040065903,0.0002813895,0.00023680304,0.000041490865,0.00024306247,0.00071226177,0.001091258,0.022184934,0.9347509],"study_design_scores_gemma":[0.00015423073,0.00022819599,0.002271752,0.02051731,0.0011962688,0.003164629,0.00011145986,0.00014810641,0.0005459638,0.0013697734,0.97025496,0.000037324124],"about_ca_topic_score_codex":0.0033466616,"about_ca_topic_score_gemma":0.007585855,"teacher_disagreement_score":0.003834499,"about_ca_system_score_codex":0.0007164037,"about_ca_system_score_gemma":0.0014992281,"threshold_uncertainty_score":0.012656152},"labels":[],"label_agreement":null},{"id":"W1965225830","doi":"10.2165/00003495-200060020-00003","title":"Potential Novel Uses of Thalidomide","year":2000,"lang":"en","type":"review","venue":"Drugs","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Thalidomide; Medicine; Erythema nodosum; Multiple myeloma; Rheumatoid arthritis; Pyoderma gangrenosum; Dermatology; Cancer; Disease; Immunology; Internal medicine","score_opus":0.06488550715583498,"score_gpt":0.383350522487704,"score_spread":0.31846501533186905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965225830","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000121899546,0.9986474,0.00008576646,0.00017043317,0.00011417674,0.0000037072655,0.000008751366,0.0000033597123,0.00084450154],"genre_scores_gemma":[0.00071315013,0.9980122,0.00021050884,0.00022477275,0.00017497024,0.0000053227986,0.000020468786,7.870477e-7,0.0006378088],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99984384,0.000031578827,0.000025720019,0.000026590824,0.000058747624,0.000013418507],"domain_scores_gemma":[0.9997769,0.0001137067,0.000037760245,0.0000069475664,0.0000477108,0.00001694851],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005175013,0.00084267405,0.0014153772,0.0024250874,0.000278695,0.0009544288,0.0007743417,0.00087108096,0.0034202912],"category_scores_gemma":[0.00064367946,0.0002165771,0.0004706687,0.0022538998,0.0004117937,0.0010790254,0.0004481071,0.0013360026,0.0012580389],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016796951,0.00008550301,0.00018973794,0.011300592,0.00011129998,0.00040659594,0.000049654627,0.00029107876,0.002231046,0.0028328672,0.017536635,0.964797],"study_design_scores_gemma":[0.00008129683,0.00016975269,0.0011891434,0.0026395344,0.00023875153,0.002394827,0.00006817661,0.00014521227,0.00084598036,0.0015940502,0.9906142,0.000019162399],"about_ca_topic_score_codex":0.0015573581,"about_ca_topic_score_gemma":0.0041795615,"teacher_disagreement_score":0.0034202912,"about_ca_system_score_codex":0.00077165314,"about_ca_system_score_gemma":0.00089985185,"threshold_uncertainty_score":0.011442006},"labels":[],"label_agreement":null},{"id":"W1966240579","doi":"10.2165/00003495-200060060-00007","title":"Current Recommendations for the Treatment of Genital Herpes","year":2000,"lang":"en","type":"review","venue":"Drugs","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Valaciclovir; Famciclovir; Aciclovir; Medicine; Foscarnet; Penciclovir; Herpes simplex virus; Asymptomatic; Intensive care medicine; Ganciclovir; Internal medicine; Immunology; Viral disease; Herpesviridae; Virus; Human cytomegalovirus","score_opus":0.09999097896334952,"score_gpt":0.42182045722408984,"score_spread":0.3218294782607403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966240579","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000466171,0.9979861,0.000120058256,0.00035554855,0.00026141707,0.000013492109,0.000029570429,0.000010990052,0.0011762854],"genre_scores_gemma":[0.00026889212,0.9981237,0.00035007522,0.00040408122,0.00015675022,0.000016821983,0.000043482287,0.0000016418322,0.00063462084],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99961925,0.00008706717,0.00007678531,0.000054333523,0.00013279919,0.000029858811],"domain_scores_gemma":[0.999382,0.0003317478,0.00012263251,0.0000147544815,0.00011177835,0.000037146503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078353245,0.0012353349,0.0026350017,0.0037928137,0.0004106641,0.001220597,0.0013636904,0.0016552071,0.0096317325],"category_scores_gemma":[0.001313518,0.00031908034,0.0010293331,0.0030804866,0.0005782075,0.0013112018,0.00058772863,0.0023775399,0.0041292533],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011601454,0.00008908115,0.000099858684,0.02625504,0.00012950074,0.0001776351,0.00003351354,0.00019638108,0.00047654018,0.0013862916,0.03916931,0.9318708],"study_design_scores_gemma":[0.00014863184,0.00014126839,0.0011575123,0.020551609,0.0006164777,0.0013347507,0.0000898785,0.000101791404,0.00024057782,0.0017218395,0.97386986,0.000025807585],"about_ca_topic_score_codex":0.0037472358,"about_ca_topic_score_gemma":0.0070748236,"teacher_disagreement_score":0.0096317325,"about_ca_system_score_codex":0.0008117178,"about_ca_system_score_gemma":0.0016078976,"threshold_uncertainty_score":0.032221317},"labels":[],"label_agreement":null},{"id":"W1966435794","doi":"10.2165/11635660-000000000-00000","title":"Ceftaroline Fosamil in the Treatment of Community-Acquired Bacterial Pneumonia and Acute Bacterial Skin and Skin Structure Infections","year":2012,"lang":"en","type":"review","venue":"Drugs","topic":"Antimicrobial Resistance in Staphylococcus","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Mount Sinai Hospital","funders":"Forest Laboratories","keywords":"Microbiology; Medicine; Cephalosporin; Enterococcus faecalis; Staphylococcus aureus; Bacterial pneumonia; Streptococcus pneumoniae; Methicillin-resistant Staphylococcus aureus; Vancomycin; Enterococcus faecium; Antibiotics; Biology; Bacteria","score_opus":0.029308340028212004,"score_gpt":0.32106770984662436,"score_spread":0.29175936981841233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966435794","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018209314,0.9993349,0.000041063096,0.00006521575,0.00005159025,0.0000035500582,0.000010290956,0.0000025684687,0.00030870337],"genre_scores_gemma":[0.0016181945,0.99774086,0.00016994198,0.00011862619,0.00007347496,0.0000049771506,0.000024938972,8.497638e-7,0.00024806272],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99982315,0.000035674882,0.000038041762,0.000025646545,0.000062092324,0.000015442723],"domain_scores_gemma":[0.9996728,0.00015381534,0.000081109814,0.0000057320776,0.000065213164,0.00002132469],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040072284,0.00058728125,0.0015199193,0.0018470039,0.0001797875,0.0005439734,0.00062339514,0.0006341744,0.0024479507],"category_scores_gemma":[0.00069718115,0.00018194543,0.0006226354,0.001681117,0.00025771826,0.00056890305,0.00033673973,0.0010682727,0.00051753165],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021923795,0.000097675394,0.00022357845,0.028801672,0.00024331945,0.00022242598,0.000043769836,0.00021128553,0.0015343952,0.0007874436,0.012457717,0.9551574],"study_design_scores_gemma":[0.00035012804,0.0008058084,0.005084085,0.020309001,0.001572178,0.005447929,0.00016897976,0.0004024724,0.0017163549,0.0011179382,0.9629657,0.000059403184],"about_ca_topic_score_codex":0.0017224122,"about_ca_topic_score_gemma":0.004184741,"teacher_disagreement_score":0.0024479507,"about_ca_system_score_codex":0.00035055724,"about_ca_system_score_gemma":0.00073391653,"threshold_uncertainty_score":0.008189261},"labels":[],"label_agreement":null},{"id":"W1967712902","doi":"10.2165/11594300-000000000-00000","title":"Therapeutic Potential of Ginseng in the Management of Cardiovascular Disorders","year":2011,"lang":"en","type":"review","venue":"Drugs","topic":"Ginseng Biological Effects and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":101,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research","keywords":"Ginseng; Medicine; Ginsenoside; Heart failure; Pharmacology; Traditional medicine; American ginseng; Cardiology; Alternative medicine; Pathology","score_opus":0.020197091009005047,"score_gpt":0.27751335339812616,"score_spread":0.2573162623891211,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967712902","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00047915545,0.99741095,0.00032149345,0.0002809215,0.00017675947,0.0000062341087,0.000027746482,0.000012300936,0.0012845293],"genre_scores_gemma":[0.0022760641,0.9960269,0.0004918995,0.00021536776,0.00020576108,0.000008883823,0.000046774807,0.0000020517832,0.00072631263],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99990463,0.00001564843,0.000016442104,0.000019567426,0.000032615502,0.000011014815],"domain_scores_gemma":[0.99987125,0.00006199135,0.000021705298,0.0000062960207,0.00002601339,0.000012768162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003657455,0.00083497766,0.0012854224,0.0016222032,0.00022460325,0.00072182895,0.0005172414,0.0007682058,0.0019242595],"category_scores_gemma":[0.0003751726,0.00021055316,0.00043864478,0.001636709,0.00039450265,0.000695477,0.0004707582,0.0015670536,0.0010493626],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017023165,0.00013011224,0.00023329433,0.006763967,0.00012849929,0.00045287347,0.000035626963,0.00046249272,0.008068382,0.003055283,0.012164817,0.9683344],"study_design_scores_gemma":[0.00009798114,0.00033115246,0.002272553,0.0019116333,0.00035447133,0.0030887877,0.00007745168,0.00030757496,0.0033456415,0.003205376,0.9849701,0.000037297705],"about_ca_topic_score_codex":0.00076314795,"about_ca_topic_score_gemma":0.0017963586,"teacher_disagreement_score":0.0019242595,"about_ca_system_score_codex":0.00032122637,"about_ca_system_score_gemma":0.00047112117,"threshold_uncertainty_score":0.006437242},"labels":[],"label_agreement":null},{"id":"W1971739828","doi":"10.2165/00003495-200969030-00004","title":"Paediatric Painful Bladder Syndrome/Interstitial Cystitis","year":2009,"lang":"en","type":"review","venue":"Drugs","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Providence Health Care","funders":"","keywords":"Interstitial cystitis; Medicine; Urinary urgency; Urinalysis; Hydroxyzine; Amitriptyline; Urinary system; Abdominal pain; Urology; Enuresis; Overactive bladder; Internal medicine; Anesthesia; Pathology","score_opus":0.03922192377809979,"score_gpt":0.35879610837070164,"score_spread":0.31957418459260184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971739828","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011155796,0.9988965,0.00004581216,0.00010110334,0.00012558489,0.0000053704307,0.000024403624,0.0000049640616,0.0006846513],"genre_scores_gemma":[0.00084136747,0.9984144,0.00014430146,0.00013737168,0.00010891551,0.0000062578124,0.000032724736,0.000001158617,0.0003133904],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99959415,0.000073837145,0.00012677416,0.000049008442,0.00012314142,0.000033148033],"domain_scores_gemma":[0.9990652,0.00045744042,0.00028859073,0.000020176962,0.00011490376,0.000053680276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006201205,0.0011976851,0.0031148246,0.004309977,0.00027903874,0.0009223665,0.0008242045,0.0010705629,0.0053113843],"category_scores_gemma":[0.0016821384,0.00044335285,0.00087750296,0.0039679892,0.00066668674,0.001369529,0.0008755144,0.00141569,0.0012571531],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013507197,0.000058544898,0.000506103,0.05966808,0.00034395492,0.0011672911,0.000051834573,0.00026216864,0.00067473407,0.00084207987,0.025391093,0.91089904],"study_design_scores_gemma":[0.0002181427,0.00026184513,0.00564406,0.04023263,0.0018848572,0.018952316,0.00018938184,0.00013547849,0.00074019236,0.0010127834,0.9306766,0.000051779],"about_ca_topic_score_codex":0.002603569,"about_ca_topic_score_gemma":0.005708383,"teacher_disagreement_score":0.0053113843,"about_ca_system_score_codex":0.0007162113,"about_ca_system_score_gemma":0.0019098469,"threshold_uncertainty_score":0.017768323},"labels":[],"label_agreement":null},{"id":"W1972079818","doi":"10.2165/00003495-200767070-00006","title":"Comparative Review of the Carbapenems","year":2007,"lang":"en","type":"review","venue":"Drugs","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":644,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Manitoba","funders":"","keywords":"Doripenem; Ertapenem; Meropenem; Imipenem; Carbapenem; Microbiology; Cilastatin; Enterococcus faecium; Medicine; Biology; Antibiotics; Antibiotic resistance","score_opus":0.11739415539138064,"score_gpt":0.45396501980962234,"score_spread":0.3365708644182417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972079818","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000072248746,0.99954164,0.000029040972,0.000056086414,0.000053652228,0.0000029660316,0.000018267956,0.0000015644771,0.00022456977],"genre_scores_gemma":[0.0003995575,0.99920315,0.00012906488,0.00008225602,0.000058063742,0.0000031183592,0.00002353483,4.9649105e-7,0.00010078325],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994961,0.000096321724,0.00014571498,0.00006940904,0.00016389659,0.00002853702],"domain_scores_gemma":[0.998993,0.0005345268,0.00020923928,0.000020380705,0.00019940596,0.000043532396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008831965,0.0009832348,0.0026709489,0.005057886,0.0002512639,0.0011950049,0.0009797502,0.0009127963,0.0035482212],"category_scores_gemma":[0.0017781969,0.0003218726,0.0009984695,0.0062899287,0.0003861889,0.0012052332,0.0006162047,0.0009277049,0.00068723946],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025875092,0.00006621102,0.00028824186,0.13033557,0.00052938086,0.00025455287,0.00006711043,0.0002427747,0.0013168263,0.001414186,0.020673707,0.84455264],"study_design_scores_gemma":[0.00010654355,0.00028514815,0.0036134871,0.042759504,0.0025264584,0.0029590055,0.00018505499,0.00013453295,0.000873385,0.0012497277,0.94525874,0.000048346996],"about_ca_topic_score_codex":0.002150545,"about_ca_topic_score_gemma":0.004445013,"teacher_disagreement_score":0.005057886,"about_ca_system_score_codex":0.00079721335,"about_ca_system_score_gemma":0.002096611,"threshold_uncertainty_score":0.011870027},"labels":[],"label_agreement":null},{"id":"W1972606475","doi":"10.2165/00003495-200565100-00002","title":"Tigecycline","year":2005,"lang":"en","type":"review","venue":"Drugs","topic":"Antibiotic Resistance in Bacteria","field":"Biochemistry, Genetics and Molecular Biology","cited_by":78,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Tigecycline; Medicine; Pharmacodynamics; Linezolid; Antibiotics; Adverse effect; Pharmacology; Pneumonia; Pharmacokinetics; Internal medicine; Microbiology; Vancomycin; Staphylococcus aureus; Biology","score_opus":0.02176675668497814,"score_gpt":0.33364893815410823,"score_spread":0.3118821814691301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972606475","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004319255,0.99180907,0.00047095554,0.0005095364,0.0008302841,0.000018934854,0.00006313177,0.000053177188,0.005813021],"genre_scores_gemma":[0.0024342488,0.987472,0.0007638283,0.00076032087,0.00038061044,0.000025191974,0.00015469544,0.000007949111,0.008001257],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998522,0.000022195942,0.00001798019,0.00003171391,0.000056016535,0.000019862247],"domain_scores_gemma":[0.99987435,0.000041195908,0.00002860857,0.000006837319,0.00003144024,0.000017556296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024085908,0.0010150138,0.0014870308,0.0016199959,0.0002909484,0.00084057776,0.0010600828,0.0009373901,0.0072470964],"category_scores_gemma":[0.00042487428,0.00020145372,0.00039318614,0.0014662747,0.0003620797,0.00067391526,0.0005424636,0.0017245298,0.004864233],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014085807,0.00006968906,0.00007315403,0.0052202535,0.000044602224,0.00028933832,0.000019632249,0.00017962187,0.0035783537,0.001211095,0.037420392,0.95175296],"study_design_scores_gemma":[0.000054156637,0.00016279258,0.0005655616,0.0012006023,0.00007926194,0.0021175235,0.000027587319,0.00007963768,0.0016506608,0.000651293,0.9933971,0.000013841619],"about_ca_topic_score_codex":0.0016505867,"about_ca_topic_score_gemma":0.0044659646,"teacher_disagreement_score":0.0072470964,"about_ca_system_score_codex":0.0006095977,"about_ca_system_score_gemma":0.0008461467,"threshold_uncertainty_score":0.02424395},"labels":[],"label_agreement":null},{"id":"W1973067762","doi":"10.2165/11532000-000000000-00000","title":"Can Improving Sleep Influence Sleep-Disordered Breathing?","year":2009,"lang":"en","type":"review","venue":"Drugs","topic":"Obstructive Sleep Apnea Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut Universitaire de Cardiologie et de Pneumologie de Québec","funders":"","keywords":"Medicine; Insomnia; Sleep and breathing; Non-rapid eye movement sleep; Hypoventilation; Sleep (system call); Zolpidem; Anesthesia; Obesity hypoventilation syndrome; Sleep disorder; Sleep apnea; Obstructive sleep apnea; Internal medicine; Psychiatry; Respiratory system; Electroencephalography","score_opus":0.020651255180025745,"score_gpt":0.32980863884302813,"score_spread":0.3091573836630024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973067762","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007270733,0.99901783,0.000025368794,0.00022872582,0.00020299072,0.0000033907418,0.000012376917,0.000002309955,0.00043432816],"genre_scores_gemma":[0.0006187317,0.9985759,0.000095738185,0.00025098087,0.00017629685,0.000006187134,0.000012638303,6.826581e-7,0.00026279324],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99967337,0.00007361363,0.00006847189,0.00004686969,0.00010968106,0.000028034054],"domain_scores_gemma":[0.99930906,0.00045658002,0.00010129433,0.000015381635,0.00008962686,0.000028179544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008880473,0.0011226909,0.0029577648,0.0020529092,0.00036587802,0.0009817792,0.000883433,0.0015021096,0.00507848],"category_scores_gemma":[0.0017943257,0.00039159897,0.001081076,0.0020385522,0.000572522,0.0012536311,0.0006077153,0.0016807433,0.0013759532],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022072211,0.00011694537,0.00042150205,0.03380773,0.00055524416,0.00015799244,0.000049371934,0.00013828899,0.0008399014,0.0011510447,0.01866065,0.94388056],"study_design_scores_gemma":[0.00034830847,0.0005741625,0.008191056,0.030157203,0.0029693057,0.0017679002,0.0002482402,0.00016364013,0.00088426913,0.0026743459,0.95195925,0.000062383326],"about_ca_topic_score_codex":0.0029674654,"about_ca_topic_score_gemma":0.009495843,"teacher_disagreement_score":0.00507848,"about_ca_system_score_codex":0.00059019827,"about_ca_system_score_gemma":0.0012405331,"threshold_uncertainty_score":0.016989231},"labels":[],"label_agreement":null},{"id":"W1973968673","doi":"10.2165/11533040-000000000-00000","title":"Infections with Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae","year":2010,"lang":"en","type":"review","venue":"Drugs","topic":"Antibiotic Resistance in Bacteria","field":"Biochemistry, Genetics and Molecular Biology","cited_by":380,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary","funders":"","keywords":"Nitrofurantoin; Medicine; Intensive care medicine; Fosfomycin; Enterobacteriaceae; Antibiotics; Microbiology; Antibiotic resistance; Escherichia coli; Biology","score_opus":0.010537909936359328,"score_gpt":0.27470445539159594,"score_spread":0.2641665454552366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973968673","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013378017,0.99845994,0.00019777293,0.00021603928,0.00024903513,0.0000028362344,0.000010778307,0.000006916336,0.00072291464],"genre_scores_gemma":[0.000716535,0.9979819,0.00024962478,0.00019055436,0.0002885102,0.000004505217,0.000023302284,0.0000014143723,0.0005436077],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99977714,0.000035139445,0.000031616528,0.000040123803,0.000092358845,0.000023642093],"domain_scores_gemma":[0.99960464,0.00016649583,0.000074995536,0.000012274753,0.000098503275,0.000043157634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004971443,0.0010915748,0.0016779893,0.0014120021,0.00021780322,0.0009860506,0.00079829927,0.0011421889,0.0020892443],"category_scores_gemma":[0.0008296943,0.00023988896,0.0003756038,0.0015021003,0.00054337335,0.0011109948,0.00055605546,0.0014821367,0.0015208878],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000088796274,0.00006344943,0.00024038917,0.0077098636,0.000055664404,0.00030440508,0.000022541539,0.00016999131,0.0017256952,0.0011045361,0.026186699,0.96232796],"study_design_scores_gemma":[0.000042954125,0.0001399804,0.0016600677,0.0035502445,0.00017227772,0.004346255,0.00007193024,0.00015496384,0.0010298,0.0011897676,0.9876187,0.000023103014],"about_ca_topic_score_codex":0.0009157559,"about_ca_topic_score_gemma":0.0018170314,"teacher_disagreement_score":0.0020892443,"about_ca_system_score_codex":0.0005128551,"about_ca_system_score_gemma":0.0008018559,"threshold_uncertainty_score":0.006989181},"labels":[],"label_agreement":null},{"id":"W1974236161","doi":"10.2165/00003495-200868001-00002","title":"Trends in Kidney Transplantation over the Past Decade","year":2008,"lang":"en","type":"review","venue":"Drugs","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":152,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Transplantation; Kidney transplantation; Immunosuppression; Azathioprine; Tacrolimus; Kidney; Surgery; Internal medicine; Disease","score_opus":0.03607397678006712,"score_gpt":0.3511537070343408,"score_spread":0.31507973025427366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974236161","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012983911,0.99900264,0.000031582997,0.00038291296,0.00012512934,0.0000016580817,0.000023606279,0.0000029974888,0.0002997572],"genre_scores_gemma":[0.00059418916,0.9987558,0.000090477006,0.00028523404,0.00013320494,0.000002541193,0.000022707996,5.690612e-7,0.00011540797],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992447,0.00015395929,0.00019193426,0.00011599854,0.00024937684,0.00004403127],"domain_scores_gemma":[0.99709713,0.0014718357,0.0007477842,0.00002879526,0.0005293085,0.00012516396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015317963,0.0008041737,0.0025343697,0.004699525,0.00026618232,0.0015920965,0.0008266852,0.0013431528,0.0030885423],"category_scores_gemma":[0.0031705964,0.00032492896,0.0009891678,0.008226712,0.0004977574,0.0017959969,0.00069070765,0.0015127871,0.00070938],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026089072,0.000082657585,0.0017496616,0.05762361,0.0005969906,0.00025438267,0.00008379782,0.00043585122,0.00040522215,0.0019720346,0.035353813,0.9011811],"study_design_scores_gemma":[0.00013346825,0.00024717994,0.013398222,0.03724787,0.0027423503,0.0030759415,0.00033033048,0.0002899339,0.00043904895,0.0013046565,0.9407357,0.000055199867],"about_ca_topic_score_codex":0.004440733,"about_ca_topic_score_gemma":0.013323701,"teacher_disagreement_score":0.004699525,"about_ca_system_score_codex":0.001624844,"about_ca_system_score_gemma":0.003443866,"threshold_uncertainty_score":0.0117890835},"labels":[],"label_agreement":null},{"id":"W1976600789","doi":"10.2165/00003495-200767180-00002","title":"Guidelines for the Management of Lyme Disease","year":2007,"lang":"en","type":"article","venue":"Drugs","topic":"Vector-borne infectious diseases","field":"Immunology and Microbiology","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Lyme disease; Pharmacotherapy; Disease management; Intensive care medicine; Disease; Internal medicine; Virology","score_opus":0.025703443869779047,"score_gpt":0.30737647899494547,"score_spread":0.2816730351251664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976600789","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006175383,0.37948954,0.07300339,0.33333418,0.023674292,0.0043370337,0.0036456813,0.002990294,0.17335024],"genre_scores_gemma":[0.039933056,0.3118544,0.38828254,0.13112807,0.019267902,0.013050445,0.008859501,0.0006597155,0.08696439],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99627376,0.0014356474,0.00092283805,0.0001300158,0.0009861144,0.0002517203],"domain_scores_gemma":[0.9907017,0.0026704248,0.0010581925,0.00026364918,0.0043383897,0.00096763053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042918297,0.0016924291,0.0025413467,0.0035263142,0.0017542862,0.0019401669,0.0048331055,0.0095413625,0.011605028],"category_scores_gemma":[0.010703534,0.00060413533,0.0030033733,0.0019671745,0.0010843725,0.001538352,0.0011861919,0.008813895,0.0071374513],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024326784,0.00087553245,0.0015762103,0.0021246485,0.00011858731,0.0022003024,0.00033286717,0.0016706261,0.0013638954,0.0065952227,0.6057149,0.37718394],"study_design_scores_gemma":[0.00046955544,0.0004015585,0.0063858437,0.006719278,0.00020689768,0.005332421,0.00027320653,0.0011415944,0.0005908937,0.008323993,0.97006714,0.00008767669],"about_ca_topic_score_codex":0.009738578,"about_ca_topic_score_gemma":0.019024558,"teacher_disagreement_score":0.011605028,"about_ca_system_score_codex":0.0019811494,"about_ca_system_score_gemma":0.0047887885,"threshold_uncertainty_score":0.03882265},"labels":[],"label_agreement":null},{"id":"W1979208548","doi":"10.2165/00003495-200565150-00004","title":"Pharmacological Treatment of Ankylosing Spondylitis","year":2005,"lang":"en","type":"review","venue":"Drugs","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child and Family Research Institute; University of British Columbia; McMaster University","funders":"Spondylitis Association of America","keywords":"Medicine; Randomized controlled trial; Ankylosing spondylitis; Internal medicine; Placebo; Rheumatology; MEDLINE; Physical therapy; Alternative medicine","score_opus":0.0811452335208391,"score_gpt":0.40616622497221516,"score_spread":0.3250209914513761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979208548","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007124541,0.99941576,0.00003741623,0.000048078084,0.000058516856,0.0000051420266,0.000013429144,0.0000028551642,0.00034759563],"genre_scores_gemma":[0.0005990136,0.9988746,0.00014191629,0.00009952828,0.000056609217,0.000006213747,0.000018462786,6.064381e-7,0.00020304834],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99974054,0.00004828954,0.0000678122,0.000038654773,0.000087803724,0.00001684528],"domain_scores_gemma":[0.9995771,0.00023589363,0.00010183678,0.000008791979,0.00005589425,0.000020399235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006025002,0.000984443,0.0026961393,0.0034677316,0.0002643563,0.00087279076,0.00088603783,0.0009882055,0.0038965659],"category_scores_gemma":[0.00095352175,0.00038155954,0.00078121276,0.0032250476,0.00044916343,0.000850398,0.00047451784,0.0012962229,0.0010114184],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023189724,0.00011625982,0.00019298268,0.080713265,0.00046935398,0.00024214247,0.000056463185,0.00025625367,0.0010911787,0.0011351741,0.015928872,0.8995661],"study_design_scores_gemma":[0.00038266968,0.0004456267,0.0033797643,0.035731502,0.0027973414,0.0030871914,0.00018022985,0.00021429702,0.0008228856,0.0015597617,0.9513475,0.00005136795],"about_ca_topic_score_codex":0.002078,"about_ca_topic_score_gemma":0.005081814,"teacher_disagreement_score":0.0038965659,"about_ca_system_score_codex":0.0004951372,"about_ca_system_score_gemma":0.0009217348,"threshold_uncertainty_score":0.013035297},"labels":[],"label_agreement":null},{"id":"W1980049759","doi":"10.2165/00003495-200161140-00002","title":"Underutilisation of ACE Inhibitors in Patients with Congestive Heart Failure","year":2001,"lang":"en","type":"review","venue":"Drugs","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics; University of Alberta","funders":"","keywords":"Medicine; Heart failure; ACE inhibitor; Angiotensin-converting enzyme; Internal medicine; Intensive care medicine; Pharmacotherapy; Dose; MEDLINE; Emergency medicine; Cardiology; Blood pressure","score_opus":0.019961910363628925,"score_gpt":0.2886777781622897,"score_spread":0.26871586779866075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980049759","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00039584326,0.9984701,0.000047056194,0.00043102773,0.00013325641,0.0000025350787,0.000020928426,0.0000033700417,0.0004958173],"genre_scores_gemma":[0.002200299,0.99697864,0.000117040894,0.00036968713,0.00018957128,0.0000036689885,0.000022486322,9.774573e-7,0.000117624106],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992799,0.0001485058,0.0001914573,0.000091368565,0.00025225963,0.000036452897],"domain_scores_gemma":[0.9965802,0.0016629677,0.0011970957,0.000037364338,0.0003987746,0.00012363301],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013526549,0.000497783,0.0019750888,0.0021990906,0.00018177532,0.00092329003,0.0006853907,0.001068119,0.0019310769],"category_scores_gemma":[0.0040354896,0.00023173612,0.00071403995,0.0028039946,0.0003468073,0.0009612221,0.0004044695,0.0011812167,0.0003891898],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003006554,0.000060686205,0.0021984633,0.027735611,0.00061860535,0.00030294646,0.00006705938,0.00019719831,0.0004360224,0.00050506653,0.018090423,0.94948727],"study_design_scores_gemma":[0.0005887797,0.0007971957,0.049706645,0.05459864,0.0063942675,0.007807614,0.00044652447,0.0005135548,0.0009009303,0.0016629141,0.8764886,0.000094354175],"about_ca_topic_score_codex":0.0031466011,"about_ca_topic_score_gemma":0.010598413,"teacher_disagreement_score":0.0031466011,"about_ca_system_score_codex":0.0007305469,"about_ca_system_score_gemma":0.0017625123,"threshold_uncertainty_score":0.0071535707},"labels":[],"label_agreement":null},{"id":"W1983382084","doi":"10.1007/s40265-014-0212-x","title":"Teriflunomide and Its Mechanism of Action in Multiple Sclerosis","year":2014,"lang":"en","type":"review","venue":"Drugs","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":352,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"Novartis Pharma; EMD Serono; Sanofi; Bayer HealthCare; Genentech; Else Kröner-Fresenius-Stiftung; Fresenius Medical Care North America; Deutsche Forschungsgemeinschaft; GlaxoSmithKline; Biogen; Teva Pharmaceutical Industries; Eli Lilly and Company","keywords":"Teriflunomide; Multiple sclerosis; Medicine; Immune system; Mechanism of action; Adverse effect; Immunology; Pharmacology; Pyrimidine metabolism; Disease; Internal medicine; Fingolimod; Enzyme; In vitro; Biology; Biochemistry","score_opus":0.11878070727903658,"score_gpt":0.3515273827265237,"score_spread":0.2327466754474871,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983382084","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001467525,0.9982736,0.0001120419,0.00011834197,0.00012323869,0.0000068515546,0.000015210757,0.000007848921,0.0011961192],"genre_scores_gemma":[0.00063232647,0.99828535,0.00020043283,0.00009907733,0.0000755498,0.000007775517,0.000020624602,0.0000012864709,0.00067766797],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999863,0.00002030016,0.000022040953,0.000025833197,0.000055396053,0.000013355389],"domain_scores_gemma":[0.99985564,0.00006280358,0.000027271824,0.000005340463,0.00003375698,0.000015147474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041879332,0.00083743106,0.0011212715,0.0026248016,0.0003274288,0.0007580583,0.00071874587,0.0009884514,0.0035534527],"category_scores_gemma":[0.0004222623,0.00028235963,0.0004196811,0.002240254,0.00040987975,0.0011742661,0.00054156105,0.0014581103,0.002483766],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000080250895,0.000069941496,0.00012541332,0.015387249,0.00007128554,0.00020928938,0.000059020058,0.000318259,0.0034120542,0.0034551017,0.014685135,0.962127],"study_design_scores_gemma":[0.000021833801,0.00011403148,0.000755415,0.0027371598,0.00009267316,0.0017093982,0.000044774257,0.00007276372,0.0008666796,0.001589603,0.9919802,0.000015465586],"about_ca_topic_score_codex":0.00092254754,"about_ca_topic_score_gemma":0.0014817549,"teacher_disagreement_score":0.0035534527,"about_ca_system_score_codex":0.0005378905,"about_ca_system_score_gemma":0.0007901761,"threshold_uncertainty_score":0.011887491},"labels":[],"label_agreement":null},{"id":"W1985627776","doi":"10.2165/00003495-200868001-00003","title":"Malignancy in Kidney Transplant Recipients","year":2008,"lang":"en","type":"review","venue":"Drugs","topic":"Polyomavirus and related diseases","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Immunosuppression; Sirolimus; Malignancy; Temsirolimus; Calcineurin; Transplantation; Population; Kidney transplantation; Tacrolimus; Discovery and development of mTOR inhibitors; Oncology; Internal medicine; PI3K/AKT/mTOR pathway; Immunology; Biology","score_opus":0.03095871917603919,"score_gpt":0.3193619925432934,"score_spread":0.2884032733672542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985627776","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017138151,0.999127,0.000033847617,0.00011129621,0.0001103282,0.0000023015982,0.000016622602,0.000002589971,0.00042478056],"genre_scores_gemma":[0.0013526271,0.9979662,0.00007851912,0.0001823879,0.0001449294,0.0000038832345,0.000025529478,5.0164846e-7,0.00024549596],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998111,0.00003892516,0.00004680115,0.0000337634,0.000054229535,0.0000150935775],"domain_scores_gemma":[0.99955183,0.00021648726,0.00014533546,0.000008273706,0.00005196675,0.000026018377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034820865,0.0005919639,0.0016977912,0.0026537145,0.00020890262,0.0007872817,0.00041842676,0.0006189744,0.0026348487],"category_scores_gemma":[0.00087765517,0.00022806178,0.0006701611,0.0029677476,0.0002729222,0.00082019623,0.00051243056,0.00073506974,0.0005136913],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014006201,0.000051340277,0.0017392151,0.03417624,0.00031007745,0.00029740564,0.00003546395,0.00017541477,0.0006536428,0.00045547387,0.019455535,0.9425101],"study_design_scores_gemma":[0.00015331614,0.00032342426,0.018547364,0.036412638,0.0031208324,0.0073037622,0.00018208828,0.0002465685,0.00096938806,0.000901261,0.9317792,0.00006009526],"about_ca_topic_score_codex":0.0016597711,"about_ca_topic_score_gemma":0.0039708326,"teacher_disagreement_score":0.0026537145,"about_ca_system_score_codex":0.00043886586,"about_ca_system_score_gemma":0.0010201761,"threshold_uncertainty_score":0.008814454},"labels":[],"label_agreement":null},{"id":"W1988335299","doi":"10.2165/00003495-200161080-00004","title":"Pharmacotherapy of Ectoparasitic Infections","year":2001,"lang":"en","type":"review","venue":"Drugs","topic":"Dermatological diseases and infestations","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"RWTH Aachen University; Centre International de Recherche sur le Cancer","keywords":"Medicine; Pharmacotherapy; Scabies; Intensive care medicine; Adverse effect; Ivermectin; Permethrin; Drug; MEDLINE; Dermatology; Pharmacology; Veterinary medicine; Psychiatry; Biology","score_opus":0.06101477888708411,"score_gpt":0.4339364530541628,"score_spread":0.37292167416707867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988335299","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019440416,0.9987098,0.00011518275,0.00007641031,0.00010445964,0.0000060807097,0.000013960532,0.0000071373497,0.00077249366],"genre_scores_gemma":[0.00124062,0.9975867,0.00029636855,0.00017296424,0.00013007557,0.00000715606,0.000028096792,0.000001575628,0.0005363589],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99982625,0.000033129556,0.000036312726,0.000032356736,0.0000581829,0.000013776068],"domain_scores_gemma":[0.9996772,0.00017005256,0.00006836267,0.00001034637,0.000055227734,0.000018815896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003830226,0.00090679334,0.0019601162,0.0023368807,0.00023958656,0.00068537344,0.0007331993,0.0008070962,0.0031972101],"category_scores_gemma":[0.00061642675,0.0002682513,0.00058247487,0.002186112,0.00033227023,0.0008081232,0.00037649446,0.0011842569,0.0011808284],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014461408,0.00012987993,0.00019723937,0.019160582,0.00019411887,0.00034275,0.00003922182,0.00028261318,0.001474117,0.00058825046,0.012256944,0.96518964],"study_design_scores_gemma":[0.00021548787,0.0005029796,0.004376199,0.009305265,0.0010561083,0.006446002,0.0001079325,0.00030991543,0.0014330153,0.000996155,0.97520816,0.00004289313],"about_ca_topic_score_codex":0.0013838506,"about_ca_topic_score_gemma":0.0032714617,"teacher_disagreement_score":0.0031972101,"about_ca_system_score_codex":0.0003180156,"about_ca_system_score_gemma":0.0006164396,"threshold_uncertainty_score":0.0106957555},"labels":[],"label_agreement":null},{"id":"W1989886020","doi":"10.1007/s40265-013-0168-2","title":"Ceftolozane/Tazobactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination with Activity Against Multidrug-Resistant Gram-Negative Bacilli","year":2013,"lang":"en","type":"review","venue":"Drugs","topic":"Antibiotic Resistance in Bacteria","field":"Biochemistry, Genetics and Molecular Biology","cited_by":335,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Boniface Hospital; Health Sciences Centre; University of Manitoba","funders":"","keywords":"Tazobactam; Cephalosporin; Microbiology; Cephem; Medicine; Pseudomonas aeruginosa; Ceftazidime; Piperacillin; Antibiotics; Ceftriaxone; Beta-Lactamase Inhibitors; Pharmacology; Imipenem; Biology; Antibiotic resistance; Bacteria; Biochemistry","score_opus":0.019337001377061867,"score_gpt":0.27622892951490785,"score_spread":0.256891928137846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989886020","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021933552,0.9985322,0.0001736353,0.00015744178,0.00015919226,0.000005443946,0.000027349888,0.000010326205,0.00071509974],"genre_scores_gemma":[0.0011846658,0.99756086,0.0003004305,0.00015728339,0.00011122471,0.0000051859656,0.00004802516,0.0000016626415,0.0006305295],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998919,0.00001169377,0.00001584778,0.000018568333,0.00004823379,0.000013758118],"domain_scores_gemma":[0.999846,0.000050214643,0.000031539985,0.000004372927,0.000045200744,0.000022670842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032332118,0.0007759882,0.0011556789,0.0015437712,0.00016663689,0.0006699478,0.0007143397,0.0006280321,0.0021520823],"category_scores_gemma":[0.00042873167,0.00019990823,0.00031138913,0.0015682715,0.00032683654,0.00073891465,0.0003654773,0.0013911951,0.001243962],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012826761,0.000077594465,0.00014014196,0.009912679,0.000081298596,0.0001948631,0.000021016673,0.00024434272,0.0033444446,0.001218326,0.022381706,0.9622554],"study_design_scores_gemma":[0.00006606988,0.00017403328,0.0010894876,0.0018359915,0.00021407154,0.0019983111,0.00003515168,0.00016111067,0.0015987762,0.0007298774,0.9920764,0.000020800402],"about_ca_topic_score_codex":0.0011827096,"about_ca_topic_score_gemma":0.0031291246,"teacher_disagreement_score":0.0021520823,"about_ca_system_score_codex":0.0004769103,"about_ca_system_score_gemma":0.0007739235,"threshold_uncertainty_score":0.007199466},"labels":[],"label_agreement":null},{"id":"W1994080743","doi":"10.2165/00003495-200059001-00005","title":"Clinical Evidence with Montelukast in the Management of Chronic Childhood Asthma","year":2000,"lang":"en","type":"review","venue":"Drugs","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Montelukast; Medicine; Placebo; Asthma; Bronchoconstriction; Adverse effect; Leukotriene receptor; Quality of life (healthcare); Randomized controlled trial; Anesthesia; Salmeterol; Internal medicine; Pediatrics; Alternative medicine","score_opus":0.04219740496768754,"score_gpt":0.3728719501084492,"score_spread":0.33067454514076167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994080743","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006469324,0.999574,0.00002199939,0.00007876782,0.00005035259,0.0000027403723,0.000006658968,0.0000014891219,0.00019918047],"genre_scores_gemma":[0.00069571444,0.9988772,0.00011570943,0.0001466379,0.000056260236,0.000004067452,0.000011687475,4.8233716e-7,0.000092223454],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99949956,0.00012376624,0.000121515055,0.0000701834,0.00016133478,0.00002363979],"domain_scores_gemma":[0.9986474,0.0009292073,0.00021300957,0.000020247828,0.00014554446,0.000044631648],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014431139,0.00095592724,0.0029860241,0.0027126987,0.00029608328,0.0011711797,0.0011078807,0.001322378,0.0034653926],"category_scores_gemma":[0.0023289963,0.0003718561,0.0010566013,0.0034434404,0.00061533786,0.0011168533,0.00062863185,0.0016146724,0.0007765287],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044339037,0.000080682425,0.0003223879,0.104988724,0.00068095693,0.00035684084,0.00007611312,0.0003323825,0.0010559359,0.0012504593,0.013775363,0.87663686],"study_design_scores_gemma":[0.0006258015,0.00067612773,0.0055727926,0.08733141,0.005065605,0.0041980743,0.0002812151,0.00033990233,0.0009893962,0.0021376759,0.89271307,0.000068895926],"about_ca_topic_score_codex":0.0032823747,"about_ca_topic_score_gemma":0.007051906,"teacher_disagreement_score":0.0034653926,"about_ca_system_score_codex":0.0007653331,"about_ca_system_score_gemma":0.0015582644,"threshold_uncertainty_score":0.011592865},"labels":[],"label_agreement":null},{"id":"W1995586381","doi":"10.2165/11593790-000000000-00000","title":"Pharmacological Modulation of Arterial Stiffness","year":2011,"lang":"en","type":"review","venue":"Drugs","topic":"Cardiovascular Health and Disease Prevention","field":"Medicine","cited_by":144,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Arterial stiffness; Medicine; Cardiology; Internal medicine; Glycation; Blood pressure; Pharmacology; Receptor","score_opus":0.06748616140121036,"score_gpt":0.3780397902019101,"score_spread":0.3105536288006997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995586381","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027785037,0.99812514,0.00022563024,0.00017418785,0.0001718229,0.000012105512,0.000032227043,0.000013123351,0.0009678644],"genre_scores_gemma":[0.0018279259,0.99655724,0.00035700863,0.00028127834,0.0002339225,0.000017333576,0.000046332054,0.0000023141117,0.0006767156],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998368,0.000026410165,0.00003231702,0.000029974022,0.000054955548,0.000019541036],"domain_scores_gemma":[0.9997367,0.00013120126,0.00006938537,0.000008078185,0.000035262194,0.000019355157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041147845,0.0011995592,0.0024784578,0.0018594489,0.00020955257,0.0007480454,0.0007806564,0.0008802615,0.0044766176],"category_scores_gemma":[0.00057998806,0.0003430512,0.000854868,0.0013111444,0.00041523582,0.0008007796,0.00051986624,0.0019808959,0.0019043946],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040668913,0.00028486043,0.00022563692,0.02437445,0.0004155853,0.0002697213,0.000034953515,0.0002920463,0.00346906,0.0011994492,0.016852256,0.95217526],"study_design_scores_gemma":[0.0007262572,0.0013219304,0.005262267,0.0089583825,0.0022283476,0.0032486133,0.000093929964,0.00055204594,0.0028076344,0.0021962158,0.9725281,0.00007633401],"about_ca_topic_score_codex":0.00082040724,"about_ca_topic_score_gemma":0.0020549158,"teacher_disagreement_score":0.0044766176,"about_ca_system_score_codex":0.00029738716,"about_ca_system_score_gemma":0.00057646417,"threshold_uncertainty_score":0.014975727},"labels":[],"label_agreement":null},{"id":"W1996424927","doi":"10.2165/00003495-200969040-00004","title":"Intravenous Proton Pump Inhibitors","year":2009,"lang":"en","type":"review","venue":"Drugs","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Western University","funders":"AstraZeneca","keywords":"Medicine; Esomeprazole; Omeprazole; Pantoprazole; Gastric acid; Lansoprazole; Bolus (digestion); Peptic; Proton-pump inhibitor; Stress ulcer; Enteral administration; Ranitidine; Drug; Intensive care medicine; Gastroenterology; Anesthesia; Internal medicine; Pharmacology; Stomach; Peptic ulcer; Parenteral nutrition","score_opus":0.02735762979096468,"score_gpt":0.33704761347312157,"score_spread":0.3096899836821569,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996424927","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026963704,0.9970305,0.00015613002,0.00017821376,0.0001964924,0.00001128172,0.000035251833,0.00000969064,0.0021127865],"genre_scores_gemma":[0.0025622684,0.9947448,0.00034600685,0.0004328587,0.000279465,0.000013021172,0.000079831094,0.0000019515533,0.001539788],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998293,0.000039266684,0.000035763536,0.000026945962,0.000051327777,0.000017350943],"domain_scores_gemma":[0.9997632,0.00009412653,0.00008737536,0.0000069187486,0.000027737617,0.000020595968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024650415,0.00083695876,0.0019481621,0.0018931986,0.00017661593,0.000712151,0.00052668713,0.00069631194,0.0069246492],"category_scores_gemma":[0.0006382822,0.00023325636,0.00058309257,0.001688888,0.0003096422,0.0008917685,0.00055936427,0.0014371674,0.0019868275],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028519277,0.000110984554,0.00018817365,0.022455892,0.0002407487,0.0002974747,0.000021169011,0.00019534279,0.0013515884,0.0007401921,0.023877094,0.9502362],"study_design_scores_gemma":[0.0005499929,0.0006041049,0.004035315,0.012164777,0.0014091928,0.004945657,0.000080347156,0.00025551106,0.0012964456,0.0010605189,0.9735555,0.000042709227],"about_ca_topic_score_codex":0.0005621342,"about_ca_topic_score_gemma":0.0016494257,"teacher_disagreement_score":0.0069246492,"about_ca_system_score_codex":0.00030774894,"about_ca_system_score_gemma":0.0005914211,"threshold_uncertainty_score":0.023165286},"labels":[],"label_agreement":null},{"id":"W1996485133","doi":"10.2165/00003495-200363030-00002","title":"Treatment of Lupus Nephritis","year":2003,"lang":"en","type":"review","venue":"Drugs","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"Kidney Foundation of Canada","keywords":"Medicine; Lupus nephritis; Systemic lupus erythematosus; Natural history; Pharmacotherapy; Intensive care medicine; Proteinuria; Disease; Immunology; Nephropathy; Internal medicine; Kidney; Endocrinology","score_opus":0.06308370758329739,"score_gpt":0.37674383238125525,"score_spread":0.31366012479795785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996485133","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000110967885,0.9987993,0.00008079979,0.000091029244,0.00014639285,0.000008540065,0.000016921736,0.0000077146215,0.0007382611],"genre_scores_gemma":[0.000958932,0.9977252,0.00022079561,0.00025923603,0.00013524719,0.000011263072,0.00003972947,0.0000015048912,0.00064810587],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99972504,0.000057143352,0.000046137113,0.000044737248,0.00010292231,0.000024015853],"domain_scores_gemma":[0.9996741,0.00014510573,0.00008299016,0.000010825078,0.000059109767,0.000027893264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005494496,0.001171827,0.0027142225,0.0030171159,0.00032995228,0.0008992253,0.0011659908,0.0010882855,0.004660371],"category_scores_gemma":[0.0007844506,0.00033023016,0.00079884223,0.0022481424,0.00046804736,0.0008781826,0.0005273796,0.0018061452,0.0018266349],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021752881,0.00014170456,0.00015677472,0.026096513,0.00021595662,0.00025086696,0.00003696172,0.00024131623,0.0010808974,0.0009088698,0.0241048,0.94654775],"study_design_scores_gemma":[0.0003609509,0.00041517348,0.0019740544,0.010419629,0.0008604621,0.002883515,0.00007753374,0.00015521936,0.0006778995,0.0010262593,0.9811173,0.000032078955],"about_ca_topic_score_codex":0.0018739027,"about_ca_topic_score_gemma":0.0040983586,"teacher_disagreement_score":0.004660371,"about_ca_system_score_codex":0.0004856634,"about_ca_system_score_gemma":0.00085418724,"threshold_uncertainty_score":0.015590489},"labels":[],"label_agreement":null},{"id":"W1997030483","doi":"10.2165/00003495-200262100-00004","title":"Metabolic and Additional Vascular Effects of Thiazolidinediones","year":2002,"lang":"en","type":"review","venue":"Drugs","topic":"Peroxisome Proliferator-Activated Receptors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":292,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Insulin resistance; Rosiglitazone; Medicine; Pioglitazone; Metabolic syndrome; PPAR agonist; Peroxisome proliferator-activated receptor; Internal medicine; Endocrinology; Type 2 diabetes; Diabetes mellitus; Glucose homeostasis; Nuclear receptor; Inflammation; Bioinformatics; Receptor; Transcription factor; Biology","score_opus":0.009726374286928614,"score_gpt":0.25146682186682573,"score_spread":0.24174044757989713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997030483","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00065542466,0.99650264,0.00044503852,0.00024663837,0.00030548277,0.0000045381303,0.000026123857,0.000016687218,0.001797404],"genre_scores_gemma":[0.0027638937,0.99397284,0.00041547045,0.00021558773,0.00030555576,0.0000087722165,0.00005188905,0.0000023330206,0.0022636934],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999892,0.000018047973,0.000015162782,0.000020588212,0.000040524304,0.000013739527],"domain_scores_gemma":[0.9998574,0.000057459365,0.00002361017,0.0000076389815,0.00003888307,0.000015008883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028225814,0.0008306416,0.0011947039,0.0010900877,0.00022787943,0.00069225434,0.0007270454,0.0007513357,0.0026999959],"category_scores_gemma":[0.00031396677,0.00021232502,0.0003052488,0.0012889967,0.0003821396,0.0005687496,0.00030414175,0.0011714011,0.0016319442],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036919423,0.00012976787,0.00031687322,0.008889332,0.000091099406,0.00142026,0.00007372306,0.00059176545,0.021637533,0.004137884,0.02578572,0.9365569],"study_design_scores_gemma":[0.00008257476,0.00021515672,0.001918903,0.000671918,0.00015427747,0.0045623477,0.000052852432,0.0001688886,0.0062782317,0.001416971,0.9844481,0.00002991892],"about_ca_topic_score_codex":0.0011494844,"about_ca_topic_score_gemma":0.0026231185,"teacher_disagreement_score":0.0026999959,"about_ca_system_score_codex":0.00051755307,"about_ca_system_score_gemma":0.00046125904,"threshold_uncertainty_score":0.009032428},"labels":[],"label_agreement":null},{"id":"W1998158725","doi":"10.2165/00003495-200262070-00002","title":"Options for Induction Immunosuppression in Liver Transplant Recipients","year":2002,"lang":"en","type":"review","venue":"Drugs","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Basiliximab; Medicine; Daclizumab; Immunosuppression; Azathioprine; Adverse effect; Calcineurin; Transplantation; Liver transplantation; Tacrolimus; Pharmacology; Tolerability; Immunology; Internal medicine","score_opus":0.08672789145602479,"score_gpt":0.3657103711825928,"score_spread":0.27898247972656803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998158725","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013936708,0.99916375,0.00005725404,0.000118842276,0.00007453617,0.000003986186,0.000010910058,0.0000029887715,0.00042836435],"genre_scores_gemma":[0.0009811919,0.998304,0.00022068681,0.0001750805,0.00008949437,0.000007475827,0.000018743589,6.693511e-7,0.00020254373],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998086,0.000045537225,0.00005295525,0.000027881168,0.0000528793,0.000012199282],"domain_scores_gemma":[0.99950874,0.00031803173,0.00010959995,0.000007500604,0.000039566155,0.00001660724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005607698,0.0007355469,0.0019558093,0.0017934061,0.00022111366,0.00067437044,0.00063542166,0.00066057686,0.002783915],"category_scores_gemma":[0.0009204877,0.00019897679,0.0006819184,0.0020978316,0.00027609445,0.00083182537,0.0003393893,0.0009847113,0.00059227005],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019626546,0.00007710144,0.00034254385,0.025979556,0.00022429017,0.00024301834,0.000029076045,0.00021521324,0.0004947726,0.0007970979,0.011144755,0.9602563],"study_design_scores_gemma":[0.00037409752,0.00048746658,0.0069946134,0.03294081,0.0032823214,0.005129339,0.00017606924,0.00023087297,0.0010955255,0.0017783779,0.94746125,0.000049132545],"about_ca_topic_score_codex":0.001104384,"about_ca_topic_score_gemma":0.0034942913,"teacher_disagreement_score":0.002783915,"about_ca_system_score_codex":0.00048975955,"about_ca_system_score_gemma":0.00081125455,"threshold_uncertainty_score":0.009313166},"labels":[],"label_agreement":null},{"id":"W2000709950","doi":"10.2165/00003495-200059050-00004","title":"Pancreatic Cancer","year":2000,"lang":"en","type":"review","venue":"Drugs","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":94,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Montreal General Hospital","funders":"","keywords":"Medicine; Pancreatic cancer; Cancer research; Cancer; Metastasis; Immunotherapy; Targeted therapy; Oncology; Internal medicine; Immunology","score_opus":0.027971764498118362,"score_gpt":0.3752909445037849,"score_spread":0.34731918000566653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000709950","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018060037,0.9879084,0.0005393135,0.00073854736,0.001523626,0.000016888034,0.000048106645,0.000044036144,0.009000558],"genre_scores_gemma":[0.0013092513,0.9847868,0.0006176349,0.0010712373,0.00080171536,0.000021720045,0.00013199798,0.0000057616535,0.0112538645],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998753,0.000019415616,0.000012293144,0.000027561964,0.000048376536,0.000016992793],"domain_scores_gemma":[0.99987113,0.000033924938,0.000019375897,0.000010660021,0.000041271396,0.000023557144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033212642,0.0011599095,0.0014438501,0.0018981681,0.0003937086,0.0011660596,0.00081820885,0.0010965529,0.0064972294],"category_scores_gemma":[0.0004085396,0.00028712305,0.00039045792,0.0020932546,0.0004766742,0.0010599302,0.00072784955,0.002509405,0.006707134],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007791457,0.000066080225,0.00010935592,0.003518665,0.000031279764,0.0003822955,0.000014388273,0.00017437602,0.0012335761,0.0018208476,0.09198309,0.9005881],"study_design_scores_gemma":[0.000022104141,0.000036767422,0.00026050644,0.0006253177,0.000034542863,0.001603069,0.000014443204,0.000038846843,0.00038860866,0.0006427555,0.9963276,0.000005409192],"about_ca_topic_score_codex":0.0010038462,"about_ca_topic_score_gemma":0.0027345314,"teacher_disagreement_score":0.0064972294,"about_ca_system_score_codex":0.00067873293,"about_ca_system_score_gemma":0.0007209827,"threshold_uncertainty_score":0.02173543},"labels":[],"label_agreement":null},{"id":"W2000947329","doi":"10.2165/11535230-000000000-00000","title":"Minimizing Repolarization-Related Proarrhythmic Risk in Drug Development and Clinical Practice","year":2010,"lang":"en","type":"review","venue":"Drugs","topic":"Cardiac electrophysiology and arrhythmias","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal; Montreal Heart Institute","funders":"Canadian Institutes of Health Research; Fondation Leducq; Heart and Stroke Foundation of Canada","keywords":"Proarrhythmia; Torsades de pointes; Afterdepolarization; Medicine; QT interval; hERG; Repolarization; Pharmacology; Drug development; Long QT syndrome; Cardiology; Internal medicine; Drug; Potassium channel; Electrophysiology","score_opus":0.01928364887580724,"score_gpt":0.3512573470904996,"score_spread":0.33197369821469236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000947329","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00054303865,0.99683315,0.0005103222,0.0004020978,0.00014022303,0.000010678949,0.000017567481,0.000013515133,0.0015294454],"genre_scores_gemma":[0.003648564,0.99371696,0.0010234237,0.0003987746,0.00030214663,0.000014985119,0.00002961174,0.000002812475,0.0008628165],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996917,0.00006579651,0.00006389501,0.000046053898,0.0001138093,0.000018751412],"domain_scores_gemma":[0.9990374,0.00051764114,0.00025111146,0.000017540364,0.00013622182,0.0000400407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000723448,0.0008382357,0.0015519578,0.0017746598,0.00016409358,0.0007555867,0.0006399229,0.0010331932,0.0033795985],"category_scores_gemma":[0.001355272,0.00023704351,0.00044650387,0.0011134704,0.0003272615,0.0010759004,0.0004732343,0.0013393533,0.0011272846],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000083252,0.00010380254,0.00023623534,0.008292665,0.00010237232,0.00017958252,0.000023678647,0.0002809104,0.0016594166,0.0010258567,0.005762569,0.98224974],"study_design_scores_gemma":[0.00021082551,0.0009254458,0.004384782,0.011065727,0.0012512656,0.0047203,0.00013715684,0.0007505607,0.0032239452,0.0042106155,0.96906394,0.000055524175],"about_ca_topic_score_codex":0.00045115428,"about_ca_topic_score_gemma":0.001486776,"teacher_disagreement_score":0.0033795985,"about_ca_system_score_codex":0.00034568793,"about_ca_system_score_gemma":0.0008853986,"threshold_uncertainty_score":0.011305928},"labels":[],"label_agreement":null},{"id":"W2003140298","doi":"10.2165/00003495-200464140-00003","title":"Treatment of Erectile Dysfunction in Patients with Cardiovascular Disease","year":2004,"lang":"en","type":"review","venue":"Drugs","topic":"Sexual function and dysfunction studies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Erectile dysfunction; Pharmacotherapy; Disease; Intensive care medicine; Internal medicine","score_opus":0.030773379094523615,"score_gpt":0.2841513024797722,"score_spread":0.2533779233852486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003140298","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018668959,0.9994444,0.000025168627,0.000043391545,0.000033782737,0.000005773677,0.00001816551,0.000001985726,0.00024063198],"genre_scores_gemma":[0.0014352113,0.9981743,0.00012376785,0.000113154114,0.000036276422,0.0000066772236,0.000019824281,5.765534e-7,0.0000901641],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996351,0.00009667058,0.00009799936,0.00005650884,0.000095285366,0.000018446015],"domain_scores_gemma":[0.9990264,0.0006733868,0.00019192125,0.000013092555,0.00006816432,0.000027029058],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008830837,0.0008011578,0.003062,0.00250877,0.0001929201,0.0007962134,0.00088602566,0.0009214525,0.003506303],"category_scores_gemma":[0.0017370766,0.00035454196,0.001313969,0.002854268,0.0003529662,0.00070388056,0.00041312622,0.0010751545,0.00039259566],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059024716,0.00015891074,0.00060147844,0.13250475,0.0018828884,0.0002528917,0.000074552816,0.00023753104,0.0008060581,0.00049734925,0.00779421,0.8545991],"study_design_scores_gemma":[0.0024206871,0.0024998693,0.023716375,0.13773702,0.026421627,0.0060986006,0.0005693383,0.00046293653,0.0017358889,0.001528907,0.7966568,0.00015199884],"about_ca_topic_score_codex":0.0021701923,"about_ca_topic_score_gemma":0.006467876,"teacher_disagreement_score":0.003506303,"about_ca_system_score_codex":0.00040997312,"about_ca_system_score_gemma":0.0008209223,"threshold_uncertainty_score":0.011729777},"labels":[],"label_agreement":null},{"id":"W2003266662","doi":"10.2165/00003495-200262170-00004","title":"Diagnosis and Management of Psoriatic Arthritis","year":2002,"lang":"en","type":"review","venue":"Drugs","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"Canadian Institutes of Health Research; Arthritis Society; University Health Network","keywords":"Medicine; Psoriatic arthritis; Dactylitis; Enthesitis; Rheumatoid arthritis; Psoriasis; Arthritis; Inflammatory arthritis; Polyarthritis; Dermatology; Ankylosis; Sacroiliitis; Sulfasalazine; Rheumatoid factor; Disease; Surgery; Internal medicine","score_opus":0.03821503565870255,"score_gpt":0.31437428154469904,"score_spread":0.2761592458859965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003266662","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006563861,0.99945015,0.000044144017,0.0000688268,0.00009590693,0.0000048657876,0.000009173843,0.000002711126,0.00025859536],"genre_scores_gemma":[0.0006265321,0.99866855,0.00019323004,0.00016255547,0.00010348205,0.00000558218,0.000019081324,6.334049e-7,0.00022035975],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994611,0.000109956636,0.00013138869,0.00007098149,0.00019671649,0.00002985739],"domain_scores_gemma":[0.9993851,0.0003199679,0.000144962,0.00001342123,0.000107506574,0.000028981287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083668606,0.0011339854,0.0025990028,0.0036924619,0.00027902308,0.001105146,0.0010753599,0.0011306616,0.0029005143],"category_scores_gemma":[0.0015117992,0.00038988996,0.0007809946,0.0034742614,0.00046857103,0.0011194246,0.00056851195,0.0013434989,0.0010228758],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014667079,0.00007877773,0.00022002046,0.050337005,0.0002230811,0.00023612088,0.000048447677,0.00022877808,0.0005908821,0.0006458169,0.014540536,0.93270373],"study_design_scores_gemma":[0.00025539834,0.00032429295,0.004041181,0.035881296,0.0019503597,0.0049679633,0.0002208133,0.00021319232,0.00063426426,0.0015114702,0.9499464,0.000053417712],"about_ca_topic_score_codex":0.0028933615,"about_ca_topic_score_gemma":0.006284894,"teacher_disagreement_score":0.0036924619,"about_ca_system_score_codex":0.0006791898,"about_ca_system_score_gemma":0.0012727488,"threshold_uncertainty_score":0.009703159},"labels":[],"label_agreement":null},{"id":"W2004594777","doi":"10.2165/00003495-200161120-00005","title":"Endometriosis","year":2001,"lang":"en","type":"review","venue":"Drugs","topic":"Endometriosis Research and Treatment","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital","funders":"","keywords":"Endometriosis; Medicine; Infertility; Etiology; Pelvic pain; Gynecology; Endometrium; Uterus; Internal medicine; Surgery; Pregnancy","score_opus":0.0800474230095203,"score_gpt":0.408748061528627,"score_spread":0.32870063851910675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004594777","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002679378,0.9866345,0.0003458849,0.00045205434,0.00067457213,0.000027544816,0.00006530958,0.000031732445,0.011500571],"genre_scores_gemma":[0.0032093297,0.97624356,0.0005945048,0.0008899998,0.00064030226,0.000030916333,0.00015734108,0.0000047882572,0.01822921],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99983466,0.000033651842,0.000025857951,0.000024790323,0.00005976146,0.000021303626],"domain_scores_gemma":[0.99983656,0.000052718482,0.00004248437,0.000012993914,0.000035146124,0.000020107564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026957065,0.00076704164,0.0011080907,0.0024685522,0.00033581114,0.0008656518,0.0005451743,0.0009330586,0.021924831],"category_scores_gemma":[0.00076254056,0.00025810138,0.00032974663,0.0018736306,0.00034338984,0.00088301685,0.0008996543,0.00084280054,0.00905823],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008254825,0.000044605313,0.00011637605,0.0069592195,0.00003641427,0.00024205772,0.000024343153,0.000077173965,0.0014251582,0.0011708435,0.04403426,0.94578713],"study_design_scores_gemma":[0.000044946577,0.00011103548,0.0005808779,0.002385362,0.00009859232,0.0022731589,0.000028602308,0.000036258432,0.0006220539,0.00045737383,0.9933548,0.0000069363696],"about_ca_topic_score_codex":0.00075783976,"about_ca_topic_score_gemma":0.0022024089,"teacher_disagreement_score":0.021924831,"about_ca_system_score_codex":0.00031202627,"about_ca_system_score_gemma":0.0007438797,"threshold_uncertainty_score":0.07334584},"labels":[],"label_agreement":null},{"id":"W2005405935","doi":"10.2165/11632860-000000000-00000","title":"Assessment and Medication Management of Paediatric Obsessive-Compulsive Disorder","year":2012,"lang":"en","type":"article","venue":"Drugs","topic":"Obsessive-Compulsive Spectrum Disorders","field":"Psychology","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Hospital for Sick Children","keywords":"Medicine; Pharmacotherapy; Psychiatry; Obsessive compulsive; Intensive care medicine; Tic disorder; Pediatrics; Psychotherapist; Tics; Psychology","score_opus":0.009313191940417713,"score_gpt":0.30810610132673794,"score_spread":0.29879290938632025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005405935","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9530524,0.020761052,0.0008681029,0.0028891983,0.00013839349,0.00017154694,0.00027889732,0.00005357254,0.021786818],"genre_scores_gemma":[0.9841166,0.010014446,0.0032540357,0.00056989625,0.00011684621,0.00010186747,0.0002859492,0.000011718931,0.0015285994],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995165,0.00014408717,0.00009446927,0.000026473283,0.00016044987,0.00005791811],"domain_scores_gemma":[0.9991136,0.00022011384,0.00024829293,0.000011731206,0.00022557814,0.0001806061],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003922328,0.0003050091,0.0005011726,0.0009061615,0.00045078117,0.0004916921,0.0003613206,0.00044404352,0.0008191176],"category_scores_gemma":[0.0029117272,0.00017248305,0.00027194788,0.00045768073,0.0002521413,0.00038489135,0.00030243373,0.00087960163,0.00023632839],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000352071,0.00055582693,0.830108,0.00035530605,0.000050435086,0.012395997,0.00064512045,0.00043869464,0.0026069635,0.00018783173,0.0033624466,0.1489414],"study_design_scores_gemma":[0.00005193136,0.0011333164,0.9575665,0.00041612738,0.0000831461,0.030485814,0.0010099385,0.0007696504,0.0018491322,0.00020556242,0.0064003286,0.000028602033],"about_ca_topic_score_codex":0.0057871584,"about_ca_topic_score_gemma":0.012272506,"teacher_disagreement_score":0.0057871584,"about_ca_system_score_codex":0.00080014614,"about_ca_system_score_gemma":0.0015177252,"threshold_uncertainty_score":0.011506975},"labels":[],"label_agreement":null},{"id":"W2005913125","doi":"10.2165/00003495-200565110-00001","title":"Drugs in Development for Hepatitis B","year":2005,"lang":"en","type":"review","venue":"Drugs","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"AGE-WELL","keywords":"Lamivudine; Adefovir; Telbivudine; Entecavir; Medicine; HBeAg; Combination therapy; Hepatitis B; Pegylated interferon; Virology; Hepatitis B virus; Pharmacotherapy; Pharmacology; Immunology; Chronic hepatitis; Internal medicine; Virus; Ribavirin; HBsAg","score_opus":0.056396667292056384,"score_gpt":0.3614276505510224,"score_spread":0.305030983258966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005913125","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012406232,0.99860173,0.000062317165,0.00014983637,0.00010922952,0.00001405894,0.000041216994,0.0000056611816,0.0008919548],"genre_scores_gemma":[0.0009962753,0.9980405,0.000198477,0.00021383972,0.0000648233,0.000013012363,0.00003067926,8.196778e-7,0.00044169728],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997093,0.00008234738,0.00007653852,0.000030695704,0.00008109537,0.000020076284],"domain_scores_gemma":[0.99898404,0.0005297259,0.0003043376,0.000021910424,0.00011193766,0.000047948226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009392685,0.00102221,0.0022010554,0.0038306145,0.0002279807,0.00084122596,0.000659094,0.0009201628,0.0067768306],"category_scores_gemma":[0.001651246,0.00034802797,0.0008012314,0.0030521832,0.00044265878,0.0009140378,0.00058596255,0.0010076843,0.001221193],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002588405,0.00007289299,0.00025283266,0.07336334,0.00042493604,0.00020333023,0.000043001415,0.00018008013,0.00086531334,0.001111567,0.0207394,0.9024843],"study_design_scores_gemma":[0.00031257226,0.00048023826,0.0024368647,0.032919783,0.0025276244,0.0015724393,0.00010682399,0.0000962788,0.0008657535,0.0008507432,0.95780355,0.00002737435],"about_ca_topic_score_codex":0.0015279918,"about_ca_topic_score_gemma":0.0056741843,"teacher_disagreement_score":0.0067768306,"about_ca_system_score_codex":0.00071462133,"about_ca_system_score_gemma":0.001545935,"threshold_uncertainty_score":0.022670805},"labels":[],"label_agreement":null},{"id":"W2010025151","doi":"10.2165/00003495-200363040-00004","title":"Management of Insomnia in Patients With Chronic Obstructive Pulmonary Disease","year":2003,"lang":"en","type":"review","venue":"Drugs","topic":"Sleep and related disorders","field":"Psychology","cited_by":81,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; COPD; Ipratropium bromide; Intensive care medicine; Population; Insomnia; Sleep disorder; Zopiclone; Bronchodilator; Internal medicine; Asthma; Psychiatry","score_opus":0.009391242436043166,"score_gpt":0.2740668925918704,"score_spread":0.2646756501558272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010025151","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024861842,0.99890864,0.00008773886,0.00014978554,0.00012251774,0.000008249039,0.000012045292,0.0000056097924,0.0004568371],"genre_scores_gemma":[0.0018979753,0.99694794,0.0003499841,0.00028153087,0.00019738794,0.000012268076,0.000025366162,0.0000013152796,0.00028629095],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998011,0.00004242428,0.00004756417,0.0000315549,0.00006365936,0.000013771821],"domain_scores_gemma":[0.99950945,0.00028446145,0.000095426236,0.000009110165,0.00007100903,0.000030546984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058647967,0.00079476525,0.002154156,0.0019341542,0.0002645459,0.0006814591,0.00096622936,0.0009280307,0.0021111097],"category_scores_gemma":[0.0010461301,0.0002695372,0.0008106908,0.0014502413,0.00030213431,0.0007217653,0.0004153512,0.0014631567,0.0005796979],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020674206,0.00016000918,0.00056597946,0.021975188,0.0003435059,0.00031792352,0.000050897022,0.00018403896,0.000688997,0.00030895387,0.011647267,0.9635504],"study_design_scores_gemma":[0.00092303735,0.0015844083,0.02433072,0.029446084,0.0037112306,0.009781431,0.00036991897,0.0007390407,0.0010382652,0.0014728281,0.9264943,0.000108773405],"about_ca_topic_score_codex":0.0023648704,"about_ca_topic_score_gemma":0.008276231,"teacher_disagreement_score":0.0023648704,"about_ca_system_score_codex":0.0003958917,"about_ca_system_score_gemma":0.0007141893,"threshold_uncertainty_score":0.0070623755},"labels":[],"label_agreement":null},{"id":"W2010355855","doi":"10.2165/00003495-200666090-00005","title":"Pharmacotherapy of Alcoholism in Patients with Co-morbid Psychiatric Disorders","year":2006,"lang":"en","type":"review","venue":"Drugs","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Psychiatry; Medicine; Anxiety; Bipolar disorder; Population; Schizophrenia (object-oriented programming); Olanzapine; Mood disorders; Alcohol dependence; Sertraline; Depression (economics); Pharmacotherapy; Mood; Antidepressant; Alcohol","score_opus":0.013158639686434687,"score_gpt":0.3306385004802578,"score_spread":0.31747986079382307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010355855","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003843246,0.998468,0.0001223325,0.000099628385,0.000078180725,0.000007776797,0.000022459066,0.000009600242,0.0008077353],"genre_scores_gemma":[0.0026881704,0.9962443,0.0003243358,0.00018977176,0.000112181995,0.000008408628,0.000038551458,0.0000020296588,0.00039219495],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9998493,0.00003153687,0.00003583851,0.000025675114,0.000048143138,0.000009453548],"domain_scores_gemma":[0.9995722,0.00024278866,0.000110336536,0.000009469205,0.00004450939,0.000020618956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033671196,0.0006296017,0.0017397072,0.0017410541,0.0001314172,0.00048701128,0.0007326754,0.0006211003,0.0030037886],"category_scores_gemma":[0.0007091451,0.00024101186,0.0006494741,0.0015148823,0.00019936268,0.00048414618,0.00029927175,0.0008500771,0.0007067955],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023880873,0.000114973554,0.00043106635,0.024088204,0.00046935497,0.00021719886,0.00003485584,0.00018447587,0.0011139747,0.00026325718,0.010588877,0.9622549],"study_design_scores_gemma":[0.0008081041,0.0010778164,0.021555467,0.028131275,0.0057574008,0.009195705,0.00021286301,0.0008069401,0.0021255459,0.0012554745,0.92897075,0.000102708786],"about_ca_topic_score_codex":0.0014176368,"about_ca_topic_score_gemma":0.005124458,"teacher_disagreement_score":0.0030037886,"about_ca_system_score_codex":0.0002505608,"about_ca_system_score_gemma":0.00048875477,"threshold_uncertainty_score":0.010048628},"labels":[],"label_agreement":null},{"id":"W2011019643","doi":"10.2165/00003495-200161070-00004","title":"Monotherapy versus Combination Therapy as First Line Treatment of Uncomplicated Arterial Hypertension","year":2001,"lang":"en","type":"review","venue":"Drugs","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Blood pressure; Pharmacotherapy; Combination therapy; Regimen; Adverse effect; Population; Antihypertensive drug; Drug; Intensive care medicine; Cardiology; Internal medicine; Pharmacology","score_opus":0.14514203928438177,"score_gpt":0.3625023986492613,"score_spread":0.21736035936487955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011019643","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005264487,0.9990877,0.000037817867,0.00003794974,0.000049134687,0.000008325233,0.0000218586,0.0000022652212,0.00022844685],"genre_scores_gemma":[0.003889432,0.9955042,0.00024899698,0.00013901392,0.000062069856,0.000012593011,0.00003255277,0.0000012450541,0.00010994588],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995523,0.00015461062,0.00012292416,0.00006322484,0.00008877746,0.000018104858],"domain_scores_gemma":[0.99879265,0.00090675696,0.00019352183,0.000015386227,0.000063157684,0.000028587405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011118731,0.0007477218,0.004428897,0.0017504552,0.00017110887,0.00072684657,0.0010285773,0.00074781344,0.004064654],"category_scores_gemma":[0.0017252547,0.00032233508,0.001629066,0.0023525178,0.00029211774,0.0007874577,0.00032967245,0.0010027909,0.0003674107],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003982911,0.00024390408,0.0005292531,0.234191,0.006020064,0.00025020563,0.000082538885,0.00025346718,0.0013392625,0.0005195302,0.0061652977,0.74642247],"study_design_scores_gemma":[0.014667841,0.011245042,0.028064629,0.19829318,0.13319042,0.007085606,0.0007500007,0.0011157427,0.0047087576,0.0026990357,0.5979462,0.00023348685],"about_ca_topic_score_codex":0.0011787068,"about_ca_topic_score_gemma":0.0038110183,"teacher_disagreement_score":0.004428897,"about_ca_system_score_codex":0.00036812032,"about_ca_system_score_gemma":0.0005711831,"threshold_uncertainty_score":0.013597608},"labels":[],"label_agreement":null},{"id":"W2011091397","doi":"10.1007/s40265-013-0145-9","title":"Should Mild COPD Be Treated? Evidence for Early Pharmacological Intervention","year":2013,"lang":"en","type":"review","venue":"Drugs","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Ministère de l'Education Nationale, de l'Enseignement Superieur et de la Recherche; European Respiratory Society; GlaxoSmithKline; AstraZeneca; Pfizer","keywords":"Medicine; COPD; Spirometry; Pharmacotherapy; Intensive care medicine; Disease; Clinical trial; Smoking cessation; Airway obstruction; Pulmonary disease; Intervention (counseling); Internal medicine; Airway; Physical therapy; Asthma; Pathology; Surgery","score_opus":0.25025002197446633,"score_gpt":0.47592606020828776,"score_spread":0.22567603823382143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011091397","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000082342245,0.99922276,0.000035011508,0.00030827336,0.00011189129,0.0000076247397,0.0000153024,0.0000018541516,0.00021483772],"genre_scores_gemma":[0.0018044815,0.99695206,0.0002653032,0.0006673269,0.0001557859,0.000017571369,0.000025187954,0.0000013489439,0.0001109991],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990746,0.00027224456,0.00023862936,0.00013205603,0.00022136702,0.00006106205],"domain_scores_gemma":[0.99689096,0.002415699,0.0003769657,0.000044214237,0.00020170613,0.00007057011],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023804654,0.0010579132,0.005618814,0.0015660365,0.0003770733,0.0019270309,0.001768367,0.0026642492,0.0074249664],"category_scores_gemma":[0.005570115,0.00060755515,0.0030748423,0.0013378711,0.0006923883,0.001828747,0.0007721559,0.0034510628,0.0010857643],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011310581,0.00022264467,0.0005414423,0.2401436,0.0023804815,0.00022991575,0.00008990897,0.00029184425,0.0006517943,0.002503488,0.017216595,0.7345972],"study_design_scores_gemma":[0.0030171045,0.0009818063,0.007650708,0.4770074,0.025409978,0.0014622094,0.0004827024,0.00041999487,0.0008266274,0.005841457,0.4767868,0.000113253845],"about_ca_topic_score_codex":0.0035957273,"about_ca_topic_score_gemma":0.008488004,"teacher_disagreement_score":0.0074249664,"about_ca_system_score_codex":0.0010496306,"about_ca_system_score_gemma":0.0023769438,"threshold_uncertainty_score":0.024839044},"labels":[],"label_agreement":null},{"id":"W2012003343","doi":"10.1007/s40265-013-0026-2","title":"Pediatric Relapsed or Refractory Leukemia: New Pharmacotherapeutic Developments and Future Directions","year":2013,"lang":"en","type":"review","venue":"Drugs","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital","funders":"","keywords":"Medicine; Leukemia; Refractory (planetary science); Myeloid leukemia; Oncology; Disease; Chemotherapy; Cancer; Childhood leukemia; Intensive care medicine; Internal medicine; Lymphoblastic Leukemia","score_opus":0.046610658832416364,"score_gpt":0.3592068213984452,"score_spread":0.3125961625660288,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012003343","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008751917,0.9990011,0.00006654209,0.00025699163,0.00010077602,0.0000032272446,0.000016290536,0.000005843824,0.00046178204],"genre_scores_gemma":[0.00052340433,0.99875724,0.00015078767,0.00022504912,0.00012119054,0.000003758153,0.000021163809,9.472531e-7,0.0001964256],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99979776,0.00003546908,0.000034174423,0.000041512983,0.000062692474,0.000028360437],"domain_scores_gemma":[0.99948525,0.00026451977,0.000090420646,0.0000111579275,0.00010705079,0.000041658182],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007871974,0.00092014176,0.0021617222,0.002280222,0.00027909968,0.0015091944,0.0009821127,0.0011111817,0.0048014973],"category_scores_gemma":[0.00084437843,0.00036761304,0.0007361244,0.0027083973,0.0006187311,0.0020058174,0.0007613646,0.0023850913,0.0015888135],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001612148,0.00012248597,0.00026498255,0.016612148,0.00012969486,0.00020765541,0.000045022098,0.00048095526,0.0010835755,0.0026949716,0.024386348,0.95381093],"study_design_scores_gemma":[0.00011459061,0.00024971645,0.0012724965,0.00644571,0.0004841935,0.0015253561,0.00014619452,0.00031237668,0.00048222003,0.0028401713,0.986088,0.000038967937],"about_ca_topic_score_codex":0.001131253,"about_ca_topic_score_gemma":0.0037471682,"teacher_disagreement_score":0.0048014973,"about_ca_system_score_codex":0.0007422259,"about_ca_system_score_gemma":0.0015226238,"threshold_uncertainty_score":0.016062677},"labels":[],"label_agreement":null},{"id":"W2012123298","doi":"10.2165/00003495-200262150-00010","title":"Gefitinib","year":2002,"lang":"sl","type":"article","venue":"Drugs","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Gefitinib; Pharmacotherapy; Pharmacology; Internal medicine; Cancer; Epidermal growth factor receptor","score_opus":0.03679783711843848,"score_gpt":0.30342954578173936,"score_spread":0.2666317086633009,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012123298","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22463587,0.09636315,0.007140567,0.014283368,0.005017564,0.00075510243,0.011358957,0.007353545,0.63309187],"genre_scores_gemma":[0.6524511,0.023203904,0.0051439344,0.003347803,0.00082959404,0.00032860544,0.011786879,0.00026891808,0.30263928],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998004,0.000021150103,0.000010543727,0.000042550586,0.00005734797,0.00006810078],"domain_scores_gemma":[0.9999213,0.000007983246,0.000008577425,0.000012723572,0.000013580153,0.000035849436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019090144,0.0004811413,0.00061792135,0.0006646247,0.00056354934,0.0007232657,0.00042333477,0.00060094777,0.047182042],"category_scores_gemma":[0.00030441993,0.00016964434,0.0004818837,0.00035718802,0.00024585563,0.00045605586,0.0003924013,0.0011652336,0.022977028],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004913954,0.00084622693,0.0036435744,0.000904371,0.00025028907,0.0013678756,0.00008093902,0.0006615552,0.12212225,0.0073294938,0.18866967,0.66920984],"study_design_scores_gemma":[0.0010125485,0.0018867457,0.0068637272,0.000082048704,0.00015664547,0.008672932,0.000031341377,0.0004072952,0.064827316,0.0007938918,0.9152279,0.000037709535],"about_ca_topic_score_codex":0.0008315425,"about_ca_topic_score_gemma":0.0019069576,"teacher_disagreement_score":0.047182042,"about_ca_system_score_codex":0.0006535872,"about_ca_system_score_gemma":0.0007544143,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W2014419865","doi":"10.2165/00003495-200666170-00001","title":"Potential of Aromatase Inhibitors for Ovulation and Superovulation Induction in Infertile Women","year":2006,"lang":"en","type":"review","venue":"Drugs","topic":"Ovarian function and disorders","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Clomifene; Ovulation induction; Ovulation; Medicine; Letrozole; Gynecology; Estrogen; Anovulation; Adverse effect; Pregnancy; Endocrinology; Aromatase; Internal medicine; Biology; Hormone; Polycystic ovary; Insulin","score_opus":0.01883640610038124,"score_gpt":0.29445222465359183,"score_spread":0.2756158185532106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014419865","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024310006,0.99883467,0.00007857711,0.00011384974,0.00006111165,0.0000036592335,0.000016764196,0.0000043236455,0.00064399594],"genre_scores_gemma":[0.0014393647,0.9975592,0.00019985905,0.00017082156,0.000114676506,0.0000058413634,0.000028599847,0.0000011513752,0.00048053096],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998388,0.000032169402,0.000031751948,0.000026612814,0.00005855486,0.000012140933],"domain_scores_gemma":[0.9995714,0.00027318535,0.00007823331,0.000007733798,0.000048697464,0.000020617246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005644549,0.00071192643,0.0018147695,0.0019615458,0.00019601623,0.0006885027,0.00063576177,0.00085399597,0.0035601468],"category_scores_gemma":[0.00076951843,0.00025117674,0.00067891896,0.0015801205,0.0002600384,0.00076939375,0.0003475573,0.0010800749,0.001104049],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030035907,0.00011597556,0.00040948874,0.01588016,0.0002792223,0.0004995285,0.000041448857,0.00025095054,0.0016730259,0.00089909555,0.010821422,0.96882933],"study_design_scores_gemma":[0.00034771324,0.00073217344,0.0050205137,0.0060376986,0.0014058884,0.007271598,0.00013444197,0.00032191342,0.001982503,0.0012484569,0.9754474,0.000049689625],"about_ca_topic_score_codex":0.000981473,"about_ca_topic_score_gemma":0.0026355593,"teacher_disagreement_score":0.0035601468,"about_ca_system_score_codex":0.000333072,"about_ca_system_score_gemma":0.00051256974,"threshold_uncertainty_score":0.011909902},"labels":[],"label_agreement":null},{"id":"W2014500898","doi":"10.1007/s40265-015-0365-2","title":"Preventive Analgesia and Novel Strategies for the Prevention of Chronic Post-Surgical Pain","year":2015,"lang":"en","type":"review","venue":"Drugs","topic":"Anesthesia and Pain Management","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; York University; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Chronic pain; Perioperative; Intensive care medicine; Analgesic; Central sensitization; Psychosocial; Quality of life (healthcare); Psychological intervention; Acute pain; Multimodal therapy; Physical therapy; Anesthesia; Nociception; Surgery; Psychiatry; Nursing","score_opus":0.04321788175516431,"score_gpt":0.3471312076987139,"score_spread":0.3039133259435496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014500898","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005789403,0.9994116,0.00005559698,0.00011602312,0.00007218929,0.0000037134369,0.000011031855,0.0000021790731,0.00026981742],"genre_scores_gemma":[0.00043312833,0.9990767,0.00012627126,0.00012132369,0.000102153484,0.0000042967677,0.000012057031,4.276754e-7,0.0001236141],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99974793,0.000050738876,0.00004961345,0.000039407354,0.00008873422,0.000023549166],"domain_scores_gemma":[0.99932945,0.00041998026,0.00011131155,0.0000132262085,0.00009902162,0.000027094196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063894474,0.0009301942,0.0019951845,0.0025063965,0.00028746953,0.0010686513,0.0009411075,0.0012653009,0.004684294],"category_scores_gemma":[0.0012259131,0.00031684776,0.0008966462,0.0020932637,0.00048967666,0.0010990968,0.0007065699,0.0020499094,0.00096266455],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013818462,0.00016539324,0.0002553229,0.046479814,0.00032387118,0.00015560938,0.00005236655,0.00028833104,0.0010456226,0.002941104,0.012044727,0.93610966],"study_design_scores_gemma":[0.0001367593,0.00039421383,0.0034602266,0.02908435,0.0013218841,0.0017537423,0.00015517179,0.00027578833,0.00075805135,0.0042349636,0.9583665,0.000058390655],"about_ca_topic_score_codex":0.0016007974,"about_ca_topic_score_gemma":0.0036166457,"teacher_disagreement_score":0.004684294,"about_ca_system_score_codex":0.00049580244,"about_ca_system_score_gemma":0.0012283213,"threshold_uncertainty_score":0.015670538},"labels":[],"label_agreement":null},{"id":"W2016675546","doi":"10.2165/00003495-200059040-00005","title":"A Risk-Benefit Assessment of Pharmacological and Nonpharmacological Treatments for Nausea and Vomiting of Pregnancy","year":2000,"lang":"en","type":"review","venue":"Drugs","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":168,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Hospital for Sick Children","funders":"","keywords":"Medicine; Ondansetron; Nausea; Metoclopramide; Pregnancy; Vomiting; Pharmacotherapy; Intensive care medicine; Pharmacology; Randomized controlled trial; Anesthesia; Internal medicine","score_opus":0.06665601290362505,"score_gpt":0.4470213298078172,"score_spread":0.3803653169041922,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016675546","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005697569,0.99867296,0.00013754072,0.00014411613,0.00004611595,0.000014898234,0.00002774452,0.000002943383,0.000383975],"genre_scores_gemma":[0.008756212,0.9895866,0.0008847239,0.00029208366,0.00012658475,0.000026761509,0.000043318745,0.0000012985495,0.00028234575],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994381,0.00017753658,0.00010256751,0.000048088557,0.00021421924,0.000019482603],"domain_scores_gemma":[0.9978638,0.0017303127,0.0002614262,0.000016459671,0.00010288835,0.000025081325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012331178,0.0007068069,0.0028340118,0.0017362037,0.00015762117,0.00062580785,0.00082536176,0.0010513695,0.0025071595],"category_scores_gemma":[0.002763532,0.00027230073,0.0015750703,0.0013420607,0.00024088367,0.0006335274,0.0002785085,0.0012042004,0.0002523349],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014793426,0.00014175216,0.0005895844,0.0706414,0.0022110806,0.00033255844,0.00005660655,0.0007367462,0.0011860412,0.0013186513,0.0047104876,0.9165957],"study_design_scores_gemma":[0.005552821,0.0064192587,0.03795553,0.13533603,0.04391759,0.011839782,0.00067714584,0.0034757312,0.004586334,0.011783404,0.7382451,0.0002113342],"about_ca_topic_score_codex":0.0011172423,"about_ca_topic_score_gemma":0.0031825986,"teacher_disagreement_score":0.0028340118,"about_ca_system_score_codex":0.0006076012,"about_ca_system_score_gemma":0.000649393,"threshold_uncertainty_score":0.008387268},"labels":[],"label_agreement":null},{"id":"W2018201647","doi":"10.1007/s40265-014-0293-6","title":"Antiepileptic Drugs for the Treatment of Agitation and Aggression in Dementia: Do They Have a Place in Therapy?","year":2014,"lang":"en","type":"review","venue":"Drugs","topic":"Pharmacological Effects and Toxicity Studies","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"H. Lundbeck A/S; Pfizer","keywords":"Oxcarbazepine; Tolerability; Medicine; Levetiracetam; Topiramate; Dementia; Gabapentin; Lamotrigine; Psychiatry; Observational study; Aggression; Vigabatrin; Carbamazepine; Donepezil; Intensive care medicine; Adverse effect; Anticonvulsant; Epilepsy; Pharmacology; Alternative medicine; Disease; Internal medicine","score_opus":0.05138615566476509,"score_gpt":0.3946525175362661,"score_spread":0.34326636187150106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018201647","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008436274,0.9995813,0.000019470217,0.00008905716,0.000040137642,0.0000024901371,0.000008340053,9.2482725e-7,0.00017397445],"genre_scores_gemma":[0.0006894889,0.9989355,0.00008551561,0.00014448035,0.000040331543,0.000003607332,0.000009069299,3.7183977e-7,0.00009165443],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99963486,0.000086985456,0.000107076616,0.00003793013,0.00011074553,0.000022384242],"domain_scores_gemma":[0.99898154,0.0006411306,0.00021017923,0.000018566703,0.00011891855,0.000029527973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011051064,0.0007260131,0.0028481972,0.0020785707,0.00023351714,0.0010501621,0.0010085357,0.0011403229,0.003733474],"category_scores_gemma":[0.0017232028,0.0002972803,0.0012471837,0.0026812982,0.0005202539,0.0012155888,0.00052294787,0.0014787116,0.00060092285],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037540868,0.00010852585,0.00027860486,0.13334638,0.0010732089,0.0002092048,0.00008898644,0.00016490446,0.0011019594,0.0020915074,0.008368723,0.8527925],"study_design_scores_gemma":[0.0006028134,0.0007248013,0.0050041373,0.10660985,0.007329567,0.0032604723,0.00045418958,0.00017357018,0.0010712948,0.0034437978,0.87124735,0.00007826459],"about_ca_topic_score_codex":0.0015227144,"about_ca_topic_score_gemma":0.0050569796,"teacher_disagreement_score":0.003733474,"about_ca_system_score_codex":0.000492632,"about_ca_system_score_gemma":0.0012750383,"threshold_uncertainty_score":0.012489736},"labels":[],"label_agreement":null},{"id":"W2022826620","doi":"10.2165/00003495-200868001-00004","title":"Pathogenesis and Management of Chronic Allograft Nephropathy","year":2008,"lang":"en","type":"review","venue":"Drugs","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"","keywords":"Medicine; Pathogenesis; Pharmacotherapy; Nephropathy; Chronic allograft nephropathy; Immunology; Pharmacology; Bioinformatics; Internal medicine; Endocrinology; Diabetes mellitus","score_opus":0.030794799613438475,"score_gpt":0.3238280722218733,"score_spread":0.29303327260843487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022826620","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007082783,0.99941206,0.000048104874,0.00016411803,0.00007384164,0.0000024087858,0.0000065455793,0.0000022565478,0.00021993573],"genre_scores_gemma":[0.0004917461,0.9990079,0.00012604131,0.00012630942,0.00011496666,0.0000036036251,0.000011170503,4.0122958e-7,0.000117945376],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999711,0.00006625567,0.00006811612,0.000037135807,0.00009666897,0.000020847518],"domain_scores_gemma":[0.9994406,0.00029290564,0.00013913396,0.000010901213,0.00008791025,0.000028425055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079411454,0.0009534532,0.0025202767,0.0024809453,0.0003105744,0.0012205185,0.0009927857,0.0011163923,0.0018404865],"category_scores_gemma":[0.0009747419,0.00028062562,0.0006687409,0.002379511,0.00058448914,0.0012746541,0.0006125905,0.0015160239,0.0005950218],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012462396,0.00009295439,0.00048429173,0.025092607,0.0001999968,0.00026820527,0.00004557666,0.0003173041,0.0005427978,0.001974903,0.015840836,0.95501596],"study_design_scores_gemma":[0.00009972126,0.00020203467,0.0034906035,0.018692648,0.0010252788,0.0036346014,0.00016368728,0.00028447417,0.0005475232,0.003710335,0.9681038,0.000045373192],"about_ca_topic_score_codex":0.0018217778,"about_ca_topic_score_gemma":0.004045535,"teacher_disagreement_score":0.0025202767,"about_ca_system_score_codex":0.000718524,"about_ca_system_score_gemma":0.0015406059,"threshold_uncertainty_score":0.006156981},"labels":[],"label_agreement":null},{"id":"W2023602620","doi":"10.2165/00003495-200565180-00009","title":"Tigecycline","year":2005,"lang":"en","type":"article","venue":"Drugs","topic":"Streptococcal Infections and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Tigecycline; Pharmacotherapy; Traditional medicine; Pharmacology; Antibiotics; Microbiology; Internal medicine; Biology","score_opus":0.012047133154302428,"score_gpt":0.30640781164521225,"score_spread":0.2943606784909098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023602620","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.35278612,0.11194795,0.004684623,0.006712461,0.004846024,0.0014806263,0.005108619,0.0024468028,0.50998676],"genre_scores_gemma":[0.7855395,0.028786499,0.003935186,0.003106642,0.00060733134,0.00034517006,0.0034933393,0.00012462515,0.17406161],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99982065,0.00002743652,0.000011698514,0.000030117895,0.000047702426,0.00006250764],"domain_scores_gemma":[0.9999093,0.0000111563495,0.000016733822,0.000011521309,0.000015887053,0.00003545704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000089037276,0.00040170632,0.00044090292,0.00041888832,0.0004231104,0.00041383886,0.0004797127,0.00053439965,0.040865056],"category_scores_gemma":[0.00031537077,0.00010526422,0.0003006582,0.00027644186,0.00018415083,0.00017543348,0.0003068036,0.0012189988,0.00913761],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0116789695,0.0013693486,0.002337658,0.0019692443,0.00013212567,0.0025010968,0.0001764688,0.00033750865,0.18191637,0.0032851694,0.06177986,0.7325163],"study_design_scores_gemma":[0.0032617792,0.013710318,0.021622876,0.0006598926,0.00020100786,0.014738377,0.00028357183,0.0005599833,0.13416526,0.0009843073,0.8097572,0.00005543189],"about_ca_topic_score_codex":0.0022232863,"about_ca_topic_score_gemma":0.004386614,"teacher_disagreement_score":0.040865056,"about_ca_system_score_codex":0.00046917322,"about_ca_system_score_gemma":0.00085464685,"threshold_uncertainty_score":0.13670725},"labels":[],"label_agreement":null},{"id":"W2024196604","doi":"10.2165/00003495-200363200-00003","title":"Dual ACE and Neutral Endopeptidase Inhibitors","year":2003,"lang":"en","type":"review","venue":"Drugs","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Memorial University of Newfoundland","funders":"","keywords":"Medicine; Blood pressure; Internal medicine; Cardiology; Heart failure; ACE inhibitor; Neprilysin; Bradykinin; Angiotensin-converting enzyme; Population; Aldosterone","score_opus":0.026725863270189346,"score_gpt":0.30546557313898653,"score_spread":0.2787397098687972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024196604","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020516073,0.9984188,0.00010759135,0.0001306293,0.0001737052,0.000006555471,0.000021424978,0.0000059376266,0.0009302159],"genre_scores_gemma":[0.0012802886,0.9970409,0.00024555039,0.00022904736,0.00018859332,0.000010115251,0.0000393565,0.0000011620147,0.0009648971],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998349,0.000027202323,0.000040603998,0.000025604104,0.000055942055,0.00001572354],"domain_scores_gemma":[0.9997099,0.00012321808,0.00009367967,0.0000068383265,0.000042433516,0.000023899034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038660204,0.0010210878,0.0020386444,0.0019472074,0.0001673346,0.00072816317,0.00066245714,0.0008039702,0.0043924223],"category_scores_gemma":[0.0006577157,0.00025126679,0.0005271781,0.0019119049,0.00023078689,0.00089090224,0.00041313094,0.0011680439,0.0013119739],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036942938,0.00012495567,0.00017835891,0.02565029,0.00030648918,0.00037715374,0.0000218794,0.0002207601,0.0014608981,0.0006566397,0.024163308,0.9464698],"study_design_scores_gemma":[0.00040436062,0.00046083127,0.0024940579,0.0080423,0.0019836465,0.004064612,0.00006489865,0.0002001904,0.0011534839,0.0007557791,0.9803454,0.00003044368],"about_ca_topic_score_codex":0.0009769185,"about_ca_topic_score_gemma":0.003360107,"teacher_disagreement_score":0.0043924223,"about_ca_system_score_codex":0.00044394322,"about_ca_system_score_gemma":0.0008909714,"threshold_uncertainty_score":0.014694095},"labels":[],"label_agreement":null},{"id":"W2025105082","doi":"10.2165/00003495-200161030-00005","title":"Does Allergen Immunotherapy Alter the Natural Course of Allergic Disorders?","year":2001,"lang":"en","type":"review","venue":"Drugs","topic":"Allergic Rhinitis and Sensitization","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Medical Research Council","keywords":"Medicine; Immunology; Allergy; Immunotherapy; Allergen immunotherapy; Desensitization (medicine); Allergen; Immunoglobulin E; Asthma; House dust mite; Immune system; Antibody; Internal medicine","score_opus":0.014827769694644733,"score_gpt":0.30504803930342833,"score_spread":0.2902202696087836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025105082","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011775826,0.9990995,0.000041951214,0.0001576384,0.00013990875,0.0000022005404,0.0000067214633,0.0000025505253,0.0004318756],"genre_scores_gemma":[0.00061641674,0.9986739,0.000076301396,0.00017935131,0.00016918684,0.0000033751426,0.000009729115,5.463233e-7,0.00027131624],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9997801,0.00004783593,0.000036989495,0.000043208165,0.00007320882,0.000018734694],"domain_scores_gemma":[0.9996087,0.00022374083,0.000071678536,0.00001580493,0.00006025758,0.00001971013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006569345,0.0007955131,0.0020260273,0.0011609171,0.00025136958,0.00091757835,0.00088622194,0.0012273899,0.0028596923],"category_scores_gemma":[0.0008466404,0.00026107155,0.00056505564,0.0015811665,0.00048516854,0.0014573914,0.00041943672,0.0012976737,0.0013620867],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023206795,0.00011729884,0.00043985073,0.016258812,0.00015852305,0.0003553578,0.000047635076,0.00019478558,0.0018792163,0.0016019684,0.013346893,0.9653675],"study_design_scores_gemma":[0.00013416764,0.0003442918,0.005115341,0.006445878,0.0006001378,0.0038927153,0.00015019286,0.00013528067,0.00103378,0.0024643727,0.979653,0.000030852818],"about_ca_topic_score_codex":0.0011203836,"about_ca_topic_score_gemma":0.0028247987,"teacher_disagreement_score":0.0028596923,"about_ca_system_score_codex":0.00043405642,"about_ca_system_score_gemma":0.0008787333,"threshold_uncertainty_score":0.009566605},"labels":[],"label_agreement":null},{"id":"W2027729256","doi":"10.2165/00003495-200161030-00006","title":"The Myocardial Na+/H+ Exchanger","year":2001,"lang":"en","type":"review","venue":"Drugs","topic":"Cardiac electrophysiology and arrhythmias","field":"Medicine","cited_by":143,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Medical Research Council; Heart and Stroke Foundation of Canada","keywords":"Intracellular pH; Sodium–hydrogen antiporter; Amiloride; Paracrine signalling; Intracellular; Angiotensin II; Autocrine signalling; Endothelin receptor; Gene isoform; Cell biology; Medicine; Receptor; Chemistry; Pharmacology; Internal medicine; Endocrinology; Biology; Biochemistry; Sodium","score_opus":0.023435077160446644,"score_gpt":0.31529117656604233,"score_spread":0.2918560994055957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027729256","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015422156,0.9978969,0.00019998144,0.00025729282,0.00031057943,0.000005219781,0.000017240947,0.0000098828905,0.0011485803],"genre_scores_gemma":[0.00062515226,0.9973767,0.0002600295,0.00029496552,0.00036134952,0.0000063067155,0.00003547824,0.000001791884,0.0010382242],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998418,0.000021485655,0.000035885198,0.000038744576,0.00004887648,0.000013149233],"domain_scores_gemma":[0.9995552,0.00021190183,0.0000992326,0.000016516906,0.000077777375,0.000039266404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006614988,0.0012644407,0.0025305708,0.0022770932,0.00030916758,0.0011486423,0.00086110324,0.0013490103,0.0042809416],"category_scores_gemma":[0.000706337,0.0003905093,0.0005442672,0.0022582994,0.00064694154,0.0023753154,0.00076399127,0.0019499543,0.0034285889],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002187407,0.00009518772,0.00022405207,0.0134413885,0.00011547663,0.00035211633,0.00003659123,0.00032257775,0.0023652683,0.0015168958,0.027070194,0.95424145],"study_design_scores_gemma":[0.00009793285,0.00022750361,0.0012797024,0.0023426637,0.00031621283,0.002034149,0.000052722848,0.00015862528,0.0008738738,0.0012247254,0.99136615,0.000025809535],"about_ca_topic_score_codex":0.0007073817,"about_ca_topic_score_gemma":0.0015535383,"teacher_disagreement_score":0.0042809416,"about_ca_system_score_codex":0.0005134086,"about_ca_system_score_gemma":0.0009881058,"threshold_uncertainty_score":0.014321208},"labels":[],"label_agreement":null},{"id":"W2028261606","doi":"10.1007/s40265-013-0092-5","title":"The Optimal Management of Follicular Lymphoma: An Evolving Field","year":2013,"lang":"en","type":"review","venue":"Drugs","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Georgetown Hospital","funders":"Pharmacyclics; Genentech; Celgene; Teva Pharmaceutical Industries; American Society of Hematology","keywords":"Medicine; Follicular lymphoma; Rituximab; Chemoimmunotherapy; Radioimmunotherapy; Bendamustine; Oncology; Tolerability; Internal medicine; Lymphoma; Vincristine; Cyclophosphamide; Immunology; Chemotherapy; Adverse effect","score_opus":0.02607585979887412,"score_gpt":0.32327577265854934,"score_spread":0.29719991285967523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028261606","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004812082,0.9991285,0.000062423824,0.00037885638,0.00011722339,0.0000017896248,0.000008104265,0.0000033406066,0.00025167406],"genre_scores_gemma":[0.0005243697,0.9984522,0.0001850301,0.00040319067,0.00027809836,0.000003385501,0.00001758454,0.0000011735023,0.00013500877],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99955183,0.000107335894,0.00010107573,0.000066605266,0.00013955637,0.000033636257],"domain_scores_gemma":[0.9986615,0.0007928935,0.00021034529,0.000021857446,0.00025354465,0.000059835136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001070103,0.0008631525,0.0025642505,0.0026346971,0.00033533064,0.0014998583,0.0011198085,0.0014273137,0.0029421593],"category_scores_gemma":[0.0018830068,0.00035620423,0.00072335976,0.0025231338,0.0007314755,0.0020286688,0.0007829936,0.0024743243,0.0009918408],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000968851,0.000058805435,0.0002626066,0.022080516,0.000121118734,0.00018250228,0.00003562909,0.0003353998,0.0005761508,0.0017973685,0.026988648,0.9474644],"study_design_scores_gemma":[0.000073248775,0.00015621101,0.0014984685,0.015808644,0.00048536438,0.0020441944,0.00012635475,0.0002624761,0.00033458602,0.002589594,0.97658396,0.000037093498],"about_ca_topic_score_codex":0.0016255705,"about_ca_topic_score_gemma":0.00397074,"teacher_disagreement_score":0.0029421593,"about_ca_system_score_codex":0.0012183059,"about_ca_system_score_gemma":0.001666085,"threshold_uncertainty_score":0.009842455},"labels":[],"label_agreement":null},{"id":"W2029403749","doi":"10.2165/0003495-200868170-00002","title":"Mild to Moderate Crohn’s Disease","year":2008,"lang":"en","type":"review","venue":"Drugs","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Mesalazine; Budesonide; Crohn's disease; Disease; Sulfasalazine; Maintenance therapy; Inflammatory bowel disease; Natural history; Intensive care medicine; Internal medicine; Gastroenterology; Ulcerative colitis; Chemotherapy; Asthma","score_opus":0.01995303257022757,"score_gpt":0.2928080993935062,"score_spread":0.27285506682327865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029403749","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001370983,0.9973449,0.00022778666,0.00031150636,0.00046667925,0.000005865651,0.000027475593,0.000013693998,0.0014651051],"genre_scores_gemma":[0.0010006037,0.99588335,0.00042038911,0.00046223227,0.0003748011,0.0000126266505,0.000054577336,0.0000028643285,0.001788593],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998369,0.000031601117,0.000025173424,0.000028251652,0.000059183873,0.000018863608],"domain_scores_gemma":[0.99976236,0.000108008964,0.000041505253,0.000009618502,0.00005334933,0.000025152707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046540244,0.0010228807,0.0020346602,0.0013866626,0.00021941694,0.00081905397,0.00082659506,0.0009649874,0.0026678285],"category_scores_gemma":[0.000619971,0.00025716895,0.00035526566,0.0015852262,0.00047378519,0.0008548199,0.0005386585,0.001760107,0.0022860386],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015175006,0.000051771716,0.00017018979,0.0077457544,0.00005912651,0.0003034557,0.000017765024,0.00024268887,0.0011184239,0.0015477104,0.040699746,0.94789153],"study_design_scores_gemma":[0.000059869886,0.00008777806,0.00079105573,0.0018273812,0.00010965406,0.0018818739,0.0000312307,0.00007951131,0.00037837794,0.0011027725,0.9936367,0.000013720509],"about_ca_topic_score_codex":0.0009172824,"about_ca_topic_score_gemma":0.0025105379,"teacher_disagreement_score":0.0026678285,"about_ca_system_score_codex":0.0005146796,"about_ca_system_score_gemma":0.0006556792,"threshold_uncertainty_score":0.008924723},"labels":[],"label_agreement":null},{"id":"W2034091655","doi":"10.2165/00003495-200868001-00001","title":"The Evolution of Immunosuppressant Therapy in Renal Transplantation","year":2008,"lang":"en","type":"article","venue":"Drugs","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"","keywords":"Medicine; Pharmacotherapy; Transplantation; Intensive care medicine; Kidney transplantation; Internal medicine","score_opus":0.016002404563374203,"score_gpt":0.2702323924178969,"score_spread":0.2542299878545227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034091655","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.54338723,0.3357083,0.0045532603,0.07637838,0.0014800864,0.00005999829,0.001017394,0.00006816024,0.037347216],"genre_scores_gemma":[0.9231406,0.06041146,0.004032275,0.0071707726,0.0026652003,0.000026718004,0.00046205375,0.000034860972,0.0020559584],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981269,0.000747987,0.0003603907,0.00015989084,0.00044871433,0.00015607664],"domain_scores_gemma":[0.9900922,0.0045745405,0.0018278236,0.00022620051,0.0023314543,0.0009478682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038104395,0.00022795047,0.0006367684,0.0015473915,0.0005741779,0.001979615,0.0005160767,0.0014362241,0.0023303463],"category_scores_gemma":[0.012974527,0.00014477788,0.00058948545,0.0024114398,0.00077220006,0.0020363068,0.0005091941,0.0024468317,0.00026730946],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002710476,0.0010106089,0.47634545,0.0007896869,0.0005112474,0.0013213585,0.00061368174,0.0027995817,0.0023196025,0.01885122,0.008043111,0.484684],"study_design_scores_gemma":[0.00022377074,0.0018458703,0.8352124,0.0011507241,0.0007339064,0.009310352,0.0015496932,0.006436306,0.0027401713,0.00916644,0.13154382,0.0000865652],"about_ca_topic_score_codex":0.0062667215,"about_ca_topic_score_gemma":0.010494929,"teacher_disagreement_score":0.0062667215,"about_ca_system_score_codex":0.0039032432,"about_ca_system_score_gemma":0.0026671332,"threshold_uncertainty_score":0.028320134},"labels":[],"label_agreement":null},{"id":"W2034943103","doi":"10.2165/00003495-200969070-00001","title":"Novel Approaches for Pharmacological Management of Atrial Fibrillation","year":2009,"lang":"en","type":"review","venue":"Drugs","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University; Montreal Heart Institute","funders":"","keywords":"Medicine; Amiodarone; Dofetilide; Atrial fibrillation; Supraventricular arrhythmia; Proarrhythmia; Cardiology; Anti-Arrhythmia Agents; Drug; Sotalol; Sinus rhythm; Internal medicine; Intensive care medicine; Adverse effect; Ibutilide; Cardiac arrhythmia; Pharmacotherapy; Dronedarone; Pharmacology","score_opus":0.2732358529622797,"score_gpt":0.42379488410236377,"score_spread":0.15055903114008407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034943103","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007601209,0.99887353,0.0001610321,0.00019209365,0.00014264954,0.0000066425405,0.000010630959,0.0000062983704,0.0005311018],"genre_scores_gemma":[0.00063801726,0.99822265,0.00040311125,0.00023065566,0.00022913018,0.0000092005075,0.000021267819,0.0000011845133,0.00024486196],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996611,0.00006134008,0.00008118346,0.00005029756,0.000120562916,0.000025521183],"domain_scores_gemma":[0.9993068,0.0004460972,0.00011093283,0.00001527703,0.00009168989,0.00002922349],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008644452,0.0011863183,0.0030835762,0.0030353002,0.0003142884,0.0011343732,0.0011411074,0.0012303612,0.0040922943],"category_scores_gemma":[0.0013680481,0.0003374445,0.0011956368,0.0020615777,0.00052453106,0.0014224281,0.00064694736,0.0025902474,0.0013419605],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015941488,0.0001327995,0.00015510088,0.02437811,0.0004273709,0.00029631754,0.00003973088,0.00033896923,0.0009408079,0.002322142,0.016714457,0.95409477],"study_design_scores_gemma":[0.00042522536,0.00047836846,0.0023738868,0.018689398,0.0021746831,0.0038098365,0.00011115072,0.0005003589,0.00075992005,0.0046268967,0.96598554,0.00006467938],"about_ca_topic_score_codex":0.0013146062,"about_ca_topic_score_gemma":0.003291246,"teacher_disagreement_score":0.0040922943,"about_ca_system_score_codex":0.00067414745,"about_ca_system_score_gemma":0.0010577373,"threshold_uncertainty_score":0.013690114},"labels":[],"label_agreement":null},{"id":"W2038962385","doi":"10.2165/00003495-200767002-00005","title":"Clinical Results of If Current Inhibition by Ivabradine","year":2007,"lang":"en","type":"review","venue":"Drugs","topic":"Heart rate and cardiovascular health","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"","keywords":"Ivabradine; Medicine; Cardiology; Coronary artery disease; Internal medicine; Tolerability; Heart failure; Angina; Heart rate; Contractility; Adverse effect; Myocardial infarction; Blood pressure","score_opus":0.11225787342870548,"score_gpt":0.47009098018204903,"score_spread":0.35783310675334357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038962385","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00066202343,0.9974802,0.00014331966,0.00023185604,0.0001908462,0.000011593984,0.000043061642,0.00000919654,0.0012278854],"genre_scores_gemma":[0.004305769,0.99344677,0.00027791678,0.00054044725,0.00021760311,0.000021655567,0.00009279786,0.0000030124197,0.0010939435],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9998324,0.000032241733,0.000042873504,0.000029881701,0.000043596156,0.000018926321],"domain_scores_gemma":[0.9995395,0.00022387091,0.00012020878,0.000013980407,0.00007164411,0.000030891606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006670248,0.0009454442,0.0024323866,0.0012272683,0.00013638221,0.0007160628,0.0008592698,0.00075728283,0.0043271733],"category_scores_gemma":[0.00093945686,0.00023424524,0.00075788493,0.0010000075,0.0003086398,0.0006266583,0.0003527904,0.001529061,0.001343968],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011985645,0.00021578009,0.00024323683,0.02440484,0.0004424093,0.00017699484,0.000044854794,0.00019823975,0.0037528763,0.00072823983,0.016021002,0.95257294],"study_design_scores_gemma":[0.0018091084,0.0027380034,0.005046339,0.01080334,0.0034698031,0.0024103222,0.00010772367,0.0002859225,0.0046968535,0.0012439478,0.9673267,0.000061934996],"about_ca_topic_score_codex":0.0006935774,"about_ca_topic_score_gemma":0.001987951,"teacher_disagreement_score":0.0043271733,"about_ca_system_score_codex":0.00040520047,"about_ca_system_score_gemma":0.0006478093,"threshold_uncertainty_score":0.014475882},"labels":[],"label_agreement":null},{"id":"W2040873599","doi":"10.2165/00003495-200565070-00002","title":"Bullous Pemphigoid","year":2005,"lang":"id","type":"review","venue":"Drugs","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Toronto","funders":"","keywords":"Bullous pemphigoid; Medicine; Autoantibody; Pemphigus vulgaris; Cicatricial pemphigoid; Immunology; Dermatology; Immune system; Pemphigoid; Antibody","score_opus":0.024711527956983777,"score_gpt":0.3257739759478527,"score_spread":0.3010624479908689,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040873599","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012640744,0.9986387,0.00006557381,0.0001162313,0.00021206158,0.0000068697136,0.000018647923,0.000005748746,0.0008096829],"genre_scores_gemma":[0.0015950495,0.9965264,0.00018020115,0.0003135462,0.00031966149,0.000011976524,0.000039221115,0.0000012784536,0.0010126494],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99980766,0.000033222623,0.0000409965,0.00002790359,0.000070212736,0.000020096248],"domain_scores_gemma":[0.9996031,0.0001632617,0.0001258977,0.000012201149,0.000062310864,0.000033176977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004222307,0.00094036135,0.0023549744,0.003384626,0.00025716823,0.0009961297,0.0006534038,0.00095245667,0.004341401],"category_scores_gemma":[0.0008053217,0.0003487437,0.00047873196,0.0024205223,0.00034773213,0.0010812938,0.0005914143,0.0012305775,0.0013662142],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015080554,0.000077992845,0.00031631597,0.033898212,0.00021204392,0.0006698535,0.000043634467,0.0002705137,0.0015499224,0.0007344249,0.046661146,0.9154151],"study_design_scores_gemma":[0.00013460805,0.00021974904,0.0019905262,0.008078613,0.0008706806,0.0054171276,0.00007535059,0.00014491372,0.0006937535,0.0005251692,0.98182595,0.000023527327],"about_ca_topic_score_codex":0.001032896,"about_ca_topic_score_gemma":0.0028252082,"teacher_disagreement_score":0.004341401,"about_ca_system_score_codex":0.00048717868,"about_ca_system_score_gemma":0.0007757461,"threshold_uncertainty_score":0.014523387},"labels":[],"label_agreement":null},{"id":"W2047657005","doi":"10.2165/11631440-000000000-00000","title":"Epidemiology and Management of Kawasaki Disease","year":2012,"lang":"en","type":"review","venue":"Drugs","topic":"Kawasaki Disease and Coronary Complications","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"Chinese Academy of Agricultural Sciences; Arthritis Society","keywords":"Kawasaki disease; Medicine; Aspirin; Vasculitis; Epidemiology; Systemic vasculitis; Disease; Macrophage activation syndrome; Internal medicine; Immunology; Pediatrics; Artery","score_opus":0.1282571116822686,"score_gpt":0.41013458331458624,"score_spread":0.28187747163231763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047657005","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007513955,0.99959,0.000027153263,0.00009168886,0.00004545334,0.000002450683,0.000009685451,0.0000014952892,0.00015687452],"genre_scores_gemma":[0.0005604736,0.9990876,0.00009201891,0.00009067536,0.000094366704,0.0000032070436,0.000016050151,3.5821557e-7,0.000055257937],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9994541,0.00011492744,0.00016453743,0.00006625817,0.00016341837,0.00003670318],"domain_scores_gemma":[0.99896383,0.0004950415,0.00032821423,0.00001633238,0.0001540376,0.000042485844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087863416,0.0009624688,0.002392647,0.0038501387,0.00027838614,0.0012337422,0.0009667943,0.0011011773,0.0019729948],"category_scores_gemma":[0.0020130388,0.00037352275,0.000946254,0.0040198714,0.00048226304,0.0013671702,0.0006703496,0.0013860355,0.00047067902],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016355093,0.000101683545,0.0013989899,0.06621282,0.00046416625,0.0002954227,0.00008524189,0.0003503801,0.00044800452,0.0011992276,0.019741578,0.90953887],"study_design_scores_gemma":[0.00020110626,0.00037453932,0.013221797,0.085337326,0.0037844235,0.0063830093,0.0003695333,0.00043373028,0.0005563578,0.002935662,0.8862946,0.000107867316],"about_ca_topic_score_codex":0.0032768194,"about_ca_topic_score_gemma":0.0061853817,"teacher_disagreement_score":0.0038501387,"about_ca_system_score_codex":0.0008155435,"about_ca_system_score_gemma":0.0018028633,"threshold_uncertainty_score":0.00660038},"labels":[],"label_agreement":null},{"id":"W2047723707","doi":"10.2165/00003495-200262170-00002","title":"Statins and Menopause","year":2002,"lang":"en","type":"review","venue":"Drugs","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Menopause; Pravastatin; Fluvastatin; Internal medicine; Clinical trial; Hormone replacement therapy (female-to-male); Lovastatin; Placebo; Cholesterol; Endocrinology; Simvastatin; Lipoprotein; Statin; Physiology; Testosterone (patch)","score_opus":0.03733087280325366,"score_gpt":0.32604547079497603,"score_spread":0.2887145979917224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047723707","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018129006,0.99834347,0.000039862327,0.00032839598,0.00028050866,0.0000068773043,0.000021971764,0.0000058577702,0.0007916937],"genre_scores_gemma":[0.001114183,0.9966208,0.00011782468,0.00059493654,0.00039647953,0.000011180802,0.000030108267,0.0000011165282,0.0011133815],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997315,0.00004925317,0.00007280917,0.000038558366,0.00008244335,0.00002542253],"domain_scores_gemma":[0.99956983,0.00017067783,0.00013980932,0.000013466691,0.000063638996,0.00004259485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063454447,0.00092327775,0.0024736875,0.0033048873,0.00043055834,0.0011810687,0.0005950505,0.0014524795,0.006569924],"category_scores_gemma":[0.0011503055,0.0004267384,0.00059469044,0.003352808,0.0005260788,0.0013144203,0.00085852866,0.0016647911,0.0021554653],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004426384,0.00017431776,0.00043212477,0.021684466,0.00024963508,0.0004438918,0.000076634045,0.00014718052,0.0013897704,0.0012105497,0.04000578,0.9337431],"study_design_scores_gemma":[0.00029698983,0.00042092983,0.004001404,0.00760661,0.0011374182,0.0021517887,0.00011449292,0.0001122569,0.0005488296,0.0010057477,0.9825721,0.000031425734],"about_ca_topic_score_codex":0.0019876626,"about_ca_topic_score_gemma":0.008499854,"teacher_disagreement_score":0.006569924,"about_ca_system_score_codex":0.0005969421,"about_ca_system_score_gemma":0.0015664473,"threshold_uncertainty_score":0.021978557},"labels":[],"label_agreement":null},{"id":"W2047794741","doi":"10.2165/00003495-200059050-00003","title":"Pharmacological Management of Intermittent Claudication","year":2000,"lang":"en","type":"review","venue":"Drugs","topic":"Peripheral Artery Disease Management","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Children's Hospital of Eastern Ontario; Agricultural Research Institute of Ontario; University of Ottawa","funders":"","keywords":"Medicine; Pentoxifylline; Intermittent claudication; Placebo; Claudication; Clinical trial; Ginkgo biloba; Physical therapy; Adverse effect; Pharmacotherapy; Internal medicine; Vascular disease; Pharmacology; Arterial disease; Alternative medicine","score_opus":0.04569416447861133,"score_gpt":0.37885352398363303,"score_spread":0.33315935950502173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047794741","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014463178,0.99863595,0.00013336678,0.000110669695,0.00013203808,0.0000076176752,0.000014258835,0.000008374618,0.0008130663],"genre_scores_gemma":[0.0011268645,0.9975483,0.00031873168,0.00025417545,0.00020806793,0.000010827305,0.00003192396,0.0000015104328,0.0004996407],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998061,0.000033415035,0.000040893854,0.000035734134,0.00007005257,0.0000137663355],"domain_scores_gemma":[0.99964833,0.00018469803,0.00008209945,0.000008157331,0.00005207894,0.000024582432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004358792,0.0010375397,0.002173918,0.0027872901,0.00026135796,0.00077748526,0.0008774649,0.00094864884,0.0032233682],"category_scores_gemma":[0.00076898,0.0002807672,0.0006667535,0.0023240878,0.00036654816,0.00092192274,0.0004364775,0.0016769057,0.0014038252],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014856296,0.00013283106,0.0002203222,0.025559695,0.0002508647,0.00034971986,0.000036628066,0.00025122933,0.00094916124,0.0006255493,0.01602285,0.95545256],"study_design_scores_gemma":[0.00040707618,0.0006553191,0.006495051,0.020209547,0.0018931623,0.0071151042,0.00013842134,0.00050126127,0.0009565151,0.0015373322,0.9600264,0.00006477266],"about_ca_topic_score_codex":0.0013444679,"about_ca_topic_score_gemma":0.0028115297,"teacher_disagreement_score":0.0032233682,"about_ca_system_score_codex":0.0003860776,"about_ca_system_score_gemma":0.00062394765,"threshold_uncertainty_score":0.0107831955},"labels":[],"label_agreement":null},{"id":"W2048287611","doi":"10.1007/s40265-015-0352-7","title":"Tedizolid: A Novel Oxazolidinone with Potent Activity Against Multidrug-Resistant Gram-Positive Pathogens","year":2015,"lang":"en","type":"review","venue":"Drugs","topic":"Antimicrobial Resistance in Staphylococcus","field":"Medicine","cited_by":187,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Boniface Hospital; Health Sciences Centre; University of Manitoba","funders":"","keywords":"Linezolid; Pharmacology; Prodrug; 23S ribosomal RNA; Microbiology; Medicine; In vivo; Staphylococcus aureus; Potency; Chemistry; Biology; Ribosome; Vancomycin; In vitro; Biochemistry; RNA; Bacteria; Gene","score_opus":0.0417442126434535,"score_gpt":0.3228652229552022,"score_spread":0.2811210103117487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048287611","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015651315,0.9964169,0.00023467111,0.00015574209,0.00011395541,0.000011126484,0.000091673835,0.00001799987,0.0013926497],"genre_scores_gemma":[0.0058163297,0.99240714,0.00033765397,0.00017883592,0.00007607872,0.000008683116,0.00013267365,0.0000023273385,0.0010403763],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99992585,0.000009435302,0.000013517804,0.000013942796,0.000025691017,0.000011564387],"domain_scores_gemma":[0.999892,0.000038824495,0.00003185178,0.0000026768007,0.00002049176,0.000014164126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023397291,0.00061812694,0.000946125,0.0012332035,0.00012946085,0.0005395382,0.00054896646,0.0003540554,0.0024630458],"category_scores_gemma":[0.000302045,0.00015384701,0.0003457074,0.0010859873,0.00023995164,0.0005161854,0.00038228973,0.0008795341,0.00070769934],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031981445,0.0001369211,0.00040201689,0.01892098,0.00017449124,0.0003115185,0.00006223066,0.0005219325,0.007767443,0.0018351298,0.015489072,0.95405847],"study_design_scores_gemma":[0.00018538442,0.00075378857,0.003030855,0.0031481676,0.0004854018,0.002945627,0.0000852059,0.00032907102,0.0053901086,0.0008484664,0.98274857,0.000049346698],"about_ca_topic_score_codex":0.0007248952,"about_ca_topic_score_gemma":0.0017544532,"teacher_disagreement_score":0.0024630458,"about_ca_system_score_codex":0.00027761667,"about_ca_system_score_gemma":0.00050602085,"threshold_uncertainty_score":0.0082396865},"labels":[],"label_agreement":null},{"id":"W2048882628","doi":"10.2165/00003495-200868001-00006","title":"Sirolimus Use in Recipients of Expanded Criteria Donor Kidneys","year":2008,"lang":"en","type":"review","venue":"Drugs","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; University of British Columbia; Vancouver General Hospital; Western University","funders":"","keywords":"Medicine; Sirolimus; Pharmacotherapy; Intensive care medicine; Internal medicine; Pharmacology","score_opus":0.0894390122475382,"score_gpt":0.3843362855487541,"score_spread":0.2948972733012159,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048882628","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003725084,0.99916434,0.000027543365,0.00010155977,0.000063640786,0.0000023183964,0.000026217349,0.0000015644058,0.00024036595],"genre_scores_gemma":[0.0025362433,0.9970457,0.00008252053,0.0001175959,0.000087064094,0.00000523287,0.000031649874,3.9778251e-7,0.000093545736],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99963605,0.00006768494,0.00012886847,0.000050210998,0.000100814505,0.00001645797],"domain_scores_gemma":[0.9989033,0.0006442272,0.00033447627,0.000009980817,0.00008000787,0.000027949269],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005618203,0.00044669502,0.0019439833,0.0017727156,0.00013498981,0.000608721,0.00050891197,0.0004982606,0.0015707675],"category_scores_gemma":[0.0017154007,0.00019769292,0.0010132929,0.002345751,0.00020280511,0.00055004016,0.0003267381,0.0006854986,0.0002131778],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003899192,0.00008822445,0.0035749157,0.060860462,0.0019936606,0.00018360953,0.000039027986,0.0002348803,0.00049991236,0.0005061614,0.011390339,0.9202389],"study_design_scores_gemma":[0.0008444225,0.0010451892,0.073636994,0.11002554,0.027144298,0.007673564,0.00033747614,0.00073124585,0.0020780787,0.0017758906,0.7745515,0.00015582485],"about_ca_topic_score_codex":0.0016394485,"about_ca_topic_score_gemma":0.0048538647,"teacher_disagreement_score":0.0019439833,"about_ca_system_score_codex":0.0004586348,"about_ca_system_score_gemma":0.0010463374,"threshold_uncertainty_score":0.0052547455},"labels":[],"label_agreement":null},{"id":"W2049940696","doi":"10.2165/00003495-200464210-00002","title":"Topical Antibacterial Therapy for Acne Vulgaris","year":2004,"lang":"en","type":"review","venue":"Drugs","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Acne; Medicine; Pharmacotherapy; Dermatology; Intensive care medicine; Internal medicine","score_opus":0.04030622317457319,"score_gpt":0.3707486903519999,"score_spread":0.33044246717742676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049940696","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018986849,0.99858654,0.00010995979,0.000060666174,0.00011978294,0.000009377222,0.0000140187485,0.0000063345956,0.0009034575],"genre_scores_gemma":[0.0014016993,0.9967374,0.0003221256,0.00013135091,0.0001249938,0.00001178909,0.000027676942,0.0000018938103,0.0012410901],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998104,0.000029181949,0.00004484068,0.000028765713,0.00007171228,0.000015120724],"domain_scores_gemma":[0.99971896,0.00013468167,0.000063077816,0.000008424246,0.000055215765,0.000019739922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042611666,0.0010829887,0.002017725,0.0032115104,0.0002808427,0.00070897787,0.00062459975,0.0009335921,0.004921569],"category_scores_gemma":[0.0005800718,0.00035508335,0.0006011271,0.0020974572,0.00034555467,0.0010535929,0.00040946732,0.0013545972,0.0016596523],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017865465,0.00011228133,0.00012673756,0.030178541,0.0001374931,0.00031698006,0.000052638952,0.00016632161,0.0036008854,0.00053457904,0.010943527,0.9536513],"study_design_scores_gemma":[0.00017211275,0.00050225644,0.002540028,0.009888733,0.0012210228,0.005254176,0.00013939124,0.0001643278,0.0026545494,0.0006815324,0.9767471,0.000034670236],"about_ca_topic_score_codex":0.0012342787,"about_ca_topic_score_gemma":0.0034732148,"teacher_disagreement_score":0.004921569,"about_ca_system_score_codex":0.00033453904,"about_ca_system_score_gemma":0.00062649563,"threshold_uncertainty_score":0.016464233},"labels":[],"label_agreement":null},{"id":"W2051693645","doi":"10.2165/11534440-000000000-00000","title":"New Lipoglycopeptides","year":2010,"lang":"en","type":"review","venue":"Drugs","topic":"Antimicrobial Resistance in Staphylococcus","field":"Medicine","cited_by":346,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Manitoba","funders":"","keywords":"Dalbavancin; Teicoplanin; Vancomycin; Microbiology; Staphylococcus aureus; Daptomycin; Pharmacology; Methicillin-resistant Staphylococcus aureus; Linezolid; Chemistry; Medicine; Biology; Bacteria","score_opus":0.028929472080892398,"score_gpt":0.3414561144664045,"score_spread":0.3125266423855121,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051693645","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00077265274,0.99706095,0.0002133971,0.00017553064,0.00017752066,0.0000130965755,0.000057243386,0.000013211421,0.0015164091],"genre_scores_gemma":[0.0025372924,0.9953348,0.00036907493,0.00025197258,0.00014020732,0.0000139521,0.00010031076,0.0000023584553,0.0012500061],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99990284,0.000013968082,0.000022080081,0.000017504302,0.000032161242,0.00001148925],"domain_scores_gemma":[0.9998406,0.00006124616,0.00004760376,0.0000053200597,0.000026703214,0.000018490691],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025223868,0.00087904657,0.0010941952,0.0015324893,0.00010240496,0.00048372964,0.00040824641,0.00047754467,0.0033297753],"category_scores_gemma":[0.00040791673,0.00016007989,0.0003242772,0.0013299932,0.00024145137,0.0006714672,0.00046497368,0.00097432826,0.0012405467],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024927547,0.00010211268,0.00018975892,0.013545296,0.00011538155,0.00022964815,0.000034122597,0.00029611262,0.0065022754,0.0008758621,0.012861656,0.9649984],"study_design_scores_gemma":[0.00019097631,0.0006333148,0.0018401691,0.0045320834,0.00053784926,0.0022766122,0.00007211898,0.0002317516,0.0046424377,0.00073441706,0.9842778,0.00003041787],"about_ca_topic_score_codex":0.0005533213,"about_ca_topic_score_gemma":0.0012297753,"teacher_disagreement_score":0.0033297753,"about_ca_system_score_codex":0.00029627472,"about_ca_system_score_gemma":0.00052058225,"threshold_uncertainty_score":0.011139214},"labels":[],"label_agreement":null},{"id":"W2053107343","doi":"10.2165/00003495-200868001-00005","title":"Mechanisms and Management of Proteinuria in Kidney Transplant Patients","year":2008,"lang":"en","type":"review","venue":"Drugs","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Proteinuria; Sirolimus; Urology; Renal function; Kidney transplantation; Transplantation; Internal medicine; Glomerulosclerosis; Kidney","score_opus":0.02363974651473585,"score_gpt":0.2998636149460597,"score_spread":0.27622386843132385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053107343","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000090094545,0.999482,0.00004895035,0.00015924341,0.000052708834,0.0000023732518,0.0000069649323,0.0000024899232,0.00015529204],"genre_scores_gemma":[0.0006234557,0.99894005,0.00012760659,0.0001255019,0.00008847348,0.0000038863122,0.000011228978,4.1926722e-7,0.000079356214],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996718,0.000076806995,0.00008315936,0.000044776945,0.000102294674,0.000021182603],"domain_scores_gemma":[0.9993048,0.00041533945,0.00017061287,0.000009275941,0.00007739898,0.000022619839],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079912355,0.0008333542,0.002703708,0.0020167439,0.00023469616,0.001036927,0.0009871188,0.0009695953,0.0013876178],"category_scores_gemma":[0.0012172757,0.00029632697,0.00094121107,0.00204839,0.00046140654,0.0010539371,0.0005320812,0.0013045918,0.00039966984],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001671584,0.000096414406,0.0008199985,0.03652918,0.00053517375,0.00023787198,0.000047131438,0.00032238764,0.0004908511,0.0016452803,0.0146615235,0.94444704],"study_design_scores_gemma":[0.00028225506,0.00040318293,0.0101589635,0.040268745,0.003769622,0.0052994015,0.00025391945,0.00053474907,0.0010292706,0.006085126,0.9318239,0.00009079181],"about_ca_topic_score_codex":0.0017975457,"about_ca_topic_score_gemma":0.004261852,"teacher_disagreement_score":0.002703708,"about_ca_system_score_codex":0.0006431123,"about_ca_system_score_gemma":0.001357711,"threshold_uncertainty_score":0.0046661496},"labels":[],"label_agreement":null},{"id":"W2054828913","doi":"10.1007/s40265-013-0014-6","title":"Mitogen-Activated Protein Kinases as Therapeutic Targets for Rheumatoid Arthritis","year":2013,"lang":"en","type":"review","venue":"Drugs","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Medicine; Rheumatoid arthritis; Druggability; Context (archaeology); Kinase; Immunology; Inflammation; Proinflammatory cytokine; Arthritis; MAPK/ERK pathway; Methotrexate; p38 mitogen-activated protein kinases; Pharmacology","score_opus":0.026024606140518408,"score_gpt":0.2893558393361413,"score_spread":0.2633312331956229,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054828913","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013740799,0.9977825,0.0002476405,0.00029575892,0.00028040615,0.000006973602,0.000025316049,0.000015004213,0.0012089009],"genre_scores_gemma":[0.0011830498,0.9966181,0.00035475875,0.00031705844,0.00027137867,0.000011382564,0.0000422479,0.0000030303652,0.0011990134],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998617,0.000020121995,0.000017165916,0.000021692094,0.000060161652,0.000019036359],"domain_scores_gemma":[0.99980325,0.00007769673,0.000037573045,0.0000071102186,0.000052138497,0.000022345883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050201867,0.0010598333,0.0014400629,0.0018978539,0.0002489041,0.00087798515,0.00085414003,0.0010235201,0.0032574248],"category_scores_gemma":[0.0005856753,0.00032525408,0.00039127024,0.001806712,0.00049120584,0.00094085146,0.00058275193,0.0024056002,0.0020014418],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016061959,0.0001165055,0.000107691216,0.008545343,0.000077820994,0.00024009885,0.000026659665,0.00048675435,0.0040642535,0.002956793,0.040129904,0.9430875],"study_design_scores_gemma":[0.000069838956,0.00013514151,0.0004933278,0.0012138814,0.00015563448,0.0010247675,0.000029875637,0.00020219466,0.0011475356,0.0017896345,0.9937192,0.000019105077],"about_ca_topic_score_codex":0.0008130016,"about_ca_topic_score_gemma":0.0030332967,"teacher_disagreement_score":0.0032574248,"about_ca_system_score_codex":0.0005708174,"about_ca_system_score_gemma":0.0007370176,"threshold_uncertainty_score":0.01089716},"labels":[],"label_agreement":null},{"id":"W2056317617","doi":"10.1007/s40265-013-0013-7","title":"Ceftazidime-Avibactam: a Novel Cephalosporin/β-lactamase Inhibitor Combination","year":2013,"lang":"en","type":"review","venue":"Drugs","topic":"Antibiotic Resistance in Bacteria","field":"Biochemistry, Genetics and Molecular Biology","cited_by":423,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Boniface Hospital; University of Manitoba; Health Sciences Centre","funders":"","keywords":"Avibactam; Ceftazidime; Ceftazidime/avibactam; Beta-Lactamase Inhibitors; Medicine; Pharmacokinetics; Pharmacology; Microbiology; Cephalosporin; Chemistry; Antibiotics; Biology; Pseudomonas aeruginosa; Bacteria","score_opus":0.02177261858170477,"score_gpt":0.29372918615663773,"score_spread":0.271956567574933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056317617","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022164517,0.99810284,0.00022176547,0.00024445346,0.00021623363,0.0000063989924,0.000029984314,0.000010855291,0.00094574556],"genre_scores_gemma":[0.0015070732,0.9967044,0.00041092862,0.00028456378,0.00017244741,0.000008391054,0.000059429938,0.0000021694434,0.0008505805],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998666,0.000017899521,0.000020225332,0.000024990439,0.000053253734,0.000016891292],"domain_scores_gemma":[0.9998282,0.00006899034,0.000031356478,0.0000050181843,0.00004570645,0.000020763686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034277447,0.0007505503,0.001214247,0.001280737,0.00015896389,0.0007096586,0.00073887873,0.0006716541,0.0021696307],"category_scores_gemma":[0.0005643783,0.00018479813,0.00033741118,0.0014467419,0.00028385685,0.000722353,0.0003804499,0.0016931688,0.0012197939],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014996094,0.00006996161,0.00013406028,0.0072540483,0.00008990319,0.00019382621,0.000016893662,0.00024539788,0.0022844418,0.0014090127,0.02699619,0.9611562],"study_design_scores_gemma":[0.00007874476,0.00018137418,0.0008327449,0.0015937407,0.00022177356,0.002071705,0.00002614401,0.00018533885,0.0014200486,0.0007724158,0.99259746,0.00001840254],"about_ca_topic_score_codex":0.0009555762,"about_ca_topic_score_gemma":0.002469047,"teacher_disagreement_score":0.0021696307,"about_ca_system_score_codex":0.00053522876,"about_ca_system_score_gemma":0.000729397,"threshold_uncertainty_score":0.007258177},"labels":[],"label_agreement":null},{"id":"W2059072558","doi":"10.2165/00003495-200464010-00003","title":"First-Line Treatment Strategies to Improve Survival in Patients with Advanced Colorectal Cancer","year":2004,"lang":"en","type":"review","venue":"Drugs","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Irinotecan; Colorectal cancer; Oxaliplatin; Oncology; Chemotherapy; Internal medicine; Disease; Cetuximab; Cancer; Intensive care medicine","score_opus":0.018532480870473243,"score_gpt":0.325341864936809,"score_spread":0.30680938406633573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059072558","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022600501,0.9992501,0.000031354997,0.00008330689,0.000044751872,0.0000059209724,0.000021305572,0.0000024065332,0.00033472833],"genre_scores_gemma":[0.001474761,0.9980642,0.00014425552,0.00012733394,0.000031540425,0.000008226094,0.000028082479,4.9333823e-7,0.000121154735],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999819,0.000057196812,0.000034956043,0.000026377576,0.00005000236,0.000012517302],"domain_scores_gemma":[0.9994254,0.00037588587,0.000118105,0.000009953925,0.000050987066,0.000019724794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006732235,0.00066285505,0.0024745162,0.0016067046,0.000178424,0.0005789679,0.0006981598,0.0006429792,0.0034284797],"category_scores_gemma":[0.0011447066,0.0002129113,0.0011957729,0.0019072844,0.00022674828,0.0005621551,0.00027958574,0.0009934547,0.00042064738],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035932966,0.00013237316,0.00052807055,0.07757053,0.0009929588,0.00013220526,0.00004264531,0.00028707468,0.0006184985,0.00076609704,0.0111680925,0.90740216],"study_design_scores_gemma":[0.0014361682,0.0021482639,0.017884608,0.091191396,0.0129024405,0.0042057834,0.00031948573,0.00047529588,0.0024941717,0.0021064333,0.8647462,0.000089866895],"about_ca_topic_score_codex":0.0017179601,"about_ca_topic_score_gemma":0.0059936927,"teacher_disagreement_score":0.0034284797,"about_ca_system_score_codex":0.000548444,"about_ca_system_score_gemma":0.00082834944,"threshold_uncertainty_score":0.011469424},"labels":[],"label_agreement":null},{"id":"W2059634850","doi":"10.2165/00003495-200464190-00003","title":"Role of Fibric Acid Derivatives in the Management of Risk Factors for Coronary Heart Disease","year":2004,"lang":"en","type":"review","venue":"Drugs","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"U.S. Department of Veterans Affairs","keywords":"Medicine; Fibrate; Internal medicine; Bezafibrate; Fenofibrate; Metabolic syndrome; Abdominal obesity; Hypertriglyceridemia; Diabetes mellitus; Risk factor; Cholesterol; Gemfibrozil; Endocrinology; Triglyceride; Obesity","score_opus":0.0231935526228265,"score_gpt":0.30793954816706903,"score_spread":0.2847459955442425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059634850","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011419011,0.999213,0.00010001289,0.0001183771,0.00009722181,0.0000028544816,0.000009108254,0.0000050967255,0.00034011563],"genre_scores_gemma":[0.0007655114,0.99826485,0.00031457614,0.00015413886,0.0001554213,0.000005088006,0.000019598296,0.0000011085606,0.0003196836],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997305,0.00005273235,0.00005567713,0.000043746055,0.000097732714,0.000019568757],"domain_scores_gemma":[0.99917907,0.0004901672,0.00012238238,0.000019387006,0.00013952774,0.000049519625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010189236,0.0011062578,0.0030028338,0.002394003,0.00031388295,0.0009239972,0.0011037319,0.001436099,0.0026865117],"category_scores_gemma":[0.0011201004,0.00033796218,0.00071283855,0.0021165775,0.00048390118,0.00090694934,0.00048270085,0.00212915,0.0016353134],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025492482,0.00014219344,0.00024688165,0.010346076,0.00023185703,0.00035951362,0.0000358826,0.0002966286,0.0012991412,0.0009880024,0.012438038,0.9733609],"study_design_scores_gemma":[0.00026192208,0.00052394136,0.0030115657,0.006181341,0.0010566046,0.004201033,0.00008826767,0.00032291314,0.0013481417,0.0016319674,0.9813214,0.000050866984],"about_ca_topic_score_codex":0.0020292704,"about_ca_topic_score_gemma":0.0043382463,"teacher_disagreement_score":0.0030028338,"about_ca_system_score_codex":0.00051383156,"about_ca_system_score_gemma":0.0008768477,"threshold_uncertainty_score":0.008987248},"labels":[],"label_agreement":null},{"id":"W2062507310","doi":"10.2165/00003495-200565040-00004","title":"An Overview of Economic Evaluations for Drugs Used in Rheumatoid Arthritis","year":2005,"lang":"en","type":"review","venue":"Drugs","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver Coastal Health Research Institute; Vancouver Coastal Health","funders":"","keywords":"Medicine; Infliximab; Adalimumab; Rheumatoid arthritis; Etanercept; Quality-adjusted life year; Quality of life (healthcare); Antirheumatic Agents; Golimumab; Pharmacoeconomics; Intensive care medicine; Physical therapy; Cost effectiveness; Disease; Internal medicine; Risk analysis (engineering)","score_opus":0.088687636478896,"score_gpt":0.43036565504091906,"score_spread":0.34167801856202307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062507310","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000084215826,0.9992318,0.00011746337,0.00013235056,0.000054804048,0.000015504093,0.000054211294,0.0000033909116,0.00030616493],"genre_scores_gemma":[0.0014005019,0.9975038,0.0006257927,0.0001869943,0.00007129755,0.0000288494,0.000047901114,0.0000023396321,0.00013252765],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99724257,0.001042077,0.0006836702,0.00018113195,0.000756702,0.000093843286],"domain_scores_gemma":[0.98884845,0.008814404,0.0014319358,0.0000929372,0.00070688844,0.00010534811],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005652059,0.0019196532,0.0059061875,0.009879795,0.00034787404,0.0024568418,0.0014994565,0.0022071798,0.004558491],"category_scores_gemma":[0.011860456,0.0007654717,0.0034030264,0.012145287,0.0006272359,0.0019635658,0.0007823764,0.0017134774,0.00046018107],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006979766,0.0001193092,0.0003712884,0.23541537,0.0025196543,0.00020467881,0.000052101455,0.0013149026,0.00033189743,0.004333833,0.01865901,0.73598],"study_design_scores_gemma":[0.0008607539,0.0008202204,0.0058218446,0.29578292,0.018113058,0.0022738427,0.00022138128,0.0013992301,0.0008749381,0.0094545325,0.6642384,0.00013889775],"about_ca_topic_score_codex":0.0046124654,"about_ca_topic_score_gemma":0.010092454,"teacher_disagreement_score":0.009879795,"about_ca_system_score_codex":0.0031412826,"about_ca_system_score_gemma":0.0033587883,"threshold_uncertainty_score":0.029891253},"labels":[],"label_agreement":null},{"id":"W2064428940","doi":"10.2165/00003495-200363210-00002","title":"Newer Formulations of the Triptans","year":2003,"lang":"en","type":"review","venue":"Drugs","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Triptans; Sumatriptan; Zolmitriptan; Rizatriptan; Medicine; Migraine; Nausea; Anesthesia; Vomiting; Intensive care medicine; Internal medicine; Agonist","score_opus":0.07537286117795669,"score_gpt":0.38038940510317326,"score_spread":0.3050165439252166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064428940","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00031192123,0.9984837,0.00007501081,0.000071342205,0.000091134745,0.000009920874,0.000040898114,0.0000049089417,0.0009112167],"genre_scores_gemma":[0.0010852586,0.9979321,0.00024196277,0.00013555727,0.0000686498,0.000008604609,0.000049451977,0.0000010817653,0.00047731868],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99979776,0.000036528563,0.000052485033,0.00003266966,0.000069263326,0.000011389221],"domain_scores_gemma":[0.99964225,0.00016860636,0.000103418504,0.000010025592,0.000056978475,0.000018739724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005485407,0.00082686765,0.0016850397,0.0025343252,0.00019521327,0.0006822674,0.0008306729,0.0006120145,0.006134867],"category_scores_gemma":[0.0008687141,0.00021964614,0.0007662705,0.0029350412,0.00030709826,0.0009444499,0.000333247,0.0009861351,0.0011728253],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032927148,0.00007483513,0.00020812213,0.03775455,0.00031006354,0.00024988427,0.000043383017,0.00017307888,0.0018483539,0.00081990095,0.009797197,0.9483915],"study_design_scores_gemma":[0.0003708584,0.0006625386,0.0038130698,0.012234571,0.0020807171,0.003538668,0.0001578948,0.00014061842,0.0016448192,0.0009370074,0.9743774,0.000041914394],"about_ca_topic_score_codex":0.0020405361,"about_ca_topic_score_gemma":0.005697273,"teacher_disagreement_score":0.006134867,"about_ca_system_score_codex":0.00040668415,"about_ca_system_score_gemma":0.0007148505,"threshold_uncertainty_score":0.02052319},"labels":[],"label_agreement":null},{"id":"W2065173886","doi":"10.2165/00003495-200868010-00004","title":"Antiretroviral Therapy","year":2008,"lang":"en","type":"review","venue":"Drugs","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Ritonavir; Medicine; Stavudine; Context (archaeology); Abacavir; Emtricitabine; Drug resistance; Antiretroviral therapy; Drug; Protease inhibitor (pharmacology); Lamivudine; Pharmacology; Intensive care medicine; Human immunodeficiency virus (HIV); Virology; Computational biology; Biology; Viral load; Virus; Genetics","score_opus":0.04814279697015873,"score_gpt":0.3389261771370195,"score_spread":0.2907833801668608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065173886","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003341547,0.95361936,0.0007308762,0.00095126795,0.0017274146,0.000108677224,0.00037623144,0.00011317857,0.042038813],"genre_scores_gemma":[0.0042392802,0.9557856,0.001816569,0.0034830307,0.0014469656,0.000114923074,0.00073476345,0.000016006277,0.03236279],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997043,0.000071375,0.00003735518,0.00004129679,0.00011089263,0.000034785768],"domain_scores_gemma":[0.9998319,0.000049550796,0.000042426556,0.000013917283,0.0000384739,0.000023640254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028425304,0.0012211505,0.0015940078,0.0018296682,0.00030994255,0.0010235455,0.0009149196,0.0010428205,0.032929376],"category_scores_gemma":[0.0007155096,0.00022960956,0.0004224823,0.001269891,0.00031821485,0.00072342216,0.0008981948,0.0016739563,0.017383913],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000064952306,0.00007292088,0.000085963264,0.0052244556,0.000041835818,0.0001560217,0.000028811555,0.00010295326,0.00080383546,0.0015763923,0.09169988,0.900142],"study_design_scores_gemma":[0.000051443945,0.000078343146,0.00030848474,0.0026593138,0.0000920173,0.0010343558,0.00001736943,0.00004142754,0.0002471126,0.00058905367,0.9948743,0.0000068712334],"about_ca_topic_score_codex":0.00080365775,"about_ca_topic_score_gemma":0.0018844617,"teacher_disagreement_score":0.032929376,"about_ca_system_score_codex":0.00035403416,"about_ca_system_score_gemma":0.00096326595,"threshold_uncertainty_score":0.110159814},"labels":[],"label_agreement":null},{"id":"W2066074321","doi":"10.2165/00003495-200464190-00004","title":"Antiepileptic Drugs in the Treatment of Anxiety Disorders","year":2004,"lang":"en","type":"review","venue":"Drugs","topic":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","field":"Psychology","cited_by":80,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences; McMaster University Medical Centre","funders":"","keywords":"Pregabalin; Anxiety; Gabapentin; Lamotrigine; Medicine; Panic disorder; Pharmacotherapy; Psychiatry; Generalized anxiety disorder; Buspirone; Mood disorders; Anxiety disorder; Social anxiety; Epilepsy; Internal medicine; Alternative medicine","score_opus":0.04106096943222905,"score_gpt":0.37773535790226986,"score_spread":0.33667438847004083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066074321","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001716716,0.9988777,0.00009572439,0.000106350846,0.00009137883,0.0000057029047,0.000012122151,0.0000054567786,0.00063388544],"genre_scores_gemma":[0.0011877565,0.997823,0.00028803546,0.0001357325,0.00011685316,0.0000066572193,0.000023429882,9.448602e-7,0.0004175677],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99982077,0.000035898753,0.00003620164,0.00002534141,0.00006817468,0.000013651382],"domain_scores_gemma":[0.999572,0.00023820666,0.00006988885,0.000011887364,0.00007618423,0.000031863525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060622935,0.0008299834,0.0016396522,0.001679315,0.00023807274,0.0006616139,0.0009163923,0.00073920196,0.0026298335],"category_scores_gemma":[0.0007442676,0.00022448144,0.00044450024,0.0020933123,0.00039769238,0.0006649928,0.00039745212,0.0015593383,0.0010934137],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013804792,0.0001329511,0.00024049275,0.011532077,0.000148833,0.00019830713,0.000034334513,0.00021745489,0.00088539906,0.00089130737,0.011863269,0.9737177],"study_design_scores_gemma":[0.00025132785,0.00041958524,0.0064804214,0.008856013,0.00091255124,0.004678284,0.00015149804,0.00024048219,0.000958737,0.0026337313,0.97437817,0.000039217004],"about_ca_topic_score_codex":0.002085596,"about_ca_topic_score_gemma":0.005442253,"teacher_disagreement_score":0.0026298335,"about_ca_system_score_codex":0.00043308246,"about_ca_system_score_gemma":0.0008030196,"threshold_uncertainty_score":0.008797705},"labels":[],"label_agreement":null},{"id":"W2067947520","doi":"10.2165/00003495-200666130-00005","title":"Cardiovascular Health and Aromatase Inhibitors","year":2006,"lang":"en","type":"review","venue":"Drugs","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Tamoxifen; Breast cancer; Myocardial infarction; Disease; Internal medicine; Cancer; Oncology; Incidence (geometry); Clinical trial; Gynecology","score_opus":0.009769732726712194,"score_gpt":0.27342216586212703,"score_spread":0.26365243313541487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067947520","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000084327134,0.9973315,0.00021782347,0.00031946207,0.00052515505,0.000005237421,0.000021468204,0.0000134013935,0.0014816036],"genre_scores_gemma":[0.00067996694,0.9957141,0.0004295098,0.00045060276,0.0007467221,0.000010019277,0.000049163533,0.000003015945,0.0019167911],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998221,0.00002773076,0.000023413879,0.00003192302,0.00007915898,0.000015754318],"domain_scores_gemma":[0.9996953,0.00014205484,0.00004735168,0.000012778536,0.000073094554,0.000029543775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053921074,0.0012888543,0.0019544063,0.001727253,0.00030288906,0.00086218177,0.0011042173,0.0011596765,0.0044946233],"category_scores_gemma":[0.0008515275,0.00033927106,0.00047149672,0.0022258265,0.0005233268,0.0009997135,0.00048479668,0.0021854495,0.0031097],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015282449,0.00011197162,0.00014398625,0.005759898,0.00009960672,0.00031570112,0.000018974284,0.0004206381,0.0011969536,0.002267047,0.07073367,0.9187788],"study_design_scores_gemma":[0.00006261329,0.00009360161,0.00070733187,0.0009697279,0.00013627972,0.0013600886,0.00002356352,0.000119878,0.00035762347,0.0013759905,0.99477863,0.000014576606],"about_ca_topic_score_codex":0.0013789454,"about_ca_topic_score_gemma":0.003687196,"teacher_disagreement_score":0.0044946233,"about_ca_system_score_codex":0.0005833557,"about_ca_system_score_gemma":0.0007619773,"threshold_uncertainty_score":0.0150360465},"labels":[],"label_agreement":null},{"id":"W2069750059","doi":"10.2165/11319210-000000000-00000","title":"Pharmacotherapy and Weight-Loss Supplements for Treatment of Paediatric Obesity","year":2010,"lang":"en","type":"review","venue":"Drugs","topic":"Pharmacology and Obesity Treatment","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Child and Family Research Institute; University of British Columbia; BC Children's Hospital","funders":"","keywords":"Sibutramine; Medicine; Orlistat; Weight loss; Pharmacotherapy; Obesity; Overweight; Psychological intervention; Adverse effect; Intensive care medicine; Pediatrics; Internal medicine; Psychiatry","score_opus":0.03809831920995511,"score_gpt":0.3969230784000468,"score_spread":0.3588247591900917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069750059","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020721524,0.9985886,0.00014071574,0.000108317516,0.00010765923,0.000008677032,0.00002601267,0.000008964858,0.00080384704],"genre_scores_gemma":[0.00088596635,0.997837,0.00039922455,0.000165805,0.00011143177,0.000008610578,0.000037118054,0.000002094293,0.00055280933],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9998271,0.000027890457,0.00003758917,0.000029146555,0.00006645328,0.000011835021],"domain_scores_gemma":[0.9996426,0.00019237949,0.00007517454,0.00000788837,0.000061141654,0.000020828009],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042016187,0.0009820515,0.0019429049,0.0025261631,0.00021168604,0.00060441263,0.0007845377,0.00085716485,0.0042990246],"category_scores_gemma":[0.00065017823,0.00031034055,0.00067094044,0.0021053525,0.00036318734,0.000828458,0.0004919464,0.0017696164,0.001620343],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016198633,0.00018404149,0.00014279329,0.025833184,0.00024263402,0.00023681027,0.0000378283,0.00024773733,0.0016637176,0.0010367134,0.014472086,0.9557405],"study_design_scores_gemma":[0.00023159916,0.0003660559,0.0027673058,0.012339523,0.001141788,0.003645424,0.00009794973,0.00030577244,0.0014084888,0.0013649634,0.97628754,0.000043510965],"about_ca_topic_score_codex":0.0017251299,"about_ca_topic_score_gemma":0.004445747,"teacher_disagreement_score":0.0042990246,"about_ca_system_score_codex":0.0003585209,"about_ca_system_score_gemma":0.00073498045,"threshold_uncertainty_score":0.014381647},"labels":[],"label_agreement":null},{"id":"W2070074427","doi":"10.2165/00003495-200262120-00006","title":"The Ketolides","year":2002,"lang":"en","type":"review","venue":"Drugs","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":181,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Manitoba","funders":"","keywords":"Telithromycin; Ketolide; Microbiology; Streptococcus pneumoniae; Erythromycin; Chemistry; Biochemistry; Antibiotics; Biology","score_opus":0.05765043488422787,"score_gpt":0.360429234636641,"score_spread":0.3027787997524131,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070074427","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002540481,0.9964886,0.00016106812,0.00025222686,0.00044890563,0.000010148411,0.000036426733,0.000014996106,0.0023336394],"genre_scores_gemma":[0.0015048845,0.9941299,0.00032501676,0.00042888816,0.0004248022,0.000014013106,0.00006879637,0.0000023763453,0.0031014234],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99973816,0.00004057673,0.000065506545,0.000042801,0.00008334694,0.000029582257],"domain_scores_gemma":[0.9996822,0.00009066281,0.00011064247,0.000013426269,0.000062746345,0.000040360883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042674353,0.0014476142,0.0019604892,0.0030647365,0.00031737835,0.0011054054,0.00082206045,0.001091985,0.0074758627],"category_scores_gemma":[0.00055278523,0.00032155422,0.00051348173,0.0027892035,0.00064740813,0.0019353237,0.0008491538,0.0019267907,0.004251681],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024755634,0.00010310153,0.00016633609,0.012128083,0.00008774095,0.0003820183,0.00003991221,0.00023323334,0.0024641987,0.0015810604,0.027680265,0.9548866],"study_design_scores_gemma":[0.000079408244,0.00031003542,0.00092191104,0.00233943,0.00020762494,0.0027030683,0.000045480232,0.000080506725,0.0010713817,0.00056875916,0.9916543,0.000018025241],"about_ca_topic_score_codex":0.0010058441,"about_ca_topic_score_gemma":0.0028211302,"teacher_disagreement_score":0.0074758627,"about_ca_system_score_codex":0.0005245626,"about_ca_system_score_gemma":0.0010556475,"threshold_uncertainty_score":0.025009215},"labels":[],"label_agreement":null},{"id":"W2074969992","doi":"10.2165/00003495-200161060-00008","title":"Desloratadine","year":2001,"lang":"en","type":"article","venue":"Drugs","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston General Hospital","funders":"","keywords":"Medicine; Desloratadine; Pharmacotherapy; Traditional medicine; Pharmacology; Dermatology; Internal medicine","score_opus":0.009520128812159313,"score_gpt":0.26069722477461477,"score_spread":0.25117709596245547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074969992","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6158985,0.069447294,0.008349563,0.009171885,0.0026939034,0.0011053028,0.002981308,0.001173385,0.28917888],"genre_scores_gemma":[0.87127084,0.015184888,0.003581423,0.0049984576,0.00064986595,0.00024661704,0.0024674104,0.000070608934,0.10152989],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998467,0.000025969968,0.000019519326,0.000038558323,0.000040703344,0.000028520852],"domain_scores_gemma":[0.9998661,0.000025921776,0.000022440296,0.000014887298,0.000026317859,0.000044287146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011122389,0.00024321824,0.00040304693,0.00038648487,0.00036086066,0.0002999313,0.0002885242,0.00037414217,0.014603843],"category_scores_gemma":[0.00045501717,0.000056873465,0.00025747463,0.0003345569,0.00010852456,0.00017630786,0.0001915237,0.00079118845,0.003916064],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014225801,0.0027010103,0.014809449,0.0009793548,0.00036445595,0.007308003,0.00018471984,0.00019442714,0.14457065,0.0025279664,0.030555947,0.7815783],"study_design_scores_gemma":[0.004640082,0.019538388,0.06536089,0.0004181491,0.0006802676,0.052655827,0.00019258737,0.0012167093,0.12107805,0.0018115693,0.7323338,0.00007371685],"about_ca_topic_score_codex":0.00061110785,"about_ca_topic_score_gemma":0.0014286342,"teacher_disagreement_score":0.014603843,"about_ca_system_score_codex":0.00023788282,"about_ca_system_score_gemma":0.00032636515,"threshold_uncertainty_score":0.04885477},"labels":[],"label_agreement":null},{"id":"W2075634944","doi":"10.2165/00003495-200767170-00014","title":"Imatinib in Relapsed or Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukaemia","year":2007,"lang":"en","type":"article","venue":"Drugs","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Imatinib; Refractory (planetary science); Philadelphia chromosome; Lymphoblastic Leukemia; Oncology; Internal medicine; Pharmacotherapy; Pediatrics; Leukemia; Genetics; Chromosomal translocation; Gene","score_opus":0.01332079583642018,"score_gpt":0.29007371630028644,"score_spread":0.27675292046386624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075634944","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83668023,0.13100424,0.00052288367,0.004383466,0.00038364594,0.00012625025,0.0006455347,0.00006908785,0.026184676],"genre_scores_gemma":[0.96136683,0.032219365,0.0006731417,0.0009887316,0.00027288706,0.00011888344,0.00058658095,0.00001413703,0.0037594384],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998611,0.00006799043,0.00001598757,0.000010382982,0.000018789553,0.000025700014],"domain_scores_gemma":[0.99986255,0.000056842957,0.00003347829,0.0000075113353,0.0000056246035,0.00003400258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035807613,0.00014156986,0.00054800266,0.0002736473,0.0001517179,0.00022556684,0.00017174389,0.00028169496,0.0031744326],"category_scores_gemma":[0.0006092672,0.00006093925,0.00018727136,0.00032534028,0.00016279895,0.00023013166,0.0002359009,0.0004945349,0.00040837348],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030438598,0.0007775192,0.026821287,0.0021489223,0.00054199336,0.0031503243,0.0003871694,0.002629723,0.024753463,0.005223351,0.021796165,0.88133144],"study_design_scores_gemma":[0.030909056,0.045750447,0.35404223,0.0017499035,0.002292927,0.032604538,0.000983768,0.0044084233,0.029164907,0.009201639,0.48878565,0.00010656446],"about_ca_topic_score_codex":0.00026915307,"about_ca_topic_score_gemma":0.0014432947,"teacher_disagreement_score":0.0031744326,"about_ca_system_score_codex":0.0002795071,"about_ca_system_score_gemma":0.00029613465,"threshold_uncertainty_score":0.010619521},"labels":[],"label_agreement":null},{"id":"W2076233570","doi":"10.2165/11317030-000000000-00000","title":"Efflux-Mediated Drug Resistance in Bacteria","year":2009,"lang":"en","type":"review","venue":"Drugs","topic":"Antibiotic Resistance in Bacteria","field":"Biochemistry, Genetics and Molecular Biology","cited_by":942,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"National Institute of Allergy and Infectious Diseases","keywords":"Efflux; Drug resistance; Drug; Biology; Multiple drug resistance; Pharmacology; Bacteria; Drug discovery; Microbiology; Biochemistry; Genetics","score_opus":0.011298438079149703,"score_gpt":0.283172131083459,"score_spread":0.2718736930043093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076233570","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006045535,0.9979103,0.00034276038,0.00025597517,0.00046716898,0.0000047092794,0.000015106993,0.000010809297,0.00093257404],"genre_scores_gemma":[0.00033722637,0.9979791,0.0003257187,0.00020604665,0.0003635143,0.0000057510338,0.000023552178,0.0000019325082,0.00075723167],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997199,0.0000449373,0.000040425315,0.000056572735,0.00010862654,0.000029552559],"domain_scores_gemma":[0.99946517,0.00022278618,0.00006810937,0.000021997585,0.00016824371,0.000053637017],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009128737,0.001739973,0.002703465,0.0026453314,0.0004443664,0.0015989435,0.0015343752,0.0021192601,0.0027905286],"category_scores_gemma":[0.0010025401,0.0006349189,0.00056131714,0.0033944503,0.001271525,0.0023413596,0.0010057823,0.003136137,0.0031823476],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011159197,0.00008898279,0.00012960682,0.012741306,0.000073742456,0.00025301188,0.000043401422,0.00058119104,0.0037549774,0.00505782,0.058596045,0.91856825],"study_design_scores_gemma":[0.00002338849,0.000061952145,0.00034630534,0.001709328,0.0000752273,0.0011063197,0.00003325113,0.00014884057,0.0007470382,0.0023475506,0.99337935,0.00002142504],"about_ca_topic_score_codex":0.0013566823,"about_ca_topic_score_gemma":0.0023434535,"teacher_disagreement_score":0.0027905286,"about_ca_system_score_codex":0.0011143119,"about_ca_system_score_gemma":0.0011802792,"threshold_uncertainty_score":0.009335279},"labels":[],"label_agreement":null},{"id":"W2078776320","doi":"10.2165/00003495-200969070-00003","title":"Ceftaroline","year":2009,"lang":"pl","type":"review","venue":"Drugs","topic":"Antimicrobial Resistance in Staphylococcus","field":"Medicine","cited_by":152,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Manitoba","funders":"","keywords":"Microbiology; Cephalosporin; Bacteroides fragilis; Medicine; Staphylococcus aureus; Penicillin binding proteins; Staphylococcus epidermidis; Antibiotics; Enterococcus faecalis; Penicillin; Biology; Bacteria","score_opus":0.026801562702451622,"score_gpt":0.3317347379774799,"score_spread":0.3049331752750283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078776320","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000279317,0.99710935,0.000097635195,0.00028209385,0.00018538207,0.000008457156,0.000033491917,0.000014221812,0.0019901004],"genre_scores_gemma":[0.002354011,0.9950824,0.00030516522,0.00041284817,0.00020539587,0.000011333278,0.000075604745,0.0000023697917,0.0015509175],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998091,0.000034394205,0.000037408474,0.000037522845,0.000061549814,0.000020049185],"domain_scores_gemma":[0.9996195,0.00014721349,0.00012696916,0.000011540862,0.00006652159,0.000028371394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025967468,0.0009863029,0.0013029408,0.0023835746,0.00019090087,0.0006939645,0.0005214178,0.00075824757,0.005878908],"category_scores_gemma":[0.00091159175,0.00021128658,0.0005384232,0.0017715675,0.00028856104,0.00064014946,0.00043606412,0.0011554143,0.0020756323],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013668607,0.000068850655,0.00022518539,0.01149482,0.00009800697,0.00024873912,0.000026342546,0.00010664561,0.0019003135,0.0005605251,0.02975282,0.9553811],"study_design_scores_gemma":[0.00017184103,0.000447783,0.002903854,0.009651239,0.0005554667,0.004711351,0.00006697948,0.00017213842,0.0019446968,0.0005419578,0.9788063,0.000026268368],"about_ca_topic_score_codex":0.0015212934,"about_ca_topic_score_gemma":0.0034562259,"teacher_disagreement_score":0.005878908,"about_ca_system_score_codex":0.00047782267,"about_ca_system_score_gemma":0.00080683595,"threshold_uncertainty_score":0.01966685},"labels":[],"label_agreement":null},{"id":"W2083965012","doi":"10.2165/00003495-200060030-00003","title":"Immune Tolerance Therapy for Haemophilia","year":2000,"lang":"en","type":"review","venue":"Drugs","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Haemophilia; Intensive care medicine; Dosing; Complication; Haemophilia B; Pharmacotherapy; Haemophilia A; Factor IX; Surgery; Internal medicine","score_opus":0.07158676984139445,"score_gpt":0.3933388190161775,"score_spread":0.32175204917478306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083965012","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011946283,0.99887985,0.00008375445,0.000112699854,0.00016860025,0.000008123029,0.0000108872855,0.000006153499,0.0006105024],"genre_scores_gemma":[0.0010829099,0.99717736,0.00019823994,0.00031974097,0.00024169356,0.000016555961,0.00002692426,0.0000016689718,0.00093495974],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999843,0.000035015473,0.00002936016,0.00002465597,0.000051758692,0.000016307888],"domain_scores_gemma":[0.99972874,0.00012864538,0.00007182832,0.0000075294206,0.000037590205,0.000025610885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055422605,0.0010441248,0.002089845,0.0022557054,0.00026792003,0.0007333073,0.000706061,0.0010648156,0.004227258],"category_scores_gemma":[0.00067089795,0.00023119939,0.0005228499,0.0019136909,0.00040521825,0.0009601064,0.0004973936,0.001703834,0.0017368458],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021573185,0.00012460064,0.00009445818,0.015164829,0.00011556207,0.00018788708,0.000030309933,0.00016913393,0.0011262292,0.0008677866,0.028698502,0.953205],"study_design_scores_gemma":[0.0003423259,0.0005616969,0.0015233437,0.0064356164,0.000635537,0.0028158934,0.00004884675,0.00013178778,0.00068363006,0.00087381806,0.9859227,0.000024696177],"about_ca_topic_score_codex":0.00091855455,"about_ca_topic_score_gemma":0.0022664496,"teacher_disagreement_score":0.004227258,"about_ca_system_score_codex":0.00038984107,"about_ca_system_score_gemma":0.0006996328,"threshold_uncertainty_score":0.01414156},"labels":[],"label_agreement":null},{"id":"W2083968901","doi":"10.2165/00003495-200161001-00001","title":"An Overview of Fungal Infections","year":2001,"lang":"en","type":"review","venue":"Drugs","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":304,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Candida albicans; Incidence (geometry); Immunosuppression; Population; Intensive care medicine; Immunology; Aspergillosis; Dermatology; Biology; Microbiology; Environmental health","score_opus":0.1098644668487232,"score_gpt":0.44102854089089116,"score_spread":0.33116407404216797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083968901","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008944346,0.99837863,0.00018153954,0.00013694164,0.0003227034,0.000009121058,0.000022628938,0.00001318407,0.0008458224],"genre_scores_gemma":[0.00040974354,0.99762267,0.00040447392,0.00026557763,0.00040926825,0.000010681141,0.000040424966,0.0000016045465,0.0008354616],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996604,0.00004610668,0.00007670539,0.000052321906,0.00013515564,0.00002935368],"domain_scores_gemma":[0.9995316,0.0002057568,0.00009888347,0.000012893435,0.00010081416,0.000050008013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005681723,0.0020033438,0.0029553797,0.0058341026,0.00039973846,0.0012869561,0.0011536771,0.001600296,0.0051772166],"category_scores_gemma":[0.0007251512,0.00049983844,0.00092104427,0.005305238,0.0004720121,0.00223075,0.0007777654,0.001934598,0.003257163],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014694288,0.00013396719,0.00021264382,0.021503288,0.000107454565,0.00052267866,0.00004044442,0.00028123648,0.001506605,0.0006915339,0.040470745,0.93438244],"study_design_scores_gemma":[0.00008308244,0.0003476428,0.0019775457,0.006920171,0.00041309992,0.006204396,0.00007417691,0.00018590258,0.0005166072,0.00081262004,0.98242605,0.000038718295],"about_ca_topic_score_codex":0.0014713794,"about_ca_topic_score_gemma":0.003954992,"teacher_disagreement_score":0.0058341026,"about_ca_system_score_codex":0.00056583737,"about_ca_system_score_gemma":0.001141861,"threshold_uncertainty_score":0.01731956},"labels":[],"label_agreement":null},{"id":"W2085386233","doi":"10.2165/00003495-200464080-00001","title":"The Management of Hypertension in the Overweight and Obese Patient","year":2004,"lang":"en","type":"review","venue":"Drugs","topic":"Pharmacology and Obesity Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Overweight; Pharmacotherapy; Obesity; Internal medicine; Intensive care medicine","score_opus":0.03228219732939595,"score_gpt":0.31852711400397843,"score_spread":0.28624491667458246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085386233","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000112119975,0.99876535,0.000121842,0.0002293256,0.00018086474,0.0000039769543,0.0000072547637,0.0000055949695,0.00057371985],"genre_scores_gemma":[0.0005974547,0.9981907,0.00026070775,0.00027691547,0.00027115058,0.000004372396,0.000014602688,9.874205e-7,0.00038317428],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99977106,0.000050941162,0.000036996957,0.0000343885,0.00008945622,0.000017162558],"domain_scores_gemma":[0.99950254,0.0002617524,0.00010686302,0.000010563873,0.00007896541,0.000039296592],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055549794,0.00096733385,0.002396326,0.0022819052,0.00028072463,0.0009586049,0.000994737,0.0012484632,0.0021982966],"category_scores_gemma":[0.00074623415,0.00029779744,0.0006105289,0.0022454166,0.00046816826,0.0012182989,0.0004897584,0.0025040156,0.0012541326],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000171442,0.00014998912,0.00022564315,0.012827832,0.00015841766,0.00043399882,0.000037068483,0.00028349913,0.0012731554,0.00088690367,0.018799452,0.9647525],"study_design_scores_gemma":[0.000203086,0.0004517048,0.0033688566,0.0072728037,0.0006902333,0.0058313496,0.000112017064,0.0003548611,0.0008087959,0.0018127254,0.97904325,0.000050286108],"about_ca_topic_score_codex":0.0012717897,"about_ca_topic_score_gemma":0.003929178,"teacher_disagreement_score":0.002396326,"about_ca_system_score_codex":0.00044629155,"about_ca_system_score_gemma":0.00076141616,"threshold_uncertainty_score":0.0073540807},"labels":[],"label_agreement":null},{"id":"W2089068120","doi":"10.2165/00003495-200464010-00005","title":"The Glycylcyclines","year":2004,"lang":"en","type":"review","venue":"Drugs","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":306,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Manitoba","funders":"","keywords":"Tigecycline; Tetracycline; Minocycline; Microbiology; Efflux; Antimicrobial; Antibiotics; Medicine; Biology","score_opus":0.04072883456676513,"score_gpt":0.39530294476270794,"score_spread":0.3545741101959428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089068120","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002911252,0.99760157,0.00015024723,0.00021978322,0.00026050146,0.000009967506,0.00002676142,0.00001151304,0.001428547],"genre_scores_gemma":[0.0022427065,0.9947743,0.00031938957,0.00038756663,0.000264731,0.0000147605515,0.00005255165,0.000002729683,0.00194137],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99978787,0.000048332557,0.000044329023,0.000034955487,0.000060743965,0.000023742237],"domain_scores_gemma":[0.9997633,0.00008036801,0.00009237633,0.000009685698,0.00003284094,0.000021381891],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034735244,0.0011028727,0.0017639993,0.0017734152,0.0001919491,0.00080356083,0.0006195894,0.0008121619,0.0053894552],"category_scores_gemma":[0.00055194076,0.0002527835,0.00038831314,0.0019393455,0.0005061132,0.0010411777,0.0006727746,0.0017967467,0.0021797472],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024129036,0.000069895665,0.00011171404,0.011841019,0.000066040964,0.00022808429,0.000041165786,0.00030238138,0.0035430673,0.0018163926,0.019232301,0.9625066],"study_design_scores_gemma":[0.000087494875,0.00036950104,0.0007070529,0.0024004974,0.00017111971,0.0015834138,0.000037014535,0.00011068525,0.0017603607,0.0007226627,0.9920316,0.000018684354],"about_ca_topic_score_codex":0.0010067621,"about_ca_topic_score_gemma":0.002146649,"teacher_disagreement_score":0.0053894552,"about_ca_system_score_codex":0.0004817434,"about_ca_system_score_gemma":0.0009368311,"threshold_uncertainty_score":0.018029511},"labels":[],"label_agreement":null},{"id":"W2089574993","doi":"10.1007/s40265-013-0105-4","title":"Non-dopaminergic Treatments for Motor Control in Parkinson’s Disease","year":2013,"lang":"en","type":"review","venue":"Drugs","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":144,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Western Hospital","funders":"","keywords":"Medicine; Dopaminergic; Pharmacology; Levodopa; Dyskinesia; Amantadine; Serotonergic; Dopamine; Neuroscience; Parkinson's disease; Internal medicine; Psychology; Serotonin; Disease","score_opus":0.027414287080916776,"score_gpt":0.3132203201985601,"score_spread":0.28580603311764335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089574993","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012387134,0.9987394,0.000072412106,0.00009166817,0.00007756788,0.000007216457,0.000023615368,0.000005344293,0.00085877546],"genre_scores_gemma":[0.0010593064,0.9978491,0.00021016676,0.0001526101,0.000094430114,0.000009199898,0.000032585165,0.0000013500057,0.0005912877],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998388,0.000027400725,0.000035975212,0.000023836332,0.000059002916,0.000014940285],"domain_scores_gemma":[0.99967587,0.00017577161,0.000066574205,0.000006955323,0.00005668987,0.000018070472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050564064,0.00092945975,0.001855595,0.002345086,0.0002521478,0.0007662705,0.0008343017,0.000922576,0.005489332],"category_scores_gemma":[0.0006508646,0.0002994016,0.00072916725,0.0017239315,0.00038905532,0.0008377838,0.0004757405,0.0016966615,0.0015228862],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018466426,0.00014822703,0.0001337583,0.028424297,0.00024397801,0.00019016978,0.000043250628,0.0002051329,0.0012698513,0.0013254056,0.01822768,0.94960356],"study_design_scores_gemma":[0.00023693655,0.00034750847,0.0021001569,0.010056977,0.001034045,0.0020975976,0.00007716251,0.00018029723,0.0006948167,0.0018418311,0.9812983,0.000034285094],"about_ca_topic_score_codex":0.0017798761,"about_ca_topic_score_gemma":0.006339048,"teacher_disagreement_score":0.005489332,"about_ca_system_score_codex":0.00047618942,"about_ca_system_score_gemma":0.00082029507,"threshold_uncertainty_score":0.018363595},"labels":[],"label_agreement":null},{"id":"W2090441507","doi":"10.1007/s40265-013-0176-2","title":"T-Cell Trafficking and Anti-Adhesion Strategies in Inflammatory Bowel Disease: Current and Future Prospects","year":2014,"lang":"en","type":"review","venue":"Drugs","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; U.S. Department of Veterans Affairs","keywords":"Vedolizumab; Natalizumab; Medicine; Inflammatory bowel disease; Crohn's disease; Immunology; Leukocyte Trafficking; Disease; Inflammatory Bowel Diseases; Efalizumab; Inflammation; Chemokine; Tumor necrosis factor alpha; Pathology; Infliximab; Multiple sclerosis","score_opus":0.007414992976670643,"score_gpt":0.26253378202931754,"score_spread":0.2551187890526469,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090441507","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015741526,0.99867815,0.00016460737,0.0003166726,0.00014896599,0.0000034610832,0.000015766696,0.0000075506878,0.00050742785],"genre_scores_gemma":[0.0008280351,0.99808514,0.00023409691,0.0002185428,0.00017083764,0.0000060848974,0.00002270446,0.000001064065,0.00043352353],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99987614,0.000023269537,0.000014292275,0.000020862617,0.000042645628,0.000022776285],"domain_scores_gemma":[0.9997788,0.000096003,0.000034068085,0.0000059698455,0.000054041615,0.000031164785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059488096,0.0007411915,0.001583903,0.0010558808,0.00020699366,0.0010878424,0.00079356274,0.0012036184,0.0030810826],"category_scores_gemma":[0.0005103808,0.00021403117,0.00044911503,0.0012604496,0.0005313919,0.0012606364,0.0006855789,0.0019123564,0.0015012631],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002029778,0.0001267382,0.00020776592,0.010040864,0.00008226958,0.00019122049,0.000038799593,0.00059888733,0.0031184482,0.0042224363,0.0283262,0.9528435],"study_design_scores_gemma":[0.000070796836,0.00023324853,0.00074614724,0.002382159,0.0001896527,0.000923951,0.00007682681,0.0002628864,0.0007538717,0.0032208627,0.9911136,0.00002610139],"about_ca_topic_score_codex":0.00062437594,"about_ca_topic_score_gemma":0.0017501961,"teacher_disagreement_score":0.0030810826,"about_ca_system_score_codex":0.00042530423,"about_ca_system_score_gemma":0.00081959186,"threshold_uncertainty_score":0.010307252},"labels":[],"label_agreement":null},{"id":"W2090738000","doi":"10.2165/00003495-200262120-00001","title":"Who Should Receive HMG CoA Reductase Inhibitors?","year":2002,"lang":"en","type":"review","venue":"Drugs","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; McMaster University","funders":"Merck Canada","keywords":"Medicine; Myocardial infarction; Internal medicine; Pharmacotherapy; Diabetes mellitus; Statin; Cholesterol; Cardiology; HMG-CoA reductase; Dyslipidemia; Placebo; Disease; Endocrinology; Reductase; Alternative medicine","score_opus":0.06530291621394826,"score_gpt":0.34205484533847247,"score_spread":0.2767519291245242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090738000","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017800002,0.9955403,0.00009531425,0.0024854124,0.0006430636,0.000008730513,0.000023678736,0.0000061777096,0.0010191342],"genre_scores_gemma":[0.0014753081,0.9932888,0.00026823912,0.0028668435,0.0010976228,0.000018678262,0.000030815165,0.0000015898536,0.0009520051],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995839,0.000115202674,0.00010505241,0.000055499968,0.00010982761,0.00003039031],"domain_scores_gemma":[0.99885666,0.00061703834,0.0002842529,0.000016955952,0.00014281974,0.00008238724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001215521,0.00081163197,0.0033475077,0.0014258674,0.00031274193,0.0009589768,0.0006545709,0.0019640734,0.0038563106],"category_scores_gemma":[0.0029833154,0.0003142099,0.0006871747,0.0014180493,0.00051043817,0.0014234397,0.00041364998,0.0021877028,0.001369439],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070370024,0.00009562518,0.0005089235,0.01873289,0.0002814094,0.0003454848,0.00004157559,0.00014431152,0.0005646235,0.001444377,0.05830999,0.91882694],"study_design_scores_gemma":[0.00100876,0.0005188338,0.0044543655,0.020996539,0.0022953206,0.0022147158,0.00016350557,0.00018603688,0.00046994156,0.0022984126,0.9653521,0.0000413615],"about_ca_topic_score_codex":0.0020201316,"about_ca_topic_score_gemma":0.008167014,"teacher_disagreement_score":0.0038563106,"about_ca_system_score_codex":0.000924671,"about_ca_system_score_gemma":0.0015730237,"threshold_uncertainty_score":0.012900591},"labels":[],"label_agreement":null},{"id":"W2095101592","doi":"10.2165/00003495-200868010-00005","title":"Pharmacological Treatment of Early Multiple Sclerosis","year":2008,"lang":"en","type":"review","venue":"Drugs","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"EMD Serono; IC Design Education Center; Teva Pharmaceutical Industries; Biogen","keywords":"Medicine; Multiple sclerosis; Pharmacotherapy; Intensive care medicine; Adverse effect; Disease; Fingolimod; Intervention (counseling); Internal medicine; Immunology; Psychiatry","score_opus":0.2802280657794406,"score_gpt":0.41739131604953694,"score_spread":0.13716325027009635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095101592","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006645318,0.99954045,0.000037482547,0.00005414278,0.000055152603,0.000005398627,0.00001260559,0.000002832645,0.00022561772],"genre_scores_gemma":[0.0006471342,0.9988613,0.0001441429,0.0001336425,0.00005319436,0.0000072314483,0.000018512594,6.1137933e-7,0.00013423261],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997008,0.00007069549,0.000077479,0.00004433078,0.000086373424,0.000020412286],"domain_scores_gemma":[0.99928623,0.00046363083,0.00013937247,0.000013229888,0.00007103767,0.000026582813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077982707,0.001098788,0.00337986,0.0032228855,0.00026579938,0.0009397554,0.0010490188,0.0011342814,0.0038809765],"category_scores_gemma":[0.0012632591,0.00036384267,0.0011349617,0.0029055357,0.0004885717,0.000916071,0.0005501673,0.0013980689,0.0008801684],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032078032,0.00013648358,0.00022497187,0.11917373,0.000879606,0.00026511148,0.00005522818,0.0002130121,0.0009556869,0.0011595192,0.014976958,0.8616389],"study_design_scores_gemma":[0.0007802192,0.0006705143,0.0055309525,0.07491561,0.0072333217,0.003571884,0.00024856481,0.00026589248,0.0012784061,0.002415573,0.90300584,0.0000831561],"about_ca_topic_score_codex":0.0021817675,"about_ca_topic_score_gemma":0.005166116,"teacher_disagreement_score":0.0038809765,"about_ca_system_score_codex":0.0005753329,"about_ca_system_score_gemma":0.0010751612,"threshold_uncertainty_score":0.012983143},"labels":[],"label_agreement":null},{"id":"W2100635876","doi":"10.2165/00003495-200262160-00005","title":"New Approaches to Atrial Fibrillation Management","year":2002,"lang":"en","type":"review","venue":"Drugs","topic":"Cardiac electrophysiology and arrhythmias","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University; Montreal Heart Institute","funders":"Canadian Institutes of Health Research; Mitacs; Heart and Stroke Foundation of Canada","keywords":"Medicine; Amiodarone; Atrial fibrillation; Sinus rhythm; Digitalis; Cardiology; Management of atrial fibrillation; Intensive care medicine; Population; Internal medicine; Sotalol; Digoxin; Heart failure","score_opus":0.08924184669275906,"score_gpt":0.30383974326204893,"score_spread":0.21459789656928988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100635876","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000117527,0.9973847,0.00031268466,0.00042456348,0.00041296936,0.000006496969,0.000008288585,0.000011940721,0.0013207492],"genre_scores_gemma":[0.0009120272,0.9961034,0.00052657136,0.00072009885,0.00082543126,0.000014327199,0.000023212975,0.0000028204638,0.00087213353],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996587,0.00007115176,0.00007768335,0.00006684331,0.000099103,0.000026454183],"domain_scores_gemma":[0.99925834,0.0004338719,0.00011615532,0.000024736535,0.00010811462,0.000058684338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090783514,0.001404185,0.0026608265,0.0036323678,0.00046070034,0.0013898946,0.0010762197,0.0015671119,0.005062767],"category_scores_gemma":[0.0014187146,0.0003483978,0.00082402024,0.0024509565,0.00080262107,0.0021451612,0.000793838,0.0028216548,0.0021752198],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001555749,0.0001471412,0.00016100337,0.009404646,0.00011144531,0.0005185887,0.000051818428,0.00033821937,0.0009509141,0.0022093717,0.01930569,0.96664566],"study_design_scores_gemma":[0.00020740421,0.00040475195,0.0013275926,0.0060583325,0.00054879993,0.0049048676,0.0000865066,0.00031016368,0.0005331187,0.0026429286,0.98293513,0.000040517963],"about_ca_topic_score_codex":0.0009811625,"about_ca_topic_score_gemma":0.0027137646,"teacher_disagreement_score":0.005062767,"about_ca_system_score_codex":0.0007659975,"about_ca_system_score_gemma":0.0011329742,"threshold_uncertainty_score":0.0169366},"labels":[],"label_agreement":null},{"id":"W2108405186","doi":"10.1007/s40265-014-0306-5","title":"Updated National and International Hypertension Guidelines: A Review of Current Recommendations","year":2014,"lang":"en","type":"review","venue":"Drugs","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":128,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"Bayer HealthCare; Medical Research Council; American Heart Association; Sanofi; Chugai Pharmaceutical; Servier; Daiichi-Sankyo; Pfizer; AstraZeneca","keywords":"Medicine; Excellence; Blood pressure; Family medicine; Intensive care medicine; Nice; Clinical trial; Health care; Internal medicine; Political science","score_opus":0.2282544500303353,"score_gpt":0.455741269330621,"score_spread":0.2274868193002857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108405186","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011779318,0.99207145,0.00039029567,0.0035857444,0.0012624161,0.00019083596,0.00076044584,0.000042174004,0.0015788006],"genre_scores_gemma":[0.00091091363,0.9914078,0.0027110064,0.0024021785,0.00046798566,0.00025677317,0.0010681333,0.000011176952,0.0007639664],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.995854,0.0009888954,0.0014029038,0.0002845418,0.0012858817,0.00018382109],"domain_scores_gemma":[0.9931838,0.0024969336,0.0016357137,0.00011389186,0.002347198,0.00022241134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0052896747,0.0015219207,0.0039295293,0.013540401,0.0006494815,0.0019462808,0.003414283,0.0022902784,0.011290948],"category_scores_gemma":[0.0141042555,0.0007990116,0.0044422806,0.010240885,0.00068663526,0.0023813772,0.0014782943,0.0027361768,0.0027746074],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018728885,0.00009091945,0.0007144395,0.20641764,0.0012348511,0.0002814181,0.00025053942,0.00032965117,0.00027087986,0.002761681,0.26071197,0.5267488],"study_design_scores_gemma":[0.00017850203,0.000067630244,0.002593018,0.22012955,0.004637651,0.00083753193,0.00017596455,0.00017352797,0.00013493432,0.002600885,0.7684091,0.00006173126],"about_ca_topic_score_codex":0.010638308,"about_ca_topic_score_gemma":0.019476166,"teacher_disagreement_score":0.013540401,"about_ca_system_score_codex":0.0030588561,"about_ca_system_score_gemma":0.01146904,"threshold_uncertainty_score":0.03777194},"labels":[],"label_agreement":null},{"id":"W2132352181","doi":"10.2165/00003495-200767150-00002","title":"Recent Advances in the Pharmacological Management of Pain","year":2007,"lang":"en","type":"review","venue":"Drugs","topic":"Pain Management and Opioid Use","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Pharmacotherapy; Intensive care medicine; Pain management; Interventional pain management; Physical therapy; Psychiatry","score_opus":0.06403223199858148,"score_gpt":0.40404591138078483,"score_spread":0.34001367938220334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132352181","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007878814,0.9989759,0.00008863762,0.00015682944,0.0001295419,0.0000039638685,0.000008557932,0.000004094616,0.0005537602],"genre_scores_gemma":[0.0003377395,0.9988611,0.00021409862,0.00013460628,0.00020631982,0.0000040931973,0.000013602687,6.8432377e-7,0.00022781682],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99969685,0.000053404274,0.000063832485,0.000046532707,0.00011383224,0.000025576139],"domain_scores_gemma":[0.9990988,0.0005390676,0.0001431776,0.000018060162,0.00014839621,0.000052566214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007632003,0.0010820816,0.0022080326,0.0026343488,0.00030881967,0.0010697937,0.001066515,0.001047683,0.004868923],"category_scores_gemma":[0.0012029719,0.00030450762,0.00070883764,0.0033751943,0.00054499164,0.0013085546,0.00078129093,0.0019348228,0.001725386],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014370539,0.00012054638,0.00022686645,0.023818472,0.00014243822,0.00021617587,0.000040242656,0.00021563249,0.0010053649,0.0010834162,0.014028759,0.9589583],"study_design_scores_gemma":[0.00010037663,0.00027206517,0.002926144,0.009523488,0.00071610557,0.0028120654,0.00012018484,0.00021737399,0.00057708635,0.0017316646,0.98096234,0.00004104825],"about_ca_topic_score_codex":0.0015524885,"about_ca_topic_score_gemma":0.0042213206,"teacher_disagreement_score":0.004868923,"about_ca_system_score_codex":0.0006037885,"about_ca_system_score_gemma":0.0013343106,"threshold_uncertainty_score":0.016288161},"labels":[],"label_agreement":null},{"id":"W2151168916","doi":"10.2165/00003495-200767040-00003","title":"The Diagnosis and Treatment of??Raynaud???s Phenomenon","year":2007,"lang":"en","type":"review","venue":"Drugs","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":121,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Medicine; Iloprost; Vasospasm; Bosentan; Apremilast; Nifedipine; Adverse effect; Cardiology; Internal medicine; Anesthesia; Dermatology; Prostacyclin; Endothelin receptor; Psoriasis","score_opus":0.09794774049646297,"score_gpt":0.3665088360733924,"score_spread":0.2685610955769294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151168916","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000080950085,0.9991153,0.00009497922,0.00019435758,0.00010934283,0.0000026968003,0.0000054994,0.0000037255295,0.00039313],"genre_scores_gemma":[0.0013890626,0.9972276,0.0002901216,0.00032157172,0.000387678,0.000006565658,0.00002129839,0.0000014986425,0.00035456853],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996401,0.00008632718,0.000068907066,0.000058058667,0.000116159594,0.000030478399],"domain_scores_gemma":[0.99946576,0.0003100829,0.00010795221,0.0000177257,0.000071147726,0.00002739745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007806419,0.0010037051,0.0027776896,0.003291332,0.00038346188,0.0010272498,0.0013233313,0.0019393751,0.0025510606],"category_scores_gemma":[0.0010897995,0.00036948148,0.00094303687,0.0017990685,0.0009689868,0.0011963175,0.000697926,0.0021726326,0.0012872019],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012068841,0.00011834381,0.00036263835,0.013186207,0.00017227117,0.00082075474,0.000051927436,0.00024918327,0.0013723522,0.0027353023,0.020340206,0.96047014],"study_design_scores_gemma":[0.00014971834,0.00021033644,0.0025244383,0.005867877,0.000538171,0.009901613,0.00010348735,0.00022518146,0.001302685,0.0037110043,0.9754131,0.000052489668],"about_ca_topic_score_codex":0.0012610399,"about_ca_topic_score_gemma":0.0019658473,"teacher_disagreement_score":0.003291332,"about_ca_system_score_codex":0.0005601397,"about_ca_system_score_gemma":0.0008741824,"threshold_uncertainty_score":0.008534133},"labels":[],"label_agreement":null},{"id":"W2151295088","doi":"10.2165/00003495-200060060-00006","title":"Can Antiarrhythmic Agents be Selected Based on Mechanism of Action?","year":2000,"lang":"en","type":"review","venue":"Drugs","topic":"Cardiac electrophysiology and arrhythmias","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Medicine; Drug; Drug action; Mechanism of action; Mechanism (biology); Gambit; Action (physics); Pharmacology; Anti-Arrhythmia Agents; Cardiology; Atrial fibrillation; Computer science","score_opus":0.029681390074495124,"score_gpt":0.323188965498077,"score_spread":0.2935075754235819,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151295088","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003641188,0.99543613,0.0004536431,0.0012363002,0.0005347269,0.0000085068295,0.000021473024,0.000013856994,0.0019312218],"genre_scores_gemma":[0.0021705485,0.9938753,0.0007627631,0.0013280432,0.0009522943,0.000013647609,0.000034410223,0.00000342873,0.000859511],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997452,0.000058307043,0.00005400909,0.000041494648,0.000082990126,0.000018021712],"domain_scores_gemma":[0.9994479,0.00033106518,0.00009354398,0.000014342657,0.00008472945,0.000028444081],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081283733,0.0011277137,0.00306695,0.0015619491,0.00025001387,0.0010821806,0.0010953138,0.0012809394,0.0040903827],"category_scores_gemma":[0.0013776507,0.00021119232,0.0007396787,0.0013630157,0.00057636667,0.0016289699,0.00032889674,0.0019711338,0.0025491598],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028765402,0.0000940096,0.00037514794,0.006246196,0.000148312,0.00066481,0.000044014712,0.00021216022,0.0020938565,0.0028177048,0.02085576,0.96616036],"study_design_scores_gemma":[0.00051002204,0.00056190946,0.0039477115,0.007149432,0.0008495226,0.009050257,0.00019186754,0.0003209257,0.0013074402,0.008222348,0.9678211,0.000067487774],"about_ca_topic_score_codex":0.00058949104,"about_ca_topic_score_gemma":0.0017185106,"teacher_disagreement_score":0.0040903827,"about_ca_system_score_codex":0.00042926654,"about_ca_system_score_gemma":0.00057526084,"threshold_uncertainty_score":0.013683617},"labels":[],"label_agreement":null},{"id":"W2170978231","doi":"10.2165/00003495-200262060-00007","title":"Tamoxifen Resistant and Refractory Breast Cancer","year":2002,"lang":"en","type":"review","venue":"Drugs","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Tamoxifen; Medicine; Aromatase; Breast cancer; Exemestane; Aminoglutethimide; Anastrozole; Letrozole; Internal medicine; Oncology; Aromatase inhibitor; Antiestrogen; Adjuvant therapy; Megestrol acetate; Cancer; Hormonal therapy; Pharmacology","score_opus":0.011704291383928169,"score_gpt":0.28244718569975796,"score_spread":0.2707428943158298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170978231","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010391549,0.9976421,0.00023978013,0.0002835241,0.0005550643,0.0000052096916,0.000016126063,0.000009226252,0.0011449317],"genre_scores_gemma":[0.00068509317,0.99628264,0.00032881412,0.0004247492,0.00049094635,0.000009781644,0.000039063158,0.0000021090111,0.0017368913],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998492,0.00002827019,0.000021128433,0.000026580774,0.000059012076,0.000015772215],"domain_scores_gemma":[0.9997528,0.00010717252,0.000033516655,0.000010118398,0.000071068396,0.000025390678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052653055,0.0011440929,0.0020692437,0.0020520303,0.00033856073,0.0009899221,0.0013253998,0.0013239016,0.0026162174],"category_scores_gemma":[0.0008088119,0.00027858766,0.0003135776,0.0024341191,0.00057987747,0.0011840386,0.00043952002,0.001747389,0.0022375889],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000122013174,0.0000760159,0.00013909314,0.0069939867,0.000055448872,0.00049265847,0.000029405343,0.00034915682,0.0016707462,0.0024142084,0.06548091,0.9221764],"study_design_scores_gemma":[0.000030469197,0.000053191754,0.0004281188,0.0010279639,0.0000922479,0.0020306816,0.000033316337,0.00008639689,0.00033831474,0.0010782657,0.9947903,0.00001073257],"about_ca_topic_score_codex":0.0011633121,"about_ca_topic_score_gemma":0.0035540338,"teacher_disagreement_score":0.0026162174,"about_ca_system_score_codex":0.0007049375,"about_ca_system_score_gemma":0.00067855866,"threshold_uncertainty_score":0.008752167},"labels":[],"label_agreement":null},{"id":"W2184974902","doi":"10.2165/00003495-200363150-00007","title":"Tenofovir Disoproxil Fumarate","year":2003,"lang":"sh","type":"letter","venue":"Drugs","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Tenofovir; Medicine; Pharmacotherapy; Pharmacology; Internal medicine; Virology; Human immunodeficiency virus (HIV)","score_opus":0.025287815416808336,"score_gpt":0.3020150207109723,"score_spread":0.27672720529416395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2184974902","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011461085,0.013851439,0.00048203478,0.8593393,0.039079137,0.00007526477,0.00024321681,0.000118522876,0.075350024],"genre_scores_gemma":[0.13627459,0.012217614,0.000851437,0.64027923,0.08944809,0.00014697705,0.0002036517,0.0000700024,0.12050845],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994824,0.00014502728,0.00006183559,0.00007131011,0.00011713604,0.00012223473],"domain_scores_gemma":[0.9987865,0.0007800288,0.000096677715,0.000046999336,0.000103382015,0.00018649643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049309403,0.00075260515,0.00093396945,0.00047241515,0.0020596636,0.0015207967,0.0009078156,0.02415766,0.01116899],"category_scores_gemma":[0.0052085277,0.00036131215,0.0008892454,0.0004564984,0.0012050075,0.0012393326,0.00046987704,0.011148235,0.0035214536],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009605339,0.00018113593,0.003446371,0.0003931951,0.000099007186,0.14562944,0.00021752964,0.00024892372,0.0017227667,0.008803441,0.7939513,0.044346474],"study_design_scores_gemma":[0.0011484742,0.00060090213,0.0047846185,0.00045075745,0.0001546698,0.09046835,0.00037918775,0.0008223422,0.0019625418,0.0086271465,0.8905503,0.000050792853],"about_ca_topic_score_codex":0.0037828728,"about_ca_topic_score_gemma":0.008094672,"teacher_disagreement_score":0.02415766,"about_ca_system_score_codex":0.0025608074,"about_ca_system_score_gemma":0.00096179644,"threshold_uncertainty_score":0.037364006},"labels":[],"label_agreement":null},{"id":"W2204576307","doi":"10.2165/11318520-000000000-00000","title":"Refractory Gastro-Oesophageal Reflux Disease","year":2009,"lang":"en","type":"review","venue":"Drugs","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Reflux; Gastroenterology; Internal medicine; Gastro-; Heartburn; Refractory (planetary science); Cisapride; Proton-pump inhibitor; Gastroparesis; Disease; Gastric emptying; Ambulatory; Achalasia; Endoscopy; Esophagus; Stomach","score_opus":0.03665236786213808,"score_gpt":0.36293938006044085,"score_spread":0.32628701219830275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2204576307","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017847506,0.99857426,0.000066248416,0.00010833972,0.00017690336,0.000007261404,0.00002014961,0.0000050301246,0.00086342153],"genre_scores_gemma":[0.0015301149,0.9971117,0.0001736327,0.00023205545,0.00020862368,0.000009967896,0.00004042222,0.000001336891,0.00069212297],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99978465,0.000044742217,0.00006276979,0.000028432452,0.0000611514,0.000018204371],"domain_scores_gemma":[0.9995882,0.0001979122,0.00012628904,0.000010633665,0.000051401017,0.00002563768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050903833,0.0009787803,0.0028219807,0.002694647,0.00023650014,0.0008551955,0.00067865726,0.00088952127,0.005576788],"category_scores_gemma":[0.00092612137,0.00027960973,0.0007661482,0.0020303077,0.00036120435,0.0010945924,0.00058837235,0.0011440499,0.0015049084],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025205326,0.00008397542,0.0002124107,0.0571614,0.00038461364,0.00034588846,0.000039488572,0.00022409105,0.0012600273,0.00079920265,0.027419897,0.9118169],"study_design_scores_gemma":[0.00033323848,0.00044187953,0.002776046,0.021069715,0.0018795861,0.0041975267,0.00011079505,0.00022232535,0.00071760936,0.00090885995,0.9673031,0.00003933823],"about_ca_topic_score_codex":0.00084876554,"about_ca_topic_score_gemma":0.0028745693,"teacher_disagreement_score":0.005576788,"about_ca_system_score_codex":0.00045210376,"about_ca_system_score_gemma":0.0007595544,"threshold_uncertainty_score":0.018656194},"labels":[],"label_agreement":null},{"id":"W2215572913","doi":"10.2165/11585360-000000000-00000","title":"Non-Hormonal Treatment Strategies for Vasomotor Symptoms","year":2011,"lang":"en","type":"review","venue":"Drugs","topic":"Menopause: Health Impacts and Treatments","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Medicine; Vasomotor; Menopause; Estrogen; Hormone; Quality of life (healthcare); Depression (economics); Internal medicine","score_opus":0.09711939744794497,"score_gpt":0.39599387646300765,"score_spread":0.2988744790150627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2215572913","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013269653,0.9988778,0.0000627442,0.0001028143,0.00008733828,0.000008425839,0.000027409342,0.0000046695095,0.00069598993],"genre_scores_gemma":[0.0012769072,0.99759537,0.0001794841,0.00019057721,0.0001277312,0.000013877427,0.000031329353,0.0000012019301,0.00058343966],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99978846,0.00004407452,0.00005174906,0.00003363967,0.00006269949,0.000019415247],"domain_scores_gemma":[0.99944454,0.00033627663,0.0001272126,0.000011180384,0.00005618814,0.000024490124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005049081,0.0010668427,0.0021887743,0.003303405,0.0002726265,0.0007410637,0.00071456004,0.00092420774,0.008123771],"category_scores_gemma":[0.0010659219,0.00035143743,0.0008838974,0.0021971967,0.00037476028,0.0010422232,0.0005241208,0.0013623895,0.001269139],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019729383,0.00012906482,0.00017318579,0.04417254,0.0003139407,0.00016388694,0.000040337607,0.00016977762,0.0009124566,0.0008730511,0.013345826,0.9395087],"study_design_scores_gemma":[0.00032675406,0.00066918397,0.004577495,0.02805981,0.0028236706,0.0031199823,0.00017627396,0.00025778136,0.0011785884,0.0015637231,0.957193,0.00005378862],"about_ca_topic_score_codex":0.0014747882,"about_ca_topic_score_gemma":0.005824732,"teacher_disagreement_score":0.008123771,"about_ca_system_score_codex":0.00051084114,"about_ca_system_score_gemma":0.0009116352,"threshold_uncertainty_score":0.027176797},"labels":[],"label_agreement":null},{"id":"W2219541779","doi":"10.2165/11585280-000000000-00000","title":"Optimizing Therapy for Iron Overload in the Myelodysplastic Syndromes","year":2011,"lang":"en","type":"review","venue":"Drugs","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Myelodysplastic syndromes; Medicine; Deferasirox; Chelation therapy; Deferiprone; Clinical trial; Internal medicine; Deferoxamine; Adverse effect; Thalassemia; Intensive care medicine; Bone marrow","score_opus":0.04430918997115647,"score_gpt":0.31667618981949,"score_spread":0.2723669998483335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2219541779","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008979343,0.9992262,0.00008635276,0.0001312511,0.000063309664,0.0000033640617,0.000009477815,0.0000037341354,0.00038652617],"genre_scores_gemma":[0.0007048839,0.9982895,0.00032542963,0.0001955497,0.00013099346,0.0000056433882,0.00002540662,0.0000012444746,0.00032129677],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997899,0.000046287132,0.000046987272,0.000029364426,0.00007239887,0.000015133454],"domain_scores_gemma":[0.9995177,0.00027290557,0.000095560805,0.000008387257,0.00008284924,0.000022637565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056041504,0.00087209704,0.0018627961,0.0019341524,0.00019626984,0.0006748925,0.0008122428,0.0008835791,0.0019254924],"category_scores_gemma":[0.0009391502,0.0002712169,0.00054808,0.0016052641,0.0003146575,0.0007526324,0.0004262347,0.0016628205,0.0008504413],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009163171,0.000085105,0.00019099546,0.013030916,0.00015934817,0.0001595915,0.000023694842,0.00031461642,0.0008263375,0.0007921568,0.016603187,0.9677224],"study_design_scores_gemma":[0.0001530525,0.00026434058,0.0029525256,0.010607939,0.0008478156,0.0033188702,0.000069338916,0.00038206408,0.0010491904,0.0017968663,0.97851664,0.000041350966],"about_ca_topic_score_codex":0.001363704,"about_ca_topic_score_gemma":0.0029957555,"teacher_disagreement_score":0.0019341524,"about_ca_system_score_codex":0.00048705464,"about_ca_system_score_gemma":0.00072460645,"threshold_uncertainty_score":0.0064414144},"labels":[],"label_agreement":null},{"id":"W2227579106","doi":"10.1007/s40265-015-0517-4","title":"Antidepressant Drugs for Postsurgical Pain: Current Status and Future Directions","year":2016,"lang":"en","type":"review","venue":"Drugs","topic":"Anesthesia and Pain Management","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Kingston General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Chronic pain; Antidepressant; Analgesic; Adverse effect; Intensive care medicine; Dosing; Clinical trial; Acute pain; Anesthesia; Physical therapy; Psychiatry; Internal medicine; Anxiety","score_opus":0.024553397916522054,"score_gpt":0.327641121540552,"score_spread":0.30308772362402997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2227579106","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000077540004,0.9993055,0.00003624141,0.00017052043,0.000088157685,0.0000030367432,0.000013362537,0.000002911095,0.00030277617],"genre_scores_gemma":[0.00057595014,0.99882907,0.00012015726,0.00017453126,0.00012627487,0.0000032758144,0.0000138575215,6.2950596e-7,0.00015618256],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99974567,0.000045117144,0.000069775044,0.000043089236,0.00007441944,0.000022008835],"domain_scores_gemma":[0.99912506,0.0004708241,0.00019699498,0.000017228387,0.00013977123,0.00005011741],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007636077,0.00086670945,0.002031133,0.0019421172,0.00024529907,0.0012473493,0.00089560024,0.0011517896,0.0050587673],"category_scores_gemma":[0.0012867894,0.00034303454,0.0007556393,0.0023273772,0.00047057786,0.0014712464,0.0007606974,0.0018420463,0.0012099688],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019531188,0.000090461064,0.00036406578,0.03545566,0.00026816485,0.0001672054,0.000060339073,0.00024200002,0.0008283215,0.0015486332,0.016675316,0.9441047],"study_design_scores_gemma":[0.00017070242,0.00034141671,0.002989468,0.024233969,0.0015777,0.0017960008,0.00020453524,0.00032342973,0.0004119859,0.0024054782,0.96549225,0.000053071362],"about_ca_topic_score_codex":0.0012564642,"about_ca_topic_score_gemma":0.005192838,"teacher_disagreement_score":0.0050587673,"about_ca_system_score_codex":0.00046818904,"about_ca_system_score_gemma":0.0013739321,"threshold_uncertainty_score":0.016923249},"labels":[],"label_agreement":null},{"id":"W2237168606","doi":"10.2165/00003495-200666180-00010","title":"Recombinant Full-Length Parathyroid Hormone (1-84)","year":2006,"lang":"en","type":"article","venue":"Drugs","topic":"Parathyroid Disorders and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Parathyroid hormone; Recombinant DNA; Pharmacotherapy; Endocrinology; Internal medicine; Calcium; Biology; Genetics","score_opus":0.006769616486914449,"score_gpt":0.2416573167543249,"score_spread":0.23488770026741043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2237168606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84817797,0.07946042,0.013857372,0.0025318398,0.0026907788,0.00060868554,0.00580703,0.0017685376,0.04509741],"genre_scores_gemma":[0.9542902,0.010713243,0.007887973,0.0005573639,0.0004154868,0.00016081339,0.0030203697,0.0000574533,0.022897119],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998048,0.00003450421,0.000013780635,0.000034710058,0.00006711282,0.0000450937],"domain_scores_gemma":[0.999793,0.00009491855,0.000024603813,0.000027370817,0.000015333284,0.000044851786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031492187,0.00031410297,0.00040187736,0.00042933592,0.00018437485,0.0003780372,0.00047427186,0.00045951043,0.006764748],"category_scores_gemma":[0.00064597913,0.00012481584,0.00033562983,0.00027242565,0.00041562231,0.0002712288,0.00030821818,0.00088847184,0.0026881618],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050427713,0.0008106655,0.001666849,0.00064252026,0.00016127167,0.00096761715,0.00008835551,0.0009527424,0.8684173,0.0020434884,0.006681874,0.11252458],"study_design_scores_gemma":[0.0021199363,0.006800541,0.011745139,0.00008640555,0.00028268053,0.006017704,0.00012332003,0.0013234165,0.84009206,0.0012374375,0.13011274,0.000058616268],"about_ca_topic_score_codex":0.00065123785,"about_ca_topic_score_gemma":0.00042106223,"teacher_disagreement_score":0.006764748,"about_ca_system_score_codex":0.0003030647,"about_ca_system_score_gemma":0.00044318236,"threshold_uncertainty_score":0.022630334},"labels":[],"label_agreement":null},{"id":"W2242338668","doi":"10.2165/11595180-000000000-00000","title":"Biomarkers of Therapeutic Response in Patients with Chronic Obstructive Pulmonary Disease","year":2011,"lang":"en","type":"review","venue":"Drugs","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; St. Paul's Hospital; Providence Health Care","funders":"AstraZeneca","keywords":"Medicine; COPD; Exacerbation; Clinical trial; Internal medicine; Intensive care medicine; Pharmacology","score_opus":0.02413078821614477,"score_gpt":0.3051262331786052,"score_spread":0.28099544496246043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2242338668","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019049126,0.99927694,0.000083820516,0.00014077823,0.00007103152,0.00000433493,0.000023434055,0.0000039344695,0.00020525524],"genre_scores_gemma":[0.0031007878,0.9957255,0.0004225344,0.00028273664,0.00021202066,0.000018998131,0.000060206607,0.0000011283787,0.0001761907],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99942964,0.0001381851,0.00012691793,0.000097403085,0.00017675206,0.00003100112],"domain_scores_gemma":[0.9984332,0.0009264882,0.0003732108,0.000021223468,0.00020340021,0.000042407384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013764749,0.0012119596,0.004022278,0.002234255,0.00018876686,0.001214136,0.00090802065,0.0010999684,0.0011101316],"category_scores_gemma":[0.0024688342,0.00034531034,0.0011217684,0.0023287958,0.00047497152,0.0010363488,0.0006231673,0.0016709118,0.000493781],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040255988,0.00011594199,0.0034607204,0.019377083,0.00074503274,0.00013553107,0.00004013755,0.0002635059,0.000769931,0.00092630944,0.012428966,0.9613343],"study_design_scores_gemma":[0.00070847885,0.0013688103,0.060855046,0.055242524,0.0096237315,0.0045792637,0.0004600969,0.0015293988,0.003361403,0.007816156,0.8541814,0.00027369353],"about_ca_topic_score_codex":0.0014529389,"about_ca_topic_score_gemma":0.0024991422,"teacher_disagreement_score":0.004022278,"about_ca_system_score_codex":0.0005653872,"about_ca_system_score_gemma":0.0009584644,"threshold_uncertainty_score":0.0072796345},"labels":[],"label_agreement":null},{"id":"W2266943560","doi":"10.1007/s40265-016-0545-8","title":"Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent","year":2016,"lang":"en","type":"review","venue":"Drugs","topic":"Antibiotic Resistance in Bacteria","field":"Biochemistry, Genetics and Molecular Biology","cited_by":319,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Saint-Boniface; St. Boniface Hospital; Health Sciences Centre; University of Manitoba","funders":"","keywords":"Pharmacokinetics; Tigecycline; Medicine; Volume of distribution; Pseudomonas aeruginosa; Pharmacology; Population; Microbiology; Antimicrobial; Bacteria; Biology","score_opus":0.02337602297000151,"score_gpt":0.3290274756530104,"score_spread":0.30565145268300886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2266943560","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014023604,0.9987318,0.000092772694,0.00013370969,0.00023072907,0.0000037700215,0.000022861117,0.000005162497,0.00063893886],"genre_scores_gemma":[0.00080247415,0.9979494,0.00018403192,0.00019301983,0.00024240329,0.000004835111,0.000036681984,0.000001324026,0.00058571715],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998386,0.000023563747,0.0000352958,0.0000292338,0.000057477133,0.000015823302],"domain_scores_gemma":[0.9997948,0.00007936211,0.00004786885,0.0000055705273,0.00004871095,0.000023591676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032744944,0.0007220973,0.001272476,0.0018351016,0.00020872742,0.00074172637,0.00071394804,0.0006909901,0.0029899464],"category_scores_gemma":[0.00057121983,0.00023611961,0.00041315617,0.001633673,0.00028076078,0.0009639854,0.00045939913,0.0011132186,0.0010261926],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013647068,0.00007864389,0.00016441206,0.027981367,0.00012106971,0.00037953942,0.000048731923,0.00028236018,0.004152174,0.0019440814,0.039290555,0.92542064],"study_design_scores_gemma":[0.00002485139,0.0001457846,0.0006774556,0.002299938,0.00017968685,0.0017550116,0.00003120257,0.00009622724,0.00095816905,0.0005833581,0.9932285,0.000019770352],"about_ca_topic_score_codex":0.0008275152,"about_ca_topic_score_gemma":0.0018345575,"teacher_disagreement_score":0.0029899464,"about_ca_system_score_codex":0.00039379834,"about_ca_system_score_gemma":0.00090212736,"threshold_uncertainty_score":0.010002375},"labels":[],"label_agreement":null},{"id":"W2279230689","doi":"10.1007/s40265-015-0491-x","title":"Diagnosis and Management of Systemic Sclerosis: A Practical Approach","year":2015,"lang":"en","type":"review","venue":"Drugs","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Joseph's Health Care; Western University","funders":"","keywords":"Medicine; Scleroderma (fungus); Disease; Intensive care medicine; Interstitial lung disease; Systemic disease; Systemic inflammation; Multisystem disease; Autoimmunity; Multiple sclerosis; Pulmonary fibrosis; Autoimmune disease; Fibrosis; Dermatology; Lung; Pathology; Immunology; Inflammation; Internal medicine","score_opus":0.1548884206716103,"score_gpt":0.36918013149120665,"score_spread":0.21429171081959636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2279230689","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003163296,0.99911267,0.00010529619,0.00027358366,0.00013979404,0.0000049212704,0.0000111903455,0.0000041329795,0.0003167974],"genre_scores_gemma":[0.00040087293,0.9984016,0.00034571285,0.00035167666,0.0002824026,0.00000670954,0.000019474279,8.0500155e-7,0.00019070394],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99952245,0.000101489364,0.000109399065,0.00006499551,0.00017100682,0.00003072865],"domain_scores_gemma":[0.9990164,0.00058219105,0.00014183264,0.0000183604,0.00020033949,0.000040842348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011329639,0.0014798301,0.0029436843,0.0042936066,0.00038892924,0.0016147246,0.0013638786,0.0018489918,0.0034489494],"category_scores_gemma":[0.0015080522,0.00044906387,0.0010691177,0.0024699136,0.0006705668,0.0021634807,0.0011005475,0.002655238,0.0012688629],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010376169,0.000115821116,0.00021862732,0.046401024,0.00022564539,0.0002732362,0.00006359718,0.0003818667,0.0010039703,0.0034775892,0.0278607,0.9198742],"study_design_scores_gemma":[0.00007939599,0.00019177028,0.0014267932,0.024897363,0.0007788667,0.0019326523,0.00013596615,0.0002453074,0.000331801,0.003904761,0.96602684,0.000048428243],"about_ca_topic_score_codex":0.001972408,"about_ca_topic_score_gemma":0.0045596855,"teacher_disagreement_score":0.0042936066,"about_ca_system_score_codex":0.00088824326,"about_ca_system_score_gemma":0.0016407697,"threshold_uncertainty_score":0.0115379095},"labels":[],"label_agreement":null},{"id":"W2288852178","doi":"10.1007/s40265-015-0471-1","title":"Intrathecal Analgesia for Chronic Refractory Pain: Current and Future Prospects","year":2015,"lang":"en","type":"review","venue":"Drugs","topic":"Pain Management and Opioid Use","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Ottawa Hospital Anesthesia Alternate Funds Association","keywords":"Medicine; Intensive care medicine; Intrathecal; Clinical Practice; Analgesic; Expert opinion; Refractory (planetary science); Anesthesia; Physical therapy","score_opus":0.03528943630869925,"score_gpt":0.34380135378461524,"score_spread":0.308511917475916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2288852178","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000084116844,0.9993698,0.000047534944,0.00012991743,0.00007078189,0.0000021030883,0.000009205671,0.0000025106208,0.00028395123],"genre_scores_gemma":[0.00044277753,0.99905306,0.000108342996,0.0001193898,0.0001056366,0.0000023664215,0.000009659232,5.397124e-7,0.00015824485],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998288,0.000028809016,0.000037747945,0.000029322893,0.00005720272,0.000018079252],"domain_scores_gemma":[0.99947065,0.0002730172,0.00011381777,0.000010200753,0.000095676594,0.000036724865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063895085,0.0006722093,0.0015109493,0.001717898,0.00022514978,0.0011106197,0.0007372146,0.0009736045,0.0045248587],"category_scores_gemma":[0.00081626815,0.00023636872,0.00060000917,0.0019815397,0.0004913606,0.0014388579,0.000705208,0.0016281953,0.0010457933],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014364885,0.000105148276,0.0002764835,0.028112156,0.0001331349,0.00014443419,0.00005205763,0.00022449072,0.001215351,0.0014911314,0.013214321,0.9548877],"study_design_scores_gemma":[0.0000975214,0.00031043086,0.0028748286,0.015121974,0.0007181666,0.002091973,0.00019005327,0.0002726438,0.0005096173,0.0023778034,0.97538537,0.000049636452],"about_ca_topic_score_codex":0.0011513858,"about_ca_topic_score_gemma":0.00429595,"teacher_disagreement_score":0.0045248587,"about_ca_system_score_codex":0.00041484708,"about_ca_system_score_gemma":0.0012768613,"threshold_uncertainty_score":0.015137136},"labels":[],"label_agreement":null},{"id":"W241406582","doi":"10.2165/00003495-200767180-00005","title":"Treatment of Lysosomal Storage Disorders","year":2007,"lang":"en","type":"review","venue":"Drugs","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":154,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke; SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Lysosomal storage disorders; Enzyme replacement therapy; Medicine; Substrate reduction therapy; Intensive care medicine; Lysosomal storage disease; Disease; Orphan drug; Reimbursement; Fabry disease; Clinical trial; Pathology; Bioinformatics; Health care","score_opus":0.061845232560002635,"score_gpt":0.392680393069236,"score_spread":0.3308351605092334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W241406582","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012269508,0.9982046,0.00015535826,0.0001383201,0.00015990694,0.000008271944,0.000019700923,0.00001109154,0.0011799595],"genre_scores_gemma":[0.0007661418,0.9977063,0.00030653417,0.00022668966,0.00013433966,0.000011374602,0.000050373434,0.000001823936,0.0007963511],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998135,0.000032513093,0.000027148508,0.000031137854,0.00007455855,0.000021088625],"domain_scores_gemma":[0.99983335,0.00006893255,0.00003488355,0.0000071450722,0.000038729402,0.000016926931],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004398765,0.0013278598,0.0023039707,0.0028843954,0.0003078986,0.0009301888,0.0010456224,0.0011771667,0.0035234254],"category_scores_gemma":[0.00047707444,0.00031730242,0.0006907425,0.0019447745,0.0004888048,0.0009652582,0.0006322433,0.0017750857,0.002452237],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001418051,0.00013889096,0.000113063346,0.012666106,0.00012652765,0.0003458983,0.00003188344,0.00028361197,0.0023081524,0.0017323488,0.029270494,0.95284116],"study_design_scores_gemma":[0.00011723322,0.00018591803,0.00086691184,0.0036243047,0.00025421992,0.002706667,0.00004071722,0.00012174362,0.00094278046,0.0011777352,0.98993975,0.000021971598],"about_ca_topic_score_codex":0.0009622446,"about_ca_topic_score_gemma":0.0020590718,"teacher_disagreement_score":0.0035234254,"about_ca_system_score_codex":0.0004932743,"about_ca_system_score_gemma":0.0007291534,"threshold_uncertainty_score":0.011787057},"labels":[],"label_agreement":null},{"id":"W2420878420","doi":"10.1007/s40265-016-0600-5","title":"Psychosis in Parkinson’s Disease: Epidemiology, Pathophysiology, and Management","year":2016,"lang":"en","type":"review","venue":"Drugs","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":122,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"","keywords":"Psychosis; Quetiapine; Medicine; Clozapine; Antipsychotic; Parkinson's disease; Psychiatry; Schizophrenia (object-oriented programming); Disease; Neuroscience; Psychology; Internal medicine","score_opus":0.04300202841631938,"score_gpt":0.3562318025215395,"score_spread":0.3132297741052201,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2420878420","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009246183,0.9993772,0.000037831385,0.00017505138,0.0000447378,0.0000029464868,0.0000111892305,0.0000024330793,0.0002561818],"genre_scores_gemma":[0.00087906996,0.99868613,0.000118063566,0.000089010246,0.00009648638,0.0000031862846,0.00001297447,4.1595663e-7,0.00011462675],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999728,0.000056758232,0.000064337095,0.000041191215,0.000087133965,0.000022585824],"domain_scores_gemma":[0.99944764,0.0002618174,0.00014805062,0.000010071281,0.00009325101,0.00003904416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061117223,0.0009037817,0.0016512539,0.0022580437,0.0003332251,0.0012486945,0.0008942999,0.0010255558,0.002360642],"category_scores_gemma":[0.00097288913,0.00030171146,0.000730971,0.0021025473,0.0006028702,0.0011022898,0.0008216376,0.001527781,0.00065760943],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012448848,0.000101737576,0.00071186305,0.027575295,0.0002026982,0.00036329761,0.00009743289,0.0003431898,0.0006772231,0.001839789,0.013724085,0.95423895],"study_design_scores_gemma":[0.00013681971,0.00033601376,0.008663054,0.030409615,0.0011368826,0.008057355,0.0004620016,0.00042932943,0.0005127259,0.006604327,0.94314957,0.00010233436],"about_ca_topic_score_codex":0.0029963753,"about_ca_topic_score_gemma":0.008441095,"teacher_disagreement_score":0.0029963753,"about_ca_system_score_codex":0.00074516964,"about_ca_system_score_gemma":0.0018042112,"threshold_uncertainty_score":0.007897139},"labels":[],"label_agreement":null},{"id":"W2490949941","doi":"10.1007/s40265-016-0624-x","title":"Erratum to: Psychosis in Parkinson’s Disease: Epidemiology, Pathophysiology, and Management","year":2016,"lang":"en","type":"erratum","venue":"Drugs","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"","keywords":"Medicine; Psychosis; Epidemiology; Disease; Pathophysiology; Pharmacotherapy; Parkinson's disease; Psychiatry; Intensive care medicine; Pathology","score_opus":0.019529352863979273,"score_gpt":0.3025946316710802,"score_spread":0.2830652788071009,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2490949941","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026203186,0.005492028,0.00020168484,0.08842091,0.9015056,0.000033266086,0.000451095,0.0000667232,0.0035666553],"genre_scores_gemma":[0.009671713,0.03231671,0.0024740715,0.20739505,0.6198055,0.00016341147,0.001506745,0.00032586887,0.1263409],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970498,0.0004879649,0.0010046352,0.00024907527,0.0009934187,0.00021508068],"domain_scores_gemma":[0.9792302,0.006579797,0.0024656395,0.000877795,0.00949024,0.0013563709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002700619,0.0017414072,0.001837347,0.0031204221,0.002354002,0.0026116464,0.0019276555,0.0071337223,0.023368709],"category_scores_gemma":[0.04125669,0.0008863494,0.0016344151,0.0021474601,0.0018670372,0.0023457846,0.0013701721,0.009080548,0.01932267],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045265453,0.000018516766,0.0003130246,0.0002173411,0.000011842538,0.00080858404,0.000025922762,0.000031952022,0.000026239366,0.00044347034,0.9885075,0.009550454],"study_design_scores_gemma":[0.00009959486,0.00008597445,0.0023734244,0.0017585759,0.00009677278,0.004128122,0.0002949255,0.00023127718,0.0002716888,0.0016682643,0.98892605,0.00006527679],"about_ca_topic_score_codex":0.009380224,"about_ca_topic_score_gemma":0.013321288,"teacher_disagreement_score":0.023368709,"about_ca_system_score_codex":0.0028838671,"about_ca_system_score_gemma":0.005204949,"threshold_uncertainty_score":0.07817614},"labels":[],"label_agreement":null},{"id":"W2508060336","doi":"10.1007/s40265-016-0628-6","title":"Second-Line Treatment of Non-Small Cell Lung Cancer: New Developments for Tumours Not Harbouring Targetable Oncogenic Driver Mutations","year":2016,"lang":"en","type":"review","venue":"Drugs","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Ontario Clinical Oncology Group; McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Medicine; Lung cancer; Cancer research; Oncology; Mutation; Cell culture; Pharmacotherapy; Cancer; Internal medicine; Gene; Biology; Genetics","score_opus":0.031521627619089235,"score_gpt":0.3615598605783705,"score_spread":0.33003823295928125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2508060336","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00038504438,0.9979234,0.00024320972,0.00019858226,0.00014063943,0.00001088071,0.00004879503,0.000015544794,0.0010339192],"genre_scores_gemma":[0.0026522076,0.9953181,0.0004014271,0.00037631407,0.00011896002,0.000014648856,0.00010601805,0.000004466477,0.0010079402],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998951,0.000015447313,0.000015408821,0.00002326554,0.000035362486,0.000015441066],"domain_scores_gemma":[0.99984694,0.00007811597,0.000028591146,0.0000045376846,0.000027668737,0.000014161137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032325863,0.0007659072,0.0017295231,0.0014224985,0.00015521722,0.00070837745,0.0006667042,0.0006942489,0.0034128616],"category_scores_gemma":[0.00037408705,0.00023093128,0.0008296972,0.0010280067,0.00023577832,0.0007314793,0.0004416489,0.0018949492,0.0012026007],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016627628,0.00011610236,0.0001789089,0.01552182,0.00022345259,0.00017402787,0.00003526031,0.00043640585,0.0040294374,0.0013203752,0.018053528,0.95974433],"study_design_scores_gemma":[0.00018817026,0.000505844,0.0015777829,0.0038654096,0.00075418066,0.0021643967,0.000046616733,0.00036235817,0.0019963123,0.0012324054,0.98726624,0.000040309274],"about_ca_topic_score_codex":0.0006687661,"about_ca_topic_score_gemma":0.0025044542,"teacher_disagreement_score":0.0034128616,"about_ca_system_score_codex":0.00039002733,"about_ca_system_score_gemma":0.00050383026,"threshold_uncertainty_score":0.01141721},"labels":[],"label_agreement":null},{"id":"W2558544919","doi":"10.1007/s40265-016-0667-z","title":"Solithromycin: A Novel Fluoroketolide for the Treatment of Community-Acquired Bacterial Pneumonia","year":2016,"lang":"en","type":"review","venue":"Drugs","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Boniface Hospital; Health Sciences Centre; University of Manitoba","funders":"","keywords":"Ketolide; Telithromycin; Streptococcus pneumoniae; Microbiology; Medicine; Biology; Pharmacology; Antibiotics","score_opus":0.09072066963484758,"score_gpt":0.3764393947325712,"score_spread":0.2857187250977236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2558544919","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00032655004,0.9989008,0.00009853968,0.00010119079,0.00008364509,0.0000059520103,0.000017519525,0.0000065853474,0.0004592148],"genre_scores_gemma":[0.0022667958,0.99647385,0.00032771975,0.0002134159,0.00010757949,0.000007468707,0.000047993326,0.0000018439351,0.0005533239],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998343,0.000027416492,0.000034327335,0.000029106877,0.000057623925,0.000017309036],"domain_scores_gemma":[0.9997881,0.000104322804,0.000043747616,0.000004747593,0.000036242393,0.000022897062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034255476,0.00069627375,0.00161822,0.0020163436,0.00022532008,0.0006979899,0.0007360381,0.000920871,0.0026415095],"category_scores_gemma":[0.00044394066,0.00022598293,0.0006087538,0.0013827624,0.00035866993,0.00078754546,0.00052272034,0.0018287731,0.0008300506],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021230706,0.00014102577,0.00021220969,0.019994624,0.00019744424,0.00031220273,0.00005531641,0.00025934947,0.0037838586,0.0010012067,0.012928461,0.960902],"study_design_scores_gemma":[0.00028334078,0.0007441913,0.0030758597,0.007427679,0.00075725844,0.0054077418,0.00010713948,0.0004058238,0.0030614496,0.0011491259,0.9775129,0.00006747787],"about_ca_topic_score_codex":0.0010964674,"about_ca_topic_score_gemma":0.0030580638,"teacher_disagreement_score":0.0026415095,"about_ca_system_score_codex":0.0003121765,"about_ca_system_score_gemma":0.00065741426,"threshold_uncertainty_score":0.008836687},"labels":[],"label_agreement":null},{"id":"W2570488703","doi":"10.1007/s40265-016-0685-x","title":"Genotype 3 Infection: The Last Stand of Hepatitis C Virus","year":2017,"lang":"en","type":"review","venue":"Drugs","topic":"Hepatitis C virus research","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Liver Centre; University of Toronto","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of General Medical Sciences","keywords":"Steatosis; Medicine; Hepatocellular carcinoma; Hepatitis C virus; Cirrhosis; Microsomal triglyceride transfer protein; Hepatitis C; Genotype; Internal medicine; Virology; Gastroenterology; Immunology; Virus; Biology; Cholesterol; Genetics; Gene","score_opus":0.1354607030590377,"score_gpt":0.43468187803377967,"score_spread":0.299221174974742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2570488703","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000031866384,0.9991357,0.000024481786,0.00027746698,0.00021183473,0.0000013568764,0.000008882076,0.0000021578774,0.0003062823],"genre_scores_gemma":[0.0003937058,0.9987073,0.000055172204,0.0003538952,0.00027202876,0.0000017159108,0.000016555086,6.979636e-7,0.00019905674],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996375,0.00008170045,0.000066294226,0.000046024794,0.00013292438,0.000035601242],"domain_scores_gemma":[0.99927026,0.00039619507,0.00012834737,0.000012528723,0.00013948006,0.000053180112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075921,0.00075067836,0.001918066,0.002142248,0.00030152022,0.0014471966,0.00092531304,0.0013078537,0.004197894],"category_scores_gemma":[0.0012358774,0.00024315123,0.0007447891,0.0020642125,0.0004614303,0.0015102158,0.0007912679,0.0018477584,0.0011013482],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011948783,0.00003753947,0.00031625593,0.032233458,0.00019231768,0.00016786392,0.000045526587,0.00013690429,0.00055989396,0.0025158792,0.053232856,0.91044205],"study_design_scores_gemma":[0.000058811176,0.000100206285,0.0012095904,0.018597148,0.0005497739,0.0015713628,0.00011086399,0.00009780951,0.00017119054,0.0018046974,0.9756992,0.00002949129],"about_ca_topic_score_codex":0.0016478113,"about_ca_topic_score_gemma":0.0044926414,"teacher_disagreement_score":0.004197894,"about_ca_system_score_codex":0.00060218765,"about_ca_system_score_gemma":0.0016109638,"threshold_uncertainty_score":0.014043331},"labels":[],"label_agreement":null},{"id":"W2573216598","doi":"10.1007/s40265-017-0690-8","title":"Chimeric Antigen Receptor (CAR) T Cells: Lessons Learned from Targeting of CD19 in B-Cell Malignancies","year":2017,"lang":"en","type":"review","venue":"Drugs","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":146,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Chimeric antigen receptor; Medicine; Immunotherapy; CD19; Cell therapy; Immunology; Lymphoma; Chronic lymphocytic leukemia; B cell; Cancer research; Clinical trial; T cell; Leukemia; Antigen; Oncology; Stem cell; Internal medicine; Immune system; Biology; Antibody","score_opus":0.15225248355467466,"score_gpt":0.40610138065618046,"score_spread":0.2538488971015058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2573216598","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012129069,0.9982774,0.00019392346,0.0005125219,0.00022184382,0.0000031207842,0.000015381576,0.000007736282,0.00064673036],"genre_scores_gemma":[0.0008958114,0.997783,0.00020272087,0.0003913508,0.00021336516,0.0000051853594,0.000024112127,0.0000017377807,0.00048266814],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998679,0.000021004447,0.000013714115,0.000026276,0.00005006999,0.00002098885],"domain_scores_gemma":[0.99969435,0.00017397372,0.000029453076,0.0000074199083,0.000064816515,0.00003003304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006753422,0.0006770713,0.0010441198,0.0011287217,0.00019654213,0.00094749214,0.0008118168,0.0011875893,0.0024298052],"category_scores_gemma":[0.00071958645,0.00020350651,0.00037501956,0.0010965922,0.0005781794,0.0014683659,0.00063016237,0.0025667555,0.0012571609],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011382066,0.00008628741,0.00012766459,0.0103993695,0.000070352566,0.0001812954,0.000044579698,0.0004709475,0.0028499665,0.006724565,0.038339827,0.9405914],"study_design_scores_gemma":[0.0000326363,0.00009869643,0.00027851446,0.0014656659,0.00007469326,0.0006952723,0.000034884717,0.000113769,0.0007742533,0.0020543705,0.99436486,0.000012378177],"about_ca_topic_score_codex":0.0008071955,"about_ca_topic_score_gemma":0.0018186545,"teacher_disagreement_score":0.0024298052,"about_ca_system_score_codex":0.0006392076,"about_ca_system_score_gemma":0.0009962778,"threshold_uncertainty_score":0.008128524},"labels":[],"label_agreement":null},{"id":"W2589910009","doi":"10.1007/s40265-017-0693-5","title":"Incidence, Prevention and Management of Anti-Drug Antibodies Against Therapeutic Antibodies in Inflammatory Bowel Disease: A Practical Overview","year":2017,"lang":"en","type":"review","venue":"Drugs","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"","keywords":"Medicine; Drug; Inflammatory bowel disease; Therapeutic drug monitoring; Pharmacology; Immunogenicity; Monoclonal antibody; Antibody; Pharmacokinetics; Dosing; Immunology; Therapeutic index; Sensitization; Pharmacotherapy; Therapeutic approach; Disease; Internal medicine","score_opus":0.08333870628314687,"score_gpt":0.41256987934238293,"score_spread":0.32923117305923605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589910009","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000066994384,0.9995597,0.000054737033,0.00014942748,0.000044140394,0.0000016975584,0.000009251703,0.0000014876684,0.00011256413],"genre_scores_gemma":[0.0008030084,0.9986076,0.00015495198,0.00015932244,0.0001793413,0.000003484003,0.000017883292,6.105476e-7,0.00007393596],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993425,0.00012948543,0.0001742068,0.000099906974,0.00021578754,0.0000382109],"domain_scores_gemma":[0.9983277,0.0009686661,0.00038230952,0.000021538479,0.0002499047,0.000049955735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013548448,0.0008072074,0.0019150348,0.0028990267,0.00018746502,0.0012611948,0.000946286,0.0015620184,0.001683469],"category_scores_gemma":[0.0024878606,0.00033702076,0.0009614588,0.001933417,0.000545095,0.0014252362,0.00061498606,0.0016516054,0.0005311741],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015725309,0.00008741642,0.0010443669,0.034646288,0.00024872358,0.00017200604,0.000053622145,0.00036708565,0.00060147524,0.0018591327,0.012229033,0.9485336],"study_design_scores_gemma":[0.0001190769,0.0006432512,0.008254229,0.042116,0.0017638485,0.006379764,0.00025535305,0.0005767683,0.0011322456,0.004615482,0.93404055,0.00010346184],"about_ca_topic_score_codex":0.0013066486,"about_ca_topic_score_gemma":0.0022113128,"teacher_disagreement_score":0.0028990267,"about_ca_system_score_codex":0.0006270643,"about_ca_system_score_gemma":0.0015020538,"threshold_uncertainty_score":0.0071651936},"labels":[],"label_agreement":null},{"id":"W2590483831","doi":"10.1007/s40265-017-0712-6","title":"The Safety of Appropriate Use of Over-the-Counter Proton Pump Inhibitors: An Evidence-Based Review and Delphi Consensus","year":2017,"lang":"en","type":"review","venue":"Drugs","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Pfizer","keywords":"Medicine; Heartburn; Intensive care medicine; Medical prescription; Proton-pump inhibitor; Internal medicine; Disease; Pharmacology; Reflux","score_opus":0.13534627224506862,"score_gpt":0.3962835822762063,"score_spread":0.2609373100311377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2590483831","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01737605,0.8311606,0.03395015,0.04203846,0.0053338334,0.055895947,0.0017644691,0.00017536899,0.012305183],"genre_scores_gemma":[0.14242423,0.6708684,0.084176116,0.013913848,0.0013467991,0.08257527,0.0018030423,0.00012089109,0.0027713936],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.71312577,0.17929494,0.067416735,0.0069314525,0.030203603,0.003027482],"domain_scores_gemma":[0.70116395,0.18856475,0.02493326,0.007281962,0.07612699,0.0019290302],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.2793795,0.0020950742,0.0058019357,0.017984156,0.0019143551,0.005602144,0.004374957,0.0043219603,0.0036277492],"category_scores_gemma":[0.31623647,0.0021497377,0.009639892,0.011059047,0.003327271,0.006885854,0.0073259263,0.0036229452,0.00079923857],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008745174,0.00011303419,0.0016746884,0.58924145,0.0043227584,0.0006663967,0.01291416,0.0014401309,0.00189958,0.0068299174,0.016842296,0.363181],"study_design_scores_gemma":[0.0004611523,0.00041868514,0.0029057616,0.8462559,0.009312232,0.0005742062,0.0062987786,0.0012000644,0.0020304115,0.0069508436,0.123324245,0.00026772168],"about_ca_topic_score_codex":0.005187065,"about_ca_topic_score_gemma":0.0071864384,"teacher_disagreement_score":0.2793795,"about_ca_system_score_codex":0.011951128,"about_ca_system_score_gemma":0.039471544,"threshold_uncertainty_score":0.8886534},"labels":[],"label_agreement":null},{"id":"W2593485868","doi":"10.1007/s40265-017-0717-1","title":"The Language of Biosimilars: Clarification, Definitions, and Regulatory Aspects","year":2017,"lang":"en","type":"review","venue":"Drugs","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":153,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Health Canada; Pfizer","keywords":"Biosimilar; Medicine; Clinical trial; Terminology; Risk analysis (engineering); Intensive care medicine; Internal medicine","score_opus":0.09806852305771535,"score_gpt":0.36849101172204035,"score_spread":0.270422488664325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593485868","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007468067,0.4763959,0.08041917,0.34401786,0.043787245,0.00023687317,0.00044755233,0.00027457072,0.04695275],"genre_scores_gemma":[0.15917444,0.41625747,0.1753923,0.1631082,0.063563496,0.0010014921,0.0012243631,0.0014295046,0.018848715],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9572258,0.022972966,0.007732685,0.0019510182,0.009266187,0.00085133914],"domain_scores_gemma":[0.9238786,0.048878506,0.0090198815,0.005149288,0.011802631,0.0012711157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.039979514,0.0016787914,0.002048862,0.0067151035,0.0027206182,0.012124235,0.003165114,0.007615918,0.002106495],"category_scores_gemma":[0.06772174,0.0009995165,0.0011096166,0.0059405793,0.025079584,0.016397756,0.0046745245,0.019191569,0.002320654],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012788994,0.00008160841,0.00038003246,0.0025268358,0.000021528496,0.0005647119,0.0077510243,0.00062844704,0.0030305262,0.8040422,0.06710131,0.1137439],"study_design_scores_gemma":[0.00001602267,0.000071402785,0.00034691163,0.0023527164,0.000016889098,0.0015388599,0.0015287693,0.00047471834,0.0014724922,0.090806104,0.9013145,0.0000605616],"about_ca_topic_score_codex":0.0034469932,"about_ca_topic_score_gemma":0.0016949824,"teacher_disagreement_score":0.039979514,"about_ca_system_score_codex":0.0058837845,"about_ca_system_score_gemma":0.012983397,"threshold_uncertainty_score":0.21143442},"labels":[],"label_agreement":null},{"id":"W2623416369","doi":"10.1007/s40265-017-0758-5","title":"A Review of Phosphate Binders in Chronic Kidney Disease: Incremental Progress or Just Higher Costs?","year":2017,"lang":"en","type":"review","venue":"Drugs","topic":"Parathyroid Disorders and Treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Winnipeg Regional Health Authority","funders":"","keywords":"Sevelamer; Hyperphosphatemia; Medicine; Phosphate binder; Kidney disease; Calcium; Phosphate; Internal medicine; Endocrinology; Intensive care medicine; Biochemistry; Chemistry","score_opus":0.08931779627646652,"score_gpt":0.4222005470744976,"score_spread":0.3328827507980311,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2623416369","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000041747087,0.9985311,0.000021948541,0.00092984503,0.00031845266,0.000006220941,0.000016459908,0.0000021857788,0.00013200798],"genre_scores_gemma":[0.00056734687,0.99788576,0.00011044607,0.0008822339,0.00043325344,0.000011599782,0.000018941335,0.0000013550305,0.00008895902],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958288,0.0015213259,0.0009979882,0.00030019932,0.0012027341,0.00014890649],"domain_scores_gemma":[0.982842,0.01208326,0.002336755,0.00021195902,0.0021437074,0.00038225137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054848096,0.0011899071,0.005110676,0.0061835586,0.00045293436,0.0029885764,0.0014217091,0.002339477,0.0055974843],"category_scores_gemma":[0.018018428,0.0007225113,0.0040856767,0.0071485434,0.0007192516,0.0032731814,0.0010108507,0.0024470855,0.0006192222],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038854778,0.000053425807,0.00038676325,0.3505303,0.0029897725,0.00013636565,0.00012387247,0.00021701309,0.00028263545,0.0028220208,0.050110947,0.5919584],"study_design_scores_gemma":[0.00033022577,0.00042268165,0.0045499788,0.40284732,0.01175956,0.0010171122,0.00024450786,0.0001996308,0.00016061374,0.003747119,0.57465285,0.00006833372],"about_ca_topic_score_codex":0.004491187,"about_ca_topic_score_gemma":0.011775224,"teacher_disagreement_score":0.0061835586,"about_ca_system_score_codex":0.0029870195,"about_ca_system_score_gemma":0.0070440136,"threshold_uncertainty_score":0.02900678},"labels":[],"label_agreement":null},{"id":"W2744053002","doi":"10.1007/s40265-017-0798-x","title":"Erratum to: A Review of Phosphate Binders in Chronic Kidney Disease: Incremental Progress or Just Higher Costs?","year":2017,"lang":"en","type":"review","venue":"Drugs","topic":"Parathyroid Disorders and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Winnipeg Regional Health Authority","funders":"","keywords":"Medicine; Intensive care medicine; Pharmacotherapy; Kidney disease; Pharmacology; Internal medicine","score_opus":0.08011405828288129,"score_gpt":0.41797205663274545,"score_spread":0.3378579983498642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2744053002","genre_codex":"review","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011136468,0.8212004,0.00024266381,0.04669955,0.12983878,0.000042502175,0.00042188822,0.000035658468,0.0014071794],"genre_scores_gemma":[0.0011576551,0.8921331,0.00075599004,0.05154258,0.050211206,0.000049981118,0.00039008,0.00003357113,0.0037257473],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99766135,0.0005160836,0.00070432643,0.0001959023,0.00080071,0.00012163573],"domain_scores_gemma":[0.9898084,0.0048740725,0.0013940913,0.00017865769,0.003409531,0.0003352101],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036458431,0.0012422156,0.0033238165,0.0034455145,0.00051781535,0.0024967396,0.0017274668,0.0037721973,0.014694787],"category_scores_gemma":[0.01966497,0.0005188277,0.0018693472,0.0038242529,0.0010550689,0.0033724012,0.0013911817,0.005540435,0.0055065393],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023284485,0.000024137233,0.00015511077,0.034826756,0.0003366644,0.00020668886,0.00006439622,0.00006156608,0.00020795623,0.0014733843,0.8020763,0.16033433],"study_design_scores_gemma":[0.00020934311,0.00007104516,0.00060433865,0.02734975,0.0009082028,0.00079927745,0.00010261174,0.00006478767,0.00014657313,0.0013743893,0.96832484,0.000044828776],"about_ca_topic_score_codex":0.0020902487,"about_ca_topic_score_gemma":0.0057183923,"teacher_disagreement_score":0.014694787,"about_ca_system_score_codex":0.0012438311,"about_ca_system_score_gemma":0.0046753366,"threshold_uncertainty_score":0.04915893},"labels":[],"label_agreement":null},{"id":"W2749275095","doi":"10.1007/s40265-017-0796-z","title":"Anti-PD-1 Antibodies as a Therapeutic Strategy in Classical Hodgkin Lymphoma","year":2017,"lang":"en","type":"review","venue":"Drugs","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Antibody; Lymphoma; Immune system; Immunology; Cancer research; Antibody therapy; Clinical trial; Tumor microenvironment; Monoclonal antibody; Oncology; Internal medicine","score_opus":0.10697743891577456,"score_gpt":0.4122133735040457,"score_spread":0.30523593458827114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2749275095","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008096427,0.99931324,0.00004880268,0.000108400665,0.000074988624,0.0000028413149,0.000008595278,0.0000030535498,0.0003590177],"genre_scores_gemma":[0.001123083,0.99803346,0.00013539444,0.0002837138,0.00013825142,0.0000054294605,0.00002065443,9.022956e-7,0.00025913442],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998573,0.000026546231,0.000034296714,0.000025454723,0.000042476382,0.0000138844935],"domain_scores_gemma":[0.9997217,0.00015929437,0.000053707146,0.0000058168685,0.000043255935,0.000016182472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044299586,0.00065442617,0.0013986382,0.0017297922,0.00017744271,0.000933328,0.0006784303,0.00087215897,0.0026120748],"category_scores_gemma":[0.00073857035,0.0002745099,0.00052064133,0.0012833268,0.00033341066,0.0010284088,0.00052197673,0.001737256,0.0007566088],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015160773,0.00007701916,0.00018596477,0.025066296,0.00020191619,0.00021206313,0.000037849848,0.0003569041,0.0009942929,0.0017376434,0.018487226,0.9524913],"study_design_scores_gemma":[0.00016281387,0.00027118277,0.0013826569,0.010029688,0.0010401972,0.0028583244,0.00006647489,0.00029258188,0.0007676462,0.0020022916,0.98109186,0.000034353216],"about_ca_topic_score_codex":0.00074932794,"about_ca_topic_score_gemma":0.0018682051,"teacher_disagreement_score":0.0026120748,"about_ca_system_score_codex":0.00045833166,"about_ca_system_score_gemma":0.00072589243,"threshold_uncertainty_score":0.008738279},"labels":[],"label_agreement":null},{"id":"W2751007471","doi":"10.1007/s40265-017-0804-3","title":"Clinical Assessment and Management of Delirium in the Palliative Care Setting","year":2017,"lang":"en","type":"review","venue":"Drugs","topic":"Intensive Care Unit Cognitive Disorders","field":"Medicine","cited_by":152,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Bruyère; University of Ottawa","funders":"","keywords":"Delirium; Medicine; Palliative care; Intensive care medicine; Neurocognitive; Distress; Population; Sedation; Psychiatry; Nursing; Cognition; Anesthesia; Clinical psychology","score_opus":0.1358180847303014,"score_gpt":0.5052551552721194,"score_spread":0.36943707054181796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2751007471","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017534247,0.99862766,0.00011203793,0.0003082911,0.000116179144,0.000010859114,0.000012138573,0.0000055290657,0.00063205825],"genre_scores_gemma":[0.0021125362,0.99695045,0.0003884708,0.00019602875,0.00017265491,0.000016378728,0.000026788777,0.0000011880846,0.00013555677],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99947876,0.0001676441,0.00013618924,0.000044109383,0.00014833604,0.000025029414],"domain_scores_gemma":[0.9991904,0.0003906371,0.0001660416,0.000015537835,0.0001989575,0.000038443308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008764325,0.0008735966,0.0013640145,0.0020106665,0.00029005075,0.0010502967,0.0010235333,0.0010270268,0.0012245651],"category_scores_gemma":[0.0028296218,0.00017762349,0.0006712881,0.0012383029,0.0004288645,0.00071161473,0.0006611645,0.001423847,0.0006098081],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048835693,0.00007368725,0.0006484191,0.029660469,0.0001642797,0.000308755,0.00014887661,0.0003341865,0.00035816446,0.0011350401,0.018499415,0.9486199],"study_design_scores_gemma":[0.00012106994,0.00033023686,0.013664579,0.11290825,0.00108175,0.013405375,0.0007123602,0.00072748587,0.0007506403,0.0054796357,0.85072374,0.00009494236],"about_ca_topic_score_codex":0.0015431803,"about_ca_topic_score_gemma":0.0031034432,"teacher_disagreement_score":0.0020106665,"about_ca_system_score_codex":0.0005574647,"about_ca_system_score_gemma":0.0013693783,"threshold_uncertainty_score":0.004635036},"labels":[],"label_agreement":null},{"id":"W2751789708","doi":"10.1007/s40265-017-0807-0","title":"Pharmacological Management of Gestational Diabetes Mellitus","year":2017,"lang":"en","type":"review","venue":"Drugs","topic":"Gestational Diabetes Research and Management","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Glycemic; Gestational diabetes; Hypoglycemia; Metformin; Insulin; Incretin; Fetal macrosomia; Pregnancy; Insulin glargine; Postprandial; Diabetes mellitus; Neonatal hypoglycemia; Insulin lispro; Intensive care medicine; Type 2 diabetes; Internal medicine; Endocrinology; Gestation","score_opus":0.11394671550315888,"score_gpt":0.4370689747843489,"score_spread":0.32312225928119004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2751789708","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000050369366,0.9994198,0.000035244295,0.00009373522,0.00007014327,0.0000034192778,0.000011381746,0.0000025572674,0.00031338213],"genre_scores_gemma":[0.0004120384,0.9991617,0.00008688949,0.00013219797,0.000075267475,0.000004018315,0.000016294072,5.2248197e-7,0.00011103568],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999742,0.000052327374,0.00006508789,0.00003883252,0.0000793608,0.000022454013],"domain_scores_gemma":[0.9994629,0.00034082896,0.000102387094,0.000010294905,0.00005844031,0.000025264157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005243654,0.0009438697,0.0020403224,0.0023369873,0.00023396489,0.0010167384,0.00088909845,0.000998322,0.0034997931],"category_scores_gemma":[0.0013086605,0.0003271564,0.00090723106,0.002058335,0.0003842234,0.00092564593,0.0006877407,0.001817155,0.0008652177],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016914359,0.000085030624,0.0001860214,0.058786504,0.00034098834,0.00018513684,0.000046367844,0.00022260002,0.0006269655,0.0014790749,0.016271794,0.92160034],"study_design_scores_gemma":[0.00028382387,0.000297884,0.0022129389,0.044270482,0.0020031084,0.002151554,0.00013405815,0.00023119432,0.0005233397,0.0024337638,0.94540733,0.000050566272],"about_ca_topic_score_codex":0.0017544333,"about_ca_topic_score_gemma":0.0033767682,"teacher_disagreement_score":0.0034997931,"about_ca_system_score_codex":0.00052832323,"about_ca_system_score_gemma":0.0010246573,"threshold_uncertainty_score":0.011708021},"labels":[],"label_agreement":null},{"id":"W2768181348","doi":"10.1007/s40265-017-0830-1","title":"Middle East Respiratory Syndrome and Severe Acute Respiratory Syndrome: Current Therapeutic Options and Potential Targets for Novel Therapies","year":2017,"lang":"en","type":"review","venue":"Drugs","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":208,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"NHLBI Division of Intramural Research; National Institutes of Health; National Institute of Allergy and Infectious Diseases; Battelle","keywords":"Medicine; Drug repositioning; Intensive care medicine; Repurposing; Middle East respiratory syndrome coronavirus; Middle East respiratory syndrome; Clinical trial; Context (archaeology); Drug development; Drug; Coronavirus; Coronavirus disease 2019 (COVID-19); Pharmacology; Infectious disease (medical specialty); Disease; Pathology","score_opus":0.1819002405095236,"score_gpt":0.40881700471606247,"score_spread":0.22691676420653886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2768181348","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006100113,0.9990376,0.000048777125,0.00027547422,0.00012813172,0.0000039222855,0.000020124748,0.0000036557035,0.00042122987],"genre_scores_gemma":[0.0004157775,0.99882776,0.00012509563,0.00023351648,0.00015852421,0.0000042848137,0.000030770523,6.076421e-7,0.00020371728],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997726,0.00003923665,0.000044332697,0.00003398214,0.000081357,0.00002844426],"domain_scores_gemma":[0.99951327,0.00023507215,0.00009096019,0.000010699158,0.00010948084,0.000040587685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007111101,0.0008447398,0.0020447215,0.001858036,0.00025352158,0.0013809911,0.00085180905,0.0012770304,0.0045697563],"category_scores_gemma":[0.0010057426,0.0002776985,0.00070167345,0.0018765526,0.00044357055,0.0016244743,0.0008931371,0.002007304,0.0013608743],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016016718,0.00009503711,0.00027221953,0.027538465,0.00017864411,0.00019326262,0.00005793689,0.0003295949,0.0010433674,0.0030846177,0.03478158,0.932265],"study_design_scores_gemma":[0.00007648536,0.00016959911,0.0011173065,0.010152808,0.00045664876,0.0011491701,0.00013931631,0.00018633853,0.00027631386,0.002206805,0.98403615,0.000033001903],"about_ca_topic_score_codex":0.0009887862,"about_ca_topic_score_gemma":0.002644359,"teacher_disagreement_score":0.0045697563,"about_ca_system_score_codex":0.00051768974,"about_ca_system_score_gemma":0.0016284675,"threshold_uncertainty_score":0.015287399},"labels":[],"label_agreement":null},{"id":"W2775239537","doi":"10.1007/s40265-017-0851-9","title":"Imipenem–Relebactam and Meropenem–Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations","year":2017,"lang":"en","type":"review","venue":"Drugs","topic":"Antibiotic Resistance in Bacteria","field":"Biochemistry, Genetics and Molecular Biology","cited_by":374,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Diagnostic Services Manitoba; University of Manitoba","funders":"","keywords":"Acinetobacter baumannii; Klebsiella pneumoniae; Imipenem; Microbiology; Medicine; Enterobacteriaceae; Meropenem; Pseudomonas aeruginosa; Avibactam; Stenotrophomonas maltophilia; Carbapenem; Biology; Antibiotics; Antibiotic resistance; Escherichia coli; Bacteria; Biochemistry; Genetics","score_opus":0.04268241867347237,"score_gpt":0.355640474932519,"score_spread":0.3129580562590466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2775239537","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027637737,0.99838245,0.00017628285,0.00019506854,0.00016487799,0.0000066578523,0.000022592021,0.000008183178,0.0007674972],"genre_scores_gemma":[0.0020208105,0.99612516,0.00045620365,0.00029272411,0.00016321256,0.000010917024,0.000055349512,0.0000024607089,0.0008731379],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998273,0.000021521808,0.000030272735,0.000032871336,0.000066460394,0.000021517208],"domain_scores_gemma":[0.99980336,0.0000834682,0.000040494444,0.000005658585,0.00004491762,0.000022041446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043315144,0.0007744218,0.0012026414,0.0013457328,0.00016214226,0.000870219,0.00080674444,0.0008095341,0.0023919016],"category_scores_gemma":[0.00065185566,0.00023520757,0.0004157678,0.0014048397,0.00035472098,0.0010392042,0.0004724352,0.0021770732,0.0010528087],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017165675,0.000090786365,0.00015040746,0.009581424,0.000099734425,0.00021072138,0.0000400787,0.00031011188,0.002644971,0.0023499555,0.018139588,0.96621054],"study_design_scores_gemma":[0.000081554856,0.00022474937,0.00079607504,0.0017775587,0.00024371433,0.001897365,0.000043360986,0.000164839,0.0016438516,0.0009957651,0.99210584,0.000025211948],"about_ca_topic_score_codex":0.00060450856,"about_ca_topic_score_gemma":0.0017423781,"teacher_disagreement_score":0.0023919016,"about_ca_system_score_codex":0.000456873,"about_ca_system_score_gemma":0.0007236966,"threshold_uncertainty_score":0.008001745},"labels":[],"label_agreement":null},{"id":"W2795962307","doi":"10.1007/s40265-018-0898-2","title":"Role of Methotrexate in the Management of Psoriatic Arthritis","year":2018,"lang":"en","type":"review","venue":"Drugs","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"","keywords":"Medicine; Psoriatic arthritis; Dactylitis; Methotrexate; Psoriasis; Rheumatoid arthritis; Arthritis; Placebo-controlled study; Enthesitis; Internal medicine; Placebo; Dermatology; Pathology; Alternative medicine","score_opus":0.02660489395612581,"score_gpt":0.34112442539587745,"score_spread":0.31451953143975164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2795962307","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000023390676,0.99955446,0.000023422372,0.00009931092,0.000081779566,0.0000018971842,0.0000064059227,0.0000019332085,0.00020731482],"genre_scores_gemma":[0.00029143412,0.9991879,0.00008434587,0.00015057602,0.00012882875,0.00000259377,0.0000111376,5.311086e-7,0.0001425515],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995803,0.000092708615,0.000098491124,0.0000585858,0.00014134556,0.0000285526],"domain_scores_gemma":[0.99879265,0.0007942768,0.00019660535,0.00002302572,0.00014258904,0.00005080601],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000881933,0.00090867537,0.0022248747,0.002975369,0.00030101728,0.0013195989,0.0010696042,0.0013795833,0.004562734],"category_scores_gemma":[0.001901005,0.00034615048,0.00092228164,0.0023771906,0.0005101259,0.0012297719,0.0007571205,0.0023448754,0.001286064],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014967028,0.000062993924,0.00015254559,0.045739036,0.00025591298,0.00016463152,0.000045799952,0.00022699613,0.00073083077,0.0015406499,0.018772585,0.9321583],"study_design_scores_gemma":[0.00013989709,0.00018649451,0.0013968999,0.02728736,0.0012428225,0.0019396143,0.000082166545,0.00014557003,0.00033737122,0.0017534238,0.96545357,0.000034863246],"about_ca_topic_score_codex":0.0020373962,"about_ca_topic_score_gemma":0.0044368035,"teacher_disagreement_score":0.004562734,"about_ca_system_score_codex":0.00064881,"about_ca_system_score_gemma":0.0014782745,"threshold_uncertainty_score":0.015263855},"labels":[],"label_agreement":null},{"id":"W2802609592","doi":"10.1007/s40265-018-0910-x","title":"Correction to: Imipenem–Relebactam and Meropenem–Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations","year":2018,"lang":"en","type":"erratum","venue":"Drugs","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Diagnostic Services Manitoba; University of Manitoba","funders":"","keywords":"Meropenem; Medicine; Heading (navigation); Microbiology; Biology; Antibiotics; Geography; Antibiotic resistance","score_opus":0.01253244302557519,"score_gpt":0.3019576257687935,"score_spread":0.28942518274321827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2802609592","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006747204,0.0014751402,0.00027350427,0.04636739,0.9504692,0.000013765274,0.00022466115,0.000076897435,0.0010318784],"genre_scores_gemma":[0.0055533103,0.010807059,0.0024182214,0.12133719,0.7735975,0.00010371135,0.00059502455,0.000489997,0.08509791],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954448,0.0007866865,0.0010094859,0.0006187311,0.0017289583,0.00041139385],"domain_scores_gemma":[0.9801619,0.0064648027,0.0014428406,0.00082458387,0.009799337,0.001306506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003440817,0.0025537957,0.0025467493,0.0031864631,0.0022940363,0.0041899723,0.0029749789,0.010518292,0.02203175],"category_scores_gemma":[0.044294797,0.0013271619,0.0021586264,0.0016014682,0.0024965592,0.0024873493,0.001575266,0.01725103,0.016335292],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053653235,0.000008215053,0.000052302355,0.0001238199,0.0000147452,0.00053790095,0.000013506525,0.000043515105,0.00003874117,0.00044372375,0.9940335,0.00463638],"study_design_scores_gemma":[0.000077184806,0.000026829779,0.00032758072,0.00027370706,0.0000477093,0.0014613979,0.000041327094,0.00022245712,0.00022824742,0.0007919826,0.996472,0.000029561968],"about_ca_topic_score_codex":0.00978986,"about_ca_topic_score_gemma":0.012696309,"teacher_disagreement_score":0.02203175,"about_ca_system_score_codex":0.0042846305,"about_ca_system_score_gemma":0.004570689,"threshold_uncertainty_score":0.07370359},"labels":[],"label_agreement":null},{"id":"W2888994582","doi":"10.1007/s40265-018-0971-x","title":"Beyond the TNF-α Inhibitors: New and Emerging Targeted Therapies for Patients with Axial Spondyloarthritis and their Relation to Pathophysiology","year":2018,"lang":"en","type":"review","venue":"Drugs","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Immunology; Medicine; Innate immune system; Unfolded protein response; Tumor necrosis factor alpha; Inflammation; Immune system; Endoplasmic reticulum; Biology; Cell biology","score_opus":0.010830699091991974,"score_gpt":0.2610095401965357,"score_spread":0.25017884110454375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888994582","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003897016,0.99963427,0.000021247703,0.00011183078,0.000054346772,0.0000013691878,0.00000860516,0.000001307368,0.00012816756],"genre_scores_gemma":[0.00034301542,0.9992244,0.000061488834,0.00015801424,0.000098453325,0.0000024752671,0.000012503597,4.4319881e-7,0.00009920961],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996476,0.00007557373,0.000079006626,0.000049181264,0.00011867586,0.000029885297],"domain_scores_gemma":[0.99924845,0.00046522502,0.00013731347,0.0000140714,0.00010157646,0.000033323417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076483336,0.0007967102,0.0022205769,0.0023226254,0.00022811203,0.0013736769,0.0008562604,0.0012372885,0.0035784252],"category_scores_gemma":[0.0013184814,0.00027200414,0.00081830035,0.0026829473,0.0005766815,0.001442011,0.0007755473,0.0020863623,0.00095128],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024825372,0.00008562181,0.00028673685,0.056621406,0.0003972164,0.00020126108,0.00008085216,0.00029163586,0.0012320185,0.0028633832,0.021194886,0.9164968],"study_design_scores_gemma":[0.00013447563,0.00023222278,0.0018999014,0.021524474,0.00097086024,0.0016170675,0.00014731979,0.0001296057,0.00041522775,0.0027991133,0.9700875,0.000042161722],"about_ca_topic_score_codex":0.0011086927,"about_ca_topic_score_gemma":0.002734979,"teacher_disagreement_score":0.0035784252,"about_ca_system_score_codex":0.00049312745,"about_ca_system_score_gemma":0.0014381552,"threshold_uncertainty_score":0.011970997},"labels":[],"label_agreement":null},{"id":"W2889874928","doi":"10.1007/s40265-018-0977-4","title":"Elagolix: First Global Approval","year":2018,"lang":"en","type":"review","venue":"Drugs","topic":"Endometriosis Research and Treatment","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Endometriosis; Hormone antagonist; Clinical trial; Gonadotropin-releasing hormone; Pharmacotherapy; Hormone; Pharmacology; Internal medicine; Luteinizing hormone; Endocrine system","score_opus":0.060296668668761516,"score_gpt":0.4022300389948175,"score_spread":0.341933370326056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889874928","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019383833,0.91630507,0.0009029118,0.0050153616,0.002406399,0.0003037076,0.0017794324,0.00032011294,0.071028665],"genre_scores_gemma":[0.014877207,0.9318985,0.0014927696,0.0054300674,0.0010937569,0.00028144007,0.0026186756,0.00006891429,0.042238742],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99967647,0.00006432163,0.000034676188,0.000043123375,0.000144354,0.000037055142],"domain_scores_gemma":[0.999647,0.00008089151,0.00007329478,0.000011814859,0.00014333638,0.00004359976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006589561,0.000619471,0.00070767204,0.0014076346,0.00028754983,0.0013580117,0.0006750848,0.0014611218,0.031179994],"category_scores_gemma":[0.0012338919,0.0002243353,0.00064856047,0.0010222684,0.0003609646,0.0010606014,0.0006166215,0.001936068,0.013736177],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034114768,0.00010547369,0.00017137289,0.011987786,0.00007243787,0.00043765648,0.000094858326,0.00015225368,0.0034694904,0.0062126904,0.18729898,0.78965586],"study_design_scores_gemma":[0.00009911679,0.000085145155,0.00026074477,0.0012853482,0.00003498892,0.00063173333,0.000015113686,0.000025044808,0.00045850134,0.00038991013,0.9967085,0.000005734878],"about_ca_topic_score_codex":0.00069181307,"about_ca_topic_score_gemma":0.001287628,"teacher_disagreement_score":0.031179994,"about_ca_system_score_codex":0.0005910207,"about_ca_system_score_gemma":0.001471261,"threshold_uncertainty_score":0.10430747},"labels":[],"label_agreement":null},{"id":"W2892402399","doi":"10.1007/s40265-018-0975-6","title":"Human Papillomavirus Vaccines: Successes and Future Challenges","year":2018,"lang":"en","type":"review","venue":"Drugs","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; McGill University; Royal Victoria Hospital; Jewish General Hospital","funders":"","keywords":"Medicine; Human papillomavirus; Pharmacotherapy; Virology; Intensive care medicine; Internal medicine","score_opus":0.0839744224305002,"score_gpt":0.4185726180101321,"score_spread":0.33459819557963194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892402399","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000032346805,0.99905986,0.000024042896,0.00044064247,0.00016226641,0.0000018846277,0.000016628761,0.0000038326257,0.0002584517],"genre_scores_gemma":[0.00035019164,0.9988656,0.00007005465,0.00037257216,0.00016388179,0.0000033254958,0.00001628511,9.818585e-7,0.00015711722],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995467,0.00010459735,0.00007766072,0.000067799694,0.00015125611,0.000052000592],"domain_scores_gemma":[0.99851733,0.00091933995,0.00021631105,0.000025348396,0.0002402181,0.00008145821],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014035017,0.00091570884,0.0024069508,0.0023918357,0.00033136675,0.0020459401,0.0009614483,0.0018100835,0.006312737],"category_scores_gemma":[0.0023203923,0.0003931408,0.00087828794,0.0028831337,0.00080786913,0.0028698058,0.0012332991,0.0028397322,0.0016038441],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013112149,0.000049868922,0.0002620021,0.046900004,0.00019816171,0.00011671634,0.000103298094,0.00026095405,0.00061766914,0.0049543264,0.051098954,0.8953068],"study_design_scores_gemma":[0.000040362087,0.00009737664,0.0006417025,0.018871514,0.00039323047,0.00050949666,0.00016367315,0.00008763174,0.00015149885,0.0025377625,0.976482,0.000023835148],"about_ca_topic_score_codex":0.0015220027,"about_ca_topic_score_gemma":0.0044040647,"teacher_disagreement_score":0.006312737,"about_ca_system_score_codex":0.0010376752,"about_ca_system_score_gemma":0.003048716,"threshold_uncertainty_score":0.021118164},"labels":[],"label_agreement":null},{"id":"W2906917595","doi":"10.1007/s40265-018-1032-1","title":"Immune Checkpoint Inhibitors in the Treatment of Gastroesophageal Cancer","year":2019,"lang":"en","type":"review","venue":"Drugs","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Nivolumab; Medicine; Pembrolizumab; Immune checkpoint; Blockade; Cancer; Oncology; Ipilimumab; Internal medicine; Atezolizumab; Immunotherapy; Microsatellite instability; Chemotherapy","score_opus":0.03974246553099459,"score_gpt":0.3481894594858245,"score_spread":0.30844699395482994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906917595","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005138833,0.9992167,0.000043752687,0.00017081697,0.0001405917,0.0000029264236,0.000013007312,0.000003440877,0.00035729952],"genre_scores_gemma":[0.00049015164,0.9986235,0.000099274366,0.0002714278,0.00015502983,0.000004882025,0.00002302371,7.728074e-7,0.00033184397],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99983156,0.000037036723,0.000029385877,0.000027920229,0.000055302306,0.000018755894],"domain_scores_gemma":[0.99959975,0.00022517517,0.00007196503,0.000007697608,0.00006627592,0.000029166647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005659959,0.0008085311,0.0017298276,0.0016506393,0.00018953877,0.00088573067,0.00075816485,0.000944863,0.0037493848],"category_scores_gemma":[0.0009439537,0.00021269867,0.0006482614,0.0014957052,0.00029508088,0.00082038925,0.0005819463,0.0021223985,0.0013063748],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018359015,0.00006271499,0.000111011104,0.021659806,0.00018593363,0.000095620104,0.000022149306,0.00033005016,0.0007376526,0.0016997047,0.027022744,0.9478891],"study_design_scores_gemma":[0.00015469136,0.0003118311,0.0010678209,0.011687998,0.00073069107,0.0008485446,0.000043051346,0.00019011437,0.00037894744,0.0016574031,0.98290426,0.000024779003],"about_ca_topic_score_codex":0.0010688993,"about_ca_topic_score_gemma":0.003171502,"teacher_disagreement_score":0.0037493848,"about_ca_system_score_codex":0.00048920733,"about_ca_system_score_gemma":0.00081562315,"threshold_uncertainty_score":0.012542903},"labels":[],"label_agreement":null},{"id":"W2912739876","doi":"10.1007/s40265-018-1024-1","title":"l-Ornithine l-Aspartate (LOLA) for Hepatic Encephalopathy in Cirrhosis: Results of Randomized Controlled Trials and Meta-Analyses","year":2019,"lang":"en","type":"review","venue":"Drugs","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Merz Pharmaceuticals; King's College London; National Institute for Health and Care Research; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research","keywords":"Medicine; Hepatic encephalopathy; Randomized controlled trial; Cirrhosis; Internal medicine; Portosystemic shunt; Portal hypertension; Meta-analysis; Transjugular intrahepatic portosystemic shunt; Concomitant; Lactulose; Gastroenterology; Intensive care medicine","score_opus":0.2483490198769808,"score_gpt":0.4534745076328866,"score_spread":0.2051254877559058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912739876","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012275603,0.9981077,0.00018080114,0.00009157935,0.000071734285,0.000071574796,0.000114392555,0.000009332206,0.00012528758],"genre_scores_gemma":[0.042512655,0.95510423,0.0010785144,0.0003964683,0.00015646781,0.00025417417,0.00029165487,0.000016635377,0.00018925872],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9950053,0.0024911808,0.0013939623,0.00044672843,0.0005012994,0.00016155365],"domain_scores_gemma":[0.98739064,0.010202762,0.0014056619,0.00023555319,0.0006205006,0.00014485311],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010457164,0.0026690455,0.014507022,0.004288269,0.0004034098,0.0025303278,0.0015737315,0.0017203859,0.00487966],"category_scores_gemma":[0.021376427,0.0009729507,0.026057515,0.00498483,0.00050919823,0.0014213218,0.0011430955,0.002160664,0.00029301783],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046839975,0.000060346698,0.0017442373,0.5128362,0.43045357,0.00009625559,0.00006179905,0.0007292744,0.0002666519,0.00025140715,0.0011824514,0.04763381],"study_design_scores_gemma":[0.0013309108,0.00038684576,0.003016058,0.034178924,0.95574933,0.00010129913,0.000043534197,0.00026261216,0.0001705989,0.00043723866,0.0042961347,0.000026524607],"about_ca_topic_score_codex":0.0035773949,"about_ca_topic_score_gemma":0.007866273,"teacher_disagreement_score":0.014507022,"about_ca_system_score_codex":0.0018332675,"about_ca_system_score_gemma":0.0020444745,"threshold_uncertainty_score":0.055303395},"labels":[],"label_agreement":null},{"id":"W2912906332","doi":"10.1007/s40265-019-1055-2","title":"Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli","year":2019,"lang":"en","type":"review","venue":"Drugs","topic":"Antibiotic Resistance in Bacteria","field":"Biochemistry, Genetics and Molecular Biology","cited_by":429,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Manitoba Health; University of Manitoba","funders":"","keywords":"Cephalosporin; Siderophore; Microbiology; Bacilli; Carbapenem; Multiple drug resistance; Medicine; Gram; Drug resistance; Pharmacotherapy; Antibiotics; Biology; Bacteria; Internal medicine","score_opus":0.02029146034473697,"score_gpt":0.281665191329291,"score_spread":0.2613737309845541,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912906332","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015989992,0.9981141,0.00016386066,0.00017294234,0.00022434743,0.0000049814635,0.00003748521,0.000011022724,0.0011113379],"genre_scores_gemma":[0.00076200184,0.99757355,0.00027289792,0.00020522531,0.00012928371,0.00000554066,0.00006952445,0.0000017489349,0.0009802206],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998734,0.000014809524,0.000016482536,0.00002162755,0.000055957382,0.000017839317],"domain_scores_gemma":[0.9998023,0.0000706637,0.000036930607,0.0000061265223,0.00005001564,0.000033884582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040825809,0.00096633803,0.0010644079,0.0018391913,0.00017262028,0.00087935687,0.0006798332,0.00080605946,0.0027178894],"category_scores_gemma":[0.0005077435,0.00018871845,0.00031213337,0.0020427795,0.0003872948,0.0008697974,0.0004760394,0.0017773837,0.002019179],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000120176104,0.0000712982,0.00010797829,0.0081994925,0.00005526132,0.00014791473,0.00001852935,0.00024605542,0.0025229796,0.0016546814,0.026418883,0.9604367],"study_design_scores_gemma":[0.000043867418,0.00013692386,0.0007563425,0.0018408339,0.00010522203,0.0011013995,0.000022238644,0.00008642659,0.0009996488,0.0007028151,0.9941894,0.0000147443625],"about_ca_topic_score_codex":0.001183038,"about_ca_topic_score_gemma":0.0023903889,"teacher_disagreement_score":0.0027178894,"about_ca_system_score_codex":0.00057073846,"about_ca_system_score_gemma":0.00090495276,"threshold_uncertainty_score":0.009092212},"labels":[],"label_agreement":null},{"id":"W2913170138","doi":"10.1007/s40265-018-1021-4","title":"l-Ornithine l-Aspartate (LOLA) for the Treatment of Hepatic Encephalopathy in Cirrhosis: Novel Insights and Translation to the Clinic","year":2019,"lang":"en","type":"editorial","venue":"Drugs","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cirrhosis; Hepatic encephalopathy; Pharmacotherapy; Translation (biology); Pharmacology; Encephalopathy; Internal medicine; Gastroenterology; Biochemistry; Chemistry","score_opus":0.019951941008156737,"score_gpt":0.2967060380770968,"score_spread":0.27675409706894005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913170138","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000052507137,0.039210923,0.00016261183,0.03957855,0.9193873,0.00002731167,0.00006076986,0.000049539118,0.0014705487],"genre_scores_gemma":[0.0005631757,0.024198862,0.00013725439,0.031423382,0.9376476,0.000023987306,0.000032832817,0.00002370572,0.0059491834],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99644,0.0009361025,0.00057325023,0.00034641213,0.0014726124,0.00023157978],"domain_scores_gemma":[0.9866065,0.006898278,0.00083919294,0.00023575184,0.0037094452,0.0017108257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007166934,0.0029912842,0.004045393,0.0024724621,0.0017758827,0.0051063406,0.0034875995,0.013048077,0.0055097053],"category_scores_gemma":[0.016347373,0.00090172933,0.0026079314,0.0012560969,0.0018352624,0.0037639742,0.0012562919,0.01974243,0.005420562],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018522625,0.00002601512,0.000020827762,0.00077560294,0.00006332212,0.00011566406,0.000012548804,0.000047231228,0.00009232181,0.0005719979,0.9828864,0.015202827],"study_design_scores_gemma":[0.00039477105,0.00019042895,0.00036509553,0.0011057288,0.00021467835,0.00036169303,0.000036526777,0.00028614514,0.00020856409,0.0016698301,0.9951267,0.000039749164],"about_ca_topic_score_codex":0.0022229848,"about_ca_topic_score_gemma":0.0058532176,"teacher_disagreement_score":0.013048077,"about_ca_system_score_codex":0.0030208821,"about_ca_system_score_gemma":0.0029423244,"threshold_uncertainty_score":0.037902832},"labels":[],"label_agreement":null},{"id":"W2914015239","doi":"10.1007/s40265-018-1017-0","title":"Hepatic Encephalopathy in Cirrhosis: Pathology and Pathophysiology","year":2019,"lang":"en","type":"review","venue":"Drugs","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":157,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Astrocytosis; Basal ganglia; Medicine; Hepatic encephalopathy; Neuroinflammation; Neuroscience; Pathophysiology; Cirrhosis; Pathology; Neuropathology; Central nervous system; Internal medicine; Inflammation; Biology","score_opus":0.0241786274564175,"score_gpt":0.31176151096361937,"score_spread":0.28758288350720185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914015239","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007321645,0.99928373,0.000028307497,0.00012882883,0.000070333655,0.000001397837,0.0000065975673,0.000002898657,0.00040465483],"genre_scores_gemma":[0.0006030767,0.99884665,0.00004944413,0.00007990351,0.00014649978,0.0000018879454,0.000014593537,5.307185e-7,0.00025730106],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999145,0.00001627273,0.000017765838,0.000013988828,0.000026704678,0.000010794173],"domain_scores_gemma":[0.99981683,0.000074360745,0.000040824896,0.000006154873,0.00004084744,0.00002097049],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031289313,0.0008556055,0.0013077498,0.0024573607,0.00025705984,0.00090599287,0.00054576254,0.000802807,0.0032025548],"category_scores_gemma":[0.00040517267,0.00019415928,0.00034878126,0.0021714875,0.0005392812,0.0009732159,0.0006130303,0.0011746599,0.0013881492],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006805478,0.000050738665,0.00028018936,0.018912002,0.000082011255,0.00035148562,0.00006459263,0.00027876475,0.000883326,0.0023724034,0.024071502,0.95258486],"study_design_scores_gemma":[0.000020114541,0.00012219246,0.0026004,0.010337547,0.00018003471,0.005503267,0.00012441653,0.00012308249,0.00030344096,0.00325829,0.97740096,0.000026284217],"about_ca_topic_score_codex":0.0012811378,"about_ca_topic_score_gemma":0.002367073,"teacher_disagreement_score":0.0032025548,"about_ca_system_score_codex":0.000483345,"about_ca_system_score_gemma":0.0008787631,"threshold_uncertainty_score":0.010713637},"labels":[],"label_agreement":null},{"id":"W2914471002","doi":"10.1007/s40265-019-1065-0","title":"Therapies Directed Against B-Cells and Downstream Effectors in Generalized Autoimmune Myasthenia Gravis: Current Status","year":2019,"lang":"en","type":"review","venue":"Drugs","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Alberta Hospital","funders":"","keywords":"Myasthenia gravis; Medicine; Immunology; Rituximab; Autoantibody; Immunopathology; Eculizumab; Autoimmune disease; Antibody; Complement system","score_opus":0.024503490715655232,"score_gpt":0.3147896148112093,"score_spread":0.2902861240955541,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914471002","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010695638,0.9992173,0.00006791743,0.000145048,0.000114724695,0.000003355848,0.000014511807,0.000006546089,0.00032357813],"genre_scores_gemma":[0.00092109194,0.9981431,0.00016233626,0.00027448655,0.00015252597,0.000007101621,0.000028351058,0.0000012690318,0.00030970175],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99987173,0.000026733094,0.00002088518,0.000023446191,0.000037945956,0.000019350036],"domain_scores_gemma":[0.9997212,0.00014898868,0.000054764623,0.0000063791163,0.00004143497,0.000027032178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051342696,0.0008409783,0.0018301045,0.0013392774,0.00017408129,0.0009873821,0.0007372009,0.0010030259,0.003695201],"category_scores_gemma":[0.0005889536,0.00023430891,0.00058057264,0.0010628018,0.00036844314,0.00093359797,0.000550736,0.0019199006,0.001359101],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002824431,0.000120772755,0.0001559485,0.023167126,0.00019926154,0.0001437981,0.000034247998,0.000473735,0.001891871,0.0016255137,0.023744598,0.9481607],"study_design_scores_gemma":[0.00022758452,0.00046593527,0.0010325442,0.007637677,0.00086425216,0.0011363566,0.000068870715,0.00028895066,0.00064677786,0.0016714403,0.98592573,0.0000338481],"about_ca_topic_score_codex":0.00060413906,"about_ca_topic_score_gemma":0.0016458797,"teacher_disagreement_score":0.003695201,"about_ca_system_score_codex":0.00037910166,"about_ca_system_score_gemma":0.0007355126,"threshold_uncertainty_score":0.012361646},"labels":[],"label_agreement":null},{"id":"W2922206637","doi":"10.1007/s40265-019-01085-1","title":"Treatment of Vulvodynia: Pharmacological and Non-Pharmacological Approaches","year":2019,"lang":"en","type":"review","venue":"Drugs","topic":"Sexual function and dysfunction studies","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Vulvodynia; Pharmacotherapy; MEDLINE; Pharmacology; Intensive care medicine; Dermatology; Internal medicine; Surgery","score_opus":0.26400019203152686,"score_gpt":0.4159392501684312,"score_spread":0.15193905813690434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2922206637","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000074589174,0.99958163,0.000031953998,0.000048056314,0.000029554305,0.0000044255994,0.00001169701,0.0000019848492,0.00021609498],"genre_scores_gemma":[0.0006898967,0.9988978,0.00012703755,0.00008810433,0.00004991157,0.0000054370034,0.000013951141,6.018165e-7,0.00012721056],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997522,0.000048624173,0.000059141847,0.00004783017,0.000071524664,0.000020732863],"domain_scores_gemma":[0.99955636,0.00029426985,0.0000717854,0.000009034823,0.000048802358,0.000019700417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064452447,0.001118777,0.0027673286,0.0033653395,0.00026193672,0.0011337089,0.00088935555,0.0011156508,0.0056844195],"category_scores_gemma":[0.00085433904,0.0003541832,0.0013600885,0.002525893,0.0004237997,0.0010478197,0.0006339224,0.0015981878,0.00081277004],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035908143,0.00021155439,0.00019064761,0.088870265,0.0006335251,0.00015755775,0.000057867088,0.0002580072,0.0013823934,0.0012243415,0.006232977,0.90042174],"study_design_scores_gemma":[0.0006879169,0.0015179284,0.0060908874,0.07361643,0.006535958,0.003551963,0.0003457431,0.00047242042,0.0018720127,0.0027276266,0.90246356,0.00011758135],"about_ca_topic_score_codex":0.0014720773,"about_ca_topic_score_gemma":0.0038684446,"teacher_disagreement_score":0.0056844195,"about_ca_system_score_codex":0.00047989265,"about_ca_system_score_gemma":0.0009300378,"threshold_uncertainty_score":0.019016206},"labels":[],"label_agreement":null},{"id":"W2937068696","doi":"10.1007/s40265-019-01110-3","title":"The Clinician’s Guide to Proton Pump Inhibitor Related Adverse Events","year":2019,"lang":"en","type":"review","venue":"Drugs","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Adverse effect; Proton-pump inhibitor; Intensive care medicine; Harm; Number needed to harm; Relative risk; Internal medicine; Confidence interval; Psychology; Number needed to treat","score_opus":0.03520317018572185,"score_gpt":0.39282732221688,"score_spread":0.35762415203115816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2937068696","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001006529,0.9596184,0.0021952654,0.010171208,0.012928978,0.0002923553,0.001658172,0.0004475201,0.012587399],"genre_scores_gemma":[0.0009092562,0.93343896,0.0070612296,0.02236184,0.009509686,0.00047885315,0.0020440712,0.000085265296,0.024110902],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99826765,0.00041080063,0.0005566073,0.00014999867,0.00055142946,0.00006345459],"domain_scores_gemma":[0.99403363,0.0025565168,0.0010255263,0.00013301802,0.0019297749,0.00032161103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014286328,0.0015123124,0.00374422,0.008206534,0.00044339974,0.002498233,0.0021756482,0.0029320228,0.035894454],"category_scores_gemma":[0.0066585285,0.0006479501,0.0020495758,0.004486755,0.0005909078,0.0027126987,0.0013268644,0.004247097,0.022462811],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000076338074,0.000050601102,0.00008220656,0.01701291,0.000096893775,0.00017830162,0.000034621004,0.00012253322,0.00039165953,0.0010791082,0.5647358,0.41613907],"study_design_scores_gemma":[0.00011439993,0.00006623272,0.0005056256,0.014883083,0.00011191667,0.0008019653,0.00003750019,0.000105727,0.00006755225,0.0016444507,0.9816328,0.000028823088],"about_ca_topic_score_codex":0.0024189742,"about_ca_topic_score_gemma":0.006821535,"teacher_disagreement_score":0.035894454,"about_ca_system_score_codex":0.0009500595,"about_ca_system_score_gemma":0.0033817496,"threshold_uncertainty_score":0.12007892},"labels":[],"label_agreement":null},{"id":"W2944756121","doi":"10.1007/s40265-019-01115-y","title":"Dacomitinib in the Management of Advanced Non-Small-Cell Lung Cancer","year":2019,"lang":"en","type":"review","venue":"Drugs","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Pfizer","keywords":"Erlotinib; Medicine; Gefitinib; Lung cancer; Tyrosine-kinase inhibitor; Epidermal growth factor receptor; Oncology; Pharmacology; Cancer; Erlotinib Hydrochloride; EGFR inhibitors; Internal medicine","score_opus":0.026113738060411805,"score_gpt":0.38656500292374024,"score_spread":0.36045126486332846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944756121","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006431329,0.9990369,0.000037149544,0.00017078705,0.00011208759,0.0000025950035,0.000018423447,0.000003705268,0.00055402005],"genre_scores_gemma":[0.00058894086,0.9985973,0.000083946885,0.0002460219,0.00010429618,0.000003900091,0.000026295169,8.2533006e-7,0.0003483137],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998429,0.000029632001,0.00002466641,0.000027817077,0.00005770702,0.000017314664],"domain_scores_gemma":[0.999694,0.00017399207,0.00005202011,0.0000050138083,0.00005144579,0.0000234105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047719156,0.00063138094,0.0014427946,0.001633333,0.00019785945,0.0009113442,0.0006685864,0.0007593535,0.003578867],"category_scores_gemma":[0.00080510066,0.00018600466,0.00057348405,0.001589766,0.00027981587,0.00073500455,0.00045520894,0.0017495072,0.0010215426],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011533539,0.000041612308,0.00010428383,0.017078644,0.00015743669,0.000078520825,0.000020640293,0.00032981255,0.00065236905,0.00169732,0.02815105,0.951573],"study_design_scores_gemma":[0.000108365326,0.00017721723,0.0010870437,0.009421316,0.00053144456,0.000939992,0.00003997342,0.00019373871,0.00031675017,0.0016531857,0.9855079,0.000023108953],"about_ca_topic_score_codex":0.0014620397,"about_ca_topic_score_gemma":0.004701281,"teacher_disagreement_score":0.003578867,"about_ca_system_score_codex":0.00060670945,"about_ca_system_score_gemma":0.000814896,"threshold_uncertainty_score":0.011972547},"labels":[],"label_agreement":null},{"id":"W2950843447","doi":"10.1007/s40265-019-01152-7","title":"Damoctocog Alfa Pegol: A Review in Haemophilia A","year":2019,"lang":"en","type":"review","venue":"Drugs","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Haemophilia; Certolizumab pegol; Haemophilia A; Interim analysis; Haemophilia B; Dosing; Internal medicine; Surgery; Clinical trial; Adalimumab","score_opus":0.12454883995485991,"score_gpt":0.44268258544071537,"score_spread":0.3181337454858555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950843447","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001231832,0.9990934,0.000044816345,0.00014362005,0.00013977014,0.0000056472268,0.000015106191,0.0000039802453,0.0004305281],"genre_scores_gemma":[0.0011167735,0.99784255,0.00015442066,0.00031849326,0.00017506651,0.000009725429,0.000042856092,0.0000017891085,0.00033824422],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997429,0.00006889628,0.00005181885,0.00004676093,0.00006850227,0.00002100148],"domain_scores_gemma":[0.999466,0.00026150604,0.000105679756,0.000011596057,0.00010715495,0.000048136477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006309274,0.00066975626,0.000971192,0.0019060893,0.0002521622,0.0010102123,0.0007679892,0.0009790773,0.0035231023],"category_scores_gemma":[0.0009162164,0.00022944981,0.00081022363,0.0020410498,0.00029713777,0.0010231555,0.0004721948,0.001327856,0.0012194912],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022139815,0.000077266515,0.00023772314,0.03819753,0.00017039836,0.00019927286,0.00006673984,0.00017161774,0.001141175,0.0016527061,0.036276065,0.92158806],"study_design_scores_gemma":[0.000063198175,0.0002286169,0.0015426145,0.012493248,0.0004397772,0.0014142159,0.000053453394,0.000070701484,0.00025484024,0.0006846519,0.9827387,0.000016021864],"about_ca_topic_score_codex":0.0011063316,"about_ca_topic_score_gemma":0.001976061,"teacher_disagreement_score":0.0035231023,"about_ca_system_score_codex":0.00043038887,"about_ca_system_score_gemma":0.0009728359,"threshold_uncertainty_score":0.011785984},"labels":[],"label_agreement":null},{"id":"W2951843738","doi":"10.1007/s40265-019-01141-w","title":"A Pharmacological Approach to Managing Inflammatory Bowel Disease During Conception, Pregnancy and Breastfeeding: Biologic and Oral Small Molecule Therapy","year":2019,"lang":"en","type":"review","venue":"Drugs","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Pregnancy; Infliximab; Adalimumab; Inflammatory bowel disease; Adverse effect; Ustekinumab; Context (archaeology); Discontinuation; Breastfeeding; Vedolizumab; Disease; Internal medicine; Intensive care medicine; Pediatrics","score_opus":0.06273772206705708,"score_gpt":0.33915724890318627,"score_spread":0.2764195268361292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2951843738","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000073353134,0.99931586,0.00006915353,0.00014894048,0.00009329306,0.000004496275,0.000010458321,0.0000038599555,0.00028048293],"genre_scores_gemma":[0.000491298,0.99875724,0.00017178715,0.00020693483,0.00011878589,0.0000067668693,0.00001381624,6.762615e-7,0.00023267152],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99976844,0.000053427353,0.00004214614,0.00003545211,0.00007648679,0.000024026403],"domain_scores_gemma":[0.9995728,0.00025422024,0.00007229195,0.0000074192044,0.000064570006,0.000028682376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006455234,0.0010627841,0.0023566552,0.0022897688,0.00024941962,0.0009990347,0.00076738815,0.0012375908,0.00390342],"category_scores_gemma":[0.0007352799,0.00027271514,0.0009002892,0.0017122265,0.00035935992,0.00094295514,0.0006610268,0.0024240424,0.0009680119],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018862459,0.00017943722,0.000119896285,0.038345937,0.00028767413,0.00016425949,0.000053490745,0.00031901986,0.001737934,0.0016790009,0.016647192,0.94027764],"study_design_scores_gemma":[0.0002834252,0.0006994841,0.0018851358,0.02262204,0.0013989034,0.0017076826,0.00014148405,0.00033010234,0.0007558258,0.001876519,0.9682491,0.000050316376],"about_ca_topic_score_codex":0.0014225697,"about_ca_topic_score_gemma":0.003847835,"teacher_disagreement_score":0.00390342,"about_ca_system_score_codex":0.00047507774,"about_ca_system_score_gemma":0.001021274,"threshold_uncertainty_score":0.013058245},"labels":[],"label_agreement":null},{"id":"W2954563654","doi":"10.1007/s40265-019-01156-3","title":"Perioperative Pain Management in Morbid Obesity","year":2019,"lang":"en","type":"review","venue":"Drugs","topic":"Anesthesia and Pain Management","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Perioperative; Intensive care medicine; Opioid; Population; Analgesic; Adverse effect; Anesthesia; Internal medicine","score_opus":0.04225692084307678,"score_gpt":0.3328268487754298,"score_spread":0.29056992793235303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954563654","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000053308482,0.99941325,0.00003535482,0.000101879625,0.000105436004,0.0000032168173,0.000009642104,0.000002322214,0.00027558964],"genre_scores_gemma":[0.00042632132,0.9989189,0.00009529913,0.00023028774,0.00016725391,0.0000048469265,0.00001281751,6.7624836e-7,0.000143512],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997156,0.00005600183,0.000082549115,0.000040581737,0.000080684105,0.000024554234],"domain_scores_gemma":[0.9992489,0.00045550943,0.00016704785,0.000010693472,0.000085712534,0.00003204958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006599485,0.00094814104,0.0020364085,0.0027357528,0.00022575402,0.0012757406,0.0007027127,0.001065872,0.0045296852],"category_scores_gemma":[0.0016018335,0.0003346118,0.0010180634,0.0023624597,0.00041585913,0.0011328112,0.0007874386,0.0021309473,0.0009437388],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016477857,0.00009456439,0.0002116911,0.06352725,0.00040603642,0.00012744303,0.000040612103,0.0002261205,0.0005067214,0.0010482843,0.015515993,0.9181305],"study_design_scores_gemma":[0.00040548708,0.00064175145,0.0050276937,0.0863591,0.003757847,0.0026428509,0.00017722682,0.00042832992,0.0005562695,0.002656171,0.89726186,0.000085368956],"about_ca_topic_score_codex":0.0015530667,"about_ca_topic_score_gemma":0.0040541473,"teacher_disagreement_score":0.0045296852,"about_ca_system_score_codex":0.0004909697,"about_ca_system_score_gemma":0.0011107472,"threshold_uncertainty_score":0.015153289},"labels":[],"label_agreement":null},{"id":"W2958757303","doi":"10.1007/s40265-019-01169-y","title":"Innovations in Oral Therapies for Inflammatory Bowel Disease","year":2019,"lang":"en","type":"review","venue":"Drugs","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":70,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Robarts Clinical Trials; University of Calgary","funders":"","keywords":"Medicine; Inflammatory bowel disease; Ulcerative colitis; Vedolizumab; Infliximab; Drug development; Tofacitinib; Internal medicine; Adverse effect; Pharmacology; Drug; Disease; Rheumatoid arthritis","score_opus":0.023645301406845717,"score_gpt":0.3107230209837264,"score_spread":0.28707771957688066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2958757303","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000043347478,0.9983523,0.00012284334,0.00032129337,0.00040486682,0.0000028349712,0.0000137959205,0.0000062164645,0.00073245104],"genre_scores_gemma":[0.0004495523,0.9976305,0.00025368537,0.00044766278,0.0005421263,0.000006859454,0.0000252655,0.000002421098,0.00064184424],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99969125,0.00007055284,0.00003794316,0.000043119446,0.00012055724,0.000036570855],"domain_scores_gemma":[0.99950576,0.00028365394,0.000061788465,0.000016069751,0.000090531474,0.000042093612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092881883,0.0010950565,0.0021503435,0.001961404,0.00028401572,0.001366153,0.00090471224,0.0013590073,0.0045429626],"category_scores_gemma":[0.0011850557,0.00028902525,0.0006305183,0.0018339439,0.0006921158,0.0014228942,0.0008666806,0.0036311373,0.002357854],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019317158,0.00009793008,0.000099262725,0.012911161,0.00008552225,0.00019133027,0.00003148163,0.00038406646,0.0015719153,0.005710125,0.046653822,0.93207026],"study_design_scores_gemma":[0.00006001667,0.00012921683,0.00032395145,0.0026000212,0.00010986746,0.00058312435,0.000027169115,0.00010138633,0.00029809674,0.002604672,0.9931477,0.000014819637],"about_ca_topic_score_codex":0.00072623417,"about_ca_topic_score_gemma":0.0017187184,"teacher_disagreement_score":0.0045429626,"about_ca_system_score_codex":0.0007132857,"about_ca_system_score_gemma":0.0008729775,"threshold_uncertainty_score":0.015197754},"labels":[],"label_agreement":null},{"id":"W2966058539","doi":"10.1007/s40265-019-01173-2","title":"Pharmacotherapies for the Treatment of Eosinophilic Esophagitis: State of the Art Review","year":2019,"lang":"en","type":"review","venue":"Drugs","topic":"Eosinophilic Esophagitis","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Calgary; Robarts Clinical Trials","funders":"AbbVie; AstraZeneca; Amgen","keywords":"Eosinophilic esophagitis; Mepolizumab; Medicine; Immunology; Omalizumab; Antibody; Eosinophil; Disease; Internal medicine; Asthma; Immunoglobulin E","score_opus":0.061181478543082264,"score_gpt":0.379496866581606,"score_spread":0.3183153880385237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2966058539","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000052955762,0.999539,0.000031012554,0.0000815103,0.00007402554,0.0000031377149,0.000016255393,0.0000032183113,0.00019889332],"genre_scores_gemma":[0.00037886505,0.9992348,0.00007836652,0.00011150797,0.00007878797,0.0000036329286,0.0000145606655,4.9718295e-7,0.000099059274],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997882,0.000040656738,0.000045915593,0.000041816114,0.00006478849,0.00001855407],"domain_scores_gemma":[0.9990908,0.0005964796,0.00015222897,0.0000139028025,0.00011104802,0.00003556549],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055113115,0.0008713914,0.0023198635,0.002205899,0.00025688982,0.0011704112,0.0010665699,0.001185675,0.0050385776],"category_scores_gemma":[0.0013051082,0.00025279337,0.001082128,0.0020542538,0.0003202375,0.00088201993,0.00053566514,0.0015215585,0.0010024217],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019658172,0.00009528753,0.00017125081,0.080789685,0.00044385227,0.00015068548,0.000041586612,0.00033906594,0.0010389894,0.001275037,0.021650208,0.8938078],"study_design_scores_gemma":[0.0001750712,0.0004492996,0.0023087524,0.0487042,0.0032323592,0.002129556,0.00013176081,0.00033141603,0.0006106344,0.0019920168,0.9398794,0.000055541954],"about_ca_topic_score_codex":0.0013264196,"about_ca_topic_score_gemma":0.0033005378,"teacher_disagreement_score":0.0050385776,"about_ca_system_score_codex":0.000399731,"about_ca_system_score_gemma":0.0011431456,"threshold_uncertainty_score":0.016855776},"labels":[],"label_agreement":null},{"id":"W2968953218","doi":"10.1007/s40265-019-01180-3","title":"Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Update on Molecular Epidemiology and Treatment Options","year":2019,"lang":"en","type":"review","venue":"Drugs","topic":"Antibiotic Resistance in Bacteria","field":"Biochemistry, Genetics and Molecular Biology","cited_by":327,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Calgary Laboratory Services","keywords":"Enterobacteriaceae; Medicine; Epidemiology; Molecular epidemiology; Pharmacotherapy; Intensive care medicine; Broad spectrum; Microbiology; Internal medicine; Biology; Genetics; Escherichia coli; Genotype","score_opus":0.03453368455422437,"score_gpt":0.32819340572051364,"score_spread":0.29365972116628924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2968953218","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005620997,0.9989942,0.00008053335,0.00028556125,0.00019006578,0.0000024261005,0.00002500223,0.000006324376,0.00035972425],"genre_scores_gemma":[0.0003247767,0.9987532,0.00018954376,0.00028982924,0.00021242778,0.0000032125197,0.00004227309,0.0000011794015,0.00018362522],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997075,0.00005565727,0.000057148347,0.000043812688,0.00010425612,0.00003147297],"domain_scores_gemma":[0.9992549,0.00037450492,0.000115555085,0.000016456104,0.0001810863,0.000057557972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007496057,0.00081492943,0.0018255163,0.0018584331,0.00018019475,0.001284513,0.00086192257,0.0010636876,0.003716486],"category_scores_gemma":[0.001449335,0.00025500692,0.00071305904,0.00191164,0.0003693494,0.0012780585,0.00066341116,0.0018735166,0.0013626277],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016028242,0.000060417566,0.00028530922,0.019102894,0.00012087414,0.00016345258,0.000027384267,0.00023850625,0.00091324904,0.001260901,0.04163508,0.93603176],"study_design_scores_gemma":[0.00006078219,0.00016156558,0.001254129,0.008413771,0.000379235,0.0013995378,0.00006298085,0.00015533419,0.00029047075,0.0012203517,0.9865737,0.000028033752],"about_ca_topic_score_codex":0.0011780052,"about_ca_topic_score_gemma":0.0025136457,"teacher_disagreement_score":0.003716486,"about_ca_system_score_codex":0.00056019315,"about_ca_system_score_gemma":0.0013847694,"threshold_uncertainty_score":0.012432933},"labels":[],"label_agreement":null},{"id":"W2991537174","doi":"10.1007/s40265-019-01227-5","title":"Treating Persistent Pain After Breast Cancer Surgery","year":2019,"lang":"en","type":"review","venue":"Drugs","topic":"Anesthesia and Pain Management","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Toronto General Hospital; St. Michael's Hospital; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Breast cancer; Perioperative; Complication; Cancer pain; Cancer; Neuropathic pain; Surgery; Breast surgery; Anesthesia; Internal medicine","score_opus":0.0407063059616526,"score_gpt":0.30341835160262703,"score_spread":0.26271204564097445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991537174","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011018221,0.99909127,0.00003726657,0.00010404421,0.00012335445,0.000006457119,0.000016335025,0.000003876295,0.0005072342],"genre_scores_gemma":[0.0009208001,0.99821657,0.000110336216,0.0002890609,0.00012408593,0.0000083939,0.000020477371,0.0000011473675,0.00030906923],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999739,0.00005549609,0.00006597694,0.00003823667,0.00007451886,0.000026709768],"domain_scores_gemma":[0.9993781,0.00034880152,0.00014976635,0.000011680608,0.0000782705,0.000033345415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006323306,0.0008535685,0.0018816484,0.0022798793,0.00022386927,0.0010480658,0.0007618542,0.001037102,0.0057784216],"category_scores_gemma":[0.0014763563,0.00030876903,0.0008755519,0.0020742954,0.00037788603,0.0009248481,0.0006526763,0.0017116804,0.0010159812],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022961797,0.000100412784,0.00015276307,0.06906232,0.00038813148,0.00010176699,0.00004766526,0.00019323865,0.0007177797,0.00064101943,0.016118556,0.91224664],"study_design_scores_gemma":[0.00062252645,0.0009943146,0.0044076135,0.059043635,0.004083263,0.0022539396,0.0002129276,0.0003160288,0.0007783993,0.00155651,0.9256633,0.00006747759],"about_ca_topic_score_codex":0.0018598753,"about_ca_topic_score_gemma":0.0062997,"teacher_disagreement_score":0.0057784216,"about_ca_system_score_codex":0.00056418194,"about_ca_system_score_gemma":0.0011656892,"threshold_uncertainty_score":0.0193308},"labels":[],"label_agreement":null},{"id":"W3001005446","doi":"10.1007/s40265-020-01257-4","title":"Omadacycline: A Novel Oral and Intravenous Aminomethylcycline Antibiotic Agent","year":2020,"lang":"en","type":"review","venue":"Drugs","topic":"Antibiotic Resistance in Bacteria","field":"Biochemistry, Genetics and Molecular Biology","cited_by":130,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Manitoba Health; University of Manitoba","funders":"","keywords":"Bioavailability; Pharmacokinetics; Cmax; Pharmacology; Medicine; Oral administration; Tetracycline; Minocycline; Efflux; Chemistry; Antibiotics; Biochemistry","score_opus":0.02617763870321694,"score_gpt":0.3066871564532287,"score_spread":0.28050951775001176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3001005446","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00028484061,0.9977368,0.00020342997,0.00018754326,0.00023631509,0.0000066198686,0.000025700425,0.000010492575,0.0013082497],"genre_scores_gemma":[0.0019590685,0.99558485,0.0004167511,0.0002828059,0.00022606271,0.000011287968,0.00005318121,0.0000028653249,0.0014631691],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99989974,0.000016229405,0.000013476686,0.000020233083,0.00003584979,0.000014435821],"domain_scores_gemma":[0.9998772,0.000051045932,0.000025506164,0.0000036122274,0.000024354382,0.000018280974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024833946,0.0007581963,0.0010545463,0.0013233608,0.00017123879,0.00068657764,0.0005918369,0.00073574105,0.002433414],"category_scores_gemma":[0.00038772292,0.00016739445,0.0002803764,0.0012960919,0.0003044478,0.00062536425,0.00042171133,0.0017668491,0.0012008179],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016097799,0.00009142922,0.000094451585,0.006811971,0.000051660714,0.00021031257,0.000024421744,0.00029171875,0.0033902696,0.0019450688,0.020166093,0.9667615],"study_design_scores_gemma":[0.000058774895,0.00023666909,0.0007275194,0.0015256967,0.00012552727,0.0015615581,0.000027672626,0.00015101071,0.001661434,0.0008466955,0.9930575,0.000019917366],"about_ca_topic_score_codex":0.0008942875,"about_ca_topic_score_gemma":0.0022688804,"teacher_disagreement_score":0.002433414,"about_ca_system_score_codex":0.00046991534,"about_ca_system_score_gemma":0.0006636284,"threshold_uncertainty_score":0.008140624},"labels":[],"label_agreement":null},{"id":"W3001438287","doi":"10.1007/s40265-019-01245-3","title":"Clinical Considerations When Initiating and Titrating Insulin Degludec/Liraglutide (IDegLira) in People with Type 2 Diabetes","year":2020,"lang":"en","type":"review","venue":"Drugs","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Family Medicine; Western University","funders":"Novo Nordisk; Novo Nordisk Fonden; Steno Diabetes Center Copenhagen","keywords":"Liraglutide; Medicine; Insulin degludec; Hypoglycemia; Type 2 diabetes; Regimen; Glycemic; Insulin; Glucagon-like peptide 1 receptor; Diabetes mellitus; Intensive care medicine; Internal medicine; Endocrinology; Insulin glargine; Agonist","score_opus":0.057567502740075806,"score_gpt":0.34438592346030833,"score_spread":0.2868184207202325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3001438287","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018026257,0.9616321,0.0014340357,0.02866608,0.0023020387,0.00011530485,0.00008301161,0.000075990065,0.0038887507],"genre_scores_gemma":[0.025598712,0.899852,0.008413835,0.05664245,0.006977347,0.00045507232,0.0001439106,0.000056817436,0.0018599355],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99107975,0.0041974573,0.0026713698,0.00044072725,0.0014052222,0.0002054013],"domain_scores_gemma":[0.9796071,0.015310923,0.0026215955,0.00018429181,0.0017962647,0.0004798033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008496837,0.000669748,0.0028705348,0.0010415879,0.0006530066,0.003611503,0.0014280201,0.0045370706,0.0020191579],"category_scores_gemma":[0.030732552,0.0006127876,0.0024011447,0.0011541063,0.0011136476,0.0040375637,0.00095762464,0.00531248,0.0011259366],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014085257,0.000108078704,0.0028557307,0.036135316,0.0007538849,0.0029229578,0.001033241,0.00034472797,0.0009109854,0.0018352305,0.07924311,0.87244815],"study_design_scores_gemma":[0.0019180118,0.001383667,0.011008308,0.11898185,0.0046321964,0.018180473,0.0036613434,0.00064942363,0.00169701,0.011195963,0.8263941,0.00029769947],"about_ca_topic_score_codex":0.002642736,"about_ca_topic_score_gemma":0.006021783,"teacher_disagreement_score":0.008496837,"about_ca_system_score_codex":0.0012729337,"about_ca_system_score_gemma":0.0028033853,"threshold_uncertainty_score":0.04493612},"labels":[],"label_agreement":null},{"id":"W3003887243","doi":"10.1007/s40265-020-01256-5","title":"The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases","year":2020,"lang":"en","type":"review","venue":"Drugs","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":101,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Celltrion; Celltrion Healthcare","keywords":"Biosimilar; Medicine; Immune system; Pharmacotherapy; Intensive care medicine; Pharmacology; Immunology; Internal medicine","score_opus":0.021357099851742094,"score_gpt":0.3110286671542852,"score_spread":0.28967156730254306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3003887243","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015812296,0.32411316,0.04025241,0.52087504,0.0046897754,0.000096192285,0.00023578318,0.00040551487,0.09351979],"genre_scores_gemma":[0.4657699,0.31323805,0.07583292,0.111638226,0.013027554,0.0002617217,0.00035614963,0.00045605347,0.019419365],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99224335,0.003779214,0.0003572329,0.0006163828,0.0024946288,0.0005091661],"domain_scores_gemma":[0.9883959,0.00497917,0.0010503938,0.00071319466,0.002428457,0.0024327568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016372833,0.00078889675,0.00084127125,0.0015195315,0.0015434853,0.009261877,0.001285341,0.0054858862,0.010425661],"category_scores_gemma":[0.020437077,0.0003741097,0.0009062138,0.0012435077,0.0035334965,0.013939421,0.0041948794,0.0049861884,0.00281938],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045690293,0.00023241114,0.0017196769,0.0019268196,0.00016061615,0.0003921736,0.0009939044,0.0030222517,0.0037162576,0.3464881,0.0777606,0.56313014],"study_design_scores_gemma":[0.00010601811,0.00041244854,0.0013307128,0.0022414988,0.00010952504,0.0007256149,0.00078956236,0.001920196,0.0015502314,0.3450296,0.64571184,0.00007266859],"about_ca_topic_score_codex":0.0011810141,"about_ca_topic_score_gemma":0.0014585943,"teacher_disagreement_score":0.016372833,"about_ca_system_score_codex":0.0042626364,"about_ca_system_score_gemma":0.0078089256,"threshold_uncertainty_score":0.08658886},"labels":[],"label_agreement":null},{"id":"W3014098355","doi":"10.1007/s40265-020-01297-w","title":"Eculizumab: A Review in Neuromyelitis Optica Spectrum Disorder","year":2020,"lang":"en","type":"review","venue":"Drugs","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Eculizumab; Medicine; Neuromyelitis optica; Spectrum disorder; Internal medicine; Intensive care medicine; Pediatrics; Immunology; Antibody; Complement system; Psychiatry","score_opus":0.06214246099619297,"score_gpt":0.3835801699538946,"score_spread":0.32143770895770163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014098355","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006390666,0.9996107,0.000019397377,0.000055404205,0.00005901151,0.0000035389553,0.0000095958985,0.0000026536734,0.00017581462],"genre_scores_gemma":[0.0006315797,0.99891853,0.000108493514,0.00011513587,0.000051810155,0.000007747979,0.000019397574,8.016841e-7,0.00014653183],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997539,0.000056722147,0.00006566168,0.000040204955,0.00006615397,0.00001735897],"domain_scores_gemma":[0.9994955,0.000291438,0.00010427646,0.000011047289,0.0000709024,0.000026886328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076723244,0.00089103886,0.0016220454,0.0032140375,0.00028174996,0.0009804743,0.0008275171,0.0009326418,0.0031932585],"category_scores_gemma":[0.0010653706,0.0002679024,0.00089163886,0.00400227,0.00033790147,0.0010013368,0.0005811069,0.0010952146,0.000850229],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001491344,0.000046671663,0.00014148567,0.08724467,0.00022507564,0.00014223652,0.000078339726,0.00018863918,0.0007434864,0.001191527,0.020745233,0.88910353],"study_design_scores_gemma":[0.00011266456,0.00026823534,0.002534143,0.059918106,0.0014104765,0.0018909258,0.00013695771,0.00013164412,0.00046511227,0.0012271232,0.9318691,0.000035526104],"about_ca_topic_score_codex":0.0015745447,"about_ca_topic_score_gemma":0.0031502454,"teacher_disagreement_score":0.0032140375,"about_ca_system_score_codex":0.00052176934,"about_ca_system_score_gemma":0.0012160178,"threshold_uncertainty_score":0.010682523},"labels":[],"label_agreement":null},{"id":"W3016167110","doi":"10.1007/s40265-020-01296-x","title":"Are Generic Drugs Used in Cardiology as Effective and Safe as their Brand-name Counterparts? A Systematic Review and Meta-analysis","year":2020,"lang":"en","type":"review","venue":"Drugs","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Trois-Rivières; McGill University; Université Laval; Institut National de Santé Publique du Québec","funders":"Université du Québec à Trois-Rivières","keywords":"Medicine; Meta-analysis; Confidence interval; MEDLINE; Brand names; Subgroup analysis; Systematic review; Internal medicine; Relative risk; Randomized controlled trial; Emergency medicine","score_opus":0.10560598533298951,"score_gpt":0.34000375411428563,"score_spread":0.23439776878129612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016167110","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011632901,0.9980028,0.0001927487,0.00015123321,0.00011229966,0.000058611946,0.00017499395,0.0000055926707,0.000138439],"genre_scores_gemma":[0.055843156,0.9410198,0.0010491451,0.0011416142,0.00028129903,0.00017329668,0.00024619573,0.000014221193,0.00023125391],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99280894,0.002917305,0.0024546406,0.00077924033,0.0008115872,0.00022836463],"domain_scores_gemma":[0.9799289,0.014200673,0.0043245493,0.00055288017,0.0008007237,0.00019220941],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011865531,0.0015417204,0.013870292,0.0042804577,0.00034802116,0.003377808,0.0016254289,0.0025629385,0.005475288],"category_scores_gemma":[0.030778479,0.00114839,0.02006267,0.004862719,0.0009597007,0.0024146491,0.0013727027,0.0022424967,0.00046111442],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021234239,0.000031964857,0.0025441714,0.54640007,0.41167143,0.00010162548,0.0000756846,0.00030950247,0.00021002398,0.00040191473,0.0011233994,0.035006788],"study_design_scores_gemma":[0.0013008185,0.00024129778,0.0042098775,0.060158905,0.9272232,0.00014206204,0.00009245811,0.00012503284,0.0001266804,0.00060157466,0.0057441182,0.000033970904],"about_ca_topic_score_codex":0.004515739,"about_ca_topic_score_gemma":0.0149667775,"teacher_disagreement_score":0.013870292,"about_ca_system_score_codex":0.0022071053,"about_ca_system_score_gemma":0.002937445,"threshold_uncertainty_score":0.06275165},"labels":[],"label_agreement":null},{"id":"W3031883039","doi":"10.1007/s40265-020-01333-9","title":"Correction to: The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases","year":2020,"lang":"en","type":"erratum","venue":"Drugs","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Biosimilar; Medicine; Immune system; Pharmacotherapy; Intensive care medicine; Immunology; Internal medicine","score_opus":0.010567851533116044,"score_gpt":0.26147632977104385,"score_spread":0.2509084782379278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3031883039","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000043417615,0.0009714994,0.00023189638,0.08831278,0.9078589,0.000013963446,0.0003527113,0.00011903264,0.002095718],"genre_scores_gemma":[0.0039137467,0.0076537468,0.0027056832,0.2536099,0.59417033,0.00011909981,0.0007875449,0.0006892301,0.13635069],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9943386,0.0010116391,0.00090525567,0.00064072973,0.0025923213,0.0005114987],"domain_scores_gemma":[0.9655267,0.010114366,0.001682814,0.0012778754,0.01940233,0.0019958972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045821713,0.0022182295,0.0020890038,0.002938209,0.0029922868,0.005608911,0.0031028131,0.013767932,0.035263438],"category_scores_gemma":[0.057661824,0.0011579556,0.0018682567,0.0017142483,0.0030789215,0.002698339,0.0016144494,0.020111669,0.030648746],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017983375,0.0000036418178,0.000020355092,0.000060100974,0.000005283686,0.00010367399,0.0000091899865,0.000018415636,0.000017824228,0.00035049187,0.9968929,0.0025001424],"study_design_scores_gemma":[0.00004590969,0.0000137699635,0.00027447662,0.00028689098,0.00002315076,0.00039893837,0.000041823216,0.00013862202,0.00016728665,0.0013491871,0.99723536,0.000024580879],"about_ca_topic_score_codex":0.019427685,"about_ca_topic_score_gemma":0.02818916,"teacher_disagreement_score":0.035263438,"about_ca_system_score_codex":0.0055124573,"about_ca_system_score_gemma":0.008504887,"threshold_uncertainty_score":0.11796796},"labels":[],"label_agreement":null},{"id":"W3036195168","doi":"10.1007/s40265-020-01323-x","title":"Dabigatran Dual Therapy vs Warfarin Triple Therapy Post-Percutaneous Coronary Intervention in Patients with Atrial Fibrillation With/Without a Proton Pump Inhibitor: A Pre-Specified Analysis of the RE-DUAL PCI Trial","year":2020,"lang":"en","type":"article","venue":"Drugs","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Boehringer Ingelheim","keywords":"Medicine; Conventional PCI; Percutaneous coronary intervention; Atrial fibrillation; Warfarin; Dabigatran; Cardiology; Pharmacotherapy; Internal medicine; Randomized controlled trial; Myocardial infarction","score_opus":0.035380281358436835,"score_gpt":0.29127684671531356,"score_spread":0.2558965653568767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3036195168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844951,0.009960001,0.00038413014,0.00074655,0.00035703255,0.0007091835,0.0013238412,0.000037011698,0.0019872035],"genre_scores_gemma":[0.9929456,0.0019467948,0.0005171978,0.0005356414,0.00039107027,0.000607231,0.0018627442,0.000011721428,0.0011820392],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99855095,0.0008329863,0.00013141583,0.0002364752,0.00008824777,0.00015996471],"domain_scores_gemma":[0.9982389,0.0006191508,0.0004660115,0.0002026967,0.00010463986,0.00036861975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002401235,0.0016071873,0.003167567,0.0002742376,0.00028756136,0.0016834507,0.0005706053,0.0012168208,0.0037078867],"category_scores_gemma":[0.0030948073,0.00051843614,0.004589629,0.00035045814,0.00046622078,0.0007657523,0.0005669883,0.0027701685,0.0005284293],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97776175,0.0010615941,0.0060044625,0.0006420183,0.0068045,0.000060702834,0.00004087419,0.00035599666,0.0009814022,0.0001082687,0.0005288837,0.0056494917],"study_design_scores_gemma":[0.87534785,0.057551794,0.041440945,0.0002147292,0.020260172,0.00022834624,0.00012707672,0.0017118107,0.00073156075,0.00060663087,0.0017105239,0.00006849485],"about_ca_topic_score_codex":0.0008433215,"about_ca_topic_score_gemma":0.0018334857,"teacher_disagreement_score":0.0037078867,"about_ca_system_score_codex":0.00055031205,"about_ca_system_score_gemma":0.0006740855,"threshold_uncertainty_score":0.012699068},"labels":[],"label_agreement":null},{"id":"W3037306288","doi":"10.1007/s40265-020-01348-2","title":"Ripretinib: First Approval","year":2020,"lang":"en","type":"review","venue":"Drugs","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"PDGFRA; Medicine; GiST; Imatinib; PDGFRB; Tyrosine kinase; Receptor tyrosine kinase; Tyrosine-kinase inhibitor; Platelet-derived growth factor receptor; Imatinib mesylate; Sunitinib; Targeted therapy; Cancer research; Growth factor receptor; Pharmacology; Oncology; Internal medicine; Cancer; Stromal cell; Receptor; Growth factor; Biology","score_opus":0.06558843503017232,"score_gpt":0.3746732657524908,"score_spread":0.3090848307223185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3037306288","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010857246,0.95555127,0.0004268766,0.0024893675,0.002309128,0.00012407484,0.0012621275,0.00017998478,0.036571465],"genre_scores_gemma":[0.009543313,0.9566363,0.00089880417,0.0051728925,0.0011908499,0.0001494657,0.0021677713,0.000037694637,0.024202859],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997782,0.00004014,0.000025571977,0.00003404819,0.00009313057,0.00002886151],"domain_scores_gemma":[0.9997987,0.00004598198,0.00004232497,0.0000060307007,0.00006928441,0.000037710975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044363886,0.0007362282,0.0008745739,0.0010998641,0.0002428306,0.0011740403,0.0007319364,0.0012220984,0.026111031],"category_scores_gemma":[0.00087313383,0.00018096839,0.0008761203,0.00079499284,0.00023752521,0.00079228013,0.00044854984,0.0019310437,0.010959872],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003615441,0.00007854511,0.000093497096,0.010297392,0.000099662764,0.0002822154,0.000034943147,0.00016623846,0.0022246172,0.0028958446,0.19294183,0.79052377],"study_design_scores_gemma":[0.00023790667,0.00015216344,0.00028943204,0.0021867007,0.00007415479,0.0007775658,0.000010268031,0.00004327395,0.0004690351,0.00055262784,0.9951971,0.000009636433],"about_ca_topic_score_codex":0.00076404255,"about_ca_topic_score_gemma":0.0023580212,"teacher_disagreement_score":0.026111031,"about_ca_system_score_codex":0.00063564087,"about_ca_system_score_gemma":0.0010727027,"threshold_uncertainty_score":0.08735013},"labels":[],"label_agreement":null},{"id":"W3037838896","doi":"10.1007/s40265-020-01338-4","title":"Strategies for the Prevention and Treatment of Iatrogenic Withdrawal from Opioids and Benzodiazepines in Critically Ill Neonates, Children and Adults: A Systematic Review of Clinical Studies","year":2020,"lang":"en","type":"review","venue":"Drugs","topic":"Intensive Care Unit Cognitive Disorders","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; Centre Hospitalier Universitaire Sainte-Justine; University of Toronto; Mount Sinai Hospital; Université de Montréal; Hôpital du Sacré-Cœur de Montréal; Sinai Health System; McGill University Health Centre","funders":"Université de Montréal","keywords":"Medicine; Psychological intervention; Methadone; Population; Clonidine; Intensive care medicine; MEDLINE; Buprenorphine; CINAHL; Randomized controlled trial; Systematic review; Data extraction; Emergency medicine; Opioid; Psychiatry; Anesthesia; Internal medicine","score_opus":0.03910036800117463,"score_gpt":0.39396514750711337,"score_spread":0.35486477950593875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3037838896","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002192495,0.99945706,0.00006379813,0.000059185146,0.00003515856,0.00004463803,0.000057388836,0.0000024815452,0.000060918814],"genre_scores_gemma":[0.002946711,0.9963863,0.0003654677,0.00014311362,0.000027887963,0.00005560807,0.00004221081,0.0000011477272,0.000031490792],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9973858,0.0007331659,0.0010920712,0.00024550885,0.00045297935,0.00009051003],"domain_scores_gemma":[0.99154985,0.006066027,0.0017115783,0.00009619598,0.00047237694,0.000103997976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004255086,0.0016618851,0.0076766224,0.005706595,0.00043856766,0.0020321016,0.001895228,0.0020066127,0.0041330103],"category_scores_gemma":[0.015455164,0.0008206454,0.008365373,0.004876572,0.00064546865,0.0017668845,0.0012860715,0.0014966612,0.0002952216],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004379547,0.000051535168,0.000564028,0.8572629,0.013762542,0.000078338344,0.0001009025,0.00019976066,0.00019585977,0.00027996278,0.0013943441,0.12567194],"study_design_scores_gemma":[0.0011034532,0.0005055811,0.005585851,0.79488695,0.15714887,0.00055104034,0.0003441351,0.00023415843,0.00031329616,0.0007796766,0.038460575,0.00008645234],"about_ca_topic_score_codex":0.0065163285,"about_ca_topic_score_gemma":0.019962512,"teacher_disagreement_score":0.0076766224,"about_ca_system_score_codex":0.0015773342,"about_ca_system_score_gemma":0.004533249,"threshold_uncertainty_score":0.022503316},"labels":[],"label_agreement":null},{"id":"W3049193001","doi":"10.1007/s40265-020-01380-2","title":"Satralizumab: First Approval","year":2020,"lang":"en","type":"review","venue":"Drugs","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Neuromyelitis optica; Drug approval; Drug development; Clinical trial; Pediatrics; Intensive care medicine; Internal medicine; Pharmacology; Immunology; Drug; Antibody","score_opus":0.05343999566156591,"score_gpt":0.35716890198382145,"score_spread":0.3037289063222555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3049193001","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025019334,0.9320419,0.0010039567,0.0028989739,0.003125282,0.00021065547,0.002157322,0.0003732838,0.055686716],"genre_scores_gemma":[0.030551102,0.8971569,0.002381279,0.005566128,0.0019924033,0.00026377378,0.005853152,0.00007456433,0.05616068],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998149,0.00004019181,0.0000189739,0.000028315062,0.00006874871,0.00002887584],"domain_scores_gemma":[0.99982435,0.000036628502,0.000040776602,0.0000068539835,0.00005701821,0.000034502817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043026538,0.00058783847,0.00051637,0.0006877423,0.00021329228,0.0009930658,0.00054465514,0.0012866717,0.027419196],"category_scores_gemma":[0.0006523162,0.00017166989,0.0005949654,0.00050421624,0.00021870827,0.00064382487,0.0004856252,0.0016454385,0.016121076],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040626692,0.000098979835,0.0001562786,0.0057102335,0.00005717254,0.0003428423,0.00004466075,0.00013099924,0.0039541298,0.0028966647,0.15697716,0.8292245],"study_design_scores_gemma":[0.00026190266,0.000198647,0.00034073988,0.0010457275,0.00004676752,0.0011666124,0.000009909558,0.00004048136,0.00070793816,0.00034875612,0.995826,0.0000066126186],"about_ca_topic_score_codex":0.00055853504,"about_ca_topic_score_gemma":0.00125299,"teacher_disagreement_score":0.027419196,"about_ca_system_score_codex":0.00033207136,"about_ca_system_score_gemma":0.0010175926,"threshold_uncertainty_score":0.09172642},"labels":[],"label_agreement":null},{"id":"W3082442646","doi":"10.1007/s40265-020-01389-7","title":"Decitabine/Cedazuridine: First Approval","year":2020,"lang":"en","type":"review","venue":"Drugs","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Decitabine; Medicine; Myelodysplastic syndromes; Cytidine deaminase; International Prognostic Scoring System; Internal medicine; Chronic myelomonocytic leukemia; Oncology; Pharmacology; Bone marrow; Immunology","score_opus":0.048028227437345174,"score_gpt":0.3567413463387515,"score_spread":0.3087131189014063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082442646","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.054121163,0.35086197,0.009775426,0.017328812,0.0045583965,0.0015125006,0.012377242,0.0021145097,0.54735],"genre_scores_gemma":[0.30250213,0.2161219,0.014323443,0.011090109,0.0018596966,0.0010562303,0.019122142,0.00029476985,0.4336297],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998466,0.000037866015,0.000010870316,0.000025440351,0.00005238608,0.000026749709],"domain_scores_gemma":[0.9998375,0.000021179267,0.000035267367,0.00000793361,0.000044360317,0.000053690273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038780374,0.0004934443,0.00029841074,0.00042864913,0.00020215931,0.0006105021,0.00039962106,0.000890329,0.02805732],"category_scores_gemma":[0.00047927874,0.00011156433,0.00025878468,0.00031875473,0.0002455127,0.00046876198,0.00038097255,0.0013248868,0.0112514915],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017802827,0.0003206985,0.00053205615,0.0015183091,0.00004180733,0.00054992107,0.000063139705,0.00029894587,0.023173062,0.0072596823,0.12678395,0.837678],"study_design_scores_gemma":[0.00052105833,0.00058301364,0.00096356694,0.00018483227,0.000020423733,0.0010193498,0.000009323792,0.00010838345,0.0041311705,0.0003469731,0.9921063,0.0000056514673],"about_ca_topic_score_codex":0.0005992071,"about_ca_topic_score_gemma":0.0025181966,"teacher_disagreement_score":0.02805732,"about_ca_system_score_codex":0.0006283646,"about_ca_system_score_gemma":0.0007851802,"threshold_uncertainty_score":0.09386104},"labels":[],"label_agreement":null},{"id":"W3090684381","doi":"10.1007/s40265-020-01411-y","title":"Targeting HER2 in Breast Cancer: Latest Developments on Treatment Sequencing and the Introduction of Biosimilars","year":2020,"lang":"en","type":"review","venue":"Drugs","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Trastuzumab; Pertuzumab; Lapatinib; Medicine; Biosimilar; Neratinib; Trastuzumab emtansine; Metastatic breast cancer; Breast cancer; Oncology; Targeted therapy; Internal medicine; Cancer; Pharmacology","score_opus":0.05352402178422109,"score_gpt":0.3772090738336325,"score_spread":0.3236850520494114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3090684381","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000093506904,0.9984402,0.0001613694,0.00047281204,0.00021908201,0.000004492862,0.000021934364,0.0000064307033,0.00058023166],"genre_scores_gemma":[0.00068738905,0.99789447,0.00022871564,0.0005907047,0.00020353781,0.0000060190646,0.000037899572,0.000002217382,0.00034901052],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999627,0.000091751914,0.000045395373,0.000057871894,0.0001376309,0.000040280174],"domain_scores_gemma":[0.9992055,0.00050847256,0.00009408622,0.000014406645,0.00013183185,0.00004569049],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014065123,0.0007728872,0.0016520701,0.0015023198,0.00013733644,0.0011584713,0.00081901613,0.0013842653,0.00467519],"category_scores_gemma":[0.0016249995,0.00022063832,0.00092742953,0.0014577488,0.0004167004,0.0016388858,0.0007108465,0.0025699192,0.001461389],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019109267,0.00006713384,0.00008934835,0.017691648,0.00013892811,0.0001240615,0.000032346805,0.00044208602,0.0015791885,0.005763621,0.027137661,0.94674283],"study_design_scores_gemma":[0.000114023795,0.00022037009,0.0005154674,0.006248644,0.00028744806,0.00066033617,0.000039462997,0.00020892335,0.0005005923,0.0033293872,0.98785317,0.00002226939],"about_ca_topic_score_codex":0.00085345993,"about_ca_topic_score_gemma":0.0019195927,"teacher_disagreement_score":0.00467519,"about_ca_system_score_codex":0.0007067514,"about_ca_system_score_gemma":0.0011150201,"threshold_uncertainty_score":0.01564002},"labels":[],"label_agreement":null},{"id":"W3105434842","doi":"10.1007/s40265-020-01429-2","title":"TRPV1-Targeted Drugs in Development for Human Pain Conditions","year":2020,"lang":"en","type":"review","venue":"Drugs","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":240,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"Crohn's and Colitis Canada; Canada Excellence Research Chairs, Government of Canada","keywords":"TRPV1; Nociceptor; Medicine; Capsaicin; Chronic pain; Transient receptor potential channel; Neuropathic pain; Analgesic; Resiniferatoxin; Nociception; Noxious stimulus; Anesthesia; Pharmacology; Internal medicine; Receptor; Physical therapy","score_opus":0.0501895548727496,"score_gpt":0.36418053419243646,"score_spread":0.31399097931968684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3105434842","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024086288,0.99646807,0.00032361512,0.00020475737,0.0002471254,0.000022650775,0.00008071367,0.00002540076,0.0023866997],"genre_scores_gemma":[0.0010920095,0.9965863,0.00037029982,0.000315862,0.00013231157,0.000019628398,0.00008761364,0.0000032994797,0.0013927582],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998591,0.000019724792,0.000019371339,0.000023792278,0.000051700717,0.000026257032],"domain_scores_gemma":[0.99977297,0.00009981818,0.000050935432,0.0000069035323,0.00004183127,0.00002762161],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005682487,0.0012735928,0.0019006061,0.0020468624,0.00020992813,0.00097341725,0.00085726083,0.0011343256,0.009526323],"category_scores_gemma":[0.00063067547,0.00031911233,0.000710341,0.0016717176,0.0003696679,0.0011650942,0.0006596618,0.0022284894,0.0030928967],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028921163,0.00015931833,0.00007664486,0.024015253,0.00014291654,0.00012320105,0.0000357725,0.00040578237,0.004643537,0.0028864732,0.02653151,0.94069046],"study_design_scores_gemma":[0.00018894166,0.00047117812,0.0007008743,0.0050693178,0.00052184163,0.00070362416,0.000036835074,0.00020306432,0.0014700639,0.0017571466,0.98884624,0.00003088974],"about_ca_topic_score_codex":0.0009497535,"about_ca_topic_score_gemma":0.002693298,"teacher_disagreement_score":0.009526323,"about_ca_system_score_codex":0.0004964411,"about_ca_system_score_gemma":0.0009812583,"threshold_uncertainty_score":0.031868696},"labels":[],"label_agreement":null},{"id":"W3107470768","doi":"10.1007/s40265-020-01443-4","title":"Lefamulin: A Novel Oral and Intravenous Pleuromutilin for the Treatment of Community-Acquired Bacterial Pneumonia","year":2020,"lang":"en","type":"review","venue":"Drugs","topic":"Veterinary medicine and infectious diseases","field":"Veterinary","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences; Manitoba Health; University of Manitoba","funders":"","keywords":"Bacteria; Medicine; Antibiotics; Protein subunit; Chemistry; Microbiology; Pharmacology; Biology; Biochemistry","score_opus":0.19314762598001795,"score_gpt":0.39461964294737595,"score_spread":0.201472016967358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3107470768","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00031117047,0.9985915,0.00012499341,0.0001244444,0.00010624517,0.0000073848482,0.00003029931,0.000008215091,0.0006958335],"genre_scores_gemma":[0.0021713453,0.996222,0.0003068307,0.00030416058,0.00009947521,0.000013308557,0.000074473515,0.0000022243717,0.0008060759],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998821,0.000024698165,0.000017038332,0.000020055277,0.00003819902,0.000017946035],"domain_scores_gemma":[0.9998209,0.000091143644,0.000037680926,0.000003306743,0.000028389752,0.000018619412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036513773,0.0006703138,0.0012853686,0.0014663454,0.00015834726,0.0006804466,0.00072536716,0.0008585942,0.0037893492],"category_scores_gemma":[0.00042979314,0.0001630172,0.0005339424,0.0009552886,0.00025487322,0.0006113965,0.0004521917,0.0016727407,0.0011358173],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020870181,0.00010927202,0.00009582121,0.013326837,0.00014976635,0.00018765141,0.00003253608,0.00027222573,0.0021583524,0.0011903333,0.014622332,0.9676462],"study_design_scores_gemma":[0.00026531506,0.0007313758,0.0014465576,0.006362402,0.0005773778,0.0028288467,0.000057010064,0.00029105303,0.0015392416,0.0009243905,0.98493963,0.00003664556],"about_ca_topic_score_codex":0.00099286,"about_ca_topic_score_gemma":0.0026975728,"teacher_disagreement_score":0.0037893492,"about_ca_system_score_codex":0.0003136305,"about_ca_system_score_gemma":0.00056035677,"threshold_uncertainty_score":0.012676597},"labels":[],"label_agreement":null},{"id":"W3120183576","doi":"10.1007/s40265-020-01460-3","title":"Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel Disease","year":2021,"lang":"en","type":"review","venue":"Drugs","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ministère de l'Agriculture, des Pêcheries et de l'Alimentation; Western University; University of Calgary","funders":"","keywords":"Medicine; Vedolizumab; Primary sclerosing cholangitis; Immunology; Inflammatory bowel disease; Erythema nodosum; Ulcerative colitis; Crohn's disease; Episcleritis; Scleritis; Pyoderma gangrenosum; Pathology; Uveitis; Disease","score_opus":0.015130346059062215,"score_gpt":0.29102815214469335,"score_spread":0.27589780608563114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120183576","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006426761,0.99905413,0.000069898226,0.00014606534,0.00017926723,0.0000019148395,0.00001020629,0.0000036816791,0.00047067332],"genre_scores_gemma":[0.0006322309,0.99808866,0.00017061745,0.00021322668,0.00032066097,0.0000046290124,0.000028719216,0.0000012576786,0.0005398778],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99985254,0.000029666757,0.000022315637,0.000021835565,0.000056492896,0.000017177483],"domain_scores_gemma":[0.9997645,0.00011454836,0.000039093986,0.0000069973107,0.00005049791,0.000024281046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005182963,0.000911405,0.0015191444,0.0017537787,0.00018069008,0.000911181,0.0007147023,0.0009764192,0.0025670803],"category_scores_gemma":[0.00065932237,0.00025027074,0.000423887,0.0016778982,0.00036182592,0.0008321615,0.0005204156,0.0019784577,0.001422361],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018400783,0.000072360344,0.00017988113,0.0099923285,0.00011038897,0.00032081822,0.000024150808,0.00040871452,0.0016530766,0.002450445,0.03900541,0.9455984],"study_design_scores_gemma":[0.00009217999,0.00014012713,0.0010955256,0.0032896106,0.00027219666,0.0018765805,0.000030833966,0.00017171649,0.00042003836,0.0017272256,0.99086446,0.000019423904],"about_ca_topic_score_codex":0.0009691368,"about_ca_topic_score_gemma":0.0021886951,"teacher_disagreement_score":0.0025670803,"about_ca_system_score_codex":0.00052638724,"about_ca_system_score_gemma":0.00063864456,"threshold_uncertainty_score":0.008587718},"labels":[],"label_agreement":null},{"id":"W3132622150","doi":"10.1007/s40265-021-01474-5","title":"MicroRNA Mimics or Inhibitors as Antiviral Therapeutic Approaches Against COVID-19","year":2021,"lang":"en","type":"review","venue":"Drugs","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Natural Sciences and Engineering Research Council of Canada; Institute of Infection and Immunity; Canadian Institutes of Health Research","keywords":"microRNA; Coronavirus; Virus; Medicine; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Virology; Coronavirus disease 2019 (COVID-19); Computational biology; Biology; Disease; Gene; Infectious disease (medical specialty); Genetics","score_opus":0.06736692272377537,"score_gpt":0.3338339917871777,"score_spread":0.26646706906340234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3132622150","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5740905,0.35948917,0.022997065,0.0016532099,0.002376011,0.0012121667,0.0016849294,0.0012255621,0.03527136],"genre_scores_gemma":[0.86202955,0.10328108,0.019429667,0.0011697928,0.00023300754,0.000814192,0.0015461941,0.00009507877,0.011401426],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99986887,0.000033808978,0.000014397415,0.000027301958,0.000032008233,0.000023476889],"domain_scores_gemma":[0.9999639,0.000007922605,0.000009152719,0.0000032654702,0.000006517728,0.000009163462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022799373,0.00041023936,0.00050755526,0.00037919168,0.00016853413,0.0003753334,0.00023673162,0.00043833046,0.0015695109],"category_scores_gemma":[0.00017000755,0.00018394866,0.00044025297,0.0001467427,0.00018123758,0.00029456033,0.00023073386,0.00074356754,0.0005556785],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021320768,0.0004993646,0.0002821885,0.0012966845,0.00011209536,0.00031882667,0.000054828688,0.0009436928,0.8635905,0.0025420194,0.0024907372,0.125737],"study_design_scores_gemma":[0.0013396422,0.011003293,0.003379389,0.00023508357,0.00040717793,0.0015317188,0.00006290326,0.004879798,0.80780643,0.0012908222,0.1679834,0.00008035641],"about_ca_topic_score_codex":0.00017125496,"about_ca_topic_score_gemma":0.00051419047,"teacher_disagreement_score":0.0015695109,"about_ca_system_score_codex":0.00025881207,"about_ca_system_score_gemma":0.0002277126,"threshold_uncertainty_score":0.0052505136},"labels":[],"label_agreement":null},{"id":"W3182349977","doi":"10.1007/s40265-021-01557-3","title":"Pharmacokinetics of Commonly Used Antimicrobials in Critically Ill Adults During Extracorporeal Membrane Oxygenation: A Systematic Review","year":2021,"lang":"en","type":"review","venue":"Drugs","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Centre Hospitalier de l’Université de Montréal; Hôpital du Sacré-Cœur de Montréal; Ottawa Hospital; Montreal Heart Institute; University of Ottawa; Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Dosing; Extracorporeal membrane oxygenation; Intensive care medicine; Antimicrobial; Observational study; Pharmacodynamics; Pharmacokinetics; Pharmacotherapy; Critically ill; Pharmacology; Internal medicine","score_opus":0.030081681397663027,"score_gpt":0.353210350668757,"score_spread":0.32312866927109396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3182349977","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000802163,0.9988153,0.00005689997,0.000044654866,0.000037472433,0.000038932365,0.00012891379,0.0000033750187,0.00007238115],"genre_scores_gemma":[0.010338855,0.9889021,0.00028100892,0.00024653433,0.000043202504,0.000052194726,0.00009022088,0.0000026173807,0.000043340744],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99739057,0.00054132304,0.0012474176,0.00029954303,0.00042014694,0.00010106622],"domain_scores_gemma":[0.9913789,0.0056351493,0.0022903902,0.00009640475,0.0004897425,0.00010942941],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002566426,0.0012486767,0.0071333037,0.0041206055,0.00029161936,0.0019402899,0.0012685492,0.0017008011,0.003270911],"category_scores_gemma":[0.012511521,0.00074819085,0.009219535,0.0052371575,0.0005500559,0.0016076227,0.0009511522,0.0014390416,0.00023120886],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060411444,0.000034791512,0.0014873059,0.9272272,0.0278924,0.00011333548,0.00010559999,0.00017320667,0.00026876605,0.00012692946,0.0013242415,0.040642213],"study_design_scores_gemma":[0.0013040804,0.0006876685,0.01634274,0.5541861,0.39659622,0.0009453918,0.00035181837,0.00025854696,0.0004490163,0.00038841116,0.028357673,0.00013221],"about_ca_topic_score_codex":0.005636005,"about_ca_topic_score_gemma":0.017335093,"teacher_disagreement_score":0.0071333037,"about_ca_system_score_codex":0.0013759414,"about_ca_system_score_gemma":0.0036760527,"threshold_uncertainty_score":0.0135727525},"labels":[],"label_agreement":null},{"id":"W3190984048","doi":"10.2165/00003495-200262050-00004","title":"Fetal Pharmacotherapy","year":2002,"lang":"en","type":"review","venue":"Drugs","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cochrane; Hospital for Sick Children; Mount Sinai Hospital; SickKids Foundation","funders":"National Institutes of Health","keywords":"Medicine; Pharmacotherapy; Fetus; Pregnancy; Intensive care medicine; Modalities; Toxoplasmosis; Obstetrics; Pediatrics; Immunology; Psychiatry","score_opus":0.0823380204129916,"score_gpt":0.4167268515802221,"score_spread":0.3343888311672305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3190984048","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00035614797,0.99280894,0.0002115418,0.0004261954,0.00027495532,0.000012842724,0.00004756571,0.000016413926,0.005845301],"genre_scores_gemma":[0.0029614775,0.9909327,0.0004187785,0.00061774574,0.00032018367,0.000016314647,0.00006511219,0.0000037577654,0.004663926],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997873,0.00005857161,0.000034707333,0.00003573769,0.00006633059,0.00001732832],"domain_scores_gemma":[0.9996991,0.0001524087,0.000068148576,0.000016315698,0.00004096864,0.000023017492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031919352,0.0008433994,0.0011751793,0.002333004,0.00026514687,0.00081452384,0.00052516646,0.0009839367,0.010315332],"category_scores_gemma":[0.00091594533,0.00022989961,0.0004168345,0.0016125215,0.00039173677,0.0007738762,0.0006487188,0.0013328278,0.0026304366],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010522738,0.000074975826,0.00018686068,0.007822104,0.00006449393,0.0004676389,0.00003894505,0.00009673139,0.0011056863,0.0012223324,0.016809711,0.9720053],"study_design_scores_gemma":[0.00008637091,0.00025105264,0.0021638644,0.0057345997,0.00034247234,0.0061876173,0.000063636064,0.00009456866,0.001381138,0.0008592733,0.98281777,0.000017699635],"about_ca_topic_score_codex":0.0013056061,"about_ca_topic_score_gemma":0.0031524925,"teacher_disagreement_score":0.010315332,"about_ca_system_score_codex":0.00042197053,"about_ca_system_score_gemma":0.0009823106,"threshold_uncertainty_score":0.03450823},"labels":[],"label_agreement":null},{"id":"W3194275796","doi":"10.1007/s40265-021-01581-3","title":"Reply to Zhang and Zhu “MicroRNA Mimics or Inhibitors as Antiviral Therapeutic Approaches Against COVID-19”","year":2021,"lang":"en","type":"letter","venue":"Drugs","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Coronavirus disease 2019 (COVID-19); Medicine; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Zhàng; microRNA; Pharmacotherapy; Virology; Pharmacology; Antiviral drug; Antiviral therapy; Drug; Virus; Internal medicine; Biology; Disease; Infectious disease (medical specialty)","score_opus":0.03243220776557968,"score_gpt":0.26826948033941367,"score_spread":0.235837272573834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3194275796","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002792361,0.002768021,0.00012121362,0.96494985,0.030612193,0.000015831694,0.000052586678,0.000023228687,0.0011778363],"genre_scores_gemma":[0.001688973,0.0009843132,0.00009966804,0.97203946,0.021268655,0.000043107004,0.000019490832,0.0000143971265,0.0038419557],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.996452,0.00081825344,0.00037969922,0.0005529525,0.0011343501,0.0006628264],"domain_scores_gemma":[0.9940427,0.0035092288,0.00051008846,0.00014353321,0.00084684155,0.0009476472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042344937,0.0012533212,0.0018689842,0.0007861977,0.0044147656,0.004834149,0.002355641,0.082344756,0.005021474],"category_scores_gemma":[0.02026306,0.0013424795,0.0014829597,0.00068372226,0.0030725438,0.0037787957,0.0026344552,0.049667306,0.0046749217],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011285923,0.000023862249,0.00020864328,0.00004688016,0.000023796529,0.00072045735,0.000085941676,0.000047384117,0.00023417937,0.0020339251,0.9921153,0.0043466603],"study_design_scores_gemma":[0.00032735366,0.00013246229,0.0010288965,0.00022762679,0.000082941406,0.0009648891,0.00033002684,0.0004954153,0.0006979896,0.010248248,0.98535025,0.000113961374],"about_ca_topic_score_codex":0.0046681147,"about_ca_topic_score_gemma":0.00779273,"teacher_disagreement_score":0.082344756,"about_ca_system_score_codex":0.0045456584,"about_ca_system_score_gemma":0.0038199665,"threshold_uncertainty_score":0.032981217},"labels":[],"label_agreement":null},{"id":"W3195782509","doi":"10.1007/s40265-021-01596-w","title":"Correction to: Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel Disease","year":2021,"lang":"en","type":"erratum","venue":"Drugs","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ministère de l'Agriculture, des Pêcheries et de l'Alimentation; Western University; University of Calgary","funders":"","keywords":"Vedolizumab; Medicine; Inflammatory bowel disease; Pharmacotherapy; Internal medicine; Gastroenterology; Dermatology; Disease","score_opus":0.005440132270510036,"score_gpt":0.2369808581589856,"score_spread":0.23154072588847555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3195782509","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007050622,0.001975678,0.00021665853,0.032129873,0.9640057,0.0000109219,0.00022010253,0.00006519665,0.0013052985],"genre_scores_gemma":[0.006272709,0.012316307,0.0022542893,0.08355983,0.77265066,0.00010108332,0.00075532927,0.0005362429,0.12155357],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972036,0.0005278492,0.00053386966,0.00034961078,0.0010776011,0.00030751346],"domain_scores_gemma":[0.9848322,0.004712122,0.0008624649,0.0007370746,0.0076204143,0.0012357987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003451947,0.0023152616,0.001991157,0.0032684028,0.002282814,0.0036983765,0.0028175402,0.007290451,0.027576761],"category_scores_gemma":[0.030986808,0.0009957406,0.0016608285,0.001451641,0.001974367,0.0018083097,0.0014997456,0.011495138,0.015979938],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046587258,0.000005965444,0.000053970885,0.00012719384,0.000012779343,0.0004669918,0.000010750843,0.000036433616,0.000034151126,0.00037415713,0.9940257,0.0048052813],"study_design_scores_gemma":[0.00008047055,0.000018914874,0.00044257878,0.0003250776,0.00005066138,0.0013456858,0.00003097036,0.00019430365,0.00021210776,0.000755965,0.9965184,0.000024789004],"about_ca_topic_score_codex":0.012425161,"about_ca_topic_score_gemma":0.016352141,"teacher_disagreement_score":0.027576761,"about_ca_system_score_codex":0.0038103159,"about_ca_system_score_gemma":0.0044647777,"threshold_uncertainty_score":0.092253506},"labels":[],"label_agreement":null},{"id":"W3197659737","doi":"10.1007/s40265-021-01593-z","title":"Belumosudil: First Approval","year":2021,"lang":"en","type":"review","venue":"Drugs","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Systemic therapy; Intensive care medicine; Internal medicine; Cancer","score_opus":0.04729427697079658,"score_gpt":0.33894574865560045,"score_spread":0.2916514716848039,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3197659737","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00088095583,0.9708143,0.00044092746,0.002032596,0.0015062585,0.000080332255,0.0008052831,0.00014972528,0.023289632],"genre_scores_gemma":[0.012767401,0.958766,0.0009952886,0.00425255,0.00083101407,0.00014193132,0.0019787478,0.000031458178,0.020235669],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998053,0.00004235872,0.000019852565,0.00002985383,0.000074584874,0.000028057493],"domain_scores_gemma":[0.9997905,0.000057537112,0.000048514034,0.000006771022,0.00006225328,0.000034473425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047797526,0.0005287013,0.0006316198,0.00083994557,0.00027505928,0.0010801001,0.00066253165,0.0013134867,0.019759424],"category_scores_gemma":[0.000751544,0.00017792538,0.00058926834,0.0007332594,0.0002780816,0.0008880325,0.0005419305,0.002042405,0.009988407],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003248503,0.00008821571,0.00008728123,0.0084664235,0.00006209912,0.00022728219,0.000045815927,0.00012191253,0.002721337,0.003995119,0.14325282,0.8406068],"study_design_scores_gemma":[0.00016722806,0.00014185303,0.00026547242,0.0014953096,0.000048358248,0.00065809785,0.000009042168,0.000027782706,0.00048162485,0.00047126238,0.99622655,0.000007453961],"about_ca_topic_score_codex":0.0006364623,"about_ca_topic_score_gemma":0.0018903508,"teacher_disagreement_score":0.019759424,"about_ca_system_score_codex":0.00046573553,"about_ca_system_score_gemma":0.0010918305,"threshold_uncertainty_score":0.06610185},"labels":[],"label_agreement":null},{"id":"W3211648887","doi":"10.1007/s40265-021-01602-1","title":"Cannabis-Based Medicines and Medical Cannabis in the Treatment of Nociplastic Pain","year":2021,"lang":"en","type":"review","venue":"Drugs","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Montreal General Hospital","funders":"","keywords":"Medicine; Chronic pain; Fibromyalgia; Cannabis; Headaches; Psychiatry; Addiction; Neurology; Intensive care medicine; Physical therapy","score_opus":0.028610056612344177,"score_gpt":0.3635209370357215,"score_spread":0.33491088042337736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211648887","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000580635,0.99948967,0.000022371622,0.00005643589,0.000051960647,0.000002356776,0.00001033381,0.0000017678474,0.00030699864],"genre_scores_gemma":[0.0005773151,0.9989555,0.00007230231,0.00008675681,0.00007026712,0.000003060408,0.000013892915,5.3665013e-7,0.00022032113],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99981445,0.00003590428,0.000033059794,0.00003146322,0.00006838667,0.000016748616],"domain_scores_gemma":[0.999516,0.0003292665,0.00006266429,0.000009054263,0.00005869992,0.000024296018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005121854,0.0007330435,0.0018065814,0.002598151,0.00027409327,0.0009877712,0.0008201325,0.0011749107,0.0060093747],"category_scores_gemma":[0.0009564201,0.00026421944,0.0007942784,0.0023220521,0.00043589622,0.0007609428,0.000557398,0.0014626198,0.0010074918],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024066845,0.000092868635,0.0001282969,0.056683328,0.0003096953,0.0001660545,0.000052607873,0.00029537472,0.0012248219,0.002185006,0.011846546,0.9267746],"study_design_scores_gemma":[0.0002144145,0.00033379535,0.0027001554,0.030209213,0.0015636998,0.0019258936,0.00014078876,0.00027623208,0.00079440844,0.0028151846,0.95896876,0.000057414865],"about_ca_topic_score_codex":0.0033209946,"about_ca_topic_score_gemma":0.009683519,"teacher_disagreement_score":0.0060093747,"about_ca_system_score_codex":0.0005905044,"about_ca_system_score_gemma":0.0011620445,"threshold_uncertainty_score":0.020103335},"labels":[],"label_agreement":null},{"id":"W3212182787","doi":"10.1007/s40265-021-01631-w","title":"Overview of DaxibotulinumtoxinA for Injection: A Novel Formulation of Botulinum Toxin Type A","year":2021,"lang":"en","type":"review","venue":"Drugs","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; University of Toronto","funders":"","keywords":"Medicine; Pharmacotherapy; Botulinum toxin; Pharmacology; Anesthesia; Intensive care medicine; Internal medicine","score_opus":0.14034393168162412,"score_gpt":0.39819710387262913,"score_spread":0.257853172191005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212182787","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004930926,0.9407084,0.00913542,0.002683158,0.0010113874,0.0003764387,0.00047523904,0.00027516665,0.040403876],"genre_scores_gemma":[0.010889924,0.95469433,0.01110042,0.002037212,0.0012773082,0.00033146513,0.0011221285,0.000055844874,0.018491419],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99964464,0.000052236875,0.000051728042,0.000080192185,0.00012924781,0.00004185946],"domain_scores_gemma":[0.99972266,0.000065471795,0.000053463642,0.000008932643,0.00009575805,0.000053743683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008364501,0.0010438184,0.0006634631,0.0026204663,0.00032999823,0.0014243834,0.0008194458,0.0014326819,0.005779635],"category_scores_gemma":[0.00047868837,0.00057561975,0.0007499944,0.0011731789,0.00028265803,0.0016515321,0.00064086006,0.0018583277,0.005096096],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030436294,0.0004782195,0.00069599604,0.009567091,0.000080049234,0.0006220742,0.0001237305,0.0008190001,0.025675366,0.008908491,0.03297261,0.91975296],"study_design_scores_gemma":[0.000038775866,0.0008234706,0.0016156373,0.0012722857,0.0000619876,0.002943995,0.0000367701,0.00055530487,0.0038492773,0.0012594822,0.9875125,0.00003057957],"about_ca_topic_score_codex":0.0016018349,"about_ca_topic_score_gemma":0.002081433,"teacher_disagreement_score":0.005779635,"about_ca_system_score_codex":0.0008446738,"about_ca_system_score_gemma":0.0012278757,"threshold_uncertainty_score":0.019334793},"labels":[],"label_agreement":null},{"id":"W3215398075","doi":"10.1007/s40265-021-01636-5","title":"Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence","year":2021,"lang":"en","type":"review","venue":"Drugs","topic":"Pharmacological Receptor Mechanisms and Effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"W. M. Keck Foundation","keywords":"Medicine; Fluvoxamine; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Pharmacotherapy; Coronavirus disease 2019 (COVID-19); 2019-20 coronavirus outbreak; Intensive care medicine; Betacoronavirus; Pandemic; Virology; Psychiatry; Internal medicine; Disease; Outbreak; Infectious disease (medical specialty); Fluoxetine","score_opus":0.16758524708011996,"score_gpt":0.4518696597222465,"score_spread":0.28428441264212656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215398075","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007064865,0.99937963,0.000027010728,0.00027637256,0.000092745446,0.0000050812287,0.000011752293,0.0000023276432,0.00013444311],"genre_scores_gemma":[0.00058689114,0.99873084,0.00011409626,0.00035400887,0.000122059224,0.000009965807,0.000016324864,0.0000010948404,0.0000645996],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99942786,0.00011980625,0.00018701545,0.00008450624,0.00015042814,0.000030257926],"domain_scores_gemma":[0.99731964,0.0017849714,0.0003699993,0.000033592238,0.00041286898,0.00007897493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018783655,0.00067194476,0.0023932173,0.0025939473,0.00032903408,0.0014331978,0.0014167872,0.001769618,0.003514712],"category_scores_gemma":[0.003578799,0.00040154438,0.0018133395,0.0022952731,0.00054128264,0.0017163622,0.00055050326,0.0019666231,0.00068621855],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041290824,0.00015119262,0.00041281784,0.12919903,0.00069205655,0.00025030243,0.0001240663,0.00021418465,0.00076065154,0.0017165939,0.025240598,0.8408256],"study_design_scores_gemma":[0.00033540803,0.00080382696,0.0034742237,0.16785206,0.004168993,0.0024325682,0.00030745895,0.00031244732,0.0006650329,0.0025756976,0.8170008,0.00007152122],"about_ca_topic_score_codex":0.0015431665,"about_ca_topic_score_gemma":0.0029733714,"teacher_disagreement_score":0.003514712,"about_ca_system_score_codex":0.0006844107,"about_ca_system_score_gemma":0.0017032876,"threshold_uncertainty_score":0.011757851},"labels":[],"label_agreement":null},{"id":"W363749682","doi":"10.2165/00003495-200565090-00004","title":"Traditional and Newer Therapeutic Options for Psoriatic Arthritis","year":2005,"lang":"en","type":"review","venue":"Drugs","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Krembil Foundation","keywords":"Psoriatic arthritis; Medicine; Psoriasis; Pathogenesis; Arthritis; Disease; Tumor necrosis factor alpha; Inflammatory arthritis; Inflammation; Immunology; Clinical trial; Dermatology; Intensive care medicine; Internal medicine","score_opus":0.06488033340554322,"score_gpt":0.29955361725219976,"score_spread":0.23467328384665653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W363749682","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011443231,0.9979557,0.00020448616,0.00019850196,0.00036563762,0.000008005537,0.000015232243,0.000012919596,0.0011251803],"genre_scores_gemma":[0.0009955022,0.9959454,0.000490749,0.00033648594,0.00056633743,0.000015966534,0.00003460583,0.000002585994,0.0016124145],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997913,0.000031532752,0.00003925913,0.00003087082,0.00008637655,0.000020627449],"domain_scores_gemma":[0.9996828,0.0001256133,0.00007468877,0.000012275607,0.000067275585,0.00003733525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057960785,0.0014673014,0.0021936765,0.0032757386,0.0003745538,0.00095188286,0.0010527761,0.0012916058,0.00631204],"category_scores_gemma":[0.0006244295,0.0003938246,0.000600713,0.0025497975,0.0005708043,0.0017462191,0.0005814435,0.0023489583,0.0031125615],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017048809,0.000120072145,0.000089184534,0.009000492,0.00007263087,0.00026145607,0.00003685914,0.0002382263,0.0019494431,0.0012254725,0.031753708,0.95508206],"study_design_scores_gemma":[0.00011177416,0.00027488166,0.000915083,0.002331405,0.00030915125,0.0028576672,0.00005004063,0.00016336041,0.0006728828,0.0012366846,0.9910523,0.00002471346],"about_ca_topic_score_codex":0.0008424151,"about_ca_topic_score_gemma":0.0026753678,"teacher_disagreement_score":0.00631204,"about_ca_system_score_codex":0.0004926083,"about_ca_system_score_gemma":0.00080741703,"threshold_uncertainty_score":0.0211159},"labels":[],"label_agreement":null},{"id":"W36416826","doi":"10.2165/00003495-200767140-00005","title":"Drugs for the Perioperative Control of Hypertension","year":2007,"lang":"en","type":"review","venue":"Drugs","topic":"Cardiac, Anesthesia and Surgical Outcomes","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Pharmacotherapy; Perioperative; Intensive care medicine; Pharmacology; Internal medicine; Anesthesia","score_opus":0.06763410134101555,"score_gpt":0.3513217376158047,"score_spread":0.28368763627478916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W36416826","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008784271,0.9990709,0.00007078448,0.00010107664,0.000121738245,0.0000048601905,0.000015661291,0.0000044470034,0.0005226219],"genre_scores_gemma":[0.00064029935,0.99867827,0.00015912326,0.0001351505,0.00012083971,0.0000050077156,0.000019550846,7.909323e-7,0.00024096976],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99978846,0.00004172916,0.000047603953,0.000028528766,0.00007636697,0.000017303142],"domain_scores_gemma":[0.99946755,0.0002885066,0.00012430022,0.000010429199,0.00007726858,0.00003197717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004538184,0.0008530432,0.0019415803,0.0027686488,0.00026848156,0.00073672616,0.0007092745,0.0008228363,0.0034630515],"category_scores_gemma":[0.000925941,0.00025734777,0.0006709149,0.002742368,0.00035976578,0.0007926713,0.00049810245,0.0015459557,0.0010528163],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012763684,0.00008755885,0.00022558103,0.024878643,0.00031525473,0.00020697004,0.000025844733,0.00022599444,0.0007664497,0.0012133503,0.020803196,0.95112354],"study_design_scores_gemma":[0.00021109868,0.00027894243,0.0032963573,0.014489001,0.0014467591,0.0025666265,0.00009025371,0.00024808166,0.0007622514,0.001634459,0.974936,0.00004009547],"about_ca_topic_score_codex":0.0020972807,"about_ca_topic_score_gemma":0.0049203457,"teacher_disagreement_score":0.0034630515,"about_ca_system_score_codex":0.0004490384,"about_ca_system_score_gemma":0.00097472704,"threshold_uncertainty_score":0.011585116},"labels":[],"label_agreement":null},{"id":"W4210391151","doi":"10.1007/s40265-021-01666-z","title":"Contemporary Drug Treatment of Advanced Heart Failure with Reduced Ejection Fraction","year":2022,"lang":"en","type":"review","venue":"Drugs","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada)","funders":"","keywords":"Medicine; Tolerability; Heart failure; Ejection fraction; Guideline; Intensive care medicine; Internal medicine; Population; Pharmacotherapy; Cardiology; Adverse effect; Pathology","score_opus":0.03752179838557585,"score_gpt":0.3217152077680374,"score_spread":0.28419340938246157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210391151","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006136037,0.99621993,0.00023497405,0.0006347476,0.00023575718,0.000016963464,0.00004441701,0.000009897814,0.00198973],"genre_scores_gemma":[0.005459226,0.9919721,0.00071577646,0.00070114963,0.00031606018,0.00003577739,0.00008498358,0.0000024070446,0.000712376],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996811,0.000107579544,0.00006654891,0.000035842288,0.0000891961,0.00001982095],"domain_scores_gemma":[0.99965537,0.0001753419,0.000079318204,0.000008070768,0.00006515398,0.000016639133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042798257,0.00031484352,0.00074023503,0.0009147802,0.00016134798,0.00053996884,0.00032908522,0.0005365985,0.0026661365],"category_scores_gemma":[0.00085998565,0.000096936834,0.0005260903,0.00071002997,0.0001873294,0.00045599238,0.0002653613,0.0010165098,0.00074719655],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021981564,0.00009633515,0.00034464546,0.021014104,0.00021370157,0.00017268721,0.000053331467,0.00019703715,0.0011206322,0.0018697919,0.017713903,0.95698404],"study_design_scores_gemma":[0.00027717798,0.00050901255,0.005091029,0.016145878,0.00096991373,0.0022240847,0.00007743848,0.00035133876,0.000964975,0.0022835685,0.9710815,0.00002412832],"about_ca_topic_score_codex":0.00094423164,"about_ca_topic_score_gemma":0.0025928766,"teacher_disagreement_score":0.0026661365,"about_ca_system_score_codex":0.00037403338,"about_ca_system_score_gemma":0.0006471499,"threshold_uncertainty_score":0.00891912},"labels":[],"label_agreement":null},{"id":"W4220973253","doi":"10.1007/s40265-022-01688-1","title":"Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria","year":2022,"lang":"en","type":"review","venue":"Drugs","topic":"Antibiotic Resistance in Bacteria","field":"Biochemistry, Genetics and Molecular Biology","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; University of Manitoba; Health Sciences Centre; Manitoba Health","funders":"","keywords":"Microbiology; Antimicrobial; Penicillin binding proteins; Medicine; Antibiotics; Stenotrophomonas maltophilia; Cephalosporin; Enterococcus faecium; Bacteria; Penicillin; Biology; Pseudomonas aeruginosa","score_opus":0.03217992979468121,"score_gpt":0.3241709958498625,"score_spread":0.29199106605518127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220973253","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000097927536,0.9988091,0.00013578683,0.00015768006,0.00020910999,0.0000055572923,0.000018643334,0.000007785838,0.00055835355],"genre_scores_gemma":[0.0006610797,0.998047,0.00028828369,0.00024264718,0.0001978069,0.000007163596,0.00003907438,0.000002068849,0.0005149083],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99980646,0.000037431284,0.000028339136,0.00003173645,0.00007546436,0.000020536254],"domain_scores_gemma":[0.9997123,0.00013065191,0.000046180372,0.000008470374,0.00006269883,0.000039655442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005477893,0.00095996587,0.0015788835,0.002340482,0.00022143812,0.00094909855,0.0009315587,0.0010533053,0.0026205124],"category_scores_gemma":[0.00072933856,0.00022290126,0.0004964335,0.0018315075,0.00051590335,0.0011047086,0.0005712721,0.0025969876,0.0018063595],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014096446,0.000093761635,0.0000812387,0.010931525,0.00007190127,0.00018711944,0.000029843728,0.00021400487,0.001852837,0.0015208897,0.023290928,0.961585],"study_design_scores_gemma":[0.000104152765,0.0002953001,0.00093527476,0.0037660818,0.00019183921,0.002722573,0.00004033509,0.00014285187,0.0008946222,0.0011003984,0.989777,0.000029464616],"about_ca_topic_score_codex":0.000942171,"about_ca_topic_score_gemma":0.0018666107,"teacher_disagreement_score":0.0026205124,"about_ca_system_score_codex":0.00042900047,"about_ca_system_score_gemma":0.0008590393,"threshold_uncertainty_score":0.008766532},"labels":[],"label_agreement":null},{"id":"W4223567640","doi":"10.1007/s40265-022-01696-1","title":"Pharmacological Treatment for Pedophilic Disorder and Compulsive Sexual Behavior Disorder: A Review","year":2022,"lang":"en","type":"review","venue":"Drugs","topic":"Sexuality, Behavior, and Technology","field":"Psychology","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Ottawa Mental Health Centre","funders":"Karolinska Institutet","keywords":"Paraphilia; Psychiatry; Medicine; Comorbidity; Anxiety; Distress; Clinical psychology; Libido; Sexual behavior","score_opus":0.11686110352792967,"score_gpt":0.4537111908426252,"score_spread":0.3368500873146955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223567640","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012490535,0.999549,0.000029370456,0.000057769503,0.000034508874,0.000009537884,0.000018449087,0.0000022625784,0.00017417218],"genre_scores_gemma":[0.0010818051,0.9985574,0.000108127635,0.000100765086,0.00005118706,0.000016867214,0.000026211297,8.962822e-7,0.000056685443],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99942017,0.00012453673,0.00021967423,0.00008944008,0.00011996082,0.000026232892],"domain_scores_gemma":[0.99746823,0.0020118915,0.00029298264,0.00003067916,0.0001589529,0.000037216465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00105272,0.0007092566,0.0023925628,0.0036573624,0.00033692038,0.0010826148,0.0012942016,0.001146587,0.0038479285],"category_scores_gemma":[0.0030844063,0.00033086608,0.0019318333,0.0030440672,0.00043617055,0.0010064763,0.0005716084,0.0009168364,0.00051669],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026171422,0.00013116002,0.0003513775,0.29437628,0.0008231952,0.00017522117,0.00012620009,0.00022482286,0.00034999894,0.0008934064,0.01091611,0.69137055],"study_design_scores_gemma":[0.00033013668,0.00089933653,0.007610725,0.4671788,0.011549136,0.0046519367,0.00042003102,0.0004643269,0.00069478905,0.0019548251,0.50415343,0.00009251053],"about_ca_topic_score_codex":0.0023311714,"about_ca_topic_score_gemma":0.0036683222,"teacher_disagreement_score":0.0038479285,"about_ca_system_score_codex":0.00081760006,"about_ca_system_score_gemma":0.0016079816,"threshold_uncertainty_score":0.012872577},"labels":[],"label_agreement":null},{"id":"W4223580441","doi":"10.1007/s40265-022-01707-1","title":"Adverse Events Associated with Immune Checkpoint Inhibitors: Overview of Systematic Reviews","year":2022,"lang":"en","type":"review","venue":"Drugs","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Waterloo; Montfort Hospital; University of British Columbia; Ottawa Hospital","funders":"","keywords":"Medicine; Systematic review; Common Terminology Criteria for Adverse Events; Interquartile range; Adverse effect; Incidence (geometry); Data extraction; MEDLINE; Internal medicine; Oncology; Intensive care medicine","score_opus":0.1008775101479818,"score_gpt":0.3539215827697252,"score_spread":0.2530440726217434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223580441","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024344427,0.9993279,0.000048109083,0.000067712754,0.000041061558,0.000035204073,0.0001636577,0.0000032476435,0.00006959394],"genre_scores_gemma":[0.0029060377,0.99643266,0.00018420856,0.00021965032,0.000061628925,0.000048861595,0.00010018981,0.0000017986229,0.00004504218],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99663335,0.00082083413,0.0014336394,0.0003797075,0.00061749836,0.00011506633],"domain_scores_gemma":[0.98818785,0.007829384,0.003118341,0.00011556435,0.0006264884,0.00012237497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004085537,0.0016752715,0.0075180526,0.005357426,0.00032675866,0.0019511638,0.0014244241,0.0014749293,0.0044773063],"category_scores_gemma":[0.013986459,0.0006752376,0.008602053,0.0070047644,0.0004471187,0.0012945795,0.0014165227,0.0013607338,0.00026508898],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056304206,0.000027267964,0.00088361575,0.88473773,0.018166682,0.00008609997,0.000058229267,0.00022287016,0.00020460086,0.0001722759,0.002824992,0.092052676],"study_design_scores_gemma":[0.0010981533,0.0006115659,0.012813178,0.6511772,0.26580006,0.0010261902,0.00024474677,0.00028251874,0.000465445,0.0008695599,0.065499306,0.00011213389],"about_ca_topic_score_codex":0.004372851,"about_ca_topic_score_gemma":0.012704747,"teacher_disagreement_score":0.0075180526,"about_ca_system_score_codex":0.0015039666,"about_ca_system_score_gemma":0.0033475826,"threshold_uncertainty_score":0.021606684},"labels":[],"label_agreement":null},{"id":"W4235055282","doi":"10.1007/s40265-017-0719-z","title":"Erratum to: Incidence, Prevention and Management of Anti-Drug Antibodies Against Therapeutic Antibodies in Inflammatory Bowel Disease: A Practical Overview","year":2017,"lang":"en","type":"erratum","venue":"Drugs","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"","keywords":"Medicine; Inflammatory bowel disease; Pharmacotherapy; Drug; Antibody; Incidence (geometry); Disease; Biological drugs; Pharmacology; Immunology; Intensive care medicine; Internal medicine","score_opus":0.030616717790005837,"score_gpt":0.34854795751473017,"score_spread":0.3179312397247243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4235055282","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00056095,0.0425741,0.00097549096,0.09792307,0.84910136,0.000058042668,0.0009096499,0.00011152606,0.0077858446],"genre_scores_gemma":[0.013456887,0.12874441,0.0076726563,0.15338546,0.59971285,0.00018236724,0.002809993,0.00042028612,0.093615144],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99710065,0.000530667,0.0009607516,0.00019912049,0.0010653493,0.0001433377],"domain_scores_gemma":[0.97933805,0.007709869,0.0023490575,0.00058913854,0.00933195,0.00068189896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028067052,0.001594867,0.0015762106,0.0037095132,0.0011183853,0.0022747598,0.0013406203,0.0044550914,0.011548196],"category_scores_gemma":[0.03036892,0.00064757135,0.0010340781,0.0023214226,0.0013556851,0.0018868552,0.00092696934,0.005157042,0.01045262],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005845681,0.000019851104,0.0004774527,0.00052283244,0.000015157924,0.0007717348,0.00002664892,0.000056091194,0.00004698073,0.0006278999,0.967518,0.02985887],"study_design_scores_gemma":[0.000042993037,0.000056893983,0.0021617692,0.0021938444,0.00007956406,0.003632696,0.00015135785,0.00015638916,0.0003097622,0.00077889767,0.9904034,0.000032386994],"about_ca_topic_score_codex":0.004436894,"about_ca_topic_score_gemma":0.0068067196,"teacher_disagreement_score":0.011548196,"about_ca_system_score_codex":0.001866918,"about_ca_system_score_gemma":0.003036117,"threshold_uncertainty_score":0.03863257},"labels":[],"label_agreement":null},{"id":"W4248311589","doi":"10.2165/00003495-200464110-00008","title":"The Management of Hypertension in the Overweight and Obese Patient","year":2004,"lang":"en","type":"article","venue":"Drugs","topic":"Pharmacology and Obesity Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Overweight; Pharmacotherapy; Obesity; Intensive care medicine; Weight management; Internal medicine","score_opus":0.011819959847611973,"score_gpt":0.25127476589534564,"score_spread":0.23945480604773367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248311589","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4214526,0.34817985,0.0044356827,0.1450352,0.0045430856,0.00015662714,0.00021442844,0.0001419218,0.07584053],"genre_scores_gemma":[0.7796497,0.17856818,0.004619557,0.018590199,0.012646372,0.00009427563,0.00012016663,0.00002606945,0.005685513],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99967027,0.00012565582,0.000032471748,0.000016411777,0.00012451503,0.000030705043],"domain_scores_gemma":[0.9994911,0.00019075045,0.00011205355,0.000007919132,0.000040125145,0.00015800637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040438608,0.00025602302,0.0006676033,0.0005826045,0.0005214901,0.0007574661,0.00027639943,0.0009820496,0.0009826374],"category_scores_gemma":[0.0016326514,0.000121158526,0.00032020546,0.00035512564,0.00026241416,0.0006411967,0.00032872715,0.0025412138,0.0002854891],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005458356,0.0026178365,0.09410067,0.0013349539,0.00036441823,0.03658426,0.00063239096,0.0010077866,0.008541436,0.0049346145,0.04207767,0.8023456],"study_design_scores_gemma":[0.003195542,0.014054507,0.614162,0.0025277229,0.0011209039,0.14226452,0.0026960021,0.0057442407,0.0070817675,0.015594375,0.19135483,0.00020346679],"about_ca_topic_score_codex":0.00081636617,"about_ca_topic_score_gemma":0.0025458713,"teacher_disagreement_score":0.0009826374,"about_ca_system_score_codex":0.0004116397,"about_ca_system_score_gemma":0.0008569415,"threshold_uncertainty_score":0.0032872558},"labels":[],"label_agreement":null},{"id":"W4281252334","doi":"10.1007/s40265-022-01722-2","title":"New Topical Therapies in Development for Atopic Dermatitis","year":2022,"lang":"en","type":"review","venue":"Drugs","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; Queen's University","funders":"","keywords":"Medicine; Atopic dermatitis; Dupilumab; Roflumilast; Intensive care medicine; Apremilast; Dermatology; Disease; Calcineurin; Drug development; Ruxolitinib; Adverse effect; Drug; Pharmacology; Psoriasis; Surgery; Internal medicine; Transplantation","score_opus":0.04522105744302725,"score_gpt":0.3383699868870051,"score_spread":0.29314892944397786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281252334","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013708184,0.99817765,0.000118167314,0.00011325014,0.00017376842,0.000013673394,0.000030097837,0.000009642543,0.0012266873],"genre_scores_gemma":[0.0007628282,0.99783236,0.0002547966,0.00022130295,0.00011991596,0.00001187928,0.00003849896,0.0000018648697,0.0007565399],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99984217,0.000027836695,0.000026632655,0.000023775612,0.00005837524,0.000021159682],"domain_scores_gemma":[0.9997342,0.00012886491,0.000054324228,0.000008698376,0.00004571968,0.000028061708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005554847,0.0012018799,0.0019507692,0.0026311683,0.0002128295,0.00095025497,0.0006737226,0.0009635492,0.0076079033],"category_scores_gemma":[0.0006041158,0.00033195078,0.000795951,0.0018661646,0.00032903784,0.0010450429,0.00062488555,0.0020776174,0.0021330582],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018206009,0.00012111462,0.00012017359,0.027449105,0.00016337451,0.0001637559,0.0000341469,0.00025418898,0.0019191346,0.0013297197,0.01844262,0.9498205],"study_design_scores_gemma":[0.00024392747,0.00037834092,0.0014382816,0.011366309,0.0010070404,0.0013990174,0.000068927286,0.00018226844,0.00085726276,0.001360903,0.981669,0.000028792749],"about_ca_topic_score_codex":0.0008716343,"about_ca_topic_score_gemma":0.0028791695,"teacher_disagreement_score":0.0076079033,"about_ca_system_score_codex":0.00037392412,"about_ca_system_score_gemma":0.00077276095,"threshold_uncertainty_score":0.025451005},"labels":[],"label_agreement":null},{"id":"W4281898190","doi":"10.1007/s40265-022-01726-y","title":"Pharmacotherapy of Generalized Myasthenia Gravis with Special Emphasis on Newer Biologicals","year":2022,"lang":"en","type":"review","venue":"Drugs","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":129,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Myasthenia gravis; Adverse effect; Eculizumab; Clinical trial; Pharmacotherapy; Immunology; Pharmacology; Antibody; Intensive care medicine; Internal medicine; Complement system","score_opus":0.07444458558377065,"score_gpt":0.373637324116084,"score_spread":0.2991927385323134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281898190","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000113446426,0.9991775,0.00007353825,0.00009619786,0.00011084298,0.000004866344,0.00001471204,0.000004337249,0.00040448664],"genre_scores_gemma":[0.0010376757,0.99793833,0.00018356694,0.00022099806,0.00018616277,0.000007806145,0.00002938836,0.000001180411,0.0003947112],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999881,0.000025532401,0.000024571838,0.000023009346,0.000034030167,0.000011903113],"domain_scores_gemma":[0.999747,0.00013905256,0.00005355762,0.0000064173933,0.000037357306,0.000016769798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035637678,0.000820276,0.001756794,0.002181182,0.0001589839,0.0006086662,0.0005811969,0.0007008394,0.0040961225],"category_scores_gemma":[0.00057965843,0.00023186146,0.0007155719,0.001660664,0.00026400844,0.0007238725,0.00039944338,0.0014254168,0.0009230276],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021990966,0.00012198053,0.00014662043,0.03246231,0.00029123685,0.00024566034,0.000041192914,0.00042440149,0.0016601259,0.0010637641,0.020438876,0.9428839],"study_design_scores_gemma":[0.000391547,0.00073911593,0.0025172755,0.012383158,0.0015207559,0.0032937543,0.00006827334,0.00041391727,0.00085692067,0.0013583013,0.97641045,0.000046373312],"about_ca_topic_score_codex":0.0008282358,"about_ca_topic_score_gemma":0.0022372259,"teacher_disagreement_score":0.0040961225,"about_ca_system_score_codex":0.0003039258,"about_ca_system_score_gemma":0.0005423392,"threshold_uncertainty_score":0.013702869},"labels":[],"label_agreement":null},{"id":"W4285587068","doi":"10.1007/s40265-022-01747-7","title":"Newly Approved and Investigational Drugs for Motor Symptom Control in Parkinson's Disease","year":2022,"lang":"en","type":"review","venue":"Drugs","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; Public Health Ontario; University of Toronto","funders":"","keywords":"Medicine; Levodopa; Dyskinesia; Parkinson's disease; Physical medicine and rehabilitation; Disease; Quality of life (healthcare); Intensive care medicine; Internal medicine","score_opus":0.029926289269795955,"score_gpt":0.29602218998937174,"score_spread":0.2660959007195758,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285587068","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014988544,0.9986457,0.00007909148,0.000094453244,0.00009985102,0.00000824686,0.000032446915,0.0000070054025,0.0008834078],"genre_scores_gemma":[0.0010546255,0.99772376,0.0002024403,0.00018720666,0.00010540835,0.000010669822,0.00004590445,0.0000013790161,0.000668495],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998623,0.000024292942,0.000027553722,0.00002361641,0.000047578516,0.0000146947295],"domain_scores_gemma":[0.99974924,0.00012744775,0.000053965134,0.0000058691303,0.00004433031,0.000019098876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004843322,0.00089620077,0.0018187705,0.0020035487,0.00020776954,0.000891921,0.00074339285,0.0008607608,0.0054725125],"category_scores_gemma":[0.0005432472,0.00026932606,0.0007156736,0.0016594123,0.0003382112,0.00088601845,0.00046750248,0.0018739331,0.0016347372],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023182864,0.00013392924,0.00013887207,0.025129326,0.00022547653,0.00020003528,0.000049241535,0.00027971127,0.0017558096,0.0015940464,0.02000474,0.95025694],"study_design_scores_gemma":[0.0002982418,0.0005056141,0.001982384,0.007799478,0.0010097601,0.0017341315,0.000068765316,0.00023241763,0.00072188914,0.0015395689,0.9840715,0.000036162],"about_ca_topic_score_codex":0.0013448187,"about_ca_topic_score_gemma":0.004436441,"teacher_disagreement_score":0.0054725125,"about_ca_system_score_codex":0.00044317264,"about_ca_system_score_gemma":0.00077120436,"threshold_uncertainty_score":0.018307388},"labels":[],"label_agreement":null},{"id":"W4296027776","doi":"10.1007/s40265-022-01773-5","title":"Multimodal Multidisciplinary Management of Patients with Moderate to Severe Pain in Knee Osteoarthritis: A Need to Meet Patient Expectations","year":2022,"lang":"en","type":"review","venue":"Drugs","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Versus Arthritis; Università degli Studi di Palermo; Medical Research Council; National Institute for Health and Care Research","keywords":"Medicine; Osteoarthritis; Multimodal therapy; Physical therapy; Quality of life (healthcare); Knee pain; Pharmacotherapy; Psychological intervention; Multidisciplinary approach; Intensive care medicine; Physical medicine and rehabilitation; Alternative medicine; Surgery; Internal medicine; Pathology","score_opus":0.014340027231513426,"score_gpt":0.2693155871649119,"score_spread":0.25497555993339843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296027776","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13221386,0.28237665,0.053921986,0.45595926,0.0088572055,0.001360309,0.00032114206,0.00048303546,0.06450658],"genre_scores_gemma":[0.6333995,0.15198548,0.094634704,0.09215808,0.012902083,0.002284883,0.0007549897,0.00015870867,0.0117215775],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978067,0.0011113309,0.00015737781,0.00014338669,0.00050852064,0.00027265988],"domain_scores_gemma":[0.99763215,0.00044455272,0.00023218388,0.00004934013,0.00047914198,0.0011626778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027384548,0.00048534473,0.0008666009,0.00046035022,0.0013536647,0.001947745,0.00090251246,0.0018112487,0.003410378],"category_scores_gemma":[0.004539052,0.00012725727,0.0007223619,0.00026499145,0.0006095265,0.002177216,0.0029364857,0.0037338568,0.0007840766],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062083144,0.0022761063,0.023729485,0.008791241,0.00041053828,0.0070251767,0.011186652,0.0020174147,0.0072366344,0.015379154,0.13780662,0.78352016],"study_design_scores_gemma":[0.0008964677,0.0048286496,0.10029704,0.02610352,0.0006010517,0.031876232,0.0327129,0.006867648,0.0020893721,0.06328791,0.72985786,0.00058142486],"about_ca_topic_score_codex":0.0008677201,"about_ca_topic_score_gemma":0.0023919437,"teacher_disagreement_score":0.003410378,"about_ca_system_score_codex":0.00081988994,"about_ca_system_score_gemma":0.0033756706,"threshold_uncertainty_score":0.014482558},"labels":[],"label_agreement":null},{"id":"W4307250618","doi":"10.1007/s40265-022-01797-x","title":"Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection","year":2022,"lang":"en","type":"article","venue":"Drugs","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":269,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Victoria","funders":"National Center for Advancing Translational Sciences","keywords":"Medicine; Placebo; Clinical endpoint; Internal medicine; Adverse effect; Diarrhea; Randomized controlled trial; Intention-to-treat analysis; Gastroenterology","score_opus":0.026048548276320364,"score_gpt":0.32775974972869437,"score_spread":0.301711201452374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307250618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99135524,0.0035904504,0.00087273656,0.00044284755,0.00022783136,0.0016587885,0.00055165065,0.00015135935,0.0011490447],"genre_scores_gemma":[0.9910836,0.0021392778,0.0018523666,0.0007555417,0.0002532107,0.0020807628,0.00058115536,0.000028347748,0.0012256065],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99898845,0.0005735911,0.00006726068,0.00014040162,0.00010518465,0.00012509666],"domain_scores_gemma":[0.9990977,0.00027464482,0.00023138178,0.000060343773,0.00007968972,0.00025626802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024622069,0.0013982706,0.0028762126,0.00045319024,0.00046795994,0.00094767904,0.00085516693,0.002021502,0.0032202133],"category_scores_gemma":[0.0020656,0.00062567636,0.0018645693,0.00034170673,0.001137559,0.00073439366,0.0003491562,0.0022741896,0.00064341293],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96276355,0.009679,0.0004938992,0.00074009254,0.0006128708,0.000027988206,0.000041152634,0.00063296105,0.0053492514,0.00011677178,0.0005179901,0.019024499],"study_design_scores_gemma":[0.87214833,0.12323618,0.0017990632,0.000054374814,0.0004466861,0.000029671424,0.000015314057,0.0009751374,0.0008355991,0.0000913532,0.000347914,0.000020358884],"about_ca_topic_score_codex":0.0009381268,"about_ca_topic_score_gemma":0.0018845935,"teacher_disagreement_score":0.0032202133,"about_ca_system_score_codex":0.0005830906,"about_ca_system_score_gemma":0.0014116263,"threshold_uncertainty_score":0.013021529},"labels":[],"label_agreement":null},{"id":"W4308369849","doi":"10.1007/s40265-022-01805-0","title":"Publisher Correction: Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection","year":2022,"lang":"en","type":"erratum","venue":"Drugs","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Victoria","funders":"National Center for Advancing Translational Sciences","keywords":"Medicine; Placebo; Clostridioides; Pharmacotherapy; Double blind; Randomized controlled trial; Internal medicine; Intensive care medicine; Alternative medicine; Pathology","score_opus":0.024358580413731075,"score_gpt":0.3212606948621724,"score_spread":0.29690211444844133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308369849","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005409729,0.0010552475,0.0004394253,0.027419776,0.9681309,0.000053449454,0.00091716036,0.00027350817,0.0016564849],"genre_scores_gemma":[0.0063817315,0.007793376,0.0047317524,0.13987385,0.64124584,0.0006200949,0.0017852065,0.0018073148,0.19576083],"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99109787,0.0021842467,0.0019889972,0.0009933435,0.0032215244,0.00051396707],"domain_scores_gemma":[0.9385413,0.023650127,0.0033674152,0.0038939752,0.028379774,0.0021673618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0106798485,0.0037277658,0.005204707,0.004885665,0.0032153714,0.005593141,0.006384665,0.011751205,0.065596245],"category_scores_gemma":[0.11987411,0.0026129633,0.0042057293,0.0037980927,0.0030005418,0.0023729051,0.001415893,0.017600507,0.034030706],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008886133,0.0000077698905,0.000027718897,0.00022096261,0.000038397724,0.00016800428,0.000011681086,0.000042189953,0.000027610145,0.0003123454,0.9957924,0.0032619536],"study_design_scores_gemma":[0.0008387403,0.0000900101,0.00096731767,0.0012635033,0.00033397914,0.0006509064,0.00005602451,0.000576612,0.00040314498,0.0021284714,0.9926053,0.00008590921],"about_ca_topic_score_codex":0.026968235,"about_ca_topic_score_gemma":0.030319145,"teacher_disagreement_score":0.065596245,"about_ca_system_score_codex":0.0067991097,"about_ca_system_score_gemma":0.008381694,"threshold_uncertainty_score":0.21944135},"labels":[],"label_agreement":null},{"id":"W4311672195","doi":"10.1007/s40265-022-01817-w","title":"The Struggle to End a Millennia-Long Pandemic: Novel Candidate and Repurposed Drugs for the Treatment of Tuberculosis","year":2022,"lang":"en","type":"review","venue":"Drugs","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Bedaquiline; Context (archaeology); Linezolid; Medicine; Tuberculosis; Intensive care medicine; Pandemic; Pharmacology; Coronavirus disease 2019 (COVID-19); Mycobacterium tuberculosis; Disease; Biology; Pathology; Infectious disease (medical specialty); Vancomycin","score_opus":0.07595104663412834,"score_gpt":0.38811534592005165,"score_spread":0.3121642992859233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311672195","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000027544267,0.9990627,0.000045348075,0.0004536315,0.00015308961,0.0000016344505,0.000007730319,0.0000040786144,0.00024420596],"genre_scores_gemma":[0.0002633774,0.99886763,0.000091574635,0.00037780416,0.00020357082,0.0000025274273,0.000011419336,9.346212e-7,0.00018120128],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996712,0.00008877143,0.000037697966,0.00004321236,0.000121802565,0.000037299407],"domain_scores_gemma":[0.9990847,0.00056578836,0.00010659671,0.000020215684,0.00015187597,0.00007086029],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009340201,0.00081119355,0.0021409,0.0021038062,0.00032116362,0.0014194389,0.0010868406,0.0019040802,0.004394933],"category_scores_gemma":[0.0015903322,0.00026490606,0.0007713432,0.002074155,0.0006860122,0.0020324334,0.00087850523,0.0034086343,0.001500752],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000103929255,0.000077259225,0.00010442392,0.020378288,0.00014376143,0.00013969,0.000050162045,0.00034953054,0.0010046699,0.005584764,0.056788765,0.9152748],"study_design_scores_gemma":[0.000057105222,0.00012246959,0.0006231363,0.010266215,0.00021026148,0.00088191556,0.000077052624,0.00016014716,0.00019530833,0.004349294,0.98303074,0.000026431528],"about_ca_topic_score_codex":0.0017816705,"about_ca_topic_score_gemma":0.0048827054,"teacher_disagreement_score":0.004394933,"about_ca_system_score_codex":0.0009004184,"about_ca_system_score_gemma":0.0017285954,"threshold_uncertainty_score":0.014702439},"labels":[],"label_agreement":null},{"id":"W4353015627","doi":"10.1007/s40265-023-01859-8","title":"The Comparative Effectiveness and Safety of Insomnia Drugs: A Systematic Review and Network Meta-Analysis of 153 Randomized Trials","year":2023,"lang":"en","type":"review","venue":"Drugs","topic":"Sleep and related disorders","field":"Psychology","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"","keywords":"Medicine; Meta-analysis; Randomized controlled trial; Tolerability; Confidence interval; Insomnia; Placebo; Primary Insomnia; Systematic review; Relative risk; Internal medicine; Psychiatry; MEDLINE; Sleep disorder; Adverse effect; Alternative medicine","score_opus":0.14544743302878824,"score_gpt":0.43565685232434453,"score_spread":0.2902094192955563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4353015627","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00890939,0.98896664,0.0006484607,0.0001354893,0.00016123545,0.0003803916,0.0005510083,0.00002738104,0.00021995672],"genre_scores_gemma":[0.2583194,0.7344525,0.0033897683,0.0011888572,0.00025540005,0.0009860743,0.0009943334,0.000044593457,0.00036905112],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98960215,0.004516434,0.0034496621,0.001111487,0.0010164662,0.0003037779],"domain_scores_gemma":[0.9780398,0.016966438,0.0032148866,0.00070063915,0.00081470003,0.00026353862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013880622,0.0026570684,0.018809663,0.004528928,0.0006859782,0.0028748263,0.0019576112,0.0021716706,0.004105905],"category_scores_gemma":[0.032408066,0.001519689,0.028997838,0.0050516725,0.0011190333,0.0019630557,0.0018772137,0.002511798,0.0003312205],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005857361,0.000045300614,0.0027652704,0.2554492,0.7231435,0.000082978244,0.00007398729,0.0002975324,0.00023196067,0.00010269699,0.0004079367,0.011542313],"study_design_scores_gemma":[0.0023928569,0.00023833562,0.0026812223,0.010669748,0.9827176,0.000053937845,0.000037916154,0.0000850763,0.00008109526,0.00015118677,0.00087008905,0.000020982387],"about_ca_topic_score_codex":0.0054645953,"about_ca_topic_score_gemma":0.014202484,"teacher_disagreement_score":0.018809663,"about_ca_system_score_codex":0.002529299,"about_ca_system_score_gemma":0.0031714025,"threshold_uncertainty_score":0.07340866},"labels":[],"label_agreement":null},{"id":"W4378171864","doi":"10.1007/s40265-023-01872-x","title":"New Pharmacologic Approaches to the Treatment of Bipolar Depression","year":2023,"lang":"en","type":"review","venue":"Drugs","topic":"Tryptophan and brain disorders","field":"Neuroscience","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; University of Ottawa; Université de Montréal; McGill University; University of British Columbia","funders":"","keywords":"Lurasidone; Bipolar disorder; Medicine; Randomized controlled trial; Antidepressant; Mood; Atypical depression; Mood disorders; Psychiatry; Schizophrenia (object-oriented programming); Internal medicine; Anxiety; Antipsychotic","score_opus":0.30201206338410325,"score_gpt":0.36725527057051566,"score_spread":0.06524320718641241,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378171864","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000086998094,0.9988318,0.000109333065,0.00015207997,0.00013807531,0.000006312466,0.000014567541,0.000005894919,0.0006548762],"genre_scores_gemma":[0.00044693527,0.99862754,0.00019943682,0.00017577206,0.00015987799,0.000006950799,0.000021692093,9.83325e-7,0.00036087644],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998746,0.000025077708,0.000019614274,0.000021537156,0.000044267974,0.000014846932],"domain_scores_gemma":[0.99978966,0.00010816158,0.00003523344,0.0000059200015,0.000037470014,0.00002362375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044294097,0.0009671178,0.0016613924,0.002054942,0.0002773495,0.0009296165,0.0010413607,0.0009849904,0.0045862123],"category_scores_gemma":[0.00055775355,0.00025290548,0.00065680745,0.0017103471,0.00044642214,0.00087672274,0.00060606416,0.002418353,0.0016646229],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020365049,0.0001691621,0.000097997305,0.014012254,0.0001528427,0.00021890971,0.000034411507,0.00035907852,0.001723941,0.0022761838,0.020750327,0.9600011],"study_design_scores_gemma":[0.00021460687,0.0003945181,0.0012698707,0.0070610605,0.00054881594,0.0016141294,0.00007147299,0.00029910431,0.00061752193,0.0030767107,0.9847973,0.000034782195],"about_ca_topic_score_codex":0.0015449343,"about_ca_topic_score_gemma":0.0050550024,"teacher_disagreement_score":0.0045862123,"about_ca_system_score_codex":0.0005015798,"about_ca_system_score_gemma":0.000779082,"threshold_uncertainty_score":0.015342414},"labels":[],"label_agreement":null},{"id":"W4379094806","doi":"10.1007/s40265-023-01882-9","title":"Targeting IL-23 for IBD: Rationale and Progress to Date","year":2023,"lang":"en","type":"review","venue":"Drugs","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Western University","funders":"","keywords":"Medicine; Ustekinumab; Ulcerative colitis; Interleukin 23; Inflammatory bowel disease; Crohn's disease; Psoriasis; Disease; Immunology; Clinical trial; Internal medicine; Gastroenterology; Immune system; Interleukin 17; Adalimumab","score_opus":0.05452225443549843,"score_gpt":0.3243609393276801,"score_spread":0.2698386848921817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379094806","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009458546,0.99879223,0.00012601746,0.0003040906,0.00019911658,0.00000537666,0.000020674866,0.000008297094,0.00044965878],"genre_scores_gemma":[0.0007347236,0.99784863,0.00029457675,0.00036732256,0.00023570207,0.000010168584,0.000033082197,0.0000022673344,0.00047357992],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997924,0.00004176328,0.000028397742,0.000037482198,0.00007098301,0.000028926455],"domain_scores_gemma":[0.9995078,0.0002528085,0.00007058545,0.000014645555,0.000103865954,0.000050350314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096048054,0.0010904912,0.001973039,0.0013544332,0.00022572002,0.0013721171,0.00090593024,0.0012722877,0.003744789],"category_scores_gemma":[0.0010801341,0.00029648578,0.00063095294,0.0012483015,0.000516769,0.0012507347,0.00068467885,0.0033907418,0.0020545188],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030355382,0.00016461463,0.00013193468,0.014172532,0.00014308201,0.00013796169,0.000037407168,0.0004497396,0.0022940754,0.002853066,0.027274847,0.95203716],"study_design_scores_gemma":[0.00013455734,0.00034993704,0.00061501545,0.0040211836,0.00036354706,0.00077489275,0.000048516184,0.00020884917,0.0009147651,0.0020586683,0.99048376,0.000026296613],"about_ca_topic_score_codex":0.00069781893,"about_ca_topic_score_gemma":0.0018671723,"teacher_disagreement_score":0.003744789,"about_ca_system_score_codex":0.00050936744,"about_ca_system_score_gemma":0.001079321,"threshold_uncertainty_score":0.012527525},"labels":[],"label_agreement":null},{"id":"W4385564760","doi":"10.1007/s40265-023-01923-3","title":"Recent Advances in Antiarrhythmic Drug Therapy","year":2023,"lang":"en","type":"review","venue":"Drugs","topic":"Cardiac electrophysiology and arrhythmias","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; ZonMw; European Commission; Danmarks Frie Forskningsfond; Universitätsklinikum Essen","keywords":"Medicine; Repurposing; Drug development; Intensive care medicine; Drug; Atrial fibrillation; Anti-Arrhythmia Agents; Cardiac electrophysiology; Cardiac arrhythmia; Torsades de pointes; Ventricular fibrillation; Cardiology; Pharmacology; Internal medicine; QT interval; Electrophysiology","score_opus":0.029735199168989385,"score_gpt":0.3505080686278434,"score_spread":0.320772869458854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385564760","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013922746,0.99614197,0.0001932298,0.000431883,0.0004308069,0.0000064612527,0.00002603875,0.000011845863,0.0026185599],"genre_scores_gemma":[0.000860678,0.99708813,0.00026192117,0.00035880497,0.00039453537,0.0000066456455,0.000046359743,0.0000022895508,0.0009806135],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99967897,0.000055133896,0.00005639944,0.000053626853,0.00012582322,0.000030117706],"domain_scores_gemma":[0.99947006,0.00026019732,0.00006672562,0.000019474865,0.0001415752,0.000042025087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007168316,0.00081424793,0.0011389165,0.001872537,0.0002707196,0.0012295868,0.0007607054,0.0008288429,0.0094590215],"category_scores_gemma":[0.0010843885,0.00022407726,0.0006498967,0.0016090116,0.0003698399,0.0012889967,0.0006915369,0.0023772144,0.0046163267],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008193828,0.00007862084,0.00015234975,0.013091946,0.00007075083,0.00020142028,0.000054192977,0.0002909303,0.001438323,0.004366217,0.030857282,0.9493159],"study_design_scores_gemma":[0.000015669662,0.00007497061,0.0004161808,0.0022287017,0.000072985495,0.00096165115,0.000024855995,0.00007365592,0.00024144675,0.0016829325,0.9941954,0.000011492412],"about_ca_topic_score_codex":0.0006009538,"about_ca_topic_score_gemma":0.0010669626,"teacher_disagreement_score":0.0094590215,"about_ca_system_score_codex":0.00050066365,"about_ca_system_score_gemma":0.0009538766,"threshold_uncertainty_score":0.03164357},"labels":[],"label_agreement":null},{"id":"W4386945070","doi":"10.1007/s40265-023-01934-0","title":"Treatment of Ovarian Cancer Beyond PARP Inhibition: Current and Future Options","year":2023,"lang":"en","type":"review","venue":"Drugs","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Ovarian cancer; DNA repair; Drug resistance; Cancer; Cancer research; Homologous recombination; Poly ADP ribose polymerase; Tumor microenvironment; Disease; Polymerase; Biology; Internal medicine; DNA; Genetics","score_opus":0.07922667141945612,"score_gpt":0.4102456523476324,"score_spread":0.3310189809281763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386945070","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013095544,0.997795,0.00011745688,0.00058192975,0.00022065676,0.0000049765044,0.000019726655,0.000009106211,0.001120198],"genre_scores_gemma":[0.00069245143,0.9978042,0.00017053273,0.000346982,0.00020602037,0.000006252467,0.000033767945,0.0000018606192,0.00073782745],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998778,0.000025816587,0.000013839909,0.000019861884,0.000047451285,0.000015182753],"domain_scores_gemma":[0.99981827,0.000079322046,0.00002659661,0.0000057155407,0.0000475027,0.000022639491],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043245463,0.0005727488,0.00093936507,0.0011039448,0.0002169487,0.0007812149,0.0006767655,0.0008166856,0.0048950166],"category_scores_gemma":[0.00041423476,0.00017779159,0.0004656623,0.0010220936,0.00033241056,0.0011944273,0.0005201143,0.002257684,0.0019536838],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008587066,0.00009006681,0.000097193195,0.011559697,0.000056683635,0.00015148988,0.00004441519,0.0003818043,0.001740331,0.003386858,0.038894895,0.94351065],"study_design_scores_gemma":[0.000026151763,0.00014771795,0.000455917,0.0025521936,0.00007154633,0.0009029641,0.000040369476,0.00012365222,0.00031467664,0.0019494252,0.99340326,0.000012161131],"about_ca_topic_score_codex":0.0006686475,"about_ca_topic_score_gemma":0.0019122863,"teacher_disagreement_score":0.0048950166,"about_ca_system_score_codex":0.00047531165,"about_ca_system_score_gemma":0.00062855484,"threshold_uncertainty_score":0.016375422},"labels":[],"label_agreement":null},{"id":"W4387948572","doi":"10.1007/s40265-023-01950-0","title":"Current and Future Treatment Landscape for Idiopathic Pulmonary Fibrosis","year":2023,"lang":"en","type":"review","venue":"Drugs","topic":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","field":"Medicine","cited_by":160,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Universitätsklinikum Essen","keywords":"Nintedanib; Medicine; Pirfenidone; Idiopathic pulmonary fibrosis; Clinical trial; Intensive care medicine; Disease; Drug development; Clinical endpoint; Internal medicine; Lung; Drug; Pharmacology","score_opus":0.03746512349581604,"score_gpt":0.3395187922293471,"score_spread":0.30205366873353107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387948572","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000059265825,0.9985543,0.000068270776,0.0005303906,0.00018137436,0.0000030096749,0.000012221496,0.000004950039,0.0005863449],"genre_scores_gemma":[0.0005032948,0.9982318,0.00019278411,0.00046925773,0.0001937621,0.0000065489385,0.000029858287,0.0000012760698,0.00037145987],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997485,0.000063665066,0.000041692485,0.000038533148,0.00008574574,0.000021920587],"domain_scores_gemma":[0.9996151,0.00020155047,0.00005332103,0.00000887581,0.00009458776,0.000026593563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007170693,0.00059785857,0.0010057162,0.0015366919,0.00027364364,0.0008191761,0.0006361991,0.0011855965,0.005535551],"category_scores_gemma":[0.0007437553,0.00017169937,0.0006352261,0.0011861647,0.0003562844,0.0013089492,0.0005423486,0.0020565034,0.0017499694],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009064358,0.00007012688,0.00011145769,0.016851781,0.00006847887,0.00016232903,0.00004328363,0.000286361,0.0010255061,0.0041844673,0.03126289,0.9458427],"study_design_scores_gemma":[0.000039453655,0.00015065483,0.000833086,0.008940488,0.00016346568,0.0012808269,0.00007409917,0.00015600622,0.00023834319,0.002853386,0.98525244,0.000017700619],"about_ca_topic_score_codex":0.000855915,"about_ca_topic_score_gemma":0.002213873,"teacher_disagreement_score":0.005535551,"about_ca_system_score_codex":0.00061201863,"about_ca_system_score_gemma":0.0011823276,"threshold_uncertainty_score":0.01851821},"labels":[],"label_agreement":null},{"id":"W4391754408","doi":"10.1007/s40265-024-02005-8","title":"Correction: New Pharmacologic Approaches to the Treatment of Bipolar Depression","year":2024,"lang":"en","type":"erratum","venue":"Drugs","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; University of Ottawa; Université de Montréal; University of British Columbia","funders":"","keywords":"Medicine; Pharmacotherapy; Depression (economics); Bipolar disorder; Psychiatry; MEDLINE; Psychotherapist; Intensive care medicine; Psychology; Lithium (medication)","score_opus":0.0630032793385217,"score_gpt":0.2979588516626277,"score_spread":0.234955572324106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391754408","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000021398022,0.0010406678,0.0001234035,0.032291263,0.96445936,0.000012500058,0.00025788663,0.00007974355,0.0017138723],"genre_scores_gemma":[0.0026442972,0.0088485405,0.0016557457,0.11674411,0.7209641,0.00012177649,0.0006625563,0.00045151697,0.14790738],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99578434,0.0007691966,0.0007781218,0.0004876389,0.001780406,0.00040027322],"domain_scores_gemma":[0.97222936,0.007253701,0.0013907382,0.0014778376,0.015926488,0.0017217798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038676711,0.0031651633,0.0028620905,0.004725563,0.0038940571,0.004779278,0.0044745994,0.011908365,0.043960456],"category_scores_gemma":[0.05062097,0.0014825297,0.0028733285,0.0026634524,0.0028770634,0.0029445272,0.0018292529,0.019416455,0.03223412],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018599123,0.0000041945177,0.000017510642,0.000074447096,0.0000069537764,0.00014011633,0.00000708825,0.000019634044,0.000010933318,0.0003583772,0.99680734,0.0025348028],"study_design_scores_gemma":[0.00007870719,0.000019748572,0.0004863234,0.00042961727,0.000047527952,0.0006081556,0.000039363596,0.00016526418,0.00011715767,0.0014033075,0.9965714,0.00003335435],"about_ca_topic_score_codex":0.030398054,"about_ca_topic_score_gemma":0.044481598,"teacher_disagreement_score":0.043960456,"about_ca_system_score_codex":0.0062204874,"about_ca_system_score_gemma":0.0069847796,"threshold_uncertainty_score":0.14706236},"labels":[],"label_agreement":null},{"id":"W4392236254","doi":"10.1007/s40265-024-02008-5","title":"Eplontersen: First Approval","year":2024,"lang":"en","type":"article","venue":"Drugs","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Transthyretin; Medicine; Amyloidosis; Polyneuropathy; Pharmacology; Antisense therapy; Internal medicine; Oligonucleotide; Biochemistry; Gene; Biology","score_opus":0.0075525067745106055,"score_gpt":0.2517355677165025,"score_spread":0.2441830609419919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392236254","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.029227097,0.19752471,0.004885575,0.038022827,0.014235236,0.0025059138,0.030321332,0.0053968,0.6778805],"genre_scores_gemma":[0.19495061,0.13788189,0.0075185406,0.04453807,0.0085141435,0.002208467,0.04784226,0.00096608215,0.55557996],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995043,0.00010169369,0.000032487074,0.00007057443,0.00020452397,0.000086294705],"domain_scores_gemma":[0.99932206,0.00008998216,0.00011601272,0.00004935871,0.0001988077,0.00022372254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090928556,0.0008478998,0.0008212165,0.00061194075,0.00036954365,0.0019013571,0.0010438941,0.0028799237,0.09487906],"category_scores_gemma":[0.0017182457,0.00023585006,0.0009231468,0.000474443,0.00040018017,0.0010717681,0.0005354148,0.002991863,0.036161423],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031850128,0.00040081202,0.0004903997,0.0019952583,0.00013428484,0.0007463458,0.000053825082,0.0002771656,0.005929801,0.0053540543,0.5475819,0.43385112],"study_design_scores_gemma":[0.0027790428,0.001161354,0.0011686707,0.00055518444,0.000052733492,0.0011696648,0.000011133564,0.00015790196,0.0012329817,0.0008147728,0.9908828,0.00001377087],"about_ca_topic_score_codex":0.00060177397,"about_ca_topic_score_gemma":0.0015166202,"teacher_disagreement_score":0.09487906,"about_ca_system_score_codex":0.0008458336,"about_ca_system_score_gemma":0.0016845025,"threshold_uncertainty_score":0.31740206},"labels":[],"label_agreement":null},{"id":"W4399193083","doi":"10.1007/s40265-024-02038-z","title":"Postpartum Depression: A Clinical Review of Impact and Current Treatment Solutions","year":2024,"lang":"en","type":"review","venue":"Drugs","topic":"Maternal Mental Health During Pregnancy and Postpartum","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Centre for Addiction and Mental Health; Health Sciences Centre; Lunenfeld-Tanenbaum Research Institute; Women's College Hospital; York University; University of Toronto","funders":"","keywords":"Medicine; Postpartum depression; Breastfeeding; Sertraline; Postpartum period; Psychiatry; Intensive care medicine; Tolerability; Behavioral activation; Antidepressant; Depression (economics); Pregnancy; Adverse effect; Pediatrics; Pharmacology","score_opus":0.14346525389096457,"score_gpt":0.5070232233612373,"score_spread":0.36355796947027275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399193083","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004664521,0.9996531,0.000020412404,0.00009425575,0.000038458507,0.0000057672382,0.000021582136,0.0000020129112,0.0001178289],"genre_scores_gemma":[0.00033623245,0.999338,0.000095658324,0.00011986542,0.000039323295,0.0000061958663,0.000017778078,5.65488e-7,0.000046329613],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9994868,0.00010437814,0.0001736762,0.000074363845,0.00013101306,0.000029679812],"domain_scores_gemma":[0.9978911,0.0014886558,0.0003118476,0.000028012002,0.00021418404,0.00006617261],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00147565,0.0009336188,0.0031902806,0.0035070546,0.0003085342,0.0014482526,0.0014412242,0.001250048,0.004619678],"category_scores_gemma":[0.003013028,0.00047252845,0.0015903027,0.0038227998,0.00046755193,0.0012974637,0.0009025661,0.001570212,0.0007349668],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002851933,0.00011459136,0.00032074132,0.14979756,0.0007278527,0.00010255333,0.000086053544,0.00022390264,0.00045807924,0.0011993399,0.016229352,0.83045477],"study_design_scores_gemma":[0.00040788428,0.00056615414,0.005593035,0.19401394,0.0068833735,0.0015618879,0.00034139425,0.00034226675,0.00042323148,0.002439102,0.7873248,0.000103001126],"about_ca_topic_score_codex":0.003009512,"about_ca_topic_score_gemma":0.0087841265,"teacher_disagreement_score":0.004619678,"about_ca_system_score_codex":0.0008761892,"about_ca_system_score_gemma":0.0024058106,"threshold_uncertainty_score":0.0154544115},"labels":[],"label_agreement":null},{"id":"W4399707657","doi":"10.1007/s40265-024-02051-2","title":"Treatment Options in Spinal Muscular Atrophy: A Pragmatic Approach for Clinicians","year":2024,"lang":"en","type":"review","venue":"Drugs","topic":"Neurogenetic and Muscular Disorders Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Biogen","keywords":"Spinal muscular atrophy; SMA*; Medicine; Clinical trial; Physical medicine and rehabilitation; Physical therapy; Disease; Intensive care medicine; Pathology","score_opus":0.09045282201644811,"score_gpt":0.44300561900128715,"score_spread":0.35255279698483905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399707657","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000038284343,0.9947456,0.00018627764,0.0035015123,0.0004919869,0.0000074226364,0.000020110618,0.0000100142015,0.0009987921],"genre_scores_gemma":[0.0008799097,0.99192,0.00093265815,0.004470903,0.0010910857,0.000029338826,0.00003512034,0.000003955958,0.00063696754],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992304,0.00029758477,0.000148006,0.00008678913,0.00018595705,0.00005120534],"domain_scores_gemma":[0.99733114,0.0019994804,0.00022587794,0.000033835273,0.00030668965,0.00010294962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024953315,0.0011774197,0.0034577192,0.0023416881,0.0005639567,0.0026685214,0.0015243124,0.003789468,0.006460719],"category_scores_gemma":[0.0036434312,0.00045271334,0.0012911907,0.0015182253,0.0009650013,0.0030921309,0.0014036889,0.0062159523,0.0021308984],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022322596,0.00012546215,0.00019294403,0.03998069,0.00030547008,0.00043804102,0.00012872716,0.0005457306,0.0006344075,0.0105435485,0.09160176,0.8552799],"study_design_scores_gemma":[0.00017801061,0.00014603106,0.000565042,0.044323005,0.0004977857,0.0011462847,0.00017152206,0.00022508939,0.00013334313,0.009009498,0.9435564,0.00004796325],"about_ca_topic_score_codex":0.0016529197,"about_ca_topic_score_gemma":0.0057237274,"teacher_disagreement_score":0.006460719,"about_ca_system_score_codex":0.0015621813,"about_ca_system_score_gemma":0.0027324527,"threshold_uncertainty_score":0.0216133},"labels":[],"label_agreement":null},{"id":"W4402036755","doi":"10.1007/s40265-024-02082-9","title":"Cefepime–Taniborbactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination","year":2024,"lang":"en","type":"review","venue":"Drugs","topic":"Antibiotic Resistance in Bacteria","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Manitoba Health; University of Manitoba","funders":"Biomedical Advanced Research and Development Authority","keywords":"Cefepime; Meropenem; Pseudomonas aeruginosa; Cephalosporin; Microbiology; Efflux; Medicine; Pharmacology; Biology; Imipenem; Antibiotic resistance; Antibiotics; Bacteria; Biochemistry; Genetics","score_opus":0.020420994014872736,"score_gpt":0.3101739363660325,"score_spread":0.2897529423511598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402036755","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019925702,0.9979518,0.00019509468,0.00022225398,0.0002618732,0.000008776904,0.000033967746,0.0000108004515,0.0011161377],"genre_scores_gemma":[0.0013255456,0.99655104,0.0004196016,0.0002970547,0.00019336965,0.0000128853535,0.00007506423,0.0000023902728,0.0011230455],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998877,0.00001719969,0.000016422739,0.000020613074,0.00004401605,0.000014066377],"domain_scores_gemma":[0.99985695,0.00006262699,0.000023788165,0.0000046821933,0.00003484992,0.000017019387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034878028,0.0008171783,0.0010676276,0.0011838683,0.0001475613,0.0006163421,0.00066020014,0.0006259985,0.0028346719],"category_scores_gemma":[0.00053248403,0.0001767566,0.00035106824,0.0012345392,0.00024771257,0.0006208251,0.00034041636,0.0017590367,0.0016454699],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001928476,0.000078291545,0.00009064957,0.0069648125,0.000090934875,0.00015554104,0.00001507214,0.00023949718,0.0020862627,0.0014714868,0.030246917,0.9583677],"study_design_scores_gemma":[0.000103485356,0.00019922173,0.0007430162,0.0016905996,0.00020620108,0.0013635814,0.000018555582,0.00014779452,0.0012009155,0.0006522698,0.9936586,0.000015694366],"about_ca_topic_score_codex":0.0009541451,"about_ca_topic_score_gemma":0.002175046,"teacher_disagreement_score":0.0028346719,"about_ca_system_score_codex":0.00045846056,"about_ca_system_score_gemma":0.0006280545,"threshold_uncertainty_score":0.00948292},"labels":[],"label_agreement":null},{"id":"W4404312631","doi":"10.1007/s40265-024-02111-7","title":"The Utilization of the Accelerated Approval Pathway in Oncology: A Case Study of Pembrolizumab","year":2024,"lang":"en","type":"review","venue":"Drugs","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Merck","keywords":"Pembrolizumab; Medicine; Oncology; Internal medicine; Pharmacotherapy; Intensive care medicine; Immunotherapy; Cancer","score_opus":0.12585733132406987,"score_gpt":0.4139733711353599,"score_spread":0.2881160398112901,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404312631","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8326205,0.05389526,0.00862985,0.034673523,0.0006969504,0.0003473138,0.00031717424,0.0001578066,0.06866155],"genre_scores_gemma":[0.9614383,0.020214243,0.0037749582,0.0069634127,0.00061172986,0.0000724263,0.00016442206,0.00009960811,0.0066609136],"study_design_codex":"case_report","study_design_gemma":"not_applicable","domain_scores_codex":[0.99851364,0.0005758844,0.00013687686,0.00014128888,0.00032989698,0.0003024226],"domain_scores_gemma":[0.9973252,0.0012983027,0.0005163877,0.000113348055,0.0002518305,0.0004949466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015461921,0.0005676002,0.0005905784,0.0011555816,0.0031195234,0.0026986417,0.0005915637,0.003511575,0.0028152354],"category_scores_gemma":[0.006849027,0.00036825598,0.0008372411,0.0012640156,0.001410996,0.0020212866,0.0011123498,0.0034665389,0.0008781374],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042129948,0.00074216275,0.03773663,0.0004655209,0.00009804782,0.8646637,0.0062842565,0.0010505016,0.0026362627,0.011710099,0.014790753,0.059400685],"study_design_scores_gemma":[0.000073239105,0.0002657377,0.0114206895,0.00043967884,0.00010006686,0.91001475,0.004441088,0.002293922,0.001618326,0.0024088188,0.06687446,0.000049302173],"about_ca_topic_score_codex":0.0064222305,"about_ca_topic_score_gemma":0.0101462845,"teacher_disagreement_score":0.0064222305,"about_ca_system_score_codex":0.0022724138,"about_ca_system_score_gemma":0.0013707184,"threshold_uncertainty_score":0.016487598},"labels":[],"label_agreement":null},{"id":"W4410076578","doi":"10.1007/s40265-025-02183-z","title":"Differentiating IL-23 Inhibitors in Crohn’s Disease","year":2025,"lang":"en","type":"review","venue":"Drugs","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Western University","funders":"","keywords":"Medicine; Crohn's disease; Pharmacotherapy; Interleukin 23; Crohn disease; Disease; Internal medicine; Immunology; Pharmacology; Gastroenterology; Interleukin 17; Inflammation","score_opus":0.009250379546394055,"score_gpt":0.2783835885818696,"score_spread":0.26913320903547555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410076578","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009210335,0.99853015,0.000119353026,0.00022314377,0.0003298905,0.000004791339,0.000022544134,0.000008255276,0.0006697311],"genre_scores_gemma":[0.00073409046,0.997285,0.00026083936,0.0004316436,0.00039282843,0.000012206334,0.000047632522,0.0000031590228,0.00083258946],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99978954,0.000043755357,0.000031615535,0.000031803935,0.00007824308,0.00002516599],"domain_scores_gemma":[0.9996259,0.00019607329,0.000060025297,0.0000105006175,0.00006819274,0.000039210696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007936868,0.0012548066,0.001909576,0.0016587401,0.00019116464,0.001114675,0.00092489395,0.0011389989,0.0035947263],"category_scores_gemma":[0.0009603369,0.00033305486,0.0006145466,0.0015905676,0.00048383197,0.0010461047,0.0006480514,0.0034241811,0.002449269],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030255652,0.00011077391,0.00010860991,0.010219356,0.00012801684,0.00015923462,0.000025861527,0.00046911355,0.0014251174,0.00271208,0.043421175,0.94091815],"study_design_scores_gemma":[0.00021195515,0.00026640052,0.0006214695,0.0030544063,0.00027712793,0.00077879004,0.00002738007,0.00017928406,0.0005913407,0.001732171,0.992239,0.000020772726],"about_ca_topic_score_codex":0.0007971108,"about_ca_topic_score_gemma":0.0022382352,"teacher_disagreement_score":0.0035947263,"about_ca_system_score_codex":0.00055768574,"about_ca_system_score_gemma":0.0006619195,"threshold_uncertainty_score":0.012025535},"labels":[],"label_agreement":null},{"id":"W4412492425","doi":"10.1007/s40265-025-02204-x","title":"Managing Pain in Fibromyalgia: Current and Future Options","year":2025,"lang":"en","type":"review","venue":"Drugs","topic":"Fibromyalgia and Chronic Fatigue Syndrome Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal General Hospital; Sinai Health System; University of Toronto; University Health Network; Toronto General Hospital; Women's College Hospital","funders":"","keywords":"Medicine; Pregabalin; Gabapentin; Fibromyalgia; Duloxetine; Analgesic; Psychological intervention; Neuromodulation; Chronic pain; Pharmacotherapy; Intensive care medicine; Anesthesia; Psychiatry; Internal medicine; Alternative medicine","score_opus":0.025462753940830356,"score_gpt":0.35072953547389324,"score_spread":0.3252667815330629,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412492425","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003290679,0.99935967,0.000037043963,0.00020373131,0.00011253108,0.0000033642734,0.000008411001,0.0000030324252,0.00023928846],"genre_scores_gemma":[0.00029746848,0.9988857,0.00014175974,0.0002985775,0.00017712162,0.000005766225,0.000012986212,7.0828884e-7,0.00017999909],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996836,0.00007600151,0.000056591187,0.00004606108,0.000104182465,0.00003357435],"domain_scores_gemma":[0.99913955,0.00051167497,0.00013206486,0.000014762035,0.00014315886,0.000058691912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011633487,0.0010939555,0.0028931429,0.0021118643,0.0003155879,0.0016867089,0.0011083342,0.0016951915,0.006989646],"category_scores_gemma":[0.0013558838,0.00038917438,0.0010838779,0.0021600947,0.00058299804,0.0021149886,0.000894955,0.0029117325,0.0016837198],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023992849,0.00012566551,0.00016384592,0.047242302,0.00025966315,0.00014727,0.00006584902,0.00029514017,0.00074241654,0.0019495058,0.026880821,0.9218876],"study_design_scores_gemma":[0.00029604216,0.0003843344,0.0016018951,0.034852624,0.0011672577,0.0013418541,0.00019786065,0.0003151034,0.00020521031,0.0030830156,0.956498,0.000056796143],"about_ca_topic_score_codex":0.0017214818,"about_ca_topic_score_gemma":0.0055690007,"teacher_disagreement_score":0.006989646,"about_ca_system_score_codex":0.0006749086,"about_ca_system_score_gemma":0.001514348,"threshold_uncertainty_score":0.023382723},"labels":[],"label_agreement":null},{"id":"W4413112966","doi":"10.1007/s40265-025-02201-0","title":"Clinical Use of Once-Weekly Insulin Icodec: Translating Clinical Trial Data into Practical Guidance for Diabetes Management","year":2025,"lang":"en","type":"review","venue":"Drugs","topic":"Diabetes Management and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"Novo Nordisk","keywords":"Medicine; Insulin; Clinical trial; Basal insulin; Intensive care medicine; Type 2 diabetes; Clinical Practice; Diabetes mellitus; Diabetes management; Family medicine; Internal medicine; Endocrinology","score_opus":0.4631296135121979,"score_gpt":0.5785854293964696,"score_spread":0.11545581588427173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413112966","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022689803,0.5886287,0.042409267,0.2920954,0.023136636,0.0055159605,0.004971587,0.0016135884,0.03935981],"genre_scores_gemma":[0.033152174,0.54225975,0.20789601,0.16613093,0.023793712,0.011475511,0.006100139,0.0013858876,0.0078057735],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.8197048,0.1227565,0.028719207,0.005195504,0.021904714,0.0017192278],"domain_scores_gemma":[0.4822213,0.3497279,0.044445597,0.015738072,0.09794462,0.00992245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.18746011,0.0017653148,0.0056461715,0.0046946546,0.0011961665,0.015145167,0.0057975776,0.00908654,0.011009349],"category_scores_gemma":[0.43049648,0.0014042545,0.005793349,0.0051600956,0.0026963546,0.009290857,0.0050955694,0.012080793,0.008464284],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012088389,0.0001668025,0.0012051491,0.026537644,0.00088061305,0.00016742054,0.00069626234,0.0007730749,0.0005615287,0.008892321,0.23322485,0.7256854],"study_design_scores_gemma":[0.0023816715,0.0013008049,0.0036933387,0.17423432,0.0026182425,0.000389784,0.0005450871,0.0021139686,0.00089720835,0.026770651,0.78476423,0.00029070614],"about_ca_topic_score_codex":0.005707655,"about_ca_topic_score_gemma":0.010014417,"teacher_disagreement_score":0.18746011,"about_ca_system_score_codex":0.005493876,"about_ca_system_score_gemma":0.025971698,"threshold_uncertainty_score":0.99139565},"labels":[],"label_agreement":null},{"id":"W4414195667","doi":"10.1007/s40265-025-02223-8","title":"Update on Medical Treatment of Cushing’s Syndrome","year":2025,"lang":"en","type":"review","venue":"Drugs","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Pharmacotherapy; Somatostatin; Disease; Medical treatment; Adverse effect; Medical therapy; Etiology; Glucocorticoid","score_opus":0.024887513794131233,"score_gpt":0.34590200606276056,"score_spread":0.3210144922686293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414195667","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012391448,0.9963934,0.000076628734,0.00044622974,0.00076619344,0.000008218668,0.000056187386,0.0000107446485,0.0021185342],"genre_scores_gemma":[0.00048884505,0.9973748,0.0001646081,0.000534564,0.00045703916,0.0000074373233,0.00008977754,0.0000022276145,0.00088063173],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99975556,0.000047768015,0.000049251303,0.000033902747,0.000092098446,0.000021401596],"domain_scores_gemma":[0.99943715,0.00029602202,0.000077220335,0.000012268565,0.00013992508,0.00003749612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047695872,0.00070992846,0.0010547533,0.0024659177,0.000282867,0.00095930585,0.0008799181,0.0010310344,0.009982392],"category_scores_gemma":[0.0011693966,0.00024053095,0.00080459367,0.0017691954,0.00024822747,0.0011174515,0.0005526298,0.0019108178,0.003124284],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000105116604,0.000078941695,0.00013092643,0.031080035,0.0001288729,0.00024296768,0.00006773053,0.00024438827,0.00085344806,0.0023313821,0.08498943,0.8797468],"study_design_scores_gemma":[0.000020418398,0.00007063415,0.00046685146,0.0069144084,0.00017008056,0.0010214405,0.000028172899,0.000049352646,0.00013185026,0.0007282533,0.99038774,0.000010859653],"about_ca_topic_score_codex":0.0012028086,"about_ca_topic_score_gemma":0.0026836505,"teacher_disagreement_score":0.009982392,"about_ca_system_score_codex":0.00055189314,"about_ca_system_score_gemma":0.0010550839,"threshold_uncertainty_score":0.033394396},"labels":[],"label_agreement":null},{"id":"W4417078467","doi":"10.1007/s40265-025-02263-0","title":"Safety and Tolerability of Glucagon-Like Peptide-1 Receptor Agonists: A State-of-the-Art Narrative Review","year":2025,"lang":"en","type":"article","venue":"Drugs","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; St. Boniface Hospital","funders":"","keywords":"Tolerability; Discontinuation; Adverse effect; Pharmacovigilance; Clinical trial; Randomized controlled trial; Narrative review; Acute kidney injury","score_opus":0.006647036455436086,"score_gpt":0.26435928212973053,"score_spread":0.25771224567429446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417078467","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029031874,0.99850875,0.00008981509,0.00055076554,0.00008810816,0.000010172875,0.00008703317,0.0000027439887,0.0003723696],"genre_scores_gemma":[0.0042728484,0.99419075,0.00018132936,0.0008407196,0.00030374163,0.000020372838,0.0001050399,0.0000023361974,0.00008287703],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981285,0.0005706083,0.00066623895,0.00021419085,0.0003545536,0.00006594495],"domain_scores_gemma":[0.9840687,0.012630509,0.0022004913,0.00013889135,0.00084535254,0.0001160536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043117986,0.00058683695,0.0032128904,0.0013193858,0.00021818007,0.0023310094,0.0010480279,0.0013077367,0.0035236878],"category_scores_gemma":[0.011738668,0.00031397186,0.0019266375,0.001740587,0.0005688643,0.0017557172,0.00067632674,0.0016877556,0.0006061756],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013517073,0.000077991164,0.0013026742,0.1710269,0.0020774603,0.0002808199,0.00016961143,0.00048104837,0.00093170576,0.0025870106,0.019638408,0.80007464],"study_design_scores_gemma":[0.00062076637,0.0017017241,0.0089658825,0.23413558,0.01733226,0.0045183944,0.0007166668,0.0005137601,0.0016953807,0.006378876,0.72324973,0.00017092131],"about_ca_topic_score_codex":0.0007821725,"about_ca_topic_score_gemma":0.0017865119,"teacher_disagreement_score":0.0043117986,"about_ca_system_score_codex":0.0006749745,"about_ca_system_score_gemma":0.0019330602,"threshold_uncertainty_score":0.022803247},"labels":[],"label_agreement":null},{"id":"W58682306","doi":"10.2165/00003495-200464050-00002","title":"Treatment of HIV Infection in Pregnant Women","year":2004,"lang":"en","type":"review","venue":"Drugs","topic":"HIV/AIDS Research and Interventions","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; McGill University; University of Toronto; Montreal General Hospital","funders":"","keywords":"Zidovudine; Medicine; Nevirapine; Lamivudine; Regimen; Pregnancy; Viral load; Clinical trial; Pharmacotherapy; Obstetrics; Pediatrics; Immunology; Internal medicine; Antiretroviral therapy; Human immunodeficiency virus (HIV); Viral disease","score_opus":0.04148333842112486,"score_gpt":0.38624661947773914,"score_spread":0.3447632810566143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W58682306","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013527967,0.9994248,0.000023220602,0.00007374265,0.000045506808,0.000007050225,0.000010798243,0.0000021055782,0.00027745808],"genre_scores_gemma":[0.0012533332,0.99837434,0.00011244319,0.0001087004,0.000030239986,0.0000069989787,0.000011264523,4.7491082e-7,0.00010216689],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99966,0.00012256221,0.00006724789,0.000038004735,0.00008996248,0.000022255788],"domain_scores_gemma":[0.9991105,0.000648551,0.0001425603,0.000011694353,0.00005935417,0.000027321816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007456143,0.0007406732,0.0021088668,0.0020254818,0.000214703,0.0007683076,0.000945175,0.0010695292,0.0034190235],"category_scores_gemma":[0.0021003825,0.0003039229,0.0010250492,0.0018891906,0.00035487552,0.0006053887,0.00036582796,0.001168429,0.00040192905],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028192214,0.00010742254,0.0002771189,0.10484145,0.00053322257,0.0002133217,0.00009263334,0.00019660102,0.00048823768,0.00083118427,0.0103382245,0.8817987],"study_design_scores_gemma":[0.001104061,0.0011001113,0.008954963,0.19443794,0.008434802,0.005213977,0.0005562917,0.00033617284,0.0012574837,0.0017896974,0.7767445,0.0000701017],"about_ca_topic_score_codex":0.004140068,"about_ca_topic_score_gemma":0.010277542,"teacher_disagreement_score":0.004140068,"about_ca_system_score_codex":0.00060565735,"about_ca_system_score_gemma":0.0012740963,"threshold_uncertainty_score":0.011437714},"labels":[],"label_agreement":null},{"id":"W7506166","doi":"10.2165/00003495-199300461-00044","title":"A Thesis in Two Parts: Estimating Willingness-to-Pay for Cellulosic Wood Ethanol and Examining the Social Costs of Hydroelectric Production in Quebec, Canada","year":2012,"lang":"en","type":"article","venue":"Drugs","topic":"Forest Management and Policy","field":"Environmental Science","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cellulosic ethanol; Production (economics); Hydroelectricity; Willingness to pay; Natural resource economics; Economics; Environmental science; Microeconomics; Engineering","score_opus":0.012770651477598994,"score_gpt":0.25180264966272503,"score_spread":0.23903199818512605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7506166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9805235,0.0017048726,0.0013670324,0.004971855,0.00006470575,0.00025407772,0.00423171,0.000015644595,0.0068665138],"genre_scores_gemma":[0.9882401,0.00086814514,0.0018506815,0.00046689942,0.000027275759,0.000088673325,0.0014168586,0.000010548767,0.007030705],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993674,0.0002022157,0.00003080034,0.000088542234,0.00011096452,0.00020012034],"domain_scores_gemma":[0.9980185,0.00093694945,0.00018289231,0.000058738766,0.00044115167,0.0003618149],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013945949,0.00040594628,0.00039751575,0.00087365194,0.0014326689,0.0013584392,0.0010658401,0.0007026487,0.0058323415],"category_scores_gemma":[0.0053873854,0.0002636118,0.0006415986,0.0014189151,0.00057554076,0.0002929589,0.00035497636,0.00055781467,0.00032100597],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005298665,0.00046397166,0.89605355,0.00018295113,0.0003345948,0.00034610552,0.0014248582,0.021284718,0.0005389966,0.002951578,0.019732967,0.05615574],"study_design_scores_gemma":[0.000120744364,0.00025850537,0.9521545,0.00021515979,0.00011391786,0.0001536486,0.0068979654,0.02977379,0.00052926753,0.00066534476,0.009026336,0.00009086716],"about_ca_topic_score_codex":0.9862889,"about_ca_topic_score_gemma":0.98683286,"teacher_disagreement_score":0.03762958,"about_ca_system_score_codex":0.03762958,"about_ca_system_score_gemma":0.019028563,"threshold_uncertainty_score":0.27302295},"labels":[],"label_agreement":null},{"id":"W78203264","doi":"10.2165/10898570-000000000-00000","title":"Pharmacotherapy for Prevention and Treatment of Acute Respiratory Distress Syndrome","year":2010,"lang":"en","type":"review","venue":"Drugs","topic":"Respiratory Support and Mechanisms","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Joseph's Health Centre; London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; ARDS; Intensive care medicine; Pharmacotherapy; Population; Surfactant therapy; Internal medicine; Lung","score_opus":0.061052418248277084,"score_gpt":0.4031176273432675,"score_spread":0.34206520909499044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W78203264","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009190757,0.9990023,0.00011085429,0.000102429934,0.00012723358,0.000008705954,0.000018493925,0.000006517729,0.0005316281],"genre_scores_gemma":[0.0006307527,0.9983882,0.0003019581,0.00014794503,0.00014730064,0.000009165425,0.000026779226,0.0000013417812,0.00034659426],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997787,0.000039163315,0.000049235678,0.0000353548,0.00008090802,0.000016651904],"domain_scores_gemma":[0.99950635,0.0002529152,0.00010194588,0.000012174027,0.00010104387,0.00002552697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049560564,0.001090393,0.0024738242,0.002456519,0.00024121923,0.0007313761,0.00096629525,0.00096254406,0.003713549],"category_scores_gemma":[0.0009444683,0.00032775456,0.0007431439,0.002108626,0.00036746604,0.0008749194,0.00054082955,0.001864981,0.0015797926],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012947945,0.00014589886,0.00015206613,0.026267387,0.00027059225,0.00014367196,0.00003057057,0.00028112496,0.0011845356,0.0009783097,0.018137962,0.9522784],"study_design_scores_gemma":[0.00024262386,0.00041349363,0.0031503337,0.015814563,0.0013731925,0.0023486943,0.0000862128,0.00034804447,0.0009421726,0.0016793287,0.9735487,0.000052550717],"about_ca_topic_score_codex":0.0017133126,"about_ca_topic_score_gemma":0.0036395781,"teacher_disagreement_score":0.003713549,"about_ca_system_score_codex":0.0004147512,"about_ca_system_score_gemma":0.0009560575,"threshold_uncertainty_score":0.0124230385},"labels":[],"label_agreement":null},{"id":"W82875543","doi":"10.2165/00003495-200262010-00002","title":"A Critical Review of the Fluoroquinolones","year":2002,"lang":"en","type":"review","venue":"Drugs","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":347,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Manitoba","funders":"","keywords":"Trovafloxacin; Gatifloxacin; Sparfloxacin; Medicine; Moxifloxacin; Chronic bronchitis; Levofloxacin; Lomefloxacin; Gemifloxacin; Ciprofloxacin; Pharmacology; Microbiology; Internal medicine; Antibiotics; Ofloxacin","score_opus":0.07449077231715541,"score_gpt":0.39260944605442294,"score_spread":0.31811867373726754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W82875543","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003795155,0.99898106,0.00005399438,0.00020770334,0.0004095298,0.0000037139123,0.000011978211,0.000002652341,0.00029140522],"genre_scores_gemma":[0.00022204917,0.99853754,0.00017271534,0.00029911115,0.0004613281,0.000005686616,0.000020343048,8.027973e-7,0.00028039975],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995041,0.00009886491,0.00013254983,0.00006312671,0.00017212887,0.000029220148],"domain_scores_gemma":[0.9986708,0.0006607659,0.0001949649,0.000026174404,0.00037382726,0.000073386516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011639734,0.001360759,0.0027181958,0.003985117,0.00035663694,0.0013769437,0.0012134094,0.0015472922,0.004041861],"category_scores_gemma":[0.002160987,0.00040481344,0.00082146766,0.0041131275,0.0005402669,0.0018707989,0.000645652,0.0016709347,0.0016348088],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019661161,0.00007846578,0.00018892722,0.045750774,0.00018417553,0.0004802914,0.000065315915,0.00023620251,0.0011415354,0.0015461773,0.08605316,0.86407834],"study_design_scores_gemma":[0.00004758758,0.00012268487,0.00086012954,0.011995151,0.0003417519,0.0022000151,0.00006609232,0.00007256156,0.000336953,0.0007680216,0.9831654,0.000023633347],"about_ca_topic_score_codex":0.00221924,"about_ca_topic_score_gemma":0.0047273817,"teacher_disagreement_score":0.004041861,"about_ca_system_score_codex":0.0010705562,"about_ca_system_score_gemma":0.0023525422,"threshold_uncertainty_score":0.013521314},"labels":[],"label_agreement":null},{"id":"W889155653","doi":"10.2165/00003495-200565050-00001","title":"Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease","year":2005,"lang":"en","type":"review","venue":"Drugs","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Fluticasone propionate; COPD; Exacerbation; Budesonide; Corticosteroid; Placebo; Adverse effect; Population; Oxygen therapy; Formoterol; Pharmacotherapy; Fluticasone; Internal medicine; Salmeterol; Intensive care medicine","score_opus":0.03199389125043568,"score_gpt":0.34635533678960156,"score_spread":0.3143614455391659,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W889155653","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000054589582,0.9992791,0.000035983132,0.00007902866,0.0001406379,0.000006516539,0.000014014618,0.0000030631868,0.0003871262],"genre_scores_gemma":[0.00041211816,0.9988167,0.00014302842,0.00016993213,0.00011757728,0.000007407762,0.000019398132,6.490782e-7,0.00031322739],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9995931,0.00007202544,0.00008748112,0.000050570547,0.00016787529,0.000028972698],"domain_scores_gemma":[0.9994412,0.00030044297,0.00013355835,0.000013037586,0.000083048246,0.00002875147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008820263,0.0011086965,0.0027915225,0.0029067541,0.0003216585,0.0011596594,0.0009616566,0.0012722386,0.0040838476],"category_scores_gemma":[0.0012125785,0.00040077665,0.0010853383,0.0036317604,0.00042693902,0.0009895033,0.0006464922,0.0017591604,0.0012631015],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015033118,0.00007904517,0.00030454766,0.058111504,0.0003727189,0.00023172171,0.000045597735,0.00026604344,0.00082698005,0.0010426199,0.025849659,0.91271925],"study_design_scores_gemma":[0.00022212641,0.00025048715,0.00347408,0.037623223,0.0023397692,0.0017782684,0.00012682407,0.00014791927,0.00049637107,0.0013220508,0.9521868,0.000032045053],"about_ca_topic_score_codex":0.0036406242,"about_ca_topic_score_gemma":0.0097438535,"teacher_disagreement_score":0.0040838476,"about_ca_system_score_codex":0.0007593948,"about_ca_system_score_gemma":0.0014780943,"threshold_uncertainty_score":0.013661802},"labels":[],"label_agreement":null},{"id":"W9182150","doi":"10.2165/00003495-200565010-00002","title":"Management of Bronchopulmonary Dysplasia in Infants","year":2005,"lang":"en","type":"review","venue":"Drugs","topic":"Neonatal Respiratory Health Research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Bronchopulmonary dysplasia; Pediatrics; Cerebral palsy; Dexamethasone; Corticosteroid; Adverse effect; Prednisolone; Methylprednisolone; Intensive care medicine; Anesthesia; Surgery; Pregnancy; Internal medicine; Gestational age; Physical therapy","score_opus":0.06658572619596828,"score_gpt":0.4361662911202804,"score_spread":0.3695805649243121,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W9182150","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000092921226,0.99934953,0.000059455346,0.00011007582,0.0000721859,0.0000037853235,0.000007892151,0.0000035328012,0.00030056504],"genre_scores_gemma":[0.00070023676,0.99866045,0.00018843183,0.00014844787,0.00010861341,0.0000057154375,0.000017797875,8.172083e-7,0.00016952128],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99969375,0.00006981263,0.000065947024,0.00004386928,0.00010558758,0.000021066442],"domain_scores_gemma":[0.9992879,0.00043008864,0.00015398153,0.00001159326,0.00007777311,0.000038618964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068108184,0.0008888346,0.0024900995,0.0025983378,0.00025010473,0.0008214911,0.0011590746,0.0010773466,0.0021302274],"category_scores_gemma":[0.0014242938,0.0002760268,0.0009157032,0.0015806381,0.00037114637,0.0007807639,0.0005267095,0.0013708652,0.00073600793],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011487856,0.000076708944,0.00037137506,0.027072374,0.00024763672,0.0005496808,0.000031892778,0.00022961419,0.0006918128,0.0006550991,0.014148091,0.95581084],"study_design_scores_gemma":[0.00031449873,0.00051632297,0.0054527316,0.036358155,0.0020977054,0.010132302,0.00019323133,0.00029904404,0.0010960986,0.0016271982,0.9418549,0.00005771791],"about_ca_topic_score_codex":0.0015922686,"about_ca_topic_score_gemma":0.0036412214,"teacher_disagreement_score":0.0025983378,"about_ca_system_score_codex":0.00050171703,"about_ca_system_score_gemma":0.0008903251,"threshold_uncertainty_score":0.007126391},"labels":[],"label_agreement":null},{"id":"W948799663","doi":"10.1007/s40265-013-0017-3","title":"HIV Protease Inhibitors in Pregnancy","year":2013,"lang":"en","type":"review","venue":"Drugs","topic":"HIV/AIDS Research and Interventions","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bayer (Canada); Women's College Hospital; University of Toronto","funders":"","keywords":"Ritonavir; Atazanavir; Medicine; Lopinavir; Pregnancy; Darunavir; Saquinavir; Protease inhibitor (pharmacology); Drugs in pregnancy; Pharmacology; Viral load; Intensive care medicine; Internal medicine; Immunology; Human immunodeficiency virus (HIV); Antiretroviral therapy; Fetus; Biology","score_opus":0.04838235867481622,"score_gpt":0.38015915827884783,"score_spread":0.3317767996040316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W948799663","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000052029034,0.9993374,0.00002019347,0.00012524733,0.00006940629,0.000005960532,0.0000135092305,0.0000020371879,0.00037430692],"genre_scores_gemma":[0.0006966323,0.99878246,0.00006612915,0.00017460785,0.000075752105,0.000010583116,0.000012043184,5.193819e-7,0.00018122973],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99955493,0.00014275585,0.00011117518,0.00004436022,0.00010764858,0.000039167997],"domain_scores_gemma":[0.99863285,0.00089384755,0.0003094896,0.000019886249,0.000084784704,0.00005913831],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009789314,0.0010055294,0.0023585933,0.0034860438,0.00028833828,0.0012128345,0.0008164914,0.0012836056,0.008515203],"category_scores_gemma":[0.0028488094,0.0004288179,0.00096855016,0.002966475,0.00051087985,0.0011487331,0.0008467186,0.0018269035,0.0009822994],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002064322,0.00008819735,0.00016130971,0.07932589,0.0004794066,0.0001605667,0.00005683717,0.00018298511,0.00031648998,0.0013832365,0.020604588,0.897034],"study_design_scores_gemma":[0.0005975899,0.00045726504,0.00258639,0.10828259,0.0044652084,0.0025420662,0.00017373351,0.00019673655,0.00062051456,0.001886624,0.8781462,0.00004501732],"about_ca_topic_score_codex":0.0023578003,"about_ca_topic_score_gemma":0.006109509,"teacher_disagreement_score":0.008515203,"about_ca_system_score_codex":0.00085659337,"about_ca_system_score_gemma":0.0023882326,"threshold_uncertainty_score":0.028486192},"labels":[],"label_agreement":null}]}